首页 » 细胞株Cell Lines 87及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

细胞株Cell Lines 87及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

  • 价  格:¥19200
  • 货  号:NTCC-CV87
  • 产  地:北京
点击询问我要采购
 竭诚为您服务!
BioVector NTCC典型培养物保藏中心
联系人:Dr.Xu, Biovector NTCC Inc.点击这里给我发消息

电话:+86-010-53513060. 工作QQ:1843439339

邮件:Biovector@163.com

手机:18901268599

地址:北京

已注册
 

细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心


http://www.biovector.net


ID   SES-MaBr-3

AC   CVCL_Z129

DR   CLO; CLO_0050497

DR   NISES; SK0004

DR   RCB; RCB0276

RX   CelloPub=CLPUB00372;

RX   DOI=10.1303/aez.20.496;

RX   PubMed=1367489;

WW   http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275016

CC   Group: Insect cell line.

OX   NCBI_TaxID=55057; ! Mamestra brassicae

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SES-MaBr-4

AC   CVCL_Z130

DR   CLO; CLO_0050500

DR   NISES; SK0007

DR   RCB; RCB0404

RX   CelloPub=CLPUB00372;

RX   DOI=10.1303/aez.20.496;

RX   PubMed=1367489;

WW   http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275017

CC   Group: Insect cell line.

OX   NCBI_TaxID=55057; ! Mamestra brassicae

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SES-MaBr-5

AC   CVCL_Z131

DR   CLO; CLO_0050498

DR   NISES; SK0011

DR   RCB; RCB0429

RX   CelloPub=CLPUB00372;

RX   DOI=10.1303/aez.20.496;

WW   http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275018

CC   Group: Insect cell line.

OX   NCBI_TaxID=55057; ! Mamestra brassicae

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SESX

AC   CVCL_M778

DR   Cosmic; 922394

RX   PubMed=3491924;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SET-2

AC   CVCL_2187

SY   Set-2; Set2; SET2

DR   BTO; BTO:0004766

DR   EFO; EFO_0006486

DR   BioSample; SAMN03473274

DR   CCLE; SET2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 1012054

DR   Cosmic; 1519162

DR   Cosmic; 1633513

DR   Cosmic; 1943610

DR   Cosmic; 2306995

DR   Cosmic-CLP; 1659820

DR   DSMZ; ACC-608

DR   GDSC; 1659820

DR   GEO; GSM887564

DR   GEO; GSM888647

DR   GEO; GSM1374868

RX   PubMed=10637490;

RX   PubMed=16408098;

RX   PubMed=22460905;

RX   PubMed=25485619;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~60-80 hours (DSMZ).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): DSMZ; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 8,10

ST   D16S539: 9,10

ST   D18S51: 13,16

ST   D21S11: 30

ST   D3S1358: 14,16

ST   D5S818: 11

ST   D7S820: 10,12

ST   D8S1179: 13,14

ST   FGA: 19,23

ST   Penta D: 11

ST   Penta E: 16,20

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 14,17

DI   NCIt; C7965; Adult acute megakaryoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SEWA

AC   CVCL_2188

DR   DSMZ; ACC-523

CC   Doubling time: ~28 hours (DSMZ).

CC   Breed/subspecies: A.SW.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Cancer cell line

//

ID   SEWA-CL-3

AC   CVCL_1N79

SY   SEWA 1Rclone3:4R; SEWA1Rclone3:4R; Clone 3:4

RX   PubMed=7129936;

CC   Breed/subspecies: A.SW.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2188 ! SEWA

SX   Male

CA   Cancer cell line

//

ID   SEWA/Rec4

AC   CVCL_4Y75

SY   SEWA1Rrec4; SEWA1Rrec4R; Rec4; Rec 4

RX   PubMed=7129936;

CC   Breed/subspecies: A.SW.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2188 ! SEWA

SX   Male

CA   Cancer cell line

//

ID   SEWA/Rec4TC1

AC   CVCL_6C61

SY   Rec4TC1

RX   PubMed=3078951;

CC   Breed/subspecies: A.SW.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4Y75 ! SEWA/Rec4

SX   Male

CA   Cancer cell line

//

ID   SEWA/TC13

AC   CVCL_4Y76

SY   SEWA1RTC13R; TC13

RX   PubMed=7129936;

CC   Breed/subspecies: A.SW.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2188 ! SEWA

SX   Male

CA   Cancer cell line

//

ID   SEWA/TC13MTXr10

AC   CVCL_4Y77

SY   TC13MTXr10

RX   PubMed=6668215;

RX   PubMed=7129936;

CC   Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).

CC   Breed/subspecies: A.SW.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4Y76 ! SEWA/TC13

SX   Male

CA   Cancer cell line

//

ID   Sez 627

AC   CVCL_5364

SY   SEZ 627; Sez627; SEZ627; Sez.627

RX   PubMed=3023492;

RX   PubMed=3263317;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=Sez627

CC   Characteristics: IL2 dependent.

DI   NCIt; C3467; Cutaneous T-cell non-Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Sez-4

AC   CVCL_8330

SY   Sez 4; SeZ4; SZ-4

RX   PubMed=1987293;

RX   PubMed=11021758;

RX   PubMed=11737246;

DI   NCIt; C9265; Mycosis fungoides and Sezary syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SF [Human fibroblast]

AC   CVCL_4790

CC   Miscellaneous: Fibroblast-like foreskin cell line that was distributed by Viromed.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   SF [Seabass]

AC   CVCL_S008

SY   Seabass Fry

RX   DOI=10.1016/S0044-8486(00)00465-8;

CC   Group: Fish cell line.

OX   NCBI_TaxID=8187; ! Lates calcarifer

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   Sf 1 Ep

AC   CVCL_3795

SY   Sf1Ep; sf1Ep; Sf 1Ep; Sf 1 Ep (NBL-11); NBL-11; CTEp

DR   CLO; CLO_0008983

DR   CLO; CLO_0008986

DR   CLDB; cl4275

DR   CLDB; cl4276

DR   ATCC; CCL-68

DR   ATCC; CRL-6502

DR   ECACC; 90092702

DR   IZSLER; BS CL 78

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

OX   NCBI_TaxID=9988; ! Sylvilagus floridanus

SX   Male

CA   Finite cell line

//

ID   SF 181

AC   CVCL_D682

DR   BCRJ; 0220

ST   Source(s): BCRJ

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11,12

ST   D16S539: 13

ST   D18S51: 13

ST   D19S433: 14

ST   D21S11: 28,31

ST   D2S1338: 19,20

ST   D3S1358: 15

ST   D5S818: 10,13

ST   D7S820: 10,11

ST   D8S1179: 13

ST   FGA: 20,24

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C67383; Epidermolysis bullosa

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   Sf-9ET

AC   CVCL_1D71

SY   SF-9ET; Sf-9 Easy Titer; Sf9-ET; Sf9-Easy Titer; Sf9 Easy Titer

RX   PubMed=19852765;

WW   http://www.ott.nih.gov/erma/development-sf-9et-easy-titer-inset-determining-baculovirus-titers

CC   Group: Insect cell line.

CC   Group: Recombinant protein production insect cell line.

CC   Transfected with: UniProtKB; P42212; GFP.

OX   NCBI_TaxID=7108; ! Spodoptera frugiperda

HI   CVCL_0549 ! Sf9

SX   Female

CA   Spontaneously immortalized cell line

//

ID   SF-CMTI-2

AC   CVCL_HE69

DR   Millipore; SF-CMTI-2

CC   Characteristics: Pre-adapted to serum-free and feeder-free cell culture conditions and is intended for use with the ESGRO cell culture system.

CC   Breed/subspecies: C57BL/6.Cg-Thy1<a>.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_K037 ! Bruce-4

SX   Male

CA   Embryonic stem cell

//

ID   SF-TY

AC   CVCL_3163

DR   BioSample; SAMN03471063

DR   JCRB; JCRB0075

DR   JCRB; NIHS0016

CC   Discontinued: JCRB; NIHS0016; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8,12

ST   D16S539: 9,11

ST   D5S818: 11

ST   D7S820: 11

ST   TH01: 8,9

ST   TPOX: 8,11

ST   vWA: 16,17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   SF-xL

AC   CVCL_D590

SY   SFxl

DR   BTO; BTO:0005311

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SF1-1

AC   CVCL_Y495

SY   ESHyb

DR   EFO; EFO_0003972

RX   PubMed=9584126;

CC   Breed/subspecies: C57BL/6 x CBA/Ca.

OX   NCBI_TaxID=186842; ! Mus musculus x Mus spretus

SX   Male

CA   Embryonic stem cell

//

ID   SF1-1.1.10

AC   CVCL_G147

DR   CLO; CLO_0008984

DR   ATCC; HB-159

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   SF1-3

AC   CVCL_Y496

RX   PubMed=9584126;

CC   Breed/subspecies: C57BL/6 x CBA/Ca.

OX   NCBI_TaxID=186842; ! Mus musculus x Mus spretus

SX   Male

CA   Embryonic stem cell

//

ID   SF1-8

AC   CVCL_Y497

RX   PubMed=9584126;

CC   Breed/subspecies: C57BL/6 x CBA/Ca.

OX   NCBI_TaxID=186842; ! Mus musculus x Mus spretus

SX   Male

CA   Embryonic stem cell

//

ID   SF1-G

AC   CVCL_Y498

RX   PubMed=9584126;

CC   Breed/subspecies: C57BL/6 x CBA/Ca.

OX   NCBI_TaxID=186842; ! Mus musculus x Mus spretus

SX   Female

CA   Embryonic stem cell

//

ID   SF126

AC   CVCL_1688

SY   SF-126; SF 126

DR   EFO; EFO_0005450

DR   BioSample; SAMN03472774

DR   CCLE; SF126_CENTRAL_NERVOUS_SYSTEM

DR   CCRID; 3111C0001CCC000049

DR   CGH-DB; 153-1

DR   ChEMBL-Cells; CHEMBL3307444

DR   ChEMBL-Targets; CHEMBL614905

DR   Cosmic; 909712

DR   Cosmic; 1175814

DR   Cosmic; 1217678

DR   Cosmic; 2367543

DR   Cosmic; 2516033

DR   Cosmic-CLP; 909712

DR   GDSC; 909712

DR   GEO; GSM887565

DR   GEO; GSM888648

DR   GEO; GSM1670416

DR   IFO; IFO50286

DR   KCB; KCB 200818YJ

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=2829496;

RX   PubMed=3708752;

RX   PubMed=16232199;

RX   PubMed=22460905;

RX   PubMed=25984343;

RX   PubMed=27397505;

WW   https://btrctissuecore.ucsf.edu/tbank/Cell_Line%20Notice.html

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=62

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 35 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 9,12

ST   D5S818: 11

ST   D7S820: 8,10

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 14,17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Sf158

AC   CVCL_2074

SY   SF158; Sf-158; SF-158; SF 158; Sf 158

DR   CLO; CLO_0008985

DR   DSMZ; ACC-292

RX   PubMed=2159542;

CC   Group: Insect cell line.

CC   Group: Recombinant protein production insect cell line.

CC   Doubling time: ~70 hours (DSMZ).

OX   NCBI_TaxID=7108; ! Spodoptera frugiperda

HI   CVCL_0518 ! Sf21

SX   Female

CA   Spontaneously immortalized cell line

//

ID   SF17

AC   CVCL_6947

DR   CCRID; 3111C0001CCC000084

DI   NCIt; C3262; Neoplasm

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SF172

AC   CVCL_V613

SY   SF-172

DR   CCLE; SF172_CENTRAL_NERVOUS_SYSTEM

DR   Cosmic; 2516034

RX   PubMed=25984343;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 24 hours (PubMed=25984343).

CC   Omics: shRNA library screening.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SF188

AC   CVCL_6948

SY   SF-188; SF 188

DR   BTO; BTO:0002824

DR   ChEMBL-Cells; CHEMBL3307445

DR   ChEMBL-Targets; CHEMBL614906

DR   Cosmic; 849884

DR   Cosmic; 1875113

DR   GEO; GSM2197886

DR   GEO; GSM2197887

DR   GEO; GSM2197888

DR   GEO; GSM2197889

DR   GEO; GSM2197890

DR   GEO; GSM2197891

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=2829496;

RX   PubMed=3708752;

RX   PubMed=22570425;

RX   PubMed=19365568;

WW   https://btrctissuecore.ucsf.edu/tbank/Cell_Line%20Notice.html

CC   Doubling time: 26 hours (PubMed=19365568).

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=22570425

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 13

ST   D16S539: 11

ST   D18S51: 17

ST   D21S11: 31

ST   D3S1358: 15,18

ST   D5S818: 11,14

ST   D7S820: 8,10

ST   D8S1179: 13,15

ST   FGA: 22,22.2

ST   Penta D: 14

ST   Penta E: 10,13

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Sf21

AC   CVCL_0518

SY   SF21; Sf-21; SF-21; IPLB-SF-21-AE; IPLB-Sf21-AE; IPLB-SF21-AE; IPLB-SF 21AE; IPLB-Sf21AE; IPLB-SF21AE; IPLB-SF-21; IPLB-Sf-21; IPLB-SF 21; IPLB-Sf21; IPLB-SF21

DR   BTO; BTO:0001196

DR   CLO; CLO_0008987

DR   MCCL; MCC:0000416

DR   CLDB; cl2906

DR   DSMZ; ACC-119

DR   ECACC; 05022801

DR   ECACC; 05030202

DR   KCB; KCB 201008YJ

DR   NCBI_Iran; C503

DR   Wikidata; Q2276068

RX   CelloPub=CLPUB00177;

RX   PubMed=68913;

RX   PubMed=1367489;

RX   PubMed=8314732;

RX   PubMed=8799737;

RX   PubMed=10777062;

RX   PubMed=12623313;

RX   PubMed=15926859;

RX   PubMed=16346059;

RX   PubMed=24672045;

WW   https://en.wikipedia.org/wiki/Sf21

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-382.html

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-385.html

WW   http://www.ars.usda.gov/sp2userfiles/person/3489/sf21.pdf

WW   http://oetltd.com/product/sf21-cells-plaque-assay/

CC   Group: Insect cell line.

CC   Group: Recombinant protein production insect cell line.

CC   Doubling time: 26-30 hours (PubMed=68913); ~3 days (DSMZ); 24 hours (ECACC).

CC   Misspelling: Occasionally 'IPBL-SF-21' or 'IPBL-SF-21AE'.

OX   NCBI_TaxID=7108; ! Spodoptera frugiperda

SX   Female

CA   Spontaneously immortalized cell line

//

ID   SF210

AC   CVCL_M425

SY   SF-210; SF 210

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=2829496;

WW   https://btrctissuecore.ucsf.edu/tbank/Cell_Line%20Notice.html

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SF268

AC   CVCL_1689

SY   SF-268; SF 268

DR   BTO; BTO:0003772

DR   EFO; EFO_0005451

DR   BioSample; SAMN03471159

DR   ChEMBL-Cells; CHEMBL3307499

DR   ChEMBL-Cells; CHEMBL3308689

DR   ChEMBL-Targets; CHEMBL613977

DR   ChEMBL-Targets; CHEMBL614907

DR   ChEMBL-Targets; CHEMBL614936

DR   Cosmic; 687581

DR   Cosmic; 905986

DR   Cosmic; 974239

DR   Cosmic; 1092629

DR   Cosmic; 1175815

DR   Cosmic; 1305358

DR   Cosmic; 1436039

DR   Cosmic; 1998472

DR   Cosmic; 2367544

DR   Cosmic; 2550357

DR   Cosmic-CLP; 905986

DR   GDSC; 905986

DR   GEO; GSM50175

DR   GEO; GSM50239

DR   GEO; GSM750787

DR   GEO; GSM750790

DR   GEO; GSM799323

DR   GEO; GSM799386

DR   GEO; GSM847112

DR   GEO; GSM844680

DR   GEO; GSM844681

DR   GEO; GSM1153392

DR   GEO; GSM1181244

DR   GEO; GSM1181320

DR   GEO; GSM1670417

DR   SKY/M-FISH/CGH; 2819

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=2041050;

RX   PubMed=2829496;

RX   PubMed=17088437;

RX   PubMed=19365568;

RX   PubMed=19372543;

RX   PubMed=22336246;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=59

WW   http://tcpaportal.org/mclp/

CC   Problematic cell line: Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).

CC   Part of: JFCR39 cancer cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Doubling time: 33.1 hours (DTP).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'SP-268' in ChEMBL CHEMBL614936 and CHEMBL3308689.

ST   Source(s): Cosmic-CLP; PubMed=19372543; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 9,13

ST   D18S51: 16

ST   D19S433: 13,15.2

ST   D21S11: 30,32.2

ST   D2S1338: 19,24

ST   D3S1358: 14,16

ST   D5S818: 11

ST   D7S820: 10,11

ST   D8S1179: 14

ST   FGA: 21

ST   Penta D: 9,12

ST   Penta E: 12,14

ST   TH01: 6,9

ST   TPOX: 8,10

ST   vWA: 17,19

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SF295

AC   CVCL_1690

SY   SF-295; SF 295

DR   BTO; BTO:0004213

DR   EFO; EFO_0005452

DR   CCLE; SF295_CENTRAL_NERVOUS_SYSTEM

DR   ChEMBL-Cells; CHEMBL3307738

DR   ChEMBL-Cells; CHEMBL3308690

DR   ChEMBL-Targets; CHEMBL614908

DR   ChEMBL-Targets; CHEMBL614937

DR   Cosmic; 875897

DR   Cosmic; 897438

DR   Cosmic; 905985

DR   Cosmic; 974240

DR   Cosmic; 1044248

DR   Cosmic; 1092630

DR   Cosmic; 1175816

DR   Cosmic; 1305359

DR   Cosmic; 1436040

DR   Cosmic; 1998473

DR   Cosmic; 2367545

DR   Cosmic; 2516035

DR   Cosmic; 2550358

DR   Cosmic-CLP; 905985

DR   GDSC; 905985

DR   GEO; GSM50176

DR   GEO; GSM50240

DR   GEO; GSM750783

DR   GEO; GSM799324

DR   GEO; GSM799387

DR   GEO; GSM847113

DR   GEO; GSM844682

DR   GEO; GSM887566

DR   GEO; GSM888649

DR   GEO; GSM1153393

DR   GEO; GSM1153394

DR   GEO; GSM1181245

DR   GEO; GSM1181260

DR   GEO; GSM1670418

DR   SKY/M-FISH/CGH; 2746

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=2041050;

RX   PubMed=2829496;

RX   PubMed=17088437;

RX   PubMed=19372543;

RX   PubMed=22336246;

RX   PubMed=22460905;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=25984343;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://btrctissuecore.ucsf.edu/tbank/Cell_Line%20Notice.html

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=60

WW   http://www.addexbio.com/productdetail?pid=415

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: JFCR39 cancer cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Doubling time: 27 hours (PubMed=25984343); 29.5 hours (DTP).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'SP-295' in ChEMBL CHEMBL614937 and CHEMBL3308690.

ST   Source(s): Cosmic-CLP; PubMed=19372543

ST   Amelogenin: X

ST   CSF1PO: 10,13

ST   D13S317: 10

ST   D16S539: 12,13

ST   D18S51: 15,18

ST   D19S433: 12,15

ST   D21S11: 28,30

ST   D2S1338: 15,20

ST   D3S1358: 16,18

ST   D5S818: 11,12

ST   D7S820: 9,13

ST   D8S1179: 13,14

ST   FGA: 22,25

ST   TH01: 9.3 (Cosmic-CLP)

ST   TH01: 9.3,10 (PubMed=19372543)

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SF3061

AC   CVCL_5892

SY   SF-3061; SF3061-Parental

DR   BTO; BTO:0004515

RX   PubMed=16554968;

CC   Characteristics: Has a finite life span like most meningioma-derived cell lines.

DI   NCIt; C3230; Meningioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   SF3061-hTERT

AC   CVCL_M426

RX   PubMed=16554968;

CC   Transfected with: HGNC; 11730; TERT.

DI   NCIt; C3230; Meningioma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5892 ! SF3061

CA   Telomerase immortalized cell line

//

ID   SF4068

AC   CVCL_5893

SY   SF-4068; SF4068-Parental

DR   BTO; BTO:0004516

RX   PubMed=16554968;

CC   Characteristics: Has a finite life span like most meningioma-derived cell lines.

DI   NCIt; C3230; Meningioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   SF4068-E6/E7-hTERT

AC   CVCL_M427

RX   PubMed=16554968;

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

DI   NCIt; C3230; Meningioma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5893 ! SF4068

CA   Transformed cell line

//

ID   SF4433

AC   CVCL_5894

SY   SF-4433; SF4433-Parental

DR   BTO; BTO:0004517

RX   PubMed=16554968;

CC   Characteristics: Has a finite life span like most meningioma-derived cell lines.

DI   NCIt; C3230; Meningioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   SF4433-E6/E7-hTERT

AC   CVCL_M428

RX   PubMed=16554968;

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

DI   NCIt; C3230; Meningioma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5894 ! SF4433

CA   Transformed cell line

//

ID   SF539

AC   CVCL_1691

AS   CVCL_F230

SY   SF-539; SF-539 BT; SF 539

DR   BTO; BTO:0004214

DR   EFO; EFO_0005453

DR   BioSample; SAMN03471111

DR   ChEMBL-Cells; CHEMBL3307721

DR   ChEMBL-Targets; CHEMBL614860

DR   Cosmic; 687582

DR   Cosmic; 875893

DR   Cosmic; 905984

DR   Cosmic; 974238

DR   Cosmic; 1092631

DR   Cosmic; 1175817

DR   Cosmic; 1305360

DR   Cosmic; 1312342

DR   Cosmic; 1436041

DR   Cosmic; 1998474

DR   Cosmic; 2367546

DR   Cosmic; 2550359

DR   Cosmic-CLP; 905984

DR   GDSC; 905984

DR   GEO; GSM50177

DR   GEO; GSM50241

DR   GEO; GSM750784

DR   GEO; GSM799325

DR   GEO; GSM799388

DR   GEO; GSM847114

DR   GEO; GSM844683

DR   GEO; GSM844684

DR   GEO; GSM1153395

DR   GEO; GSM1181246

DR   GEO; GSM1181261

DR   GEO; GSM1670419

DR   SKY/M-FISH/CGH; 2744

RX   PubMed=2041050;

RX   PubMed=3019542;

RX   PubMed=17088437;

RX   PubMed=19372543;

RX   PubMed=22336246;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=61

WW   http://tcpaportal.org/mclp/

CC   Part of: JFCR39 cancer cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Doubling time: 35.4 hours (DTP).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; PubMed=19372543; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,11,13 (Cosmic-CLP)

ST   CSF1PO: 11,13 (PubMed=19372543; PubMed=25877200)

ST   D13S317: 12

ST   D16S539: 11,12

ST   D18S51: 20

ST   D19S433: 14

ST   D21S11: 29

ST   D2S1338: 17,23

ST   D3S1358: 15

ST   D5S818: 14

ST   D7S820: 11

ST   D8S1179: 15,17

ST   FGA: 20,21

ST   Penta D: 10

ST   Penta E: 12,15

ST   TH01: 7,8,9 (Cosmic-CLP)

ST   TH01: 7,8 (PubMed=19372543; PubMed=25877200)

ST   TPOX: 9,10

ST   vWA: 16,17

DI   NCIt; C3796; Gliosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SF763

AC   CVCL_6949

SY   SF-763; SF 763

DR   BTO; BTO:0004215

DR   CCRID; 3111C0001CCC000050

DR   Cosmic; 849885

DR   Cosmic; 1175818

DR   Cosmic; 1217677

DR   Cosmic; 2367500

RX   PubMed=22570425;

WW   https://btrctissuecore.ucsf.edu/tbank/Cell_Line%20Notice.html

ST   Source(s): PubMed=22570425

ST   Amelogenin: X

ST   CSF1PO: 9

ST   D13S317: 10,12

ST   D16S539: 10

ST   D18S51: 16

ST   D21S11: 27,30

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 11,12

ST   D8S1179: 13,14

ST   FGA: 22

ST   Penta D: 11,12

ST   Penta E: 5,13

ST   TH01: 9

ST   TPOX: 10,11

ST   vWA: 16,17

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SF767

AC   CVCL_6950

SY   SF-767; SF 767

DR   BTO; BTO:0001557

DR   BioSample; SAMN03151844

DR   CCLE; SF767_CENTRAL_NERVOUS_SYSTEM

DR   CCRID; 3111C0001CCC000051

DR   Cosmic; 849886

DR   Cosmic; 2036688

DR   Cosmic; 2367501

DR   Cosmic; 2516036

RX   PubMed=22570425;

RX   PubMed=25984343;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a ME-180 derivative (PubMed=22570425).

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 29 hours (PubMed=25984343).

CC   Transformant: NCBI_TaxID; 45240; Human papillomavirus type 68 (HPV68).

CC   Omics: shRNA library screening.

ST   Source(s): PubMed=22570425

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11,13

ST   D16S539: 12,13

ST   D18S51: 12

ST   D21S11: 30,31

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 9,10

ST   D8S1179: 14

ST   FGA: 23

ST   Penta D: 9,14

ST   Penta E: 12,14

ST   TH01: 8,9.3

ST   TPOX: 8,10

ST   vWA: 15,17

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1401 ! ME-180

SX   Female

CA   Cancer cell line

//

ID   SF7761

AC   CVCL_IT45

DR   Cosmic; 1925952

DR   GEO; GSM1508943

DR   GEO; GSM1508944

DR   GEO; GSM1508945

DR   GEO; GSM1508946

DR   GEO; GSM1508947

DR   GEO; GSM1508948

DR   GEO; GSM1508951

RX   PubMed=22983601;

RX   PubMed=23603901;

RX   PubMed=25939062;

RX   PubMed=26115193;

CC   Characteristics: Has a H3F3A p.Lys28Met mutation (H3.3K27M).

CC   Omics: CNV analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C94764; Diffuse intrinsic pontine glioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Telomerase immortalized cell line

//

ID   SF8402

AC   CVCL_K062

DR   CLO; CLO_0050657

DR   BioSample; SAMN03472292

DR   RCB; RCB0580

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11,12

ST   D16S539: 9,13

ST   D5S818: 13

ST   D7S820: 8,12

ST   TH01: 7,9

ST   TPOX: 9,11

ST   vWA: 17

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_K066 ! SF8410

SX   Female

CA   Finite cell line

//

ID   SF8404

AC   CVCL_K063

SY   SF A-2; SFA2

DR   CLO; CLO_0050658

DR   BioSample; SAMN03472293

DR   RCB; RCB0582

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 8,11

ST   D16S539: 9,11

ST   D5S818: 10,12

ST   D7S820: 11

ST   TH01: 6,9,9.3

ST   TPOX: 8,11

ST   vWA: 16,17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   SF8405

AC   CVCL_K064

SY   SF A-3; SFA3

DR   CLO; CLO_0050688

DR   BioSample; SAMN03472294

DR   RCB; RCB0583

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10,13

ST   D13S317: 12

ST   D16S539: 11,13

ST   D5S818: 10,13

ST   D7S820: 8,10

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 14,16

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   SF8406

AC   CVCL_K065

SY   SF A-4; SFA4

DR   CLO; CLO_0050659

DR   BioSample; SAMN03472295

DR   RCB; RCB0584

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8,9

ST   D16S539: 11,12

ST   D5S818: 12

ST   D7S820: 9,10

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 14,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   SF8410

AC   CVCL_K066

DR   CLO; CLO_0050678

DR   BioSample; SAMN03472261

DR   RCB; RCB0635

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11,12

ST   D16S539: 9,13

ST   D5S818: 13

ST   D7S820: 8,12

ST   TH01: 7,9

ST   TPOX: 7,9,11

ST   vWA: 17

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_K062 ! SF8402

SX   Female

CA   Finite cell line

//

ID   SF8413

AC   CVCL_K067

SY   SF A-8; SFA8

DR   CLO; CLO_0050677

DR   BioSample; SAMN03472260

DR   RCB; RCB0634

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8,13

ST   D16S539: 10

ST   D5S818: 10,11

ST   D7S820: 9,11

ST   TH01: 6,7

ST   TPOX: 11,13

ST   vWA: 16,17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   SF8414

AC   CVCL_K068

SY   SF B-12; SFB12

DR   CLO; CLO_0050676

DR   BioSample; SAMN03472259

DR   RCB; RCB0633

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 11,13

ST   D16S539: 12,13

ST   D5S818: 11,13

ST   D7S820: 10,11

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 16,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   SF8416

AC   CVCL_K069

SY   SF D2-12; SFD212

DR   CLO; CLO_0050675

DR   BioSample; SAMN03472257

DR   RCB; RCB0631

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10,14

ST   D13S317: 8,11

ST   D16S539: 9,13

ST   D5S818: 10,11,12

ST   D7S820: 8,12

ST   TH01: 7,9,9.3

ST   TPOX: 9

ST   vWA: 14,16,17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   SF8425

AC   CVCL_K070

DR   CLO; CLO_0050674

DR   BioSample; SAMN03472256

DR   RCB; RCB0624

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 9,12

ST   D16S539: 8,10

ST   D5S818: 9,11

ST   D7S820: 12

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 14,16

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_K071 ! SF8428

SX   Female

CA   Finite cell line

//

ID   SF8428

AC   CVCL_K071

DR   CLO; CLO_0050673

DR   BioSample; SAMN03472255

DR   RCB; RCB0621

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,9,12

ST   D16S539: 8,10

ST   D5S818: 9,11

ST   D7S820: 12

ST   TH01: 9,9.3

ST   TPOX: 11

ST   vWA: 14,16

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_K070 ! SF8425

SX   Female

CA   Finite cell line

//

ID   SF8429

AC   CVCL_K072

SY   SF D2-13; SFD213

DR   CLO; CLO_0050672

DR   BioSample; SAMN03472254

DR   RCB; RCB0620

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,10

ST   D16S539: 10

ST   D5S818: 10,12,13

ST   D7S820: 8,13

ST   TH01: 9

ST   TPOX: 8,10

ST   vWA: 14,16,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   SF8433

AC   CVCL_K073

SY   SF D1-2; SFD12

DR   CLO; CLO_0050671

DR   BioSample; SAMN03472253

DR   RCB; RCB0617

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,9

ST   D16S539: 12

ST   D5S818: 12,13

ST   D7S820: 8,12

ST   TH01: 7,9,9.3

ST   TPOX: 8,12

ST   vWA: 18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   SF8536

AC   CVCL_K074

SY   SF C2-7; SFC27

DR   CLO; CLO_0050670

DR   BioSample; SAMN03472252

DR   RCB; RCB0614

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,9

ST   D16S539: 9,12

ST   D5S818: 11,12

ST   D7S820: 10,11

ST   TH01: 7,10

ST   TPOX: 8

ST   vWA: 16,17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   SF8538

AC   CVCL_K075

SY   SF B-11; SFB11

DR   CLO; CLO_0050669

DR   BioSample; SAMN03472251

DR   RCB; RCB0613

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 8,11

ST   D16S539: 10,12

ST   D5S818: 10,12

ST   D7S820: 8,10

ST   TH01: 7,9,9.3

ST   TPOX: 8,11

ST   vWA: 15,16,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   SF8541

AC   CVCL_K076

SY   SF A-10; SFA10

DR   CLO; CLO_0050668

DR   BioSample; SAMN03472250

DR   RCB; RCB0610

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 8,11,12

ST   D16S539: 11,13

ST   D5S818: 11,13

ST   D7S820: 12

ST   TH01: 9,9.3

ST   TPOX: 9,11

ST   vWA: 16,17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   SF8543

AC   CVCL_K077

SY   SF B-14; SFB14

DR   CLO; CLO_0050667

DR   BioSample; SAMN03472249

DR   RCB; RCB0608

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 8,11

ST   D16S539: 9,11

ST   D5S818: 10,11,12

ST   D7S820: 11,12

ST   TH01: 7,9

ST   TPOX: 8

ST   vWA: 16,17,19

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   SF8546

AC   CVCL_K078

SY   SF A-11; SFA11

DR   CLO; CLO_0050693

DR   RCB; RCB0605

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   SF8628

AC   CVCL_IT46

SY   SF-8628

DR   Cosmic; 1925953

DR   GEO; GSE59366

DR   GEO; GSE59496

DR   GEO; GSM1508949

DR   GEO; GSM1508952

RX   PubMed=23603901;

CC   Characteristics: Has a H3F3A p.Lys28Met mutation (H3.3K27M).

CC   Omics: Deep RNAseq analysis.

DI   NCIt; C94764; Diffuse intrinsic pontine glioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SF8647

AC   CVCL_K079

SY   SF D1-5; SFD15

DR   CLO; CLO_0050692

DR   RCB; RCB0604

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   SF8649

AC   CVCL_K080

SY   SF D1-6; SFD16

DR   CLO; CLO_0050666

DR   BioSample; SAMN03472248

DR   RCB; RCB0603

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 8,11

ST   D16S539: 9,10

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   TH01: 9

ST   TPOX: 8,10

ST   vWA: 14

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   SF8650

AC   CVCL_K081

SY   SF D1-7; SFD17

DR   CLO; CLO_0050665

DR   BioSample; SAMN03472246

DR   RCB; RCB0602

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,10

ST   D16S539: 9

ST   D5S818: 10

ST   D7S820: 9,12

ST   TH01: 9

ST   TPOX: 8,9

ST   vWA: 16,19

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   SF8653

AC   CVCL_K082

SY   SF C2-6; SFC26

DR   CLO; CLO_0050716

DR   BioSample; SAMN03472245

DR   RCB; RCB0600

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11,12

ST   D16S539: 10,12

ST   D5S818: 13

ST   D7S820: 8

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 14,16

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   SF8655

AC   CVCL_K083

SY   SF C2-9; SFC29

DR   CLO; CLO_0050691

DR   BioSample; SAMN03472244

DR   RCB; RCB0598

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8,11

ST   D16S539: 9,10

ST   D5S818: 11,12

ST   D7S820: 11,13

ST   TH01: 6,8

ST   TPOX: 11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   SF8656

AC   CVCL_K084

SY   SF A-13; SFA13

DR   CLO; CLO_0050664

DR   BioSample; SAMN03472243

DR   RCB; RCB0597

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 10

ST   D16S539: 11,13

ST   D5S818: 10,13

ST   D7S820: 12

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   SF8657

AC   CVCL_K085

SY   SF A-14; SFA14

DR   CLO; CLO_0050660

DR   BioSample; SAMN03472297

DR   RCB; RCB0585

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8,13

ST   D16S539: 9,12

ST   D5S818: 12

ST   D7S820: 11,12

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   SF8758

AC   CVCL_K086

SY   SF D2-16; SFD216

DR   CLO; CLO_0050663

DR   BioSample; SAMN03472242

DR   RCB; RCB0596

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,12

ST   D16S539: 9,13

ST   D5S818: 10,12

ST   D7S820: 8,13

ST   TH01: 8,9

ST   TPOX: 11

ST   vWA: 14,16

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   SF8759

AC   CVCL_K087

SY   SF D1-9; SFD19

DR   CLO; CLO_0050661

DR   BioSample; SAMN03472298

DR   RCB; RCB0587

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11,12

ST   D16S539: 9

ST   D5S818: 11,12

ST   D7S820: 10,11

ST   TH01: 6,9

ST   TPOX: 8,9

ST   vWA: 14,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   SF8760

AC   CVCL_K088

SY   SF D2-17; SFD217

DR   CLO; CLO_0050689

DR   BioSample; SAMN03472299

DR   RCB; RCB0588

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8,11

ST   D16S539: 9,11

ST   D5S818: 11

ST   D7S820: 11

ST   TH01: 9

ST   TPOX: 8,9

ST   vWA: 18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   SF8761

AC   CVCL_K089

SY   SF B-6; SFB6

DR   CLO; CLO_0050690

DR   BioSample; SAMN03472300

DR   RCB; RCB0589

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,10,11

ST   D16S539: 9

ST   D5S818: 11,12

ST   D7S820: 11,12

ST   TH01: 7

ST   TPOX: 9,11

ST   vWA: 16,19

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   SF8762

AC   CVCL_K090

SY   SF D1-10; SFD110

DR   CLO; CLO_0050662

DR   BioSample; SAMN03472241

DR   RCB; RCB0590

RX   PubMed=1762123;

RX   PubMed=2354455;

CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,11

ST   D16S539: 10,11

ST   D5S818: 13

ST   D7S820: 10,11

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 16,17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   Sf9

AC   CVCL_0549

SY   SF9; SF-9; Sf-9; Sf 9; Spodoptera frugiperda clone 9; Sf clone 9; IPLB-Sf-9AE; IPLB-SF-9AE; IPLB-SF-9; IPLB-Sf-9; IPLB-Sf9

DR   BTO; BTO:0001240

DR   CLO; CLO_0008988

DR   CLO; CLO_0008989

DR   CLO; CLO_0008990

DR   MCCL; MCC:0000450

DR   CLDB; cl4277

DR   CLDB; cl4278

DR   CLDB; cl4279

DR   ATCC; CRL-1711

DR   BCRC; 60011

DR   CCLV; CCLV-RIE 0352

DR   ChEMBL-Cells; CHEMBL3308860

DR   CLS; 604328/p700_Sf9

DR   DSMZ; ACC-125

DR   ECACC; 05011001

DR   ECACC; 89070101

DR   IZSLER; BS CL 157

DR   KCB; KCB 200807YJ

DR   MeSH; D061987

DR   NCBI_Iran; C425

DR   NISES; SK0002

DR   RCB; RCB0563

DR   TOKU-E; 3107

DR   Wikidata; Q7459700

RX   DOI=10.3923/jas.2007.4040.4043;

RX   PubMed=1367489;

RX   PubMed=8314732;

RX   PubMed=8799737;

RX   PubMed=10777062;

RX   PubMed=12052082;

RX   PubMed=14668217;

RX   PubMed=15926859;

RX   PubMed=19003226;

RX   PubMed=19941903;

RX   PubMed=23891577;

RX   PubMed=24375231;

RX   PubMed=24672045;

WW   https://en.wikipedia.org/wiki/Sf9

WW   http://www.thermofisher.com/order/catalog/product/B82501

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-311.html

WW   http://www.ars.usda.gov/sp2userfiles/person/3489/sf9.pdf

WW   http://oetltd.com/product/sf9-cells/

WW   http://www.the-scientist.com/?articles.view/articleNo/40052/title/Virus-Found-in-Sf9-Cell-Line/

CC   Group: Insect cell line.

CC   Group: Recombinant protein production insect cell line.

CC   Characteristics: Heterogeneous, contains a mixture of diploid and tetraploid cells.

CC   Doubling time: ~50 hours (DSMZ).

CC   Omics: ESTs sequenced.

CC   Discontinued: RCB; RCB0563; true.

OX   NCBI_TaxID=7108; ! Spodoptera frugiperda

HI   CVCL_0518 ! Sf21

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Sf9-P35AcV5-1

AC   CVCL_Z457

DR   ATCC; PTA-3099

RX   Patent=US7405038;

RX   PubMed=11513084;

CC   Group: Insect cell line.

CC   Group: Recombinant protein production insect cell line.

CC   Transfected with: UniProtKB; P08160; AcMNPV p35.

OX   NCBI_TaxID=7108; ! Spodoptera frugiperda

HI   CVCL_0549 ! Sf9

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Sf9-P35AcV5-3

AC   CVCL_Z458

DR   ATCC; PTA-3100

RX   Patent=US7405038;

RX   PubMed=11513084;

CC   Group: Insect cell line.

CC   Group: Recombinant protein production insect cell line.

CC   Transfected with: UniProtKB; P08160; AcMNPV p35.

OX   NCBI_TaxID=7108; ! Spodoptera frugiperda

HI   CVCL_0549 ! Sf9

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Sf900+

AC   CVCL_4U10

DR   ATCC; CRL-12579

RX   Patent=US6103526;

CC   Group: Insect cell line.

CC   Group: Recombinant protein production insect cell line.

CC   Discontinued: ATCC; CRL-12579; probable.

OX   NCBI_TaxID=7108; ! Spodoptera frugiperda

HI   CVCL_0549 ! Sf9

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Sf9S

AC   CVCL_Z459

SY   Sf9s; Sf-9S

DR   ATCC; PTA-4047

RX   Patent=US7041500;

CC   Group: Insect cell line.

CC   Group: Recombinant protein production insect cell line.

OX   NCBI_TaxID=7108; ! Spodoptera frugiperda

HI   CVCL_0549 ! Sf9

SX   Female

CA   Spontaneously immortalized cell line

//

ID   SFAF-PI 38

AC   CVCL_9V84

DR   NCBI_Iran; C465

OX   NCBI_TaxID=9940; ! Ovis aries

SX   Male

CA   Finite cell line

//

ID   SFAT-3

AC   CVCL_1N75

SY   Spleen Focus-derived Ascites Tumor-3

RX   PubMed=5973415;

CC   Breed/subspecies: DDD.

DI   NCIt; C21604; Mouse leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Cancer cell line

//

ID   Sfbeta4GalT

AC   CVCL_Z364

RX   PubMed=9597545;

RX   PubMed=11181556;

RX   PubMed=12475259;

CC   Group: Insect cell line.

CC   Group: Recombinant protein production insect cell line.

CC   Transfected with: UniProtKB; P08037; Bovine B4GALT1.

OX   NCBI_TaxID=7108; ! Spodoptera frugiperda

HI   CVCL_0549 ! Sf9

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Sfbeta4GalT/ST6

AC   CVCL_Z365

RX   PubMed=11181556;

RX   PubMed=12475259;

CC   Group: Insect cell line.

CC   Group: Recombinant protein production insect cell line.

CC   Transfected with: UniProtKB; P08037; Bovine B4GALT1.

CC   Transfected with: RGD; 3676; St6gal1.

OX   NCBI_TaxID=7108; ! Spodoptera frugiperda

HI   CVCL_Z364 ! Sfbeta4GalT

SX   Female

CA   Spontaneously immortalized cell line

//

ID   SFBF-PI 39

AC   CVCL_9V85

DR   NCBI_Iran; C467

OX   NCBI_TaxID=9940; ! Ovis aries

SX   Male

CA   Finite cell line

//

ID   SFBF-PI 41

AC   CVCL_9V86

DR   NCBI_Iran; C469

OX   NCBI_TaxID=9940; ! Ovis aries

SX   Male

CA   Finite cell line

//

ID   SFEC

AC   CVCL_IM35

SY   Souther Flounder Embryonic Cell line

RX   CelloPub=CLPUB00053;

CC   Group: Fish cell line.

OX   NCBI_TaxID=141886; ! Paralichthys lethostigma

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SFH-R

AC   CVCL_0I79

DR   CCLV; CCLV-RIE 0042

OX   NCBI_TaxID=9940; ! Ovis aries

SX   Male

CA   Finite cell line

//

ID   SFIF-PI 44

AC   CVCL_9V87

DR   NCBI_Iran; C472

OX   NCBI_TaxID=9940; ! Ovis aries

SX   Male

CA   Finite cell line

//

ID   SFK

AC   CVCL_R925

SY   Southern Flounder Kidney

RX   PubMed=21210550;

CC   Group: Fish cell line.

OX   NCBI_TaxID=141886; ! Paralichthys lethostigma

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SFKF-PI 37

AC   CVCL_9V88

DR   NCBI_Iran; C464

OX   NCBI_TaxID=9940; ! Ovis aries

SX   Male

CA   Finite cell line

//

ID   SFLF-PI 35

AC   CVCL_9V89

DR   NCBI_Iran; C460

OX   NCBI_TaxID=9940; ! Ovis aries

SX   Male

CA   Finite cell line

//

ID   SFLSF-PI 36

AC   CVCL_9V90

DR   NCBI_Iran; C462

OX   NCBI_TaxID=9940; ! Ovis aries

SX   Male

CA   Finite cell line

//

ID   SFR3-DR5

AC   CVCL_9237

DR   CLO; CLO_0008992

DR   ATCC; HB-151

DR   IZSLER; BS Hy 14

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   SFR8-B6

AC   CVCL_9238

DR   CLO; CLO_0008993

DR   ATCC; HB-152

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   SFSF-PI 45

AC   CVCL_9V91

DR   NCBI_Iran; C473

OX   NCBI_TaxID=9940; ! Ovis aries

SX   Male

CA   Finite cell line

//

ID   SfSWT-1

AC   CVCL_Z366

SY   Sf SWT1; SfSWT1; Mimic; Mimic Sf9

RX   PubMed=12475259;

RX   PubMed=12626399;

RX   PubMed=20574041;

WW   http://www.thermofisher.com/order/catalog/product/12552014

WW   http://tools.thermofisher.com/content/sfs/manuals/mimic_cell_man.pdf

CC   Group: Insect cell line.

CC   Group: Recombinant protein production insect cell line.

CC   Transfected with: HGNC; 7044; MGAT1.

CC   Transfected with: HGNC; 7045; MGAT2.

CC   Transfected with: MGI; MGI:1316743; St3gal4.

CC   Transfected with: RGD; 3676; St6gal1.

CC   Transfected with: UniProtKB; P08037; Bovine B4GALT1.

OX   NCBI_TaxID=7108; ! Spodoptera frugiperda

HI   CVCL_Z364 ! Sfbeta4GalT

SX   Female

CA   Spontaneously immortalized cell line

//

ID   SfSWT-3

AC   CVCL_Z367

SY   Sf SWT3; SfSWT3

RX   PubMed=12626399;

CC   Group: Insect cell line.

CC   Group: Recombinant protein production insect cell line.

CC   Transfected with: HGNC; 7044; MGAT1.

CC   Transfected with: HGNC; 7045; MGAT2.

CC   Transfected with: MGI; MGI:1337124; Cmas.

CC   Transfected with: MGI; MGI:2149820; Nans.

CC   Transfected with: MGI; MGI:1316743; St3gal4.

CC   Transfected with: RGD; 3676; St6gal1.

CC   Transfected with: UniProtKB; P08037; Bovine B4GALT1.

OX   NCBI_TaxID=7108; ! Spodoptera frugiperda

HI   CVCL_Z366 ! SfSWT-1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   SFT-8606

AC   CVCL_IS67

SY   SFT8606

RX   PubMed=10929770;

RX   PubMed=16557275;

RX   PubMed=19756736;

DI   NCIt; C3714; Epithelioid sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SFT-R

AC   CVCL_Y470

SY   SFTR

DR   CCLV; CCLV-RIE 0043

RX   PubMed=19941903;

OX   NCBI_TaxID=9940; ! Ovis aries

CA   Finite cell line

//

ID   SFTF-PI 40

AC   CVCL_9V92

DR   NCBI_Iran; C468

OX   NCBI_TaxID=9940; ! Ovis aries

SX   Male

CA   Finite cell line

//

ID   SFTF-PI 42

AC   CVCL_9V93

DR   NCBI_Iran; C470

OX   NCBI_TaxID=9940; ! Ovis aries

SX   Male

CA   Finite cell line

//

ID   SFTF-PI 43

AC   CVCL_9V35

SY   SFTF-PI43

DR   NCBI_Iran; C471

OX   NCBI_TaxID=9940; ! Ovis aries

SX   Male

CA   Finite cell line

//

ID   SG

AC   CVCL_M617

RX   PubMed=8689637;

DI   NCIt; C2946; Chondrosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SG0002

AC   CVCL_5G99

DR   ECACC; 00040402

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0003

AC   CVCL_5H00

DR   ECACC; 00040403

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0004

AC   CVCL_5H01

DR   ECACC; 00040404

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0005

AC   CVCL_5H02

DR   ECACC; 00040405

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SG0008

AC   CVCL_5H03

DR   ECACC; 00040408

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0010

AC   CVCL_5H04

DR   ECACC; 00040410

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0015

AC   CVCL_5H05

DR   ECACC; 00041910

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0018

AC   CVCL_5H06

DR   ECACC; 00041913

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0020

AC   CVCL_5H07

DR   ECACC; 00041915

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0022

AC   CVCL_5H08

DR   ECACC; 00041917

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0024

AC   CVCL_5H09

DR   ECACC; 00041919

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0026

AC   CVCL_5H10

DR   ECACC; 00041921

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0030

AC   CVCL_5H11

DR   ECACC; 00042213

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0034

AC   CVCL_5H12

DR   ECACC; 00051819

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0035

AC   CVCL_5H13

DR   ECACC; 00051820

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0038

AC   CVCL_5H14

DR   ECACC; 00051823

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0040

AC   CVCL_5H15

DR   ECACC; 00051825

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0041

AC   CVCL_5H16

DR   ECACC; 00051826

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0042

AC   CVCL_5H17

DR   ECACC; 00051827

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0046

AC   CVCL_5H18

DR   ECACC; 00052307

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0052

AC   CVCL_5H19

DR   ECACC; 00052313

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0054

AC   CVCL_5H20

DR   ECACC; 00052315

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0055

AC   CVCL_5H21

DR   ECACC; 00052401

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SG0057

AC   CVCL_5H22

DR   ECACC; 00052403

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0058

AC   CVCL_5H23

DR   ECACC; 00052404

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0059

AC   CVCL_5H24

DR   ECACC; 00052405

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0060

AC   CVCL_5H25

DR   ECACC; 00052406

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SG0062

AC   CVCL_5H26

DR   ECACC; 00052408

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SG0063

AC   CVCL_5H27

DR   ECACC; 00052409

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0064

AC   CVCL_5H28

DR   ECACC; 00052410

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0066

AC   CVCL_5H29

DR   ECACC; 00052512

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0067

AC   CVCL_5H30

DR   ECACC; 00052514

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0069

AC   CVCL_5H31

DR   ECACC; 00052516

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0070

AC   CVCL_5H32

DR   ECACC; 00052517

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0071

AC   CVCL_5H33

DR   ECACC; 00052518

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SG0072

AC   CVCL_5H34

DR   ECACC; 00052519

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0073

AC   CVCL_5H35

DR   ECACC; 00052520

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SG0074

AC   CVCL_5H36

DR   ECACC; 00052521

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0077

AC   CVCL_5H37

DR   ECACC; 00052524

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0078

AC   CVCL_5H38

DR   ECACC; 00052525

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SG0080

AC   CVCL_5H39

DR   ECACC; 00052527

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0081

AC   CVCL_5H40

DR   ECACC; 00052528

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0082

AC   CVCL_5H41

DR   ECACC; 00052529

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0084

AC   CVCL_5H42

DR   ECACC; 00052531

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0086

AC   CVCL_5H43

DR   ECACC; 00052533

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0088

AC   CVCL_5H44

DR   ECACC; 00052535

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0089

AC   CVCL_5H45

DR   ECACC; 00052536

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0090

AC   CVCL_5H46

DR   ECACC; 00052537

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0094

AC   CVCL_5H47

DR   ECACC; 00052541

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0095

AC   CVCL_5H48

DR   ECACC; 00052542

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0097

AC   CVCL_5H49

DR   ECACC; 00052544

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0099

AC   CVCL_5H50

DR   ECACC; 00052546

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0100

AC   CVCL_5H51

DR   ECACC; 00052447

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0101

AC   CVCL_5H52

DR   ECACC; 00052413

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0102

AC   CVCL_5H53

DR   ECACC; 00052414

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0104

AC   CVCL_5H54

DR   ECACC; 00052416

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0105

AC   CVCL_5H55

DR   ECACC; 00052417

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0107

AC   CVCL_5H56

DR   ECACC; 00052419

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0109

AC   CVCL_5H57

DR   ECACC; 00052548

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0111

AC   CVCL_5H58

DR   ECACC; 00052550

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0112

AC   CVCL_5H59

DR   ECACC; 00052551

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0114

AC   CVCL_5H60

DR   ECACC; 00052553

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SG0115

AC   CVCL_5H61

DR   ECACC; 00052554

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0117

AC   CVCL_5H62

DR   ECACC; 00052556

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SG0118

AC   CVCL_5H63

DR   ECACC; 00052557

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SG0120

AC   CVCL_5H64

DR   ECACC; 00052559

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SG0121

AC   CVCL_5H65

DR   ECACC; 00052560

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SG0125

AC   CVCL_5H66

DR   ECACC; 00052564

CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SG231

AC   CVCL_0519

SY   PCI:SG231; PCI-SG231; PCI:SG-231

DR   BTO; BTO:0002935

DR   MCCL; MCC:0000417

DR   ATCC; CRL-2126

DR   BioSample; SAMN03472551

RX   CelloPub=CLPUB00275;

RX   PubMed=2176543;

CC   Discontinued: ATCC; CRL-2126; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 9,10

ST   D16S539: 14

ST   D5S818: 12

ST   D7S820: 11

ST   TH01: 8,9

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C35417; Intrahepatic cholangiocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SG3

AC   CVCL_Y569

RX   PubMed=15141090;

CC   Group: Fish cell line.

CC   Breed/subspecies: Albino strain i3.

OX   NCBI_TaxID=8090; ! Oryzias latipes

SX   Male

CA   Spontaneously immortalized cell line

//

ID   Sg4

AC   CVCL_Z707

SY   Sf4; SF4

DR   EFO; EFO_0005839

DR   DGRC; 179

DR   ENCODE; ENCBS418XCA

RX   PubMed=21177962;

RX   PubMed=24434506;

RX   PubMed=24985917;

RX   PubMed=25262759;

WW   http://flybase.org/reports/FBrf0205934.html

CC   Group: Insect cell line.

CC   Omics: Deep RNAseq analysis.

CC   Breed/subspecies: Oregon-R.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z232 ! Schneider 2

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Sg4-PP-27F

AC   CVCL_5I18

DR   DGRC; 238

RX   PubMed=26450921;

CC   Group: Insect cell line.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Breed/subspecies: Oregon-R.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z707 ! Sg4

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Sg4-PP-3A

AC   CVCL_5I19

DR   DGRC; 237

RX   PubMed=26450921;

CC   Group: Insect cell line.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Breed/subspecies: Oregon-R.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z707 ! Sg4

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Sg4-PP-49B

AC   CVCL_5I20

DR   DGRC; 239

RX   PubMed=26450921;

CC   Group: Insect cell line.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Breed/subspecies: Oregon-R.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z707 ! Sg4

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Sg4-PP-57B

AC   CVCL_5I21

DR   DGRC; 241

RX   PubMed=26450921;

CC   Group: Insect cell line.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Breed/subspecies: Oregon-R.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z707 ! Sg4

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Sg4-PP-70F

AC   CVCL_5I22

DR   DGRC; 242

RX   PubMed=26450921;

CC   Group: Insect cell line.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Breed/subspecies: Oregon-R.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z707 ! Sg4

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Sg4-PP-84E

AC   CVCL_5I23

DR   DGRC; 240

RX   PubMed=26450921;

CC   Group: Insect cell line.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Breed/subspecies: Oregon-R.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z707 ! Sg4

SX   Female

CA   Spontaneously immortalized cell line

//

ID   SG5-1.13

AC   CVCL_U457

RX   PubMed=12514093;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_U450 ! G5

SX   Male

CA   Transformed cell line

//

ID   SG5-2

AC   CVCL_U458

RX   PubMed=12514093;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_U450 ! G5

SX   Male

CA   Transformed cell line

//

ID   SGBS

AC   CVCL_GS28

DR   GEO; GSM1543665

DR   GEO; GSM1543666

DR   GEO; GSM1543667

RX   PubMed=11244452;

RX   PubMed=25925588;

CC   Omics: Deep RNAseq analysis.

DI   NCIt; C118787; Simpson Golabi Behmel syndrome type 1

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Spontaneously immortalized cell line

//

ID   SGC-7901

AC   CVCL_0520

SY   SGC 7901; SGC7901

DR   BTO; BTO:0002392

DR   EFO; EFO_0006293

DR   MCCL; MCC:0000418

DR   CCRID; 3111C0001CCC000236

DR   CCRID; 3131C0001000700046

DR   ChEMBL-Cells; CHEMBL3307739

DR   ChEMBL-Targets; CHEMBL614909

DR   GEO; GSM844685

DR   GEO; GSM1374869

DR   TOKU-E; 3764

RX   DOI=10.1360/sb1982-27-12-1355;

RX   DOI=10.1007/978-4-431-68252-3_114;

RX   PubMed=6443274;

CC   Omics: Transcriptome analysis.

DI   NCIt; C4911; Gastric carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SGC-996

AC   CVCL_M737

SY   SGC996

RX   CelloPub=CLPUB00379;

RX   PubMed=22387537;

CC   Doubling time: ~48 hours (CelloPub=CLPUB00379).

DI   NCIt; C3844; Gallbladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SGE-1

AC   CVCL_2189

SY   SGE1

DR   CLO; CLO_0008999

DR   DSMZ; ACC-343

RX   PubMed=3242847;

CC   Doubling time: 21.6 hours (PubMed=3242847); ~33 hours (DSMZ).

CC   Breed/subspecies: Wistar.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Spontaneously immortalized cell line

//

ID   SGE-RC

AC   CVCL_X538

DR   Cosmic; 849368

RX   PubMed=11146448;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SGHPL-4

AC   CVCL_0521

SY   CTB-CL-MC4; MC4; Saint Georges Hospital Placental cell Line-4

DR   BTO; BTO:0003980

DR   MCCL; MCC:0000419

RX   PubMed=9804259;

RX   PubMed=10498850;

RX   PubMed=11723542;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SGHPL-5

AC   CVCL_D727

SY   SGHPL5; Saint Georges Hospital Placental cell Line-5

RX   PubMed=11723542;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].

CC   Misspelling: 'SHGPL-5' in PubMed=16896069.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SGP

AC   CVCL_6F88

SY   Snakeskin Gourami caudal Peduncle

RX   PubMed=1717644;

CC   Group: Fish cell line.

OX   NCBI_TaxID=313238; ! Trichopodus pectoralis

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SGS

AC   CVCL_4007

SY   Sarcoma Galliera strain; SGS-2

DR   BTO; BTO:0001210

DR   CLO; CLO_0009000

DR   CLDB; cl4284

RX   DOI=10.1007/978-1-4612-5008-1_23;

RX   PubMed=652394;

RX   PubMed=2982624;

CC   Breed/subspecies: Galliera.

DI   NCIt; C60505; Rat sarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Cancer cell line

//

ID   SGS/3A

AC   CVCL_F738

DR   CLO; CLO_0009001

DR   CLDB; cl4285

CC   Breed/subspecies: Galliera.

DI   NCIt; C60505; Rat sarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4007 ! SGS

CA   Cancer cell line

//

ID   SGS/4A

AC   CVCL_L436

RX   PubMed=10832101;

CC   Breed/subspecies: Galliera.

DI   NCIt; C60505; Rat sarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4007 ! SGS

CA   Cancer cell line

//

ID   SH [Dog hemangiosarcoma]

AC   CVCL_GY96

DR   GEO; GSM1122231

RX   PubMed=24582862;

DI   NCIt; C122783; Canine hemangiosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

CA   Cancer cell line

//

ID   SH [Sturgeon]

AC   CVCL_S945

SY   Sturgeon Heart

RX   DOI=10.1139/z85-427;

CC   Group: Fish cell line.

OX   NCBI_TaxID=36177; ! Acipenser oxyrinchus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   Sh #1

AC   CVCL_1E45

SY   SH #1; SH 1

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=994214;

RX   PubMed=5030962;

CC   Doubling time: 30 hours (at 41th passage), 31 hours (at 142th passage) (PubMed=994214).

CC   Derived from metastatic site: Axillary lymph node.

DI   NCIt; C3802; Amelanotic melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SH-10-TC

AC   CVCL_5167

SY   SH10TC; SH-10

DR   CCLE; SH10TC_STOMACH

DR   Cosmic; 889109

DR   Cosmic; 1187292

DR   GEO; GSM887567

DR   GEO; GSM888650

DR   RCB; RCB1940

DR   TKG; TKG 0338

DR   TKG; TKG 0412

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 13

ST   D13S317: 11

ST   D16S539: 11,13

ST   D5S818: 12

ST   D7S820: 11

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C5248; Mucinous gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SH-2 [Human contaminated breast cancer]

AC   CVCL_M622

SY   SH2

DR   BioSample; SAMN03151757

RX   CelloPub=CLPUB00114;

RX   CelloPub=CLPUB00262;

RX   PubMed=1246601;

RX   PubMed=6451928;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601, PubMed=6451928, PubMed=20143388). Originally thought to originate from a breast carcinoma.

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0030 ! HeLa

SX   Female

CA   Cancer cell line

//

ID   SH-2 [Human leukemia]

AC   CVCL_2190

DR   BioSample; SAMN03473457

DR   DSMZ; ACC-643

RX   PubMed=18715689;

CC   Doubling time: ~80 hours (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 10,12

ST   D16S539: 9

ST   D5S818: 10,11

ST   D7S820: 12

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 18,20

DI   NCIt; C3171; Acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SH-224

AC   CVCL_S708

DR   Cosmic; 1493302

RX   PubMed=21372829;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SH-289

AC   CVCL_S709

DR   Cosmic; 1493303

RX   PubMed=21372829;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SH-3

AC   CVCL_M383

SY   SH3

DR   BioSample; SAMN03151758

RX   CelloPub=CLPUB00114;

RX   CelloPub=CLPUB00262;

RX   PubMed=1246601;

RX   PubMed=1260689;

RX   PubMed=6451928;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601, PubMed=6451928, PubMed=20143388). Originally thought to originate from a breast carcinoma.

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0030 ! HeLa

SX   Female

CA   Cancer cell line

//

ID   SH-34

AC   CVCL_F764

DR   CLO; CLO_0009004

DR   ATCC; CRL-2405

RX   PubMed=3614206;

CC   Monoclonal antibody target: ChEBI; CHEBI:27938; Asialo-GM1 ganglioside.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   SH-39-HOM

AC   CVCL_C585

DR   ESTDAB; ESTDAB-060

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 11

ST   D3S1358: 16

ST   D5S818: 11

ST   D7S820: 8,11

ST   FGA: 23

ST   TH01: 8,9.3

ST   TPOX: 8,11

ST   vWA: 14

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C577 ! RE-25-HOM

SX   Male

CA   Cancer cell line

//

ID   SH-4

AC   CVCL_1692

SY   SH4

DR   CLO; CLO_0009006

DR   ATCC; CRL-7724

DR   BCRJ; 0337

DR   BioSample; SAMN03471142

DR   CCLE; SH4_SKIN

DR   ChEMBL-Cells; CHEMBL3308177

DR   ChEMBL-Targets; CHEMBL2366309

DR   Cosmic; 687440

DR   Cosmic; 909713

DR   Cosmic; 2159447

DR   Cosmic-CLP; 909713

DR   GDSC; 909713

DR   GEO; GSM887568

DR   GEO; GSM888651

DR   GEO; GSM1670420

DR   IGRhCellID; SH4

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=1176156;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 9,12

ST   D16S539: 11,12

ST   D5S818: 11,12

ST   D7S820: 13

ST   TH01: 8,9.3

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SH-405

AC   CVCL_S710

DR   Cosmic; 1493308

RX   PubMed=21372829;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SH-416

AC   CVCL_S711

DR   Cosmic; 1493305

RX   PubMed=21372829;

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SH-437

AC   CVCL_S712

DR   Cosmic; 1493307

RX   PubMed=21372829;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SH-450

AC   CVCL_S713

DR   Cosmic; 1493306

RX   PubMed=21372829;

DI   NCIt; C9133; Adenosquamous lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SH-498

AC   CVCL_S714

DR   Cosmic; 1493309

RX   PubMed=21372829;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SH-543

AC   CVCL_S715

DR   Cosmic; 1493304

RX   PubMed=21372829;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SH-A

AC   CVCL_0C25

DR   Cosmic; 2239085

RX   PubMed=1311980;

RX   PubMed=7736387;

RX   PubMed=9559344;

RX   PubMed=9815546;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SH-EP

AC   CVCL_0524

SY   SHEP

DR   BTO; BTO:0005397

DR   EFO; EFO_0006294

DR   MCCL; MCC:0000423

DR   Cosmic; 1212535

DR   Cosmic; 2393640

DR   GEO; GSM1622295

RX   PubMed=2535691;

RX   PubMed=6137586;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-530.html

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0531 ! SK-N-SH

SX   Female

CA   Cancer cell line

//

ID   SH-EP007

AC   CVCL_0522

SY   SH-EP 007 SH-EPII

DR   MCCL; MCC:0000420

RX   PubMed=2364393;

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0524 ! SH-EP

SX   Female

CA   Cancer cell line

//

ID   SH-EP1

AC   CVCL_0F47

SY   SH-EPi

DR   BTO; BTO:0005788

DR   ATCC; CRL-2269

RX   PubMed=6137586;

RX   PubMed=6582512;

CC   Discontinued: ATCC; CRL-2269; true.

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 8,13

ST   D5S818: 12

ST   D7S820: 7,10

ST   TH01: 7,10

ST   TPOX: 8,11

ST   vWA: 14,18

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0524 ! SH-EP

SX   Female

CA   Cancer cell line

//

ID   SH-FE

AC   CVCL_W973

RX   PubMed=6137586;

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0531 ! SK-N-SH

SX   Female

CA   Cancer cell line

//

ID   SH-IN

AC   CVCL_W974

RX   PubMed=2535691;

RX   PubMed=6137586;

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0531 ! SK-N-SH

SX   Female

CA   Cancer cell line

//

ID   SH-J1

AC   CVCL_HE82

RX   PubMed=11850072;

CC   Characteristics: Has lost chromosome Y.

DI   NCIt; C43627; Sarcomatoid hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SH-SY5Y

AC   CVCL_0019

SY   SHSY5Y; SHSY-5Y; SH-Sy5y; SK-SH-SY5Y; SY5Y

DR   BTO; BTO:0000793

DR   CLO; CLO_0009015

DR   EFO; EFO_0002717

DR   MCCL; MCC:0000421

DR   CLDB; cl4287

DR   CLDB; cl4288

DR   CLDB; cl4289

DR   CLDB; cl4290

DR   ATCC; CRL-2266

DR   BCRJ; 0223

DR   CCLE; SHSY5Y_AUTONOMIC_GANGLIA

DR   CCRID; 3111C0001CCC000026

DR   CCRID; 3131C0001000700097

DR   CCRID; 3142C0001000000486

DR   CGH-DB; 63-1

DR   ChEMBL-Cells; CHEMBL3307740

DR   ChEMBL-Targets; CHEMBL614910

DR   CLS; 300154/p822_SH-SY5Y

DR   Cosmic; 688084

DR   Cosmic; 1019933

DR   Cosmic; 1167410

DR   Cosmic; 1212536

DR   Cosmic; 2058109

DR   Cosmic; 2239470

DR   Cosmic; 2393641

DR   DSMZ; ACC-209

DR   ECACC; 94030304

DR   ENCODE; ENCBS264AAA

DR   GEO; GSM692874

DR   GEO; GSM887570

DR   GEO; GSM888653

DR   GEO; GSM1622294

DR   ICLC; HTL95013

DR   IZSLER; BS TCL 232

DR   KCB; KCB 2006107YJ

DR   KCLB; 22266

DR   NCBI_Iran; C611

DR   PRIDE; PXD003105

DR   PRIDE; PXD003914

DR   TOKU-E; 3118

DR   Wikidata; Q7390126

RX   PubMed=2535691;

RX   PubMed=2846152;

RX   PubMed=4748425;

RX   PubMed=6137586;

RX   PubMed=15150091;

RX   PubMed=16120276;

RX   PubMed=22213050;

RX   PubMed=22460905;

RX   PubMed=25182563;

RX   PubMed=26972028;

RX   PubMed=27141528;

RX   PubMed=28118852;

WW   https://en.wikipedia.org/wiki/SH-SY5Y

WW   http://www.proteinatlas.org/learn/cellines

WW   http://genome.ucsc.edu/ENCODE/protocols/cell/human/SH-SY5Y_Farnham_protocol.pdf

WW   http://www.addexbio.com/productdetail?pid=63

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-101.html

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-neuroblastoma-cell-line-sh-sy5y

CC   Problematic cell line: Partially contaminated. Some laboratories that are redistributing this cell line are in fact redistributing a contaminated cell line of mouse origin (PubMed=25182563).

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: ENCODE project common cell types; tier 3.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 810.

CC   Doubling time: >55 hours (DSMZ).

CC   Omics: Deep antibody staining analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: GPI-anchored proteins analysis by proteomics.

CC   Omics: Mitochondrial proteome analysis by 2D-DE/MS.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'SH-SY5' in ChEMBL CHEMBL614910.

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): ATCC; CLS; DSMZ; ECACC; KCLB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 8,13

ST   D18S51: 13,16

ST   D21S11: 31,31.2

ST   D3S1358: 15,16

ST   D5S818: 12

ST   D7S820: 7,10

ST   D8S1179: 15

ST   FGA: 23.2,24

ST   Penta D: 10,12

ST   Penta E: 7,11

ST   TH01: 7,10

ST   TPOX: 8,11

ST   vWA: 14,18

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0531 ! SK-N-SH

SX   Female

CA   Cancer cell line

//

ID   SH-SY5Y Rho0 64/5

AC   CVCL_U924

SY   Rho0 64/5

RX   PubMed=8863494;

CC   Characteristics: Cell line devoid of mitochondrial DNA (rho0).

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0019 ! SH-SY5Y

SX   Female

CA   Cancer cell line

//

ID   SH-SY5Y-HFE

AC   CVCL_5I52

RX   PubMed=17194693;

WW   https://www.kerafast.com/product/1277/stable-sh-sy5y-hfe-expressing-cell-lines

CC   Transfected with: HGNC; 4886; HFE.

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0019 ! SH-SY5Y

SX   Female

CA   Cancer cell line

//

ID   SH-SY5Y-HFE C282Y

AC   CVCL_5I53

RX   PubMed=17194693;

WW   https://www.kerafast.com/product/1277/stable-sh-sy5y-hfe-expressing-cell-lines

CC   Transfected with: HGNC; 4886; HFE (with Y-282).

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0019 ! SH-SY5Y

SX   Female

CA   Cancer cell line

//

ID   SH-SY5Y-HFE H63D

AC   CVCL_5I54

RX   PubMed=17194693;

WW   https://www.kerafast.com/product/1277/stable-sh-sy5y-hfe-expressing-cell-lines

CC   Transfected with: HGNC; 4886; HFE (with D-63).

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0019 ! SH-SY5Y

SX   Female

CA   Cancer cell line

//

ID   SH-SY5Y-SPA4CT

AC   CVCL_0523

SY   SH-SY5Y SPA4CT; SHSY5Y-SPA4CT

DR   MCCL; MCC:0000422

RX   PubMed=8243673;

CC   Transfected with: HGNC; 620; APP (1-19 in frame with 672-770).

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0019 ! SH-SY5Y

SX   Female

CA   Cancer cell line

//

ID   SH1

AC   CVCL_C722

SY   SSMUe001-A

DR   hPSCreg; SSMUe001-A

RX   PubMed=15955827;

CC   From: Shanghai Second Medical University; Shanghai; China.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   SH101-P4

AC   CVCL_A669

SY   SH101P4; SH-101-P4

DR   CGH-DB; 130-1

DR   CGH-DB; 9018-4

DR   Cosmic; 877039

DR   Cosmic; 897531

DR   Cosmic; 1122339

DR   Cosmic; 1187291

DR   Cosmic; 1518240

RX   PubMed=8242641;

RX   PubMed=15723654;

DI   NCIt; C5473; Gastric tubular adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SH2 [Human ESC]

AC   CVCL_C723

SY   SSMUe002-A

DR   hPSCreg; SSMUe002-A

RX   PubMed=15955827;

CC   From: Shanghai Second Medical University; Shanghai; China.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   SH2 [Mouse hybridoma]

AC   CVCL_7700

DR   CLO; CLO_0009002

DR   ATCC; HB-10743

DR   CCRID; 3111C0001CCC000204

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   SH28

AC   CVCL_C726

SY   SSMUe005-A

DR   hPSCreg; SSMUe005-A

DR   ISCR; 1592

RX   PubMed=15916726;

CC   From: Shanghai Second Medical University; Shanghai; China.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SH3

AC   CVCL_7701

DR   CLO; CLO_0009003

DR   ATCC; HB-10744

DR   CCRID; 3111C0001CCC000205

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   SH35

AC   CVCL_C727

SY   SSMUe006-A

DR   hPSCreg; SSMUe006-A

DR   ISCR; 1593

RX   PubMed=15916726;

CC   From: Shanghai Second Medical University; Shanghai; China.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SH35a

AC   CVCL_C728

SY   SSMUe007-A

DR   hPSCreg; SSMUe007-A

DR   ISCR; 1594

CC   From: Shanghai Second Medical University; Shanghai; China.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SH38

AC   CVCL_C729

SY   SSMUe008-A

DR   hPSCreg; SSMUe008-A

DR   ISCR; 1595

RX   PubMed=15916726;

CC   From: Shanghai Second Medical University; Shanghai; China.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SH39

AC   CVCL_C730

SY   SSMUe009-A

DR   hPSCreg; SSMUe009-A

DR   ISCR; 1596

RX   PubMed=15916726;

CC   From: Shanghai Second Medical University; Shanghai; China.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SH4 [Human ESC]

AC   CVCL_C724

SY   SSMUe004-A

DR   hPSCreg; SSMUe004-A

DR   ISCR; 1597

RX   PubMed=15916726;

CC   From: Shanghai Second Medical University; Shanghai; China.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SH4 [Mouse hybridoma]

AC   CVCL_7702

DR   CLO; CLO_0009005

DR   EFO; EFO_0002327

DR   ATCC; HB-10745

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   SH42

AC   CVCL_C731

SY   SSMUe010-A

DR   hPSCreg; SSMUe010-A

DR   ISCR; 1598

RX   PubMed=15916726;

CC   From: Shanghai Second Medical University; Shanghai; China.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SH7

AC   CVCL_C725

SY   SSMUe003-A

DR   hPSCreg; SSMUe003-A

DR   ISCR; 1599

RX   PubMed=15955827;

CC   From: Shanghai Second Medical University; Shanghai; China.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SHAC

AC   CVCL_D522

SY   Shac

DR   BTO; BTO:0003763

RX   PubMed=3284824;

DI   NCIt; C6605; Soft tissue fibrosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Shadow

AC   CVCL_0D17

SY   SHADOW; SHA

RX   PubMed=11467477;

RX   PubMed=12944992;

RX   PubMed=26842912;

CC   Derived from metastatic site: Lung.

DI   NCIt; C120298; Canine melanoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

CA   Cancer cell line

//

ID   Shamba

AC   CVCL_R797

RX   PubMed=1690682;

RX   PubMed=8891732;

WW   http://www.zooatlanta.org/home/headlines/gorilla_shamba_50birthday

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla

SX   Female

CA   Transformed cell line

//

ID   Shay

AC   CVCL_6018

DR   JCRB; JCRB0241

RX   PubMed=6585112;

CC   Breed/subspecies: Wistar.

DI   NCIt; C60505; Rat sarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Cancer cell line

//

ID   sHCC29

AC   CVCL_HE83

RX   DOI=10.1158/1538-7445.AM2014-3622;

CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).

DI   NCIt; C43627; Sarcomatoid hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   sHCC63

AC   CVCL_HE84

RX   DOI=10.1158/1538-7445.AM2014-3622;

CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).

DI   NCIt; C43627; Sarcomatoid hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   sHCC74

AC   CVCL_HE85

RX   DOI=10.1158/1538-7445.AM2014-3622;

DI   NCIt; C3098; Hepatitis C infection

DI   NCIt; C43627; Sarcomatoid hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SHCE

AC   CVCL_6E72

SY   SV40-immortalized Human Corneal Epithelial cells

RX   PubMed=26631824;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SHEE10

AC   CVCL_4M96

RX   PubMed=11712078;

RX   PubMed=12569775;

RX   PubMed=12439909;

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18) [E6/E7].

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SHEE100

AC   CVCL_4N01

SY   H5E973

RX   PubMed=16364037;

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18) [E6/E7].

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4N00 ! SHEE85

CA   Transformed cell line

//

ID   SHEE31

AC   CVCL_4M97

RX   PubMed=11712078;

RX   PubMed=12569775;

RX   PubMed=12439909;

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18) [E6/E7].

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4M96 ! SHEE10

CA   Transformed cell line

//

ID   SHEE61

AC   CVCL_4M98

RX   PubMed=11712078;

RX   PubMed=12569775;

RX   PubMed=12439909;

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18) [E6/E7].

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4M97 ! SHEE31

CA   Transformed cell line

//

ID   SHEE61A

AC   CVCL_4M99

RX   PubMed=11712078;

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18) [E6/E7].

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4M98 ! SHEE61

CA   Transformed cell line

//

ID   SHEE85

AC   CVCL_4N00

RX   PubMed=12015026;

RX   PubMed=12439909;

RX   PubMed=12851721;

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18) [E6/E7].

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4M98 ! SHEE61

CA   Transformed cell line

//

ID   Shef1

AC   CVCL_9788

SY   SHEF1; Shef-1; SHEF-1; Shef 1; SHEFF-1; AXORe001-A

DR   EFO; EFO_0005454

DR   hPSCreg; AXORe001-A

DR   ISCR; 184

RX   PubMed=15345125;

RX   PubMed=17572666;

RX   PubMed=20224972;

WW   http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_lines/available_human_cell_lines/laboratory_grade/shef-1.aspx

CC   From: University of Sheffield; Sheffield; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); R-05-007, Steering comm. appl. SCSC04-23(1).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   Shef2

AC   CVCL_9789

SY   SHEF2; Shef-2; SHEF-2; Shef 2; SHEFF-2; AXORe002-A

DR   EFO; EFO_0005456

DR   hPSCreg; AXORe002-A

DR   ISCR; 185

RX   PubMed=17572666;

RX   PubMed=20224972;

WW   http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_lines/available_human_cell_lines/laboratory_grade/shef-2.aspx

CC   From: University of Sheffield; Sheffield; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); R-05-028, Steering comm. appl. SCSC04-23(2).

CC   Misspelling: 'SHEP-2' in EFO EFO_0005456.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   Shef3

AC   CVCL_9790

SY   SHEF3; Shef-3; SHEF-3; Shef 3; SHEFF-3; AXORe003-A; UOSe003-A

DR   EFO; EFO_0005455

DR   hPSCreg; UOSe003-A

DR   ISCR; 1405

RX   PubMed=17572666;

RX   PubMed=20224972;

WW   http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_lines/available_human_cell_lines/laboratory_grade/shef-3.aspx

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=423

CC   From: University of Sheffield; Sheffield; UK.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0077.

CC   Registration: UK Stem Cell Bank (UKSCB); R-05-008, Steering comm. appl. SCSC04-24.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   Shef3.2

AC   CVCL_BW72

CC   Group: Clinical grade hESC cell line.

CC   From: University of Sheffield; Sheffield; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-34.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9790 ! Shef3

SX   Male

CA   Embryonic stem cell

//

ID   Shef4

AC   CVCL_9791

SY   SHEF4; Shef-4; SHEF-4; Shef 4; AXORe004-A

DR   hPSCreg; AXORe004-A

DR   ISCR; 1406

RX   PubMed=20224972;

CC   From: University of Sheffield; Sheffield; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); R-05-029, Steering comm. appl. SCSC05-22.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   Shef5

AC   CVCL_9792

SY   SHEF5; Shef-5; SHEF-5; Shef 5; AXORe005-A

DR   hPSCreg; AXORe005-A

DR   ISCR; 1407

RX   PubMed=20224972;

CC   From: University of Sheffield; Sheffield; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); R-08-009, Steering comm. appl. SCSC05-22.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   Shef6

AC   CVCL_9793

SY   SHEF6; Shef-6; SHEF-6; Shef 6; AXORe006-A; UOSe006-A

DR   hPSCreg; UOSe006-A

DR   ISCR; 1408

RX   PubMed=20224972;

WW   http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_lines/available_human_cell_lines/laboratory_grade/shef-6.aspx

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=424

CC   From: University of Sheffield; Sheffield; UK.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0078.

CC   Registration: UK Stem Cell Bank (UKSCB); R-05-031, Steering comm. appl. SCSC05-23.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   Shef6.1

AC   CVCL_BW73

RX   PubMed=26607962;

CC   Group: Clinical grade hESC cell line.

CC   From: University of Sheffield; Sheffield; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-35.

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9793 ! Shef6

SX   Female

CA   Embryonic stem cell

//

ID   Shef7

AC   CVCL_9794

SY   SHEF7; Shef-7; SHEF-7; Shef 7; AXORe007-A

DR   hPSCreg; AXORe007-A

DR   ISCR; 1409

RX   PubMed=20224972;

WW   http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_lines/available_human_cell_lines/laboratory_grade/shef-7.aspx

CC   From: University of Sheffield; Sheffield; UK.

CC   From: Pfizer, Inc.

CC   Registration: UK Stem Cell Bank (UKSCB); R-07-008, Steering comm. appl. SCSC06-30.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   Shef8

AC   CVCL_9795

SY   SHEF8; Shef-8; Shef 8

DR   ISCR; 1410

RX   PubMed=20224972;

WW   http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_lines/available_human_cell_lines/laboratory_grade/shef-8.aspx

CC   From: University of Sheffield; Sheffield; UK.

CC   From: Pfizer, Inc.

CC   Registration: UK Stem Cell Bank (UKSCB); R-08-015, Steering comm. appl. SCSC07-31.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SHEP-SF

AC   CVCL_2A38

SY   SH-EP/SF

DR   EFO; EFO_0002857

RX   PubMed=15150091;

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0524 ! SH-EP

SX   Female

CA   Cancer cell line

//

ID   SHEP-TR-miR-17-92

AC   CVCL_EI12

DR   PRIDE; PRD000321

RX   PubMed=21145484;

CC   Characteristics: Transfected with a Tet-on system to induce the oncogenic miR-17-92 cluster with the addition of tetracycline to the culture medium.

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0524 ! SH-EP

SX   Female

CA   Cancer cell line

//

ID   SHER-I

AC   CVCL_M782

SY   SHER-1

DR   Cosmic; 1590842

RX   PubMed=15126569;

RX   PubMed=19424640;

RX   PubMed=22038905;

DI   NCIt; C3879; Thyroid gland medullary carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SHEFP-1

AC   CVCL_Z071

RX   DOI=10.1007/BF01404489;

CC   Group: Hybridoma fusion partner cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C97074; Hereditary spherocytosis

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6544 ! WIL2

SX   Male

CA   Transformed cell line

//

ID   SHF-1

AC   CVCL_6F89

SY   SheepsHead Fin-1

RX   DOI=10.1139/f78-081;

CC   Group: Fish cell line.

OX   NCBI_TaxID=119682; ! Archosargus probatocephalus

SX   Male

CA   Spontaneously immortalized cell line

//

ID   SHG [Channa]

AC   CVCL_6F90

SY   SnakeHead Gonad

RX   CelloPub=CLPUB00305;

CC   Group: Fish cell line.

OX   NCBI_TaxID=64152; ! Channa striata

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SHG [Verasper]

AC   CVCL_IN54

SY   Spotted Halibut Gill

RX   CelloPub=CLPUB00366;

CC   Group: Fish cell line.

CC   Doubling time: 43.6 hours (CelloPub=CLPUB00366).

OX   NCBI_TaxID=82366; ! Verasper variegatus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SHG-139

AC   CVCL_2H28

SY   SHG139; Suzhou Human Glioma-139

RX   PubMed=25879429;

RX   PubMed=25975682;

DI   NCIt; C4322; Fibrillary astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SHG-44

AC   CVCL_6728

SY   SHG 44; SHG44; Suzhou Human Glioma-44

DR   BTO; BTO:0003231

DR   CCRID; 3131C0001000700048

RX   DOI=10.3321/j.issn:1000-5404.2001.03.006;

RX   PubMed=6525937;

RX   PubMed=22038279;

RX   PubMed=25333456;

CC   Doubling time: 26.67 hours (PubMed=25333456).

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SHG-44/ADM

AC   CVCL_HF68

RX   PubMed=25333456;

CC   Doubling time: 32.22 hours (PubMed=25333456).

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC   Misspelling: 'SGH-44/ADM' in abstract and many part of text of PubMed=25333456.

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6728 ! SHG-44

CA   Cancer cell line

//

ID   SHH [Snakehead heart Japan]

AC   CVCL_R856

SY   SnakeHead Heart

RX   DOI=10.1577/1548-8667(1993)005<0137:EACOSC>2.3.CO;2;

RX   DOI=10.3147/jsfp.28.27;

CC   Group: Fish cell line.

OX   NCBI_TaxID=64152; ! Channa striata

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SHH [Snakehead heart Philippine]

AC   CVCL_6F91

SY   SnakeHead Heart

RX   CelloPub=CLPUB00305;

CC   Group: Fish cell line.

OX   NCBI_TaxID=64152; ! Channa striata

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   Shh Light II

AC   CVCL_2721

SY   Shh-Light II; Shh Light 2; Shh LIGHT 2; Shh Light2; Shh-L2

DR   CLO; CLO_0009010

DR   ATCC; CRL-2795

DR   ATCC; JHU-68

CC   Transfected with: UniProtKB; P27652; Renilla-type luciferase.

CC   Discontinued: ATCC; CRL-2795; true.

CC   Discontinued: ATCC; JHU-68; true.

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0594 ! NIH 3T3

SX   Male

CA   Spontaneously immortalized cell line

//

ID   SHH-1

AC   CVCL_IQ83

SY   ShowChwan-Hwang-Hu-1

RX   PubMed=17554590;

CC   Doubling time: 36 hours (PubMed=17554590).

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SHhES1

AC   CVCL_C732

SY   SJTUe001-A

DR   hPSCreg; SJTUe001-A

DR   ISCR; 1399

RX   PubMed=16319131;

CC   From: Shanghai Institutes for Biological Sciences; Shanghai; China.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SHhES2

AC   CVCL_C733

DR   ISCR; 584

RX   PubMed=20186511;

CC   From: Shanghai Institutes for Biological Sciences; Shanghai; China.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SHhES3

AC   CVCL_C734

DR   ISCR; 1400

RX   PubMed=20186511;

CC   From: Shanghai Institutes for Biological Sciences; Shanghai; China.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Embryonic stem cell

//

ID   SHhES4

AC   CVCL_C735

DR   ISCR; 1401

RX   PubMed=20186511;

CC   From: Shanghai Institutes for Biological Sciences; Shanghai; China.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Embryonic stem cell

//

ID   SHHT

AC   CVCL_S148

SY   SnakeHead HearT

RX   PubMed=15801161;

CC   Group: Fish cell line.

OX   NCBI_TaxID=64152; ! Channa striata

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SHI-1

AC   CVCL_2191

DR   BTO; BTO:0005745

DR   BioSample; SAMN03473459

DR   Cosmic; 1601065

DR   DSMZ; ACC-645

RX   PubMed=15951289;

CC   Doubling time: ~60-70 hours (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 9

ST   D16S539: 9,10

ST   D5S818: 12,13

ST   D7S820: 11,12

ST   TH01: 6,7

ST   TPOX: 8,9

ST   vWA: 17

DI   NCIt; C8263; Adult acute monocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Shi/FeT-1C

AC   CVCL_V314

DR   ATCC; CRL-11976

RX   Patent=US5846825;

CC   Discontinued: ATCC; CRL-11976; probable.

OX   NCBI_TaxID=9685; ! Felis catus

HI   CVCL_3686 ! FeT-1C

CA   Spontaneously immortalized cell line

//

ID   Shimozuma-1

AC   CVCL_F748

RX   PubMed=2579855;

CC   Characteristics: Infected by porcine retrovirus Tsukuba-1.

OX   NCBI_TaxID=9823; ! Sus scrofa

CA   Cancer cell line

//

ID   SHIN-3

AC   CVCL_A670

SY   SHIN3; Shin3

DR   Cosmic; 877481

DR   Cosmic; 945374

DR   Cosmic; 1152561

DR   Cosmic; 1526883

DR   GEO; GSM459739

RX   CelloPub=CLPUB00115;

RX   DOI=10.5795/jjscc.27.926;

RX   PubMed=2314830;

RX   PubMed=2469292;

RX   PubMed=8718548;

RX   PubMed=15677628;

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SHIN-3/PTEN

AC   CVCL_W128

RX   PubMed=18347155;

CC   Transfected with: HGNC; 9588; PTEN.

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_A670 ! SHIN-3

SX   Female

CA   Cancer cell line

//

ID   ShiPS-miFF1

AC   CVCL_1E69

SY   ShiPS-MIFF1; MIFF1; MIFF-1; UOSi001-A

DR   hPSCreg; UOSi001-A

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2769 ! CCD-1112Sk

SX   Male

CA   Induced pluripotent stem cell

//

ID   ShiPS-miFF3

AC   CVCL_1E70

SY   ShiPS-MIFF3; MIFF3; MIFF-3; UOSi001-B

DR   hPSCreg; UOSi001-B

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2769 ! CCD-1112Sk

SX   Male

CA   Induced pluripotent stem cell

//

ID   SHJO

AC   CVCL_E827

SY   SH.JO; SMJ

DR   dbMHC; 49018

DR   ECACC; 94022547

DR   IHW; IHW9239

DR   IMGT/HLA; 11384

WW   http://bioinformatics.hsanmartino.it/ecbr/cl239.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SHK [Halibut]

AC   CVCL_W850

SY   Spotted Halibut Kidney

RX   DOI=10.1007/s11802-010-0162-1;

CC   Group: Fish cell line.

OX   NCBI_TaxID=82366; ! Verasper variegatus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SHK [Snakehead]

AC   CVCL_6F92

SY   SnakeHead Kidney

RX   CelloPub=CLPUB00305;

CC   Group: Fish cell line.

OX   NCBI_TaxID=64152; ! Channa striata

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SHK-1

AC   CVCL_4299

SY   SHK1; Salmon Head Kidney-1

DR   ECACC; 97111106

RX   DOI=10.1006/fsim.1996.0076;

RX   PubMed=7782764;

RX   PubMed=15825496;

RX   PubMed=19162334;

CC   Group: Fish cell line.

OX   NCBI_TaxID=8030; ! Salmo salar

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SHL

AC   CVCL_6F93

SY   SnakeHead Liver

RX   CelloPub=CLPUB00305;

CC   Group: Fish cell line.

OX   NCBI_TaxID=64152; ! Channa striata

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SHM-D33

AC   CVCL_3419

SY   SHMD-33; SHMD33; D-33

DR   CLO; CLO_0009011

DR   CLDB; cl4294

DR   CLDB; cl4295

DR   ATCC; CRL-1668

DR   ICLC; ATL94001

DR   RCB; RCB0267

RX   PubMed=6316357;

CC   Group: Hybridoma fusion partner cell line.

CC   Discontinued: RCB; RCB0267; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

HI   CVCL_J236 ! FU-266 clone E1

CA   Hybrid cell line

//

ID   Shmac 1

AC   CVCL_AR57

DR   ECACC; 11102001

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6].

ST   Source(s): ECACC

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 8,9

ST   D16S539: 12

ST   D5S818: 10,12

ST   D7S820: 7,10

ST   TH01: 6,9.3

ST   TPOX: 8,9

ST   vWA: 16,17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   Shmac 2

AC   CVCL_F280

RX   PubMed=17163777;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6].

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   Shmac 3

AC   CVCL_F281

RX   PubMed=17163777;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6].

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   Shmac 4

AC   CVCL_2722

DR   ECACC; 10112302

RX   PubMed=17163777;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6].

ST   Source(s): ECACC

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 11,14

ST   D5S818: 12,13

ST   D7S820: 7,10

ST   TH01: 7,9

ST   TPOX: 8

ST   vWA: 17,19

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   Shmac 5

AC   CVCL_2723

DR   ECACC; 10112303

RX   PubMed=17163777;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6].

ST   Source(s): ECACC

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 12,13

ST   D16S539: 11,12

ST   D5S818: 12,14

ST   D7S820: 7,12

ST   TH01: 6,9.3

ST   TPOX: 8,12

ST   vWA: 15,17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   Shmac 6

AC   CVCL_F282

RX   PubMed=17163777;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6].

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SHMS

AC   CVCL_S149

SY   SnakeHead MuScle

RX   PubMed=15801161;

CC   Group: Fish cell line.

OX   NCBI_TaxID=64152; ! Channa striata

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SHOK

AC   CVCL_3164

SY   Syrian Hamster Osaka-Kanazawa cells

DR   CLO; CLO_0009012

DR   CLDB; cl4296

DR   ECACC; 90071805

DR   IFO; IFO50367

DR   RCB; RCB0453

RX   PubMed=2181436;

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

HI   CVCL_8153 ! GHE-L

CA   Spontaneously immortalized cell line

//

ID   Shox2

AC   CVCL_2Z99

DR   ATCC; CRL-3256

RX   PubMed=23877224;

CC   Breed/subspecies: 129S1/SvImJ.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_C316 ! CJ7

SX   Male

CA   Finite cell line

//

ID   SHP-77

AC   CVCL_1693

SY   SHP77; Shadyside Hospital Pittsburgh-77

DR   BTO; BTO:0003726

DR   CLO; CLO_0009013

DR   EFO; EFO_0002328

DR   ATCC; CRL-2195

DR   BioSample; SAMN03472563

DR   CCLE; SHP77_LUNG

DR   ChEMBL-Cells; CHEMBL3308363

DR   ChEMBL-Targets; CHEMBL612569

DR   Cosmic; 724872

DR   Cosmic; 844577

DR   Cosmic; 877392

DR   Cosmic; 1152487

DR   Cosmic; 1759309

DR   Cosmic; 1995626

DR   Cosmic; 2125288

DR   Cosmic; 2239081

DR   Cosmic-CLP; 724872

DR   ECACC; 98110201

DR   GDSC; 724872

DR   GEO; GSM169447

DR   GEO; GSM887569

DR   GEO; GSM888652

DR   GEO; GSM1374870

DR   IGRhCellID; SHP77

RX   PubMed=212181;

RX   PubMed=7736387;

RX   PubMed=9559344;

RX   PubMed=9815546;

RX   PubMed=22460905;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 96 hours (ECACC).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; ECACC

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8

ST   D16S539: 11

ST   D5S818: 12

ST   D7S820: 11

ST   TH01: 7

ST   TPOX: 9,11

ST   vWA: 16

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   sHPT-1

AC   CVCL_0I22

RX   PubMed=17126301;

DI   NCIt; C3630; Benign parathyroid gland neoplasm

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SHS

AC   CVCL_6F94

SY   SnakeHead Spleen

RX   CelloPub=CLPUB00305;

CC   Group: Fish cell line.

OX   NCBI_TaxID=64152; ! Channa striata

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SHSB

AC   CVCL_S150

SY   SnakeHead Swim Bladder

RX   PubMed=15801161;

CC   Group: Fish cell line.

OX   NCBI_TaxID=64152; ! Channa striata

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SHT-1

AC   CVCL_IQ81

SY   ShowChwan-Hwang-Tsai-1

RX   PubMed=17554590;

CC   Doubling time: 39 hours (PubMed=17554590).

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SHT290

AC   CVCL_G213

RX   PubMed=15772261;

CC   Transfected with: HGNC; 11730; TERT.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Telomerase immortalized cell line

//

ID   SHY

AC   CVCL_E828

DR   dbMHC; 49019

DR   IHW; IHW9379

DR   IMGT/HLA; 25988

CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   SHZ-88

AC   CVCL_7163

DR   CCRID; 3131C0001001000005

DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Female

CA   Cancer cell line

//

ID   Si-1

AC   CVCL_3165

DR   JCRB; JCRB1369

RX   PubMed=6122826;

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).

OX   NCBI_TaxID=9543; ! Macaca fuscata fuscata

CA   Transformed cell line

//

ID   Si-2

AC   CVCL_3166

DR   JCRB; JCRB1321

RX   PubMed=6309601;

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 33747; Simian T-lymphotropic virus 1 (STLV-1).

OX   NCBI_TaxID=9543; ! Macaca fuscata fuscata

SX   Male

CA   Transformed cell line

//

ID   Si-IIA

AC   CVCL_X690

RX   PubMed=2118885;

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 11909; Human T-lymphotropic virus 2 (HTLV-2).

OX   NCBI_TaxID=9541; ! Macaca fascicularis

SX   Male

CA   Transformed cell line

//

ID   SI-PMEC

AC   CVCL_W953

SY   Spontaneously Immortalized-Porcine Mammary Epithelial Cell line

RX   PubMed=16919976;

CC   Breed/subspecies: Landrace.

OX   NCBI_TaxID=9823; ! Sus scrofa

SX   Female

CA   Spontaneously immortalized cell line

//

ID   SIA

AC   CVCL_F582

SY   TER197

DR   IMGT/HLA; 12184

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SIB-1

AC   CVCL_S924

RX   PubMed=8039117;

DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SIB186

AC   CVCL_F406

DR   CLO; CLO_0051119

DR   RCB; HSC0096

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SICE

AC   CVCL_R922

SY   Sahul Indian Catla Eye

RX   DOI=10.1111/j.1095-8649.2008.01851.x;

WW   http://mail.nbfgr.res.in/nrfc/celldetail.php?id=18

CC   Group: Fish cell line.

CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC018.

OX   NCBI_TaxID=72446; ! Gibelion catla

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SICH

AC   CVCL_R811

SY   Sahul Indian Catla Heart

RX   DOI=10.1016/j.aquaculture.2009.05.012;

WW   http://mail.nbfgr.res.in/nrfc/celldetail.php?id=19

CC   Group: Fish cell line.

CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC019.

OX   NCBI_TaxID=72446; ! Gibelion catla

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SIE-EO-801

AC   CVCL_AV41

RX   CelloPub=CLPUB00312;

CC   Group: Insect cell line.

OX   NCBI_TaxID=248899; ! Ectropis obliqua

SX   Female

CA   Spontaneously immortalized cell line

//

ID   SIE-EO-803

AC   CVCL_AV42

RX   CelloPub=CLPUB00312;

CC   Group: Insect cell line.

OX   NCBI_TaxID=248899; ! Ectropis obliqua

SX   Female

CA   Spontaneously immortalized cell line

//

ID   SIE-Ha-798

AC   CVCL_Z954

RX   CelloPub=CLPUB00212;

CC   Group: Insect cell line.

OX   NCBI_TaxID=29058; ! Helicoverpa armigera

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SIE-Ha-806

AC   CVCL_Z955

RX   CelloPub=CLPUB00212;

CC   Group: Insect cell line.

OX   NCBI_TaxID=29058; ! Helicoverpa armigera

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SIG-M5

AC   CVCL_1694

SY   SigM5; SIGM5

DR   CLO; CLO_0009016

DR   EFO; EFO_0006751

DR   BioSample; SAMN03473111

DR   BioSample; SAMN03473559

DR   CCLE; SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   ChEMBL-Cells; CHEMBL3308248

DR   ChEMBL-Targets; CHEMBL2366251

DR   Cosmic; 787476

DR   Cosmic; 975299

DR   Cosmic; 909715

DR   Cosmic; 1012117

DR   Cosmic; 1281352

DR   Cosmic; 1465968

DR   Cosmic; 2131558

DR   Cosmic; 2306238

DR   Cosmic-CLP; 909715

DR   DSMZ; ACC-468

DR   GDSC; 909715

DR   GEO; GSM887571

DR   GEO; GSM888654

DR   GEO; GSM1374871

DR   GEO; GSM1670421

RX   PubMed=10848831;

RX   PubMed=15843827;

RX   PubMed=16408098;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~72 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11,12

ST   D16S539: 11,12

ST   D18S51: 15,16,18

ST   D21S11: 29,32.2

ST   D3S1358: 18

ST   D5S818: 11,13

ST   D7S820: 9,11 (Cosmic-CLP; PubMed=25877200)

ST   D7S820: 9 (DSMZ)

ST   D8S1179: 14,16

ST   FGA: 22,26

ST   Penta D: 10,13

ST   Penta E: 7,19

ST   TH01: 7,9.3

ST   TPOX: 8,11

ST   vWA: 17,19

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SIGC

AC   CVCL_6729

SY   Spontaneously Immortalized Granulosa Cell line

RX   PubMed=1845958;

RX   PubMed=15541573;

CC   Breed/subspecies: Berlin Duckrey (BD IV).

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Female

CA   Spontaneously immortalized cell line

//

ID   SIGE

AC   CVCL_R923

SY   Sahul Indian Grouper Eye

RX   PubMed=17216384;

WW   http://mail.nbfgr.res.in/nrfc/celldetail.php?id=16

CC   Group: Fish cell line.

CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC016.

OX   NCBI_TaxID=94232; ! Epinephelus coioides

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SIGi001-A

AC   CVCL_EE38

SY   iPSC0028; IPSC0028; iPSC Epithelial-1; iPSC EPITHELIAL-1

WW   http://www.sigmaaldrich.com/catalog/product/sigma/ipsc0028

ST   Source(s): Sigma-Aldrich

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8,12

ST   D16S539: 11,12

ST   D5S818: 12,13

ST   D7S820: 8,11

ST   TH01: 9,9.3

ST   TPOX: 8,9

ST   vWA: 16

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   SIGi001-A-1

AC   CVCL_EF83

SY   iPSC0028 SLC17A7/GFP E3

DR   BioSamples; SAMEA4451096

DR   EBiSC; SIGi001-A-1

DR   ECACC; 66540356

DR   hPSCreg; SIGi001-A-1

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_EE38 ! SIGi001-A

SX   Female

CA   Induced pluripotent stem cell

//

ID   SIGi001-A-10

AC   CVCL_II92

SY   iPSC0028 MAPT P301S+Ex10+16/Clone 7G4A8

DR   BioSamples; SAMEA4451117

DR   EBiSC; SIGi001-A-10

DR   ECACC; 66540358

DR   hPSCreg; SIGi001-A-10

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_EE38 ! SIGi001-A

SX   Female

CA   Induced pluripotent stem cell

//

ID   SIGi001-A-2

AC   CVCL_II91

SY   iPSC0028 SLC17A7/GFP C3

DR   BioSamples; SAMEA4451116

DR   EBiSC; SIGi001-A-2

DR   ECACC; 66540357

DR   hPSCreg; SIGi001-A-2

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_EE38 ! SIGi001-A

SX   Female

CA   Induced pluripotent stem cell

//

ID   SIGi001-A-3

AC   CVCL_EF84

SY   iPSC0028 MAPT P301L C4

DR   BioSamples; SAMEA4448571

DR   EBiSC; SIGi001-A-3

DR   ECACC; 66540331

DR   hPSCreg; SIGi001-A-3

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_EE38 ! SIGi001-A

SX   Female

CA   Induced pluripotent stem cell

//

ID   SIGi001-A-4

AC   CVCL_EF85

SY   iPSC0028 MAPT P301L D4

DR   BioSamples; SAMEA4448632

DR   EBiSC; SIGi001-A-4

DR   ECACC; 66540332

DR   hPSCreg; SIGi001-A-4

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_EE38 ! SIGi001-A

SX   Female

CA   Induced pluripotent stem cell

//

ID   SIGi001-A-5

AC   CVCL_EF86

SY   iPSC0028 MAPT P301S 1C9C4

DR   BioSamples; SAMEA4448708

DR   EBiSC; SIGi001-A-5

DR   ECACC; 66540333

DR   hPSCreg; SIGi001-A-5

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_EE38 ! SIGi001-A

SX   Female

CA   Induced pluripotent stem cell

//

ID   SIGi001-A-6

AC   CVCL_EF87

SY   iPSC0028 MAPT P301S 1B9C9

DR   BioSamples; SAMEA4447426

DR   EBiSC; SIGi001-A-6

DR   ECACC; 66540326

DR   hPSCreg; SIGi001-A-6

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_EE38 ! SIGi001-A

SX   Female

CA   Induced pluripotent stem cell

//

ID   SIGi001-A-7

AC   CVCL_EF88

SY   iPSC0028 MAPT P301S 2G2B7

DR   BioSamples; SAMEA4448730

DR   EBiSC; SIGi001-A-7

DR   ECACC; 66540334

DR   hPSCreg; SIGi001-A-7

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_EE38 ! SIGi001-A

SX   Female

CA   Induced pluripotent stem cell

//

ID   SIGi001-A-8

AC   CVCL_EF89

SY   iPSC0028 MAPT P301S+Ex10+16/Clone 7D11A7

DR   BioSamples; SAMEA4448777

DR   EBiSC; SIGi001-A-8

DR   ECACC; 66540335

DR   hPSCreg; SIGi001-A-8

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_EE38 ! SIGi001-A

SX   Female

CA   Induced pluripotent stem cell

//

ID   SIGi001-A-9

AC   CVCL_EF90

SY   iPSC0028 MAPT P301S+Ex10+16/Clone 7H6A1

DR   BioSamples; SAMEA4447499

DR   EBiSC; SIGi001-A-9

DR   ECACC; 66540327

DR   hPSCreg; SIGi001-A-9

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_EE38 ! SIGi001-A

SX   Female

CA   Induced pluripotent stem cell

//

ID   SiHa

AC   CVCL_0032

SY   Siha; SIHA

DR   BTO; BTO:0002210

DR   CLO; CLO_0009017

DR   EFO; EFO_0002379

DR   MCCL; MCC:0000451

DR   CLDB; cl4298

DR   CLDB; cl4299

DR   CLDB; cl4900

DR   ATCC; HTB-35

DR   BioSample; SAMN03473215

DR   CCRID; 3111C0001CCC000294

DR   CCRID; 3131C0001000700113

DR   CCRID; 3142C0001000000089

DR   ChEMBL-Cells; CHEMBL3307968

DR   ChEMBL-Targets; CHEMBL612542

DR   Cosmic; 760220

DR   Cosmic; 809229

DR   Cosmic; 846184

DR   Cosmic; 877467

DR   Cosmic; 925356

DR   Cosmic; 928911

DR   Cosmic; 930297

DR   Cosmic; 1019306

DR   Cosmic; 1131517

DR   Cosmic; 1193028

DR   Cosmic; 1201773

DR   Cosmic; 1324212

DR   Cosmic; 1995627

DR   Cosmic; 2301542

DR   Cosmic-CLP; 930297

DR   GDSC; 930297

DR   GEO; GSM113866

DR   GEO; GSM226740

DR   GEO; GSM226876

DR   GEO; GSM253302

DR   GEO; GSM675738

DR   GEO; GSM685444

DR   GEO; GSM723057

DR   GEO; GSM723058

DR   GEO; GSM1670422

DR   ICLC; HTL98017

DR   IGRhCellID; SiHa

DR   IZSLER; BS TCL 112

DR   KCB; KCB 2013026YJ

DR   KCLB; 30035

DR   TOKU-E; 3119

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=2990217;

RX   PubMed=3029430;

RX   PubMed=3029760;

RX   PubMed=5529598;

RX   PubMed=15531914;

RX   PubMed=17311676;

RX   PubMed=21439369;

RX   PubMed=23881600;

RX   PubMed=25485619;

RX   PubMed=27397505;

WW   http://www.proteinatlas.org/learn/cellines

WW   http://www.addexbio.com/productdetail?pid=372

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-22.html

CC   Characteristics: Contains a complete HPV16 genome with a disruption of the E2 region and a small deletion.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).

CC   Omics: CNV analysis.

CC   Omics: Deep antibody staining analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

ST   Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 12

ST   D18S51: 15

ST   D21S11: 29,31

ST   D3S1358: 16,17

ST   D5S818: 9

ST   D7S820: 10

ST   D8S1179: 13,16

ST   FGA: 21

ST   Penta D: 9,12

ST   Penta E: 10,12

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 14,17

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SiHa-NTRpuro

AC   CVCL_X529

RX   PubMed=14997211;

CC   Characteristics: Contains a complete HPV16 genome with a disruption of the E2 region and a small deletion.

CC   Transfected with: UniProtKB; P38489; E.coli nitroreductase nfnB.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0032 ! SiHa

SX   Female

CA   Cancer cell line

//

ID   SiHa/cDDP

AC   CVCL_K031

RX   PubMed=22650020;

CC   Characteristics: Contains a complete HPV16 genome with a disruption of the E2 region and a small deletion.

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0032 ! SiHa

SX   Female

CA   Cancer cell line

//

ID   SIHN-005A

AC   CVCL_W318

RX   PubMed=10760816;

RX   PubMed=11497283;

RX   PubMed=12124801;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W319 ! SIHN-005B

SX   Male

CA   Cancer cell line

//

ID   SIHN-005B

AC   CVCL_W319

RX   PubMed=10760816;

RX   PubMed=11497283;

RX   PubMed=12124801;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W318 ! SIHN-005A

SX   Male

CA   Cancer cell line

//

ID   SIHN-006

AC   CVCL_H947

SY   SI-HN-006; HN006

DR   ChEMBL-Cells; CHEMBL3308668

DR   ChEMBL-Targets; CHEMBL614827

RX   PubMed=10760816;

RX   PubMed=11497283;

RX   PubMed=15197768;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SIHN-008

AC   CVCL_W320

RX   PubMed=10760816;

RX   PubMed=11497283;

RX   PubMed=12124801;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SIHN-011A

AC   CVCL_W321

RX   PubMed=10760816;

RX   PubMed=11497283;

RX   PubMed=12124801;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W322 ! SIHN-011B

CA   Cancer cell line

//

ID   SIHN-011B

AC   CVCL_W322

RX   PubMed=10760816;

RX   PubMed=11497283;

RX   PubMed=12124801;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W321 ! SIHN-011A

CA   Cancer cell line

//

ID   SIHN-013

AC   CVCL_W323

RX   PubMed=10760816;

RX   PubMed=11497283;

RX   PubMed=12124801;

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W325 ! SIHN-13/2

CA   Cancer cell line

//

ID   SIHN-015B

AC   CVCL_W324

RX   PubMed=10760816;

RX   PubMed=11497283;

RX   PubMed=12124801;

DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SIHN-034B

AC   CVCL_W326

RX   PubMed=10760816;

RX   PubMed=11497283;

RX   PubMed=12124801;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SIHN-13/2

AC   CVCL_W325

RX   PubMed=10760816;

RX   PubMed=11497283;

RX   PubMed=12124801;

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W323 ! SIHN-013

CA   Cancer cell line

//

ID   SIK

AC   CVCL_D525

RX   PubMed=7949178;

RX   PubMed=10936422;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SIKR

AC   CVCL_5T83

RX   PubMed=4416368;

RX   PubMed=4672577;

CC   Breed/subspecies: 129/Sv-SlJ-CP.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Cancer cell line

//

ID   SIKR-OSB

AC   CVCL_5T84

RX   PubMed=650144;

CC   Breed/subspecies: 129/Sv-SlJ-CP.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_5T83 ! SIKR

SX   Male

CA   Cancer cell line

//

ID   SIL-6/1

AC   CVCL_U118

DR   CLO; CLO_0050547

DR   RCB; RCB1792

CC   Characteristics: IL6 or KITLG dependent.

CC   Breed/subspecies: C3H/He.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_N545 ! A-6

SX   Male

CA   Factor-dependent cell line

//

ID   Silfere

AC   CVCL_W936

SY   NK9c; NK-9; NK 9

DR   CGH-DB; 9202-4

DR   Cosmic; 931133

RX   PubMed=4174339;

RX   PubMed=4178827;

RX   PubMed=4320167;

RX   PubMed=4321974;

RX   PubMed=5786183;

RX   PubMed=9473234;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SIM-A9

AC   CVCL_5I31

DR   ATCC; CRL-3265

RX   PubMed=24975292;

WW   https://www.kerafast.com/product/2118/microglial-cell-line-sim-a9

CC   Doubling time: 2-3 days (Kerafast).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   SIM/EW27

AC   CVCL_0097

SY   SIM(EW27); SIM-EW27; SIMON; Simon; SIM

DR   Cosmic; 721018

CC   From: Delattre O.; Institut Curie; Paris; France.

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SIM.2

AC   CVCL_1Y14

DR   NIH-ARP; 511-27

CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   SIM.4

AC   CVCL_1Y15

DR   NIH-ARP; 512-23

CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   SiMa

AC   CVCL_1695

SY   SIMA

DR   CLO; CLO_0009018

DR   CLDB; cl4300

DR   BioSample; SAMN03470930

DR   CCLE; SIMA_AUTONOMIC_GANGLIA

DR   ChEMBL-Cells; CHEMBL3308828

DR   ChEMBL-Targets; CHEMBL2366067

DR   Cosmic; 753620

DR   Cosmic; 2485949

DR   Cosmic-CLP; 753620

DR   DSMZ; ACC-164

DR   GDSC; 753620

DR   GEO; GSM563363

DR   GEO; GSM887572

DR   GEO; GSM888655

DR   GEO; GSM1366410

DR   GEO; GSM1670423

RX   PubMed=10686945;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~34-100 hours, highly variable (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 12

ST   D16S539: 12,13

ST   D18S51: 14,16

ST   D19S433: 13,14

ST   D21S11: 28

ST   D2S1338: 19,21

ST   D3S1358: 18

ST   D5S818: 11

ST   D7S820: 10

ST   D8S1179: 13,14

ST   FGA: 20,22

ST   Penta D: 14

ST   Penta E: 11,12

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 15,17

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SIMH

AC   CVCL_R924

SY   Sahul Indian Milkfish Heart

RX   PubMed=17216384;

CC   Group: Fish cell line.

OX   NCBI_TaxID=29144; ! Chanos chanos

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SINJ

AC   CVCL_M783

SY   SIN-J

DR   Cosmic; 1590843

RX   PubMed=12089864;

RX   PubMed=15126569;

RX   PubMed=21573635;

RX   PubMed=22038905;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3879; Thyroid gland medullary carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SIPS

AC   CVCL_DF10

SY   Spontaneously Immortalized Pancreatic Stellate cell line

RX   PubMed=14669327;

CC   Breed/subspecies: Wistar.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Spontaneously immortalized cell line

//

ID   SIRC

AC   CVCL_2724

SY   Sirc; Statens Seruminstitut Rabbit Cornea

DR   BTO; BTO:0004495

DR   CLO; CLO_0009019

DR   CLO; CLO_0009020

DR   CLO; CLO_0050407

DR   CLDB; cl4301

DR   CLDB; cl4302

DR   CLDB; cl4304

DR   CLDB; cl4305

DR   CLDB; cl4306

DR   CLDB; cl4307

DR   ATCC; CCL-60

DR   ATCC; CRL-6595

DR   BCRC; 60093

DR   BCRJ; 0224

DR   ECACC; 89090404

DR   ICLC; AL96001

DR   IFO; IFO50020

DR   IZSLER; BS CL 79

DR   JCRB; JCRB9122

DR   Lonza; 1197

DR   RCB; RCB1835

DR   TOKU-E; 3120

RX   PubMed=2228906;

RX   PubMed=6500159;

WW   http://www.rccc.cytspb.rssi.ru/ecellbank/animal/asirc.htm

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6595; true.

OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus

CA   Spontaneously immortalized cell line

//

ID   SISE

AC   CVCL_S946

SY   Sahul India Seabass Embryonic

RX   PubMed=16919787;

CC   Group: Fish cell line.

OX   NCBI_TaxID=8187; ! Lates calcarifer

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SISK

AC   CVCL_M424

SY   Sahul India Seabass Kidney

RX   DOI=10.1016/j.aquaculture.2006.01.011;

WW   http://mail.nbfgr.res.in/nrfc/celldetail.php?id=14

CC   Group: Fish cell line.

CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC014.

OX   NCBI_TaxID=8187; ! Lates calcarifer

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SiSo

AC   CVCL_2193

SY   SISO

DR   CLO; CLO_0009021

DR   BioSample; SAMN03470956

DR   BioSample; SAMN03473350

DR   ChEMBL-Cells; CHEMBL3307272

DR   ChEMBL-Targets; CHEMBL613527

DR   Cosmic; 1995628

DR   Cosmic-CLP; 1240212

DR   DSMZ; ACC-327

DR   GDSC; 1240212

DR   GEO; GSM1670424

RX   PubMed=21556646;

RX   PubMed=27397505;

CC   Doubling time: ~35 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11

ST   D16S539: 9

ST   D18S51: 14,16

ST   D19S433: 14,16.2

ST   D21S11: 30,31

ST   D2S1338: 19

ST   D3S1358: 15

ST   D5S818: 9,12

ST   D7S820: 11,12

ST   D8S1179: 12

ST   FGA: 23

ST   Penta D: 11,13

ST   Penta E: 11,13

ST   TH01: 7,9 (Cosmic-CLP; DSMZ)

ST   TH01: 7 (PubMed=25877200)

ST   TPOX: 11

ST   vWA: 18

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SISS

AC   CVCL_R812

SY   Sahul Indian Seabass Spleen

RX   DOI=10.1016/j.aquaculture.2006.07.034;

WW   http://mail.nbfgr.res.in/nrfc/celldetail.php?id=15

CC   Group: Fish cell line.

CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC015.

OX   NCBI_TaxID=8187; ! Lates calcarifer

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SJ-89

AC   CVCL_S860

RX   PubMed=11229593;

DI   NCIt; C5250; Signet ring cell gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SJ-GBM2

AC   CVCL_M141

SY   SJ-G2; SJG2

RX   PubMed=7634381;

RX   PubMed=9220028;

WW   http://www.cogcell.org/dl/BrainTumorDataSheets/SJ-GBM2_Cell_Line_Data_Sheet_COGcell_org.pdf

WW   http://www.cogcell.org/cellreqs-ncipptp.php

WW   http://www.pptpinvitro.org/cell_lines_panel.php

CC   Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.

ST   Source(s): COG

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11,12

ST   D16S539: 11

ST   D18S51: 16,17

ST   D19S433: 12,14

ST   D2S1338: 17,24

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 12

ST   D8S1179: 8,12

ST   FGA: 24

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SJ-N-CG

AC   CVCL_Y141

DR   CGH-DB; 76-1

DR   CGH-DB; 9102-4

RX   PubMed=11129446;

RX   PubMed=12702577;

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SJ-N-KP

AC   CVCL_4608

DR   CLO; CLO_0009029

DR   CLDB; cl4308

DR   CGH-DB; 60-1

DR   CGH-DB; 9092-4

RX   DOI=10.1007/0-306-46872-7_2;

RX   PubMed=12702577;

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   SJ-S6

AC   CVCL_AQ32

RX   PubMed=9220028;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SJ3.6

AC   CVCL_B463

RX   PubMed=9819136;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   SJD.1

AC   CVCL_5895

SY   SJD1

DR   CLO; CLO_0009022

DR   ATCC; CRL-2296

RX   PubMed=9891354;

CC   Group: Fish cell line.

CC   Breed/subspecies: SJD.

OX   NCBI_TaxID=7955; ! Danio rerio

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SJES-1

AC   CVCL_5168

DR   Cosmic; 1104563

DR   GEO; GSM393029

DR   IGRhCellID; SJES1%20GEO

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SJES-2

AC   CVCL_5169

DR   Cosmic; 801763

DR   Cosmic; 1104564

DR   GEO; GSM393030

DR   IGRhCellID; SJES2%20GEO

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SJES-3

AC   CVCL_5170

DR   Cosmic; 801764

DR   Cosmic; 1104565

DR   GEO; GSM393031

DR   IGRhCellID; SJES3%20GEO

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SJES-4

AC   CVCL_A459

DR   Cosmic; 1104566

DR   IGRhCellID; SJES4%20GEO

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SJES-5

AC   CVCL_5171

DR   Cosmic; 801765

DR   Cosmic; 1104567

DR   GEO; GSM393032

DR   IGRhCellID; SJES5%20GEO

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SJES-6

AC   CVCL_5172

DR   Cosmic; 801766

DR   Cosmic; 1104568

DR   GEO; GSM393033

DR   IGRhCellID; SJES6%20GEO

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SJES-7

AC   CVCL_5173

DR   Cosmic; 801767

DR   GEO; GSM393034

DR   IGRhCellID; SJES7%20GEO

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SJES-8

AC   CVCL_5174

DR   Cosmic; 801768

DR   GEO; GSM393035

DR   IGRhCellID; SJES8%20GEO

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SJK-132-20

AC   CVCL_4300

SY   SJK 132-20

DR   CLO; CLO_0009023

DR   ATCC; CRL-1640

DR   ATCC; TIB-177

DR   ECACC; 88041903

RX   PubMed=7085672;

CC   Monoclonal antibody target: UniProtKB; P09884; Human POLA1.

CC   Discontinued: ATCC; TIB-177; true.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   SJK-237-71

AC   CVCL_4301

SY   SJK 237-71

DR   CLO; CLO_0009024

DR   ATCC; CRL-1645

DR   ATCC; TIB-178

DR   JCRB; JCRB9032

RX   PubMed=7085672;

CC   Monoclonal antibody target: UniProtKB; P09884; Human POLA1.

CC   Discontinued: ATCC; TIB-178; true.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   SJK-287-38

AC   CVCL_4302

SY   SJK 287-38

DR   CLO; CLO_0009025

DR   ATCC; CRL-1644

DR   ATCC; TIB-179

DR   ECACC; 90112228

RX   PubMed=7085672;

CC   Monoclonal antibody target: UniProtKB; P09884; Human POLA1.

CC   Discontinued: ATCC; TIB-179; true.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   SJL/JA

AC   CVCL_S359

DR   ATCC; CRL-6451

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6451; true.

CC   Breed/subspecies: SJL/J.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Finite cell line

//

ID   SJL/JB

AC   CVCL_5896

DR   CLO; CLO_0009026

DR   ATCC; CRL-6452

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6452; true.

CC   Breed/subspecies: SJL/J.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Finite cell line

//

ID   SJL/JC

AC   CVCL_5897

DR   CLO; CLO_0009027

DR   ATCC; CRL-6453

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6453; true.

CC   Breed/subspecies: SJL/J.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Finite cell line

//

ID   SJMRF

AC   CVCL_4303

DR   CLO; CLO_0009028

DR   CLDB; cl4309

DR   ATCC; CRL-6072

DR   ECACC; 92020421

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6072; true.

OX   NCBI_TaxID=9901; ! Bison bison

SX   Sex undetermined

CA   Finite cell line

//

ID   SJNB-1

AC   CVCL_8812

SY   SJ-NB-1; SJNB1; SJNB-1(EB); NB1

DR   ChEMBL-Cells; CHEMBL3308822

DR   ChEMBL-Targets; CHEMBL2366284

DR   Cosmic; 947712

DR   Cosmic; 1037331

DR   Cosmic; 1099128

DR   Cosmic; 1109106

DR   Cosmic; 1153792

DR   Cosmic; 1518073

DR   Cosmic; 1526641

DR   Cosmic; 2131598

DR   Cosmic; 2239468

DR   GEO; GSM314019

DR   GEO; GSM333806

DR   GEO; GSM692870

RX   DOI=10.1007/0-306-46872-7_2;

RX   PubMed=7838528;

RX   PubMed=8516298;

RX   PubMed=10935473;

RX   PubMed=11550280;

RX   PubMed=18923524;

RX   PubMed=22213050;

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SJNB-10

AC   CVCL_1441

SY   SJ-NB-10; SJNB10; NB10; NB10-DH

DR   ChEMBL-Cells; CHEMBL3308172

DR   ChEMBL-Targets; CHEMBL2366243

DR   Cosmic; 688069

DR   Cosmic; 949171

DR   Cosmic; 1109121

DR   Cosmic; 1518076

DR   Cosmic; 1526644

DR   Cosmic; 1543770

DR   Cosmic; 2239458

DR   Cosmic-CLP; 949171

DR   GDSC; 949171

DR   GEO; GSM692861

DR   GEO; GSM1670146

RX   DOI=10.1007/0-306-46872-7_2;

RX   PubMed=8516298;

RX   PubMed=10935473;

RX   PubMed=22213050;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 11,12

ST   D5S818: 11

ST   D7S820: 11,12

ST   TH01: 6

ST   TPOX: 8,10

ST   vWA: 16,17

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SJNB-11

AC   CVCL_8813

SY   SJNB11; NB11; NB11-DH

DR   Cosmic; 688070

RX   PubMed=10935473;

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SJNB-12

AC   CVCL_1442

SY   SJ-NB-12; SJNB12; NB12

DR   ChEMBL-Cells; CHEMBL3308173

DR   ChEMBL-Targets; CHEMBL2366285

DR   Cosmic; 949172

DR   Cosmic; 1109107

DR   Cosmic; 1518077

DR   Cosmic; 1526645

DR   Cosmic; 2239457

DR   Cosmic-CLP; 949172

DR   GDSC; 949172

DR   GEO; GSM692857

DR   GEO; GSM1670147

RX   DOI=10.1007/0-306-46872-7_2;

RX   PubMed=7838528;

RX   PubMed=9516836;

RX   PubMed=10935473;

RX   PubMed=11550280;

RX   PubMed=22213050;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 12

ST   D16S539: 11

ST   D5S818: 11,13

ST   D7S820: 8,10

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 18,20

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SJNB-13

AC   CVCL_1443

SY   SJNB13; NB13; NB13-DH

DR   ChEMBL-Cells; CHEMBL3308174

DR   ChEMBL-Targets; CHEMBL2366225

DR   Cosmic; 688071

DR   Cosmic; 949177

DR   Cosmic; 1526634

DR   Cosmic-CLP; 949177

DR   GDSC; 949177

DR   GEO; GSM1670148

RX   DOI=10.1007/0-306-46872-7_2;

RX   PubMed=8516298;

RX   PubMed=10935473;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 9,14

ST   D16S539: 11

ST   D5S818: 11,13

ST   D7S820: 8,10

ST   TH01: 8,9

ST   TPOX: 8

ST   vWA: 14,17

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SJNB-14

AC   CVCL_1444

SY   SJNB14; NB14; NB14-DH; NCC

DR   BTO; BTO:0005073

DR   ChEMBL-Cells; CHEMBL3308827

DR   ChEMBL-Targets; CHEMBL2366212

DR   Cosmic; 688072

DR   Cosmic; 922663

DR   Cosmic; 949178

DR   Cosmic; 1526635

DR   Cosmic-CLP; 949178

DR   GDSC; 949178

DR   GEO; GSM1670149

RX   DOI=10.1007/0-306-46872-7_2;

RX   PubMed=6171342;

RX   PubMed=8516298;

RX   PubMed=10935473;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 11,12

ST   D16S539: 9,12

ST   D5S818: 12

ST   D7S820: 12

ST   TH01: 9.3

ST   TPOX: 10

ST   vWA: 16,18

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SJNB-15

AC   CVCL_8814

SY   SJNB15; NB15

RX   PubMed=10935473;

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SJNB-16

AC   CVCL_8815

SY   SJNB16; NB16; NB16-DH; NKP

DR   Cosmic; 688073

RX   DOI=10.1007/0-306-46872-7_2;

RX   PubMed=6171342;

RX   PubMed=8516298;

RX   PubMed=10935473;

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SJNB-17

AC   CVCL_1445

SY   SJNB17; NB17; NB17-DH

DR   ChEMBL-Cells; CHEMBL3308175

DR   ChEMBL-Targets; CHEMBL2366064

DR   Cosmic; 688075

DR   Cosmic; 922664

DR   Cosmic; 949175

DR   Cosmic-CLP; 949175

DR   GDSC; 949175

DR   GEO; GSM1670150

RX   DOI=10.1007/0-306-46872-7_2;

RX   PubMed=10935473;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 11,12

ST   D5S818: 11,13

ST   D7S820: 10,12

ST   TH01: 8

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SJNB-18

AC   CVCL_8816

SY   SJNB18; NB18

RX   PubMed=10935473;

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SJNB-19

AC   CVCL_8817

SY   SJNB19; NB19; NB19-DH

DR   Cosmic; 688076

RX   DOI=10.1007/0-306-46872-7_2;

RX   PubMed=8516298;

RX   PubMed=10935473;

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SJNB-2

AC   CVCL_8818

SY   SJNB2; NB2; N0303L

DR   Cosmic; 947713

DR   Cosmic; 1037332

DR   Cosmic; 1099129

DR   Cosmic; 1153793

DR   Cosmic; 2131584

DR   GEO; GSM314020

DR   GEO; GSM333807

RX   DOI=10.1007/0-306-46872-7_2;

RX   PubMed=8516298;

RX   PubMed=10935473;

RX   PubMed=18923524;

CC   Omics: SNP array analysis.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SJNB-20

AC   CVCL_8819

SY   SJNB20; NB20; NB20-DH

DR   Cosmic; 688078

DR   Cosmic; 922665

RX   PubMed=10935473;

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SJNB-3

AC   CVCL_8820

SY   SJNB3; NB3; N1003L

DR   Cosmic; 947714

DR   Cosmic; 1037333

DR   Cosmic; 1099130

DR   Cosmic; 1153794

DR   GEO; GSM314021

DR   GEO; GSM333808

RX   DOI=10.1007/0-306-46872-7_2;

RX   PubMed=8516298;

RX   PubMed=10935473;

RX   PubMed=18923524;

CC   Omics: SNP array analysis.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SJNB-4

AC   CVCL_8821

SY   SJNB4; SJNB-4(SD); NB4; NB4-DH

DR   Cosmic; 688079

DR   Cosmic; 801747

DR   Cosmic; 947715

DR   Cosmic; 1037334

DR   Cosmic; 1099131

DR   Cosmic; 1153795

DR   Cosmic; 2131585

DR   GEO; GSM314022

DR   GEO; GSM333809

RX   DOI=10.1007/0-306-46872-7_2;

RX   PubMed=8516298;

RX   PubMed=10935473;

RX   PubMed=18923524;

CC   Omics: SNP array analysis.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SJNB-5

AC   CVCL_8822

AS   CVCL_1446

SY   SJNB5; NB5; NB5-DH; NJF

DR   BTO; BTO:0005072

DR   ChEMBL-Cells; CHEMBL3308156

DR   ChEMBL-Targets; CHEMBL2366328

DR   Cosmic; 688080

DR   Cosmic; 922662

DR   Cosmic; 949176

DR   Cosmic; 947716

DR   Cosmic; 1037335

DR   Cosmic; 1099132

DR   Cosmic; 1153796

DR   Cosmic; 1526633

DR   Cosmic; 2131586

DR   Cosmic-CLP; 949176

DR   GDSC; 949176

DR   GEO; GSM314023

DR   GEO; GSM333810

DR   GEO; GSM1670152

RX   DOI=10.1007/0-306-46872-7_2;

RX   PubMed=6171342;

RX   PubMed=8516298;

RX   PubMed=10935473;

RX   PubMed=18923524;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 13

ST   D16S539: 9,10

ST   D5S818: 12,13

ST   D7S820: 11

ST   TH01: 7,8

ST   TPOX: 8,11

ST   vWA: 16,19

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SJNB-6

AC   CVCL_8823

AS   CVCL_1447

SY   SJ-NB-6; SJNB6; NB6; NB6-DH; N2307L

DR   ChEMBL-Cells; CHEMBL3308157

DR   ChEMBL-Targets; CHEMBL2366318

DR   Cosmic; 688082

DR   Cosmic; 949173

DR   Cosmic; 1037336

DR   Cosmic; 1099133

DR   Cosmic; 1109117

DR   Cosmic; 1153797

DR   Cosmic; 1518074

DR   Cosmic; 1526642

DR   Cosmic-CLP; 949173

DR   GDSC; 949173

DR   GEO; GSM314024

DR   GEO; GSM333811

DR   GEO; GSM692877

DR   GEO; GSM1670153

RX   DOI=10.1007/0-306-46872-7_2;

RX   PubMed=7838528;

RX   PubMed=8516298;

RX   PubMed=10935473;

RX   PubMed=11550280;

RX   PubMed=18923524;

RX   PubMed=22213050;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 8,13

ST   D16S539: 9,12

ST   D5S818: 13

ST   D7S820: 8,11

ST   TH01: 8,9

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SJNB-7

AC   CVCL_8824

AS   CVCL_1449

SY   SJ-NB-7; SJNB7; NB7; NB7-DH; NCG; SJ-NCG

DR   BTO; BTO:0003439

DR   ChEMBL-Cells; CHEMBL3308158

DR   ChEMBL-Targets; CHEMBL2366345

DR   Cosmic; 688083

DR   Cosmic; 801748

DR   Cosmic; 949174

DR   Cosmic; 947717

DR   Cosmic; 1037337

DR   Cosmic; 1099134

DR   Cosmic; 1153798

DR   Cosmic; 2131587

DR   Cosmic-CLP; 949174

DR   GDSC; 949174

DR   GEO; GSM314025

DR   GEO; GSM333812

DR   GEO; GSM1670155

RX   DOI=10.1007/0-306-46872-7_2;

RX   PubMed=6171342;

RX   PubMed=8516298;

RX   PubMed=10935473;

RX   PubMed=18923524;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

ST   Source(s): Cosmic-CLP

ST   Amelogenin: X,Y

ST   CSF1PO: 11,13

ST   D13S317: 8,13

ST   D16S539: 8,11

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   TH01: 9.3

ST   TPOX: 11

ST   vWA: 17,19

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SJNB-8

AC   CVCL_8825

SY   SJ-NB-8; SJNB8; NB8; N1108L

DR   Cosmic; 947718

DR   Cosmic; 1037338

DR   Cosmic; 1099135

DR   Cosmic; 1109115

DR   Cosmic; 1153799

DR   Cosmic; 1518075

DR   Cosmic; 1526643

DR   Cosmic; 1543778

DR   Cosmic; 2131588

DR   GEO; GSM314026

DR   GEO; GSM333813

DR   GEO; GSM692860

RX   PubMed=7838528;

RX   PubMed=8516298;

RX   PubMed=9516836;

RX   PubMed=10935473;

RX   PubMed=11550280;

RX   PubMed=18923524;

RX   PubMed=22213050;

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SJNB-9

AC   CVCL_8826

SY   SJNB9; NB9

RX   DOI=10.1007/0-306-46872-7_2;

RX   PubMed=8516298;

RX   PubMed=10935473;

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SJO

AC   CVCL_0T73

DR   ATCC; CRL-2293

DR   BioSample; SAMN03471860

RX   PubMed=2299498;

RX   PubMed=7615790;

RX   PubMed=8106283;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Discontinued: ATCC; CRL-2293; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 8,12

ST   D16S539: 9,11

ST   D5S818: 10,12

ST   D7S820: 11

ST   TH01: 7

ST   TPOX: 11

ST   vWA: 14,18

DI   NCIt; C3895; Bare lymphocyte syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SJPL

AC   CVCL_1T04

SY   St. Jude Porcine Lung; St-Jude Porcine Lung

DR   ATCC; PTA-3256

DR   BioSample; SAMN03152028

RX   Patent=WO2009059411A1;

RX   PubMed=11533214;

RX   PubMed=20200241;

RX   PubMed=23148668;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Group: Non-human primate cell line.

CC   Problematic cell line: Misidentified. Originally thought to be of pig origin but found to be from Chlorocebus aethiops (PubMed=20200241).

CC   Discontinued: ATCC; PTA-3256; probable.

OX   NCBI_TaxID=9534; ! Chlorocebus aethiops

SX   Sex undetermined

CA   Undefined cell line type

//

ID   SJSA-1

AC   CVCL_1697

SY   SJSA1; SJSA; OsA-CL; OSA-CL; OsACL; OSACL; OSA; OsA

DR   BTO; BTO:0004216

DR   CLO; CLO_0009031

DR   EFO; EFO_0002330

DR   ATCC; CRL-2098

DR   BioSample; SAMN03472540

DR   CCLE; SJSA1_BONE

DR   ChEMBL-Cells; CHEMBL3308885

DR   ChEMBL-Targets; CHEMBL2366298

DR   Cosmic; 687931

DR   Cosmic; 909717

DR   Cosmic; 931911

DR   Cosmic; 1070843

DR   Cosmic; 1074396

DR   Cosmic; 1097756

DR   Cosmic; 1188476

DR   Cosmic; 1529912

DR   Cosmic-CLP; 909717

DR   ENCODE; ENCBS327EZG

DR   ENCODE; ENCBS489PLT

DR   GDSC; 909717

DR   GEO; GSM320826

DR   GEO; GSM879221

DR   GEO; GSM887574

DR   GEO; GSM888657

DR   GEO; GSM1670426

DR   GEO; GSM1676316

DR   GEO; GSM1701650

DR   IGRhCellID; SJSA1

RX   PubMed=8275086;

RX   PubMed=12645653;

RX   PubMed=15150091;

RX   PubMed=19787792;

RX   PubMed=21519327;

RX   PubMed=22460905;

RX   PubMed=25984343;

RX   PubMed=26351324;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.addexbio.com/productdetail?pid=64

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 31 hours (PubMed=25984343).

CC   Microsatellite instability: Instable (MSI-low) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'SISA' in Cosmic 1529912.

CC   Misspelling: 'SJSA2' in Cosmic 1097756.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 12,13

ST   D16S539: 9,10

ST   D5S818: 12

ST   D7S820: 9,11

ST   TH01: 7,9

ST   TPOX: 8,9

ST   vWA: 19

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK

AC   CVCL_CV33

SY   Scatophagus Kidney

RX   PubMed=26911257;

CC   Group: Fish cell line.

OX   NCBI_TaxID=75038; ! Scatophagus argus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SK 7

AC   CVCL_L697

SY   SK7

DR   ATCC; HB-8584

RX   Patent=US4665032;

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_L699 ! KE 37.3.2

CA   Hybridoma

//

ID   SK 8

AC   CVCL_L698

SY   SK8

DR   ATCC; HB-8585

RX   Patent=US4665032;

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_L699 ! KE 37.3.2

CA   Hybridoma

//

ID   SK-5

AC   CVCL_5H87

SY   SK5

DR   ChEMBL-Cells; CHEMBL3307446

DR   ChEMBL-Targets; CHEMBL614911

RX   PubMed=2536714;

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   SK-6

AC   CVCL_D296

SY   SK6; Swine Kidney-6

DR   BTO; BTO:0005887

DR   BCRJ; 0225

DR   CCLV; CCLV-RIE 0262

RX   PubMed=4336054;

RX   PubMed=19941903;

CC   Discontinued: BCRJ; 0225; probable.

OX   NCBI_TaxID=9823; ! Sus scrofa

CA   Spontaneously immortalized cell line

//

ID   SK-9

AC   CVCL_D593

RX   PubMed=20471447;

DI   NCIt; C4967; Adult acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-Ala-1

AC   CVCL_8591

SY   SKAla-1

RX   PubMed=9717829;

DI   NCIt; C40318; Vulvar leiomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0628 ! SK-LMS-1

SX   Female

CA   Cancer cell line

//

ID   SK-Ala-10

AC   CVCL_8592

SY   SKAla-10

RX   PubMed=17513613;

DI   NCIt; C40318; Vulvar leiomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0628 ! SK-LMS-1

SX   Female

CA   Cancer cell line

//

ID   SK-Ala-14

AC   CVCL_8593

SY   SKAla-14

RX   PubMed=17513613;

DI   NCIt; C40318; Vulvar leiomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0628 ! SK-LMS-1

SX   Female

CA   Cancer cell line

//

ID   SK-Ala-2

AC   CVCL_8594

SY   SKAla-2

RX   PubMed=9717829;

DI   NCIt; C40318; Vulvar leiomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0628 ! SK-LMS-1

SX   Female

CA   Cancer cell line

//

ID   SK-Ala-21

AC   CVCL_8595

SY   SKAla-21

RX   PubMed=17513613;

DI   NCIt; C40318; Vulvar leiomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0628 ! SK-LMS-1

SX   Female

CA   Cancer cell line

//

ID   SK-Ala-3

AC   CVCL_8596

SY   SKAla-3

RX   PubMed=9717829;

DI   NCIt; C40318; Vulvar leiomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0628 ! SK-LMS-1

SX   Female

CA   Cancer cell line

//

ID   SK-AO2

AC   CVCL_8567

SY   SKAO2; AO2

RX   PubMed=6182568;

RX   PubMed=8943096;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-astrocyte-IDH1

AC   CVCL_Z595

RX   PubMed=22343889;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK2012-113.

CC   Transfected with: HGNC; 5382; IDH1.

CC   Transfected with: HGNC; 11730; TERT.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Telomerase immortalized cell line

//

ID   SK-astrocyte-IDH1-R132H

AC   CVCL_Z596

RX   PubMed=22343889;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK2012-113.

CC   Transfected with: HGNC; 5382; IDH1 (with H-132).

CC   Transfected with: HGNC; 11730; TERT.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Telomerase immortalized cell line

//

ID   SK-beta2.7

AC   CVCL_J125

RX   PubMed=8977199;

CC   Problematic cell line: Contaminated. Parent cell line (SKW-3) has been shown to be a KE-37 derivative.

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2197 ! SKW-3

SX   Male

CA   Cancer cell line

//

ID   SK-BR-1 III

AC   CVCL_T283

SY   SK-BR-1-III; SK-Br-1 III; Lev III

DR   ATCC; HTB-28

RX   PubMed=212193;

RX   PubMed=327080;

RX   PubMed=833871;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Discontinued: ATCC; HTB-28; true.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-BR-2 III

AC   CVCL_T284

SY   SK-BR-2-III; SK-Br-2 III; Sal III

DR   ATCC; HTB-29

RX   PubMed=212193;

RX   PubMed=327080;

RX   PubMed=833871;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Discontinued: ATCC; HTB-29; true.

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-BR-3

AC   CVCL_0033

SY   SK-Br-3; Sk-Br-3; SKBR-3; SKBr-3; SK-BR3; SKBr3; SkBr3; SKBR3

DR   BTO; BTO:0002419

DR   CLO; CLO_0009034

DR   EFO; EFO_0001236

DR   MCCL; MCC:0000424

DR   CLDB; cl4310

DR   CLDB; cl7143

DR   ATCC; HTB-30

DR   BCRJ; 0226

DR   BioSample; SAMN01821597

DR   BioSample; SAMN03471462

DR   CCLE; SKBR3_BREAST

DR   CCRID; 3111C0001CCC000085

DR   CCRID; 3131C0001000700049

DR   ChEMBL-Cells; CHEMBL3308062

DR   ChEMBL-Targets; CHEMBL613834

DR   CLS; 300333/p3803_SK-BR-3

DR   Cosmic; 687499

DR   Cosmic; 755294

DR   Cosmic; 759896

DR   Cosmic; 871159

DR   Cosmic; 894090

DR   Cosmic; 897742

DR   Cosmic; 904385

DR   Cosmic; 921974

DR   Cosmic; 923062

DR   Cosmic; 934531

DR   Cosmic; 944297

DR   Cosmic; 979713

DR   Cosmic; 991329

DR   Cosmic; 997935

DR   Cosmic; 1000127

DR   Cosmic; 1010922

DR   Cosmic; 1018478

DR   Cosmic; 1044209

DR   Cosmic; 1046958

DR   Cosmic; 1129655

DR   Cosmic; 1136357

DR   Cosmic; 1176645

DR   Cosmic; 1287914

DR   Cosmic; 1289405

DR   Cosmic; 1308997

DR   Cosmic; 1434957

DR   Cosmic; 1524342

DR   Cosmic; 1571789

DR   Cosmic; 1609462

DR   Cosmic; 2036669

DR   Cosmic; 2165013

DR   Cosmic; 2301535

DR   Cosmic; 2318379

DR   Cosmic; 2361351

DR   DSMZ; ACC-736

DR   GEO; GSM69195

DR   GEO; GSM73742

DR   GEO; GSM115115

DR   GEO; GSM149978

DR   GEO; GSM149986

DR   GEO; GSM149994

DR   GEO; GSM152556

DR   GEO; GSM152557

DR   GEO; GSM152558

DR   GEO; GSM152559

DR   GEO; GSM154096

DR   GEO; GSM154097

DR   GEO; GSM154098

DR   GEO; GSM154099

DR   GEO; GSM154100

DR   GEO; GSM154101

DR   GEO; GSM154102

DR   GEO; GSM154104

DR   GEO; GSM154107

DR   GEO; GSM155215

DR   GEO; GSM170624

DR   GEO; GSM170625

DR   GEO; GSM170626

DR   GEO; GSM170627

DR   GEO; GSM170630

DR   GEO; GSM170631

DR   GEO; GSM170633

DR   GEO; GSM170634

DR   GEO; GSM183440

DR   GEO; GSM183441

DR   GEO; GSM186457

DR   GEO; GSM186458

DR   GEO; GSM217596

DR   GEO; GSM344357

DR   GEO; GSM344407

DR   GEO; GSM350501

DR   GEO; GSM378146

DR   GEO; GSM481334

DR   GEO; GSM590106

DR   GEO; GSM595617

DR   GEO; GSM783927

DR   GEO; GSM827582

DR   GEO; GSM845399

DR   GEO; GSM847432

DR   GEO; GSM847499

DR   GEO; GSM844686

DR   GEO; GSM844687

DR   GEO; GSM887575

DR   GEO; GSM888658

DR   GEO; GSM1008913

DR   GEO; GSM1038850

DR   GEO; GSM1038851

DR   GEO; GSM1038852

DR   GEO; GSM1038853

DR   GEO; GSM1038854

DR   GEO; GSM1214572

DR   GEO; GSM1264069

DR   GEO; GSM1264074

DR   GEO; GSM1264111

DR   GEO; GSM1264116

DR   GEO; GSM1374872

DR   GEO; GSM1374873

DR   GEO; GSM1374874

DR   GEO; GSM1401659

DR   GEO; GSM1661988

DR   GEO; GSM1833627

DR   ICLC; HTL03005

DR   IMGT/HLA; 12368

DR   IZSLER; BS TCL 156

DR   KCB; KCB 200723YJ

DR   KCLB; 30030

DR   LINCS; 50057

DR   Lonza; 70

DR   NCBI_Iran; C207

DR   PRIDE; PXD000691

DR   PRIDE; PXD002053

DR   PRIDE; PXD002057

DR   PRIDE; PXD002281

DR   PRIDE; PXD002486

DR   RCB; RCB2132

DR   TOKU-E; 3129

DR   Wikidata; Q7390592

RX   DOI=10.1007/978-1-4757-1647-4_5;

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=1013510;

RX   PubMed=6500159;

RX   PubMed=6582512;

RX   PubMed=6935474;

RX   PubMed=9671407;

RX   PubMed=10862037;

RX   PubMed=11044355;

RX   PubMed=12800145;

RX   PubMed=15677628;

RX   PubMed=17157791;

RX   PubMed=19582160;

RX   PubMed=19727395;

RX   PubMed=20070913;

RX   PubMed=21247443;

RX   PubMed=21378333;

RX   PubMed=22460905;

RX   PubMed=23601657;

RX   PubMed=23671654;

RX   PubMed=24162158;

RX   PubMed=25485619;

RX   PubMed=26055192;

RX   PubMed=26378940;

RX   PubMed=28196595;

WW   https://en.wikipedia.org/wiki/SKBR3

WW   http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/sk-br-3.htm

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=SK-BR-3

WW   http://www.proteinatlas.org/learn/cellines

WW   http://lincs.hms.harvard.edu/resources/reagents/icbp43/

WW   http://www.addexbio.com/productdetail?pid=65

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-57.html

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-breast-cell-line-sk-br-3

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: ICBP43 breast cancer cell line panel.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 808.

CC   Doubling time: ~2-3 days (DSMZ).

CC   Microsatellite instability: Stable (MSS) (PubMed=23671654).

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: Deep antibody staining analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Exosome proteome analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'SKBR3B' in PubMed=26378940.

CC   Discontinued: RCB; RCB2132; true.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; CLS; DSMZ; KCLB; PubMed=25877200; RCB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11,12

ST   D16S539: 9

ST   D18S51: 10,13

ST   D21S11: 30,30.2

ST   D3S1358: 17

ST   D5S818: 9,12

ST   D7S820: 9,12

ST   D8S1179: 11,12 (CLS)

ST   D8S1179: 12 (PubMed=25877200)

ST   FGA: 20

ST   Penta D: 9,13 (CLS)

ST   Penta D: 9,12 (PubMed=25877200)

ST   Penta E: 10,11

ST   TH01: 8,9

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1074 ! AU565

SX   Female

CA   Cancer cell line

//

ID   SK-BR-3-LR

AC   CVCL_4V52

RX   PubMed=23811285;

CC   Selected for resistance to: ChEBI; CHEBI:49603; Lapatinib.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0033 ! SK-BR-3

SX   Female

CA   Cancer cell line

//

ID   SK-BR-3-Luc

AC   CVCL_4Y11

DR   JCRB; NIHS0735

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0033 ! SK-BR-3

SX   Female

CA   Cancer cell line

//

ID   SK-BR-5

AC   CVCL_5217

SY   SKBR-5; SKBr5; SkBr5; SKBR5

DR   Cosmic; 997936

DR   Cosmic; 1046938

DR   Cosmic; 1287912

DR   Cosmic; 1289406

DR   GEO; GSM1661989

RX   PubMed=6582512;

RX   PubMed=23601657;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Omics: miRNA expression profiling.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-BR-7

AC   CVCL_5218

SY   SKBR-7; SKBr7; SKBR7

DR   Cosmic; 1046946

DR   Cosmic; 1287927

DR   Cosmic; 1289407

DR   GEO; GSM75171

DR   GEO; GSM217597

RX   PubMed=11044355;

RX   PubMed=15677628;

RX   PubMed=23601657;

WW   http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/sk-br-7.htm

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Omics: miRNA expression profiling.

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-ChA-1

AC   CVCL_6952

SY   SK-CHA-1; SK-ChA1; SkChA-1; SkChA1

DR   BTO; BTO:0004655

DR   Cosmic; 924011

DR   Cosmic; 927191

RX   CelloPub=CLPUB00275;

RX   PubMed=4056357;

RX   PubMed=9824643;

RX   PubMed=21533411;

CC   Doubling time: 26 hours (PubMed=9824643).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C4436; Cholangiocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-CO-1

AC   CVCL_0626

SY   SKCO-1; SKCO1; SKCol1; SK-Col-1; SK Col 1

DR   CLO; CLO_0009035

DR   EFO; EFO_0006752

DR   ATCC; HTB-39

DR   BioSample; SAMN03472359

DR   BioSample; SAMN03472743

DR   CCLE; SKCO1_LARGE_INTESTINE

DR   CCRID; 3131C0001001200006

DR   ChEMBL-Cells; CHEMBL3308784

DR   ChEMBL-Targets; CHEMBL1075576

DR   Cosmic; 724846

DR   Cosmic; 876726

DR   Cosmic; 909718

DR   Cosmic; 948125

DR   Cosmic; 948852

DR   Cosmic; 986016

DR   Cosmic; 995402

DR   Cosmic; 1071892

DR   Cosmic; 1175844

DR   Cosmic; 1176593

DR   Cosmic; 1187318

DR   Cosmic; 1312310

DR   Cosmic; 1466820

DR   Cosmic; 1479586

DR   Cosmic; 1482520

DR   Cosmic; 1676740

DR   Cosmic; 1805265

DR   Cosmic; 2302006

DR   Cosmic-CLP; 909718

DR   GDSC; 909718

DR   GEO; GSM206541

DR   GEO; GSM513919

DR   GEO; GSM514306

DR   GEO; GSM741251

DR   GEO; GSM827412

DR   GEO; GSM887576

DR   GEO; GSM888659

DR   GEO; GSM1346852

DR   GEO; GSM1374875

DR   GEO; GSM1374876

DR   GEO; GSM1374877

DR   GEO; GSM1448193

DR   GEO; GSM1670427

DR   SKY/M-FISH/CGH; 5015

RX   DOI=10.1007/978-1-4757-1647-4_5;

RX   PubMed=833871;

RX   PubMed=6582512;

RX   PubMed=10737795;

RX   PubMed=19927377;

RX   PubMed=20606684;

RX   PubMed=22460905;

RX   PubMed=24755471;

RX   PubMed=25485619;

RX   PubMed=25926053;

RX   PubMed=25984343;

RX   PubMed=27397505;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-colorectal-adenocarcinoma-cell-line-sk-co-1

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: KuDOS 95 cell line panel.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK2010-072.

CC   Doubling time: 46 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y (ATCC; Cosmic-CLP)

ST   Amelogenin: X (PubMed=25877200)

ST   CSF1PO: 13

ST   D13S317: 14

ST   D16S539: 13

ST   D18S51: 19

ST   D21S11: 28,30

ST   D3S1358: 17,18

ST   D5S818: 9,11

ST   D7S820: 8,10

ST   D8S1179: 12,14

ST   FGA: 20,25

ST   Penta D: 11

ST   Penta E: 13,16

ST   TH01: 8,9

ST   TPOX: 8,11

ST   vWA: 18,19

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-CO-10

AC   CVCL_GS25

RX   PubMed=6582512;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-CO-15

AC   CVCL_A337

SY   SKCO-15; SK-CO15; SKCO15

DR   BTO; BTO:0005068

RX   PubMed=2687880;

RX   PubMed=22556145;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-DHL2A

AC   CVCL_E051

SY   SK-DHL2a; SKDHL2A; Manca; MANCA

DR   ChEMBL-Cells; CHEMBL3307363

DR   ChEMBL-Targets; CHEMBL614320

RX   PubMed=6608987;

CC   Doubling time: 17.9 +- 2.6 hours (PubMed=6608987).

DI   NCIt; C3457; B-cell non-Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-DHL2B

AC   CVCL_E052

SY   SK-DHL2b; SKDHL2B

RX   PubMed=6608987;

CC   Doubling time: 17.1 +- 2.1 hours (PubMed=6608987).

DI   NCIt; C3457; B-cell non-Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_E051 ! SK-DHL2A

SX   Male

CA   Cancer cell line

//

ID   SK-ES-1

AC   CVCL_0627

SY   Sk-Es-1; Sk-ES-1; SK-ES1; SKES1; SK-ES

DR   CLO; CLO_0009036

DR   EFO; EFO_0002858

DR   ATCC; HTB-86

DR   BCRJ; 0266

DR   BioSample; SAMN03472758

DR   BioSample; SAMN03473516

DR   CCLE; SKES1_BONE

DR   ChEMBL-Cells; CHEMBL3307826

DR   ChEMBL-Targets; CHEMBL613970

DR   CLS; 300435/p738_SK-ES-1

DR   Cosmic; 684072

DR   Cosmic; 759888

DR   Cosmic; 1078385

DR   Cosmic; 1082505

DR   Cosmic; 1388894

DR   Cosmic; 1718430

DR   Cosmic; 1995629

DR   Cosmic; 2060800

DR   Cosmic; 2228231

DR   Cosmic; 2250467

DR   Cosmic-CLP; 684072

DR   DSMZ; ACC-518

DR   GDSC; 684072

DR   GEO; GSM393027

DR   GEO; GSM510008

DR   GEO; GSM510017

DR   GEO; GSM510018

DR   GEO; GSM827589

DR   GEO; GSM887577

DR   GEO; GSM888660

DR   GEO; GSM1670428

DR   GEO; GSM1676343

DR   GEO; GSM1701674

DR   IGRhCellID; SKES%20%20GEO

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=8221663;

RX   PubMed=8617485;

RX   PubMed=19787792;

RX   PubMed=22460905;

RX   PubMed=25010205;

RX   PubMed=25223734;

RX   PubMed=26351324;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-es-1-human-ewing-sarcoma-cell-line

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-542.

CC   Doubling time: ~35 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; CLS; Cosmic-CLP; DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 8,9

ST   D16S539: 11 (ATCC; CLS; Cosmic-CLP)

ST   D16S539: 12 (DSMZ)

ST   D18S51: 13,15

ST   D21S11: 30

ST   D3S1358: 16,18

ST   D5S818: 12

ST   D7S820: 10,11

ST   D8S1179: 11,13

ST   FGA: 20,21

ST   Penta D: 11,13

ST   Penta E: 11

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 14,17

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-ES-2

AC   CVCL_T285

DR   ATCC; HTB-87

RX   PubMed=327080;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Discontinued: ATCC; HTB-87; probable.

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-GT-1

AC   CVCL_9585

SY   SKGT1

RX   PubMed=8334620;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-GT-2

AC   CVCL_2194

SY   SKGT2

DR   BioSample; SAMN03473450

DR   Cosmic-CLP; 1503364

DR   DSMZ; ACC-702

DR   ECACC; 11012008

DR   GDSC; 1503364

DR   GEO; GSM1670430

RX   PubMed=8334620;

RX   PubMed=27397505;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Doubling time: ~48 hours (DSMZ); ~44 hours (ECACC).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP; DSMZ; ECACC

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 12,13

ST   D16S539: 11,12

ST   D5S818: 10

ST   D7S820: 9,10

ST   TH01: 8,9

ST   TPOX: 9,12

ST   vWA: 15,18

DI   NCIt; C8398; Gastric fundus carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-GT-3

AC   CVCL_9584

SY   SKGT3

RX   PubMed=8334620;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C8398; Gastric fundus carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-GT-4

AC   CVCL_2195

SY   SKGT4

DR   EFO; EFO_0001237

DR   BioSample; SAMN03473395

DR   Cosmic; 1599346

DR   Cosmic-CLP; 1503365

DR   DSMZ; ACC-712

DR   ECACC; 11012007

DR   GDSC; 1503365

DR   GEO; GSM337722

DR   GEO; GSM337723

DR   GEO; GSM337724

DR   GEO; GSM337725

DR   GEO; GSM337726

DR   GEO; GSM337727

DR   GEO; GSM337730

DR   GEO; GSM337732

DR   GEO; GSM337733

DR   GEO; GSM337734

DR   GEO; GSM337735

DR   GEO; GSM337736

DR   GEO; GSM337737

DR   GEO; GSM337738

DR   GEO; GSM337739

DR   GEO; GSM337740

DR   GEO; GSM1374878

DR   GEO; GSM1670431

RX   PubMed=8334620;

RX   PubMed=20075370;

RX   PubMed=20139130;

RX   PubMed=23795680;

RX   PubMed=27397505;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Doubling time: ~30-35 hours (DSMZ); 39 hours (ECACC).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'SJGT4' in GEO GSM337727.

ST   Source(s): Cosmic-CLP; DSMZ

ST   Amelogenin: X

ST   CSF1PO: 11,15

ST   D13S317: 9,10

ST   D16S539: 11,12,13

ST   D5S818: 12

ST   D7S820: 7,11

ST   TH01: 6,9.3

ST   TPOX: 8,10

ST   vWA: 17,19

DI   NCIt; C4025; Esophageal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-GT-5

AC   CVCL_8114

SY   SKGT5

DR   BioSample; SAMN03151916

RX   PubMed=8334620;

RX   PubMed=20075370;

RX   PubMed=23795680;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a SK-GT-2 derivative (PubMed=20075370). Was originally thought to originate from a esophageal adenocarcinoma.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C8398; Gastric fundus carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2194 ! SK-GT-2

SX   Male

CA   Cancer cell line

//

ID   SK-HD-1

AC   CVCL_1E50

RX   DOI=10.1007/978-1-4757-1647-4_5;

RX   PubMed=833871;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C9357; Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-HEP-1

AC   CVCL_0525

SY   SK-Hep-1; SK-Hep1; Sk-Hep1; SK Hep1; SKHEP-1; SKHEP1; SKHep1; SK_HEP1

DR   BTO; BTO:0003477

DR   CLO; CLO_0009037

DR   MCCL; MCC:0000425

DR   CLDB; cl4312

DR   CLDB; cl4313

DR   CLDB; cl4314

DR   CLDB; cl4315

DR   CLDB; cl7214

DR   ATCC; HTB-52

DR   BioSample; SAMN01821598

DR   BioSample; SAMN01821664

DR   BioSample; SAMN03472884

DR   CCLE; SKHEP1_LIVER

DR   CCRID; 3111C0002000000060

DR   CCRID; 3131C0001000700109

DR   CCRID; 3142C0001000000133

DR   CGH-DB; 9071-4

DR   ChEMBL-Cells; CHEMBL3307741

DR   ChEMBL-Targets; CHEMBL614912

DR   CLS; 300334/p485_SK-HEP-1

DR   Cosmic; 684195

DR   Cosmic; 928139

DR   Cosmic; 932990

DR   Cosmic; 979728

DR   Cosmic; 873394

DR   Cosmic; 735607

DR   Cosmic; 909719

DR   Cosmic; 1187333

DR   Cosmic; 1518231

DR   Cosmic; 2162539

DR   Cosmic; 2321042

DR   Cosmic-CLP; 909719

DR   DSMZ; ACC-141

DR   ECACC; 91091816

DR   GDSC; 909719

DR   GEO; GSM481451

DR   GEO; GSM565878

DR   GEO; GSM887578

DR   GEO; GSM888661

DR   GEO; GSM936776

DR   GEO; GSM1374879

DR   GEO; GSM1670432

DR   ICLC; HTL10001

DR   KCB; KCB 2013038YJ

DR   KCLB; 30052

DR   PRIDE; PXD002957

DR   TOKU-E; 3132

RX   DOI=10.1007/978-1-4757-1647-4_5;

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=2439335;

RX   PubMed=6582512;

RX   PubMed=6935474;

RX   PubMed=7459858;

RX   PubMed=12029633;

RX   PubMed=20069059;

RX   PubMed=22460905;

RX   PubMed=23505090;

RX   PubMed=23887712;

RX   PubMed=25574106;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-397.html

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-hep-1-human-hepatic-adenocarcinoma-cell-line

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-535.

CC   Characteristics: Has lost chromosome Y.

CC   Doubling time: ~30 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: Secretome proteome analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

ST   Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; ECACC; KCLB; PubMed=11416159; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,12 (ATCC; Cosmic-CLP; DSMZ; ECACC; KCLB; PubMed=25877200)

ST   CSF1PO: 11 (CLS)

ST   D13S317: 8,12

ST   D16S539: 12

ST   D18S51: 13,15

ST   D19S433: 12,15.2

ST   D21S11: 29,31

ST   D2S1338: 20,23

ST   D3S1358: 16

ST   D5S818: 10,13

ST   D7S820: 8,11

ST   D8S1179: 13,14

ST   FGA: 17

ST   Penta D: 13,14

ST   Penta E: 13,21 (CLS)

ST   Penta E: 13 (PubMed=25877200)

ST   TH01: 7,9

ST   TPOX: 9

ST   vWA: 14,17

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-Hep-1-FIX

AC   CVCL_AU01

RX   PubMed=26802680;

CC   Characteristics: Has lost chromosome Y.

CC   Transfected with: HGNC; 3551; F9.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0525 ! SK-HEP-1

SX   Male

CA   Cancer cell line

//

ID   SK-Hep-1-NIS

AC   CVCL_6019

SY   SK-Hep1-NIS

RX   PubMed=15347726;

CC   Characteristics: Has lost chromosome Y.

CC   Transfected with: HGNC; 11040; SLC5A5.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0525 ! SK-HEP-1

SX   Male

CA   Cancer cell line

//

ID   SK-Hep-1/CDDP

AC   CVCL_M182

SY   SK-Hep1/DDP

RX   PubMed=20109345;

RX   PubMed=20458768;

CC   Characteristics: Has lost chromosome Y.

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

CC   Caution: PubMed=20458768 describes SK-Hep-1/CDDP and does not cite PubMed=20109345 which describes SK-Hep1/DDP. As the two papers are from the same authors and that the described cell lines have identical characteristics it is probable that they are identical.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0525 ! SK-HEP-1

SX   Male

CA   Cancer cell line

//

ID   SK-JHRCC-12

AC   CVCL_Z029

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK-JHRCC-12.

CC   Derived from metastatic site: Bone.

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-JHRCC-120

AC   CVCL_Z030

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK-JHRCC-120.

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-JHRCC-3

AC   CVCL_Z031

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK-JHRCC-3.

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-JHRCC-92

AC   CVCL_Z032

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK-JHRCC-92.

CC   Derived from metastatic site: Bone.

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-L1

AC   CVCL_IU60

SY   SKL-1; SKL 1; SKL1

RX   PubMed=170370;

RX   PubMed=5229525;

RX   PubMed=4325933;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C7463; Acute myelomonocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-la

AC   CVCL_CV34

SY   Scatophagus Kidney-low-osmolarity adapted

RX   PubMed=26911257;

CC   Group: Fish cell line.

OX   NCBI_TaxID=75038; ! Scatophagus argus

HI   CVCL_CV33 ! SK

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SK-LC-1

AC   CVCL_5458

RX   PubMed=6582512;

RX   PubMed=9636188;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-LC-10

AC   CVCL_5459

SY   SK-Luci-10; Sk-Luci-10; SkLuci 10; Luci-10; Luci10

DR   Cosmic; 934463

RX   PubMed=1778766;

RX   PubMed=6582512;

RX   PubMed=8384671;

RX   PubMed=9636188;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C9133; Adenosquamous lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-LC-11

AC   CVCL_5460

RX   PubMed=6582512;

RX   PubMed=9636188;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-LC-12

AC   CVCL_5461

DR   Cosmic; 923381

RX   PubMed=1409687;

RX   PubMed=6208122;

RX   PubMed=6582512;

RX   PubMed=9636188;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-LC-13

AC   CVCL_5462

SY   SKLC-13; SK-Luci-13; SkLuci 13; Luci-13

DR   GEO; GSM784225

RX   PubMed=1778766;

RX   PubMed=6582512;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-LC-14

AC   CVCL_5463

RX   PubMed=6582512;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-LC-15

AC   CVCL_5464

RX   PubMed=6582512;

RX   PubMed=9636188;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-LC-16

AC   CVCL_5465

DR   BTO; BTO:0003229

RX   PubMed=6582512;

RX   PubMed=9636188;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-LC-17

AC   CVCL_5466

DR   GEO; GSM784221

RX   PubMed=1409687;

RX   PubMed=2540905;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-LC-19

AC   CVCL_5467

RX   PubMed=9636188;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-LC-2

AC   CVCL_5468

SY   SK-LC2

DR   Cosmic; 1089233

RX   PubMed=2540905;

RX   PubMed=6208122;

RX   PubMed=6582512;

RX   PubMed=9636188;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-LC-20

AC   CVCL_5469

RX   PubMed=9636188;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-LC-21

AC   CVCL_5470

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-LC-3

AC   CVCL_5471

DR   CGH-DB; 209-1

DR   CGH-DB; 9171-4

DR   Cosmic; 1089219

DR   GEO; GSM784256

RX   PubMed=6208122;

RX   PubMed=6582512;

RX   PubMed=14581340;

RX   PubMed=15746151;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-LC-4

AC   CVCL_5472

RX   PubMed=6582512;

RX   PubMed=9636188;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-LC-5

AC   CVCL_5473

SY   SK-LC5

RX   PubMed=6582512;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-LC-6

AC   CVCL_5474

SY   SKLC6; SK-Luci-6; Sk-Luci-6; SK-LuCi6; Luci-6; Luci6

DR   Cosmic; 923380

DR   Cosmic; 1089232

DR   NCBI_Iran; C566

RX   PubMed=2535957;

RX   PubMed=6208122;

RX   PubMed=6582512;

RX   PubMed=7116286;

RX   PubMed=8384671;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-LC-7

AC   CVCL_5475

SY   SK-Luci-7; Luci-7

RX   PubMed=1778766;

RX   PubMed=6582512;

RX   PubMed=9636188;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-LC-8

AC   CVCL_5476

DR   BTO; BTO:0003228

RX   PubMed=6208122;

RX   PubMed=6582512;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-LC-9

AC   CVCL_5477

RX   PubMed=6582512;

RX   PubMed=9636188;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-LMS-1

AC   CVCL_0628

SY   SKLMS-1; SKLMS1

DR   BTO; BTO:0002607

DR   CLO; CLO_0009038

DR   EFO; EFO_0002331

DR   ATCC; HTB-88

DR   BioSample; SAMN03472759

DR   CCLE; SKLMS1_SOFT_TISSUE

DR   ChEMBL-Cells; CHEMBL3308552

DR   ChEMBL-Targets; CHEMBL2366096

DR   CLS; 300125/p629_SK-LMS-1

DR   Cosmic; 687594

DR   Cosmic; 909720

DR   Cosmic; 1834891

DR   Cosmic-CLP; 909720

DR   GDSC; 909720

DR   GEO; GSM887579

DR   GEO; GSM888662

DR   GEO; GSM1670433

DR   GEO; GSM1676326

DR   GEO; GSM1701659

DR   IGRhCellID; SKLMS1

DR   LINCS; 50042

RX   DOI=10.1007/978-1-4757-1647-4_5;

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=7459858;

RX   PubMed=22460905;

RX   PubMed=26351324;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-476.html

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; CLS; Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 9,10

ST   D13S317: 12 (ATCC; CLS)

ST   D13S317: 11,12 (Cosmic-CLP)

ST   D16S539: 8,11

ST   D18S51: 14,19

ST   D21S11: 28,30

ST   D3S1358: 15,16

ST   D5S818: 11,13

ST   D7S820: 8,9

ST   D8S1179: 12

ST   FGA: 22,25

ST   Penta D: 12,13

ST   Penta E: 7,13

ST   TH01: 6,7

ST   TPOX: 8,9

ST   vWA: 18,20 (ATCC; Cosmic-CLP)

ST   vWA: 18 (CLS)

DI   NCIt; C40318; Vulvar leiomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-LU-1

AC   CVCL_0629

SY   SK-Lu-1; SK LU 1; SKLU-1; SKLU1

DR   BTO; BTO:0003029

DR   CLO; CLO_0009032

DR   CLO; CLO_0009039

DR   CLDB; cl4317

DR   CLDB; cl4318

DR   CLDB; cl4319

DR   ATCC; HTB-57

DR   BioSample; SAMN03472748

DR   CCLE; SKLU1_LUNG

DR   CCRID; 3111C0001CCC000237

DR   ChEMBL-Cells; CHEMBL3307447

DR   ChEMBL-Targets; CHEMBL614913

DR   CLS; 300335/p478_SK-LU-1

DR   Cosmic; 724877

DR   Cosmic; 909721

DR   Cosmic; 929967

DR   Cosmic; 932920

DR   Cosmic; 933576

DR   Cosmic; 1089218

DR   Cosmic; 1146944

DR   Cosmic; 1434960

DR   Cosmic; 1733129

DR   Cosmic; 1995631

DR   Cosmic-CLP; 909721

DR   ECACC; 93120835

DR   GDSC; 909721

DR   GEO; GSM385525

DR   GEO; GSM385536

DR   GEO; GSM434291

DR   GEO; GSM513973

DR   GEO; GSM514560

DR   GEO; GSM784226

DR   GEO; GSM794407

DR   GEO; GSM827413

DR   GEO; GSM887580

DR   GEO; GSM888663

DR   GEO; GSM1670434

DR   ICLC; HTL96023

DR   IGRhCellID; SK-LU-1%20GEO

DR   IZSLER; BS TCL 81

DR   KCLB; 30057

DR   PRIDE; PXD002556

RX   PubMed=833871;

RX   PubMed=6935474;

RX   PubMed=22460905;

RX   PubMed=24135919;

RX   PubMed=26361996;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-lu-1-human-lung-cell-line

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK2005-049.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep phosphoproteome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; CLS; Cosmic-CLP; ECACC; KCLB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 10

ST   D16S539: 8

ST   D18S51: 18

ST   D21S11: 29,30.2

ST   D3S1358: 18

ST   D5S818: 11

ST   D7S820: 9

ST   D8S1179: 10

ST   FGA: 21,22

ST   Penta D: 10,13

ST   Penta E: 5

ST   TH01: 7

ST   TPOX: 8,10

ST   vWA: 16,17

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-LU-1b

AC   CVCL_IV51

RX   PubMed=6935474;

RX   PubMed=7459858;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0629 ! SK-LU-1

SX   Female

CA   Cancer cell line

//

ID   SK-LY-16

AC   CVCL_GS22

SY   SK-Ly-16; SKLY-16; SKLy-16; SKLY16

RX   PubMed=6193516;

RX   PubMed=6582512;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3457; B-cell non-Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-LY-18

AC   CVCL_GS23

SY   SK-Ly-18; SKLY-18; SKLY18

RX   PubMed=6193516;

RX   PubMed=6582512;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3457; B-cell non-Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-1

AC   CVCL_0068

SY   SK-Mel-1; SK Mel 1; SK-Mel1; SKMEL-1; SkMEL-1; SKMEL1; SK 1

DR   BTO; BTO:0002129

DR   CLO; CLO_0009040

DR   EFO; EFO_0002332

DR   ATCC; HTB-67

DR   BioSample; SAMN01821599

DR   BioSample; SAMN01821665

DR   BioSample; SAMN03473224

DR   CCLE; SKMEL1_SKIN

DR   CCRID; 3111C0001CCC000052

DR   ChEMBL-Cells; CHEMBL3308365

DR   ChEMBL-Targets; CHEMBL614916

DR   CLS; 300424/p609_SK-MEL-1

DR   Cosmic; 688052

DR   Cosmic; 888065

DR   Cosmic; 909723

DR   Cosmic; 928696

DR   Cosmic; 1022279

DR   Cosmic; 1303052

DR   Cosmic; 1459639

DR   Cosmic; 1669128

DR   Cosmic; 1995632

DR   Cosmic-CLP; 909723

DR   DSMZ; ACC-303

DR   GDSC; 909723

DR   GEO; GSM784507

DR   GEO; GSM827506

DR   GEO; GSM887582

DR   GEO; GSM888665

DR   GEO; GSM1670436

DR   IGRhCellID; SKMEL1

DR   KCB; KCB 200724YJ

DR   KCLB; 30067

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=4879578;

RX   PubMed=6895502;

RX   PubMed=8755562;

RX   PubMed=21725359;

RX   PubMed=22460905;

RX   PubMed=24576830;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-melanoma-cell-line-sk-mel-1

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK2004-052.

CC   Doubling time: ~100 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Thoracic lymph duct.

ST   Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; KCLB; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 11

ST   D16S539: 11,12

ST   D18S51: 13,16

ST   D21S11: 29,32.2

ST   D3S1358: 14,16

ST   D5S818: 12,13

ST   D7S820: 12

ST   D8S1179: 13,16

ST   FGA: 18,20

ST   Penta D: 11,13

ST   Penta E: 7,21

ST   TH01: 6

ST   TPOX: 11

ST   vWA: 16,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-MEL-10

AC   CVCL_6020

SY   SK-MEL 10

RX   PubMed=327080;

RX   PubMed=833871;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-100

AC   CVCL_6067

SY   SK-Mel-100; SK-MEL 100; SK-Mel 100; SKMEL-100; SKMEL100; DY-Mel

DR   Cosmic; 685206

DR   Cosmic; 721848

DR   Cosmic; 1122257

DR   Cosmic; 1507611

DR   Cosmic; 1669160

DR   Cosmic; 2233670

DR   Cosmic; 2440476

DR   GEO; GSM555179

DR   GEO; GSM784522

DR   Lonza; 1336

RX   PubMed=2983346;

RX   PubMed=6933476;

RX   PubMed=7747814;

RX   PubMed=15299072;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-101

AC   CVCL_6068

SY   DZ-Mel

DR   Cosmic; 923391

RX   PubMed=6933476;

RX   PubMed=7747814;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-102

AC   CVCL_4U05

RX   PubMed=7747814;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-103

AC   CVCL_6069

SY   SK-Mel-103; SKMEL-103; SkMel103; SKMEL103

DR   Cosmic; 685207

DR   Cosmic; 1054850

DR   Cosmic; 1122258

DR   Cosmic; 1507613

DR   Cosmic; 1669161

DR   GEO; GSM555180

DR   GEO; GSM784512

DR   Lonza; 1337

RX   PubMed=7747814;

RX   PubMed=17308088;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-104

AC   CVCL_4U06

RX   PubMed=7747814;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-105

AC   CVCL_6070

SY   SK-Mel-105; SKMEL-105

DR   Cosmic; 1669162

DR   GEO; GSM784523

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-106

AC   CVCL_6071

SY   EE-Mel

RX   PubMed=6933476;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-108

AC   CVCL_6072

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-109

AC   CVCL_6073

SY   SK-Mel-109; SK-MEL109; SKMEL-109

DR   Cosmic; 1669163

DR   GEO; GSM784518

RX   PubMed=3005411;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-11

AC   CVCL_D702

SY   SK-Mel-11; SKMEL-11; AF-Mel

DR   Cosmic; 1669132

DR   GEO; GSM784514

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-110

AC   CVCL_3875

SY   SK-Mel-110; SK-Mel 110; SKMEL-110; EI-Mel

DR   BTO; BTO:0004994

DR   Cosmic; 1669164

RX   PubMed=1716514;

RX   PubMed=2983346;

RX   PubMed=6864164;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-111

AC   CVCL_U938

SY   SK-Mel-111; EJ-Mel

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-112

AC   CVCL_6963

SY   SK-Mel-112; EK-Mel

DR   Cosmic; 923392

RX   PubMed=7747814;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-113

AC   CVCL_6074

SY   SK-Mel-113; SKMEL-113; EL-Mel

DR   Cosmic; 721830

DR   Cosmic; 1060421

DR   Cosmic; 1669165

DR   GEO; GSM784519

RX   PubMed=2983346;

RX   PubMed=6864164;

RX   PubMed=6933476;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-114

AC   CVCL_U936

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-115

AC   CVCL_8075

DR   Cosmic; 1507602

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-117

AC   CVCL_6075

SY   SK-Mel-117; SKMEL-117

DR   Cosmic; 1669166

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-118

AC   CVCL_6076

SY   SK-Mel-118; SK-mel-118; SKMEL-118; EQ-Mel

DR   Cosmic; 1669167

DR   GEO; GSM784524

RX   PubMed=6864164;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-119

AC   CVCL_6077

SY   SK-Mel-119; SK Mel 119; SKMEL-119; SKMEL119

DR   Cosmic; 706089

DR   Cosmic; 721807

DR   Cosmic; 851034

DR   Cosmic; 888833

DR   Cosmic; 897473

DR   Cosmic; 1054853

DR   Cosmic; 1507604

DR   Cosmic; 1669168

DR   Cosmic; 2233669

RX   PubMed=7747814;

RX   PubMed=10766161;

RX   PubMed=15009714;

RX   PubMed=17308088;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Misspelling: 'SK-ME-119' in Cosmic 2233669.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-12

AC   CVCL_6021

SY   SK-Mel-12; SKMEL-12; AG-Mel

DR   Cosmic; 923384

DR   Cosmic; 1669133

DR   GEO; GSM784515

RX   PubMed=327080;

RX   PubMed=7747814;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-122

AC   CVCL_4U00

RX   PubMed=6864164;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-123

AC   CVCL_4U01

RX   PubMed=7747814;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-124

AC   CVCL_8076

DR   Cosmic; 923393

RX   PubMed=7747814;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-125

AC   CVCL_4U02

RX   PubMed=7747814;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-127

AC   CVCL_6078

SY   SK-Mel-127; SK MEL 127; SKMEL-127; EZ-Mel

DR   Cosmic; 721814

DR   Cosmic; 1669169

RX   PubMed=1716514;

RX   PubMed=6582512;

RX   PubMed=6864164;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-128

AC   CVCL_6079

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-129

AC   CVCL_4U03

RX   PubMed=7747814;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-13

AC   CVCL_6022

SY   SK-Mel-13; SKMEL-13; SKMEL13; AH-Mel

DR   Cosmic; 721822

DR   Cosmic; 889040

DR   Cosmic; 928711

DR   Cosmic; 1669134

DR   GEO; GSM170980

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=978138;

RX   PubMed=1716514;

RX   PubMed=2983346;

RX   PubMed=6582512;

RX   PubMed=6864164;

RX   PubMed=6933476;

RX   PubMed=15048078;

RX   PubMed=17516929;

RX   PubMed=21725359;

RX   PubMed=23039341;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-130

AC   CVCL_6080

SY   SK-Mel-130; SKMEL-130

DR   Cosmic; 933131

DR   Cosmic; 1507605

DR   Cosmic; 1669170

DR   Cosmic; 2233671

DR   GEO; GSM784525

RX   PubMed=6582512;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-131

AC   CVCL_6081

SY   SK-Mel-131; SK-mel-131; SK-Mel 131; SK Mel 131; Sk Mel131; SKMEL-131; FD-Mel

DR   Cosmic; 851055

DR   Cosmic; 706112

DR   Cosmic; 721849

DR   Cosmic; 888847

DR   Cosmic; 923394

DR   Cosmic; 933132

DR   Cosmic; 1020273

DR   Cosmic; 1060428

DR   Cosmic; 1507595

DR   Cosmic; 1669171

DR   Cosmic; 2233672

RX   PubMed=2453881;

RX   PubMed=2983346;

RX   PubMed=6864164;

RX   PubMed=7747814;

RX   PubMed=9692547;

RX   PubMed=10766161;

RX   PubMed=15009714;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-132

AC   CVCL_4U04

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-133

AC   CVCL_6082

SY   SK-Mel-133; SK-Mel 133; SKMEL-133; FF-MEL; FF-Mel

DR   Cosmic; 1669172

RX   PubMed=2983346;

RX   PubMed=7814883;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-135

AC   CVCL_6083

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-136

AC   CVCL_8077

DR   Cosmic; 721812

RX   PubMed=1716514;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-139

AC   CVCL_4U07

RX   PubMed=7747814;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-14

AC   CVCL_6023

SY   SK-Mel-14; AI-Mel

RX   PubMed=327080;

RX   PubMed=978138;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-140

AC   CVCL_U907

RX   PubMed=1716514;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-144

AC   CVCL_6084

SY   SK-Mel-144

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-145

AC   CVCL_8078

DR   Cosmic; 923395

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-146

AC   CVCL_6085

SY   SK-Mel-146; SKMEL-146

DR   Cosmic; 721805

DR   Cosmic; 933118

DR   Cosmic; 1669173

RX   PubMed=1716514;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-147

AC   CVCL_3876

SY   SK-Mel-147; SK MEL 147; SKMEL-147; SkMel147; SKMEL147; FT-Mel

DR   Cosmic; 685208

DR   Cosmic; 721808

DR   Cosmic; 933133

DR   Cosmic; 1054851

DR   Cosmic; 1122259

DR   Cosmic; 1247853

DR   Cosmic; 1507623

DR   Cosmic; 1669174

DR   Cosmic; 2233673

DR   GEO; GSM555181

DR   Lonza; 1338

RX   PubMed=1716514;

RX   PubMed=6864164;

RX   PubMed=7747814;

RX   PubMed=17308088;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-15

AC   CVCL_6964

SY   SK-Mel-15; SKMEL-15; BO-Mel

DR   Cosmic; 1669135

RX   PubMed=833871;

RX   PubMed=978138;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-150

AC   CVCL_8079

DR   Cosmic; 923396

RX   PubMed=7747814;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-153

AC   CVCL_6087

SY   SK-Mel-153; SKMEL-153

DR   Cosmic; 721831

DR   Cosmic; 1507627

DR   Cosmic; 1669175

DR   Cosmic; 2233674

RX   PubMed=6582512;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-158

AC   CVCL_8080

DR   Cosmic; 923397

RX   PubMed=6864164;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-16

AC   CVCL_1E23

SY   SK-Mel-16

RX   PubMed=327080;

RX   PubMed=833871;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-161

AC   CVCL_6088

SY   SK-Mel-161; SKMEL-161

DR   Cosmic; 721833

DR   Cosmic; 1669176

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-162

AC   CVCL_4U08

RX   PubMed=7747814;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-163

AC   CVCL_U940

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-165

AC   CVCL_J708

SY   GL-Mel

RX   PubMed=6864164;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-166

AC   CVCL_8081

DR   Cosmic; 721834

RX   PubMed=6864164;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-168

AC   CVCL_U941

RX   PubMed=6864164;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-169

AC   CVCL_U942

RX   PubMed=6864164;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-17

AC   CVCL_6024

SY   SK-Mel-17; AJ-Mel

DR   Cosmic; 721809

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=7747814;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-170

AC   CVCL_6089

SY   SK-Mel-170; SKMEL-170

DR   Cosmic; 933117

DR   Cosmic; 1669177

RX   PubMed=3081645;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-172

AC   CVCL_J709

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-173

AC   CVCL_6090

SY   SK-Mel-173; SKMEL-173; SKMEL173

DR   Cosmic; 685209

DR   Cosmic; 933115

DR   Cosmic; 1054847

DR   Cosmic; 1122260

DR   Cosmic; 1155285

DR   Cosmic; 1507628

DR   Cosmic; 1669178

DR   Cosmic; 2233675

DR   GEO; GSM555182

DR   GEO; GSM784511

DR   Lonza; 1339

RX   PubMed=7747814;

RX   PubMed=17308088;

RX   PubMed=21725359;

RX   PubMed=24576830;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-174

AC   CVCL_6091

SY   SK-Mel-174; SKMEL-174

DR   Cosmic; 1669179

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-176

AC   CVCL_6092

SY   SK-Mel-176; SKMEL-176

DR   Cosmic; 1669180

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-177

AC   CVCL_4U09

RX   PubMed=7747814;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-178

AC   CVCL_6093

SY   SK-Mel-178; SKMEL-178

DR   Cosmic; 923398

DR   Cosmic; 1669181

DR   GEO; GSM784526

RX   PubMed=7747814;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-18

AC   CVCL_U933

SY   AK-Mel

RX   PubMed=327080;

RX   PubMed=833871;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-181

AC   CVCL_6094

SY   SK-Mel-181; SKMEL-181

DR   Cosmic; 1507597

DR   Cosmic; 1669182

DR   Cosmic; 2233676

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-182

AC   CVCL_6095

SY   SK-Mel-182; SKMEL-182

DR   Cosmic; 1669183

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-186

AC   CVCL_6096

SY   SK-Mel-186; SK-Mel 186; SKMEL-186

DR   Cosmic; 721813

DR   Cosmic; 923399

DR   Cosmic; 1507614

DR   Cosmic; 1669184

DR   Cosmic; 2233677

RX   PubMed=1716514;

RX   PubMed=7747814;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-187

AC   CVCL_6097

SY   SK-Mel-187; SKMEL-187; SKMEL187

DR   Cosmic; 685210

DR   Cosmic; 1054845

DR   Cosmic; 1122261

DR   Cosmic; 1507593

DR   Cosmic; 1669185

DR   Cosmic; 2233678

DR   GEO; GSM555183

DR   GEO; GSM784527

DR   Lonza; 1340

RX   PubMed=7747814;

RX   PubMed=17308088;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-188

AC   CVCL_6098

SY   SK-Mel-188; SKMEL-188

DR   Cosmic; 933116

DR   Cosmic; 1669186

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-19

AC   CVCL_6025

SY   SK-Mel-19; SKMEL-19; SkMEL-19; SK-MEL19; Sk Mel19; SKMEL19; AL-Mel

DR   ChEMBL-Cells; CHEMBL3307448

DR   ChEMBL-Targets; CHEMBL614915

DR   Cosmic; 685202

DR   Cosmic; 721841

DR   Cosmic; 886830

DR   Cosmic; 923385

DR   Cosmic; 933126

DR   Cosmic; 1047686

DR   Cosmic; 1060427

DR   Cosmic; 1122255

DR   Cosmic; 1669136

DR   GEO; GSM156032

DR   GEO; GSM555175

DR   GEO; GSM784508

DR   Lonza; 1332

RX   PubMed=833871;

RX   PubMed=978138;

RX   PubMed=2983346;

RX   PubMed=6582512;

RX   PubMed=6864164;

RX   PubMed=6933476;

RX   PubMed=17260012;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Omics: Array-based CGH.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-190

AC   CVCL_6099

SY   SK-Mel-190; SKMEL-190

DR   Cosmic; 1507617

DR   Cosmic; 1669187

DR   Cosmic; 2233679

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-191

AC   CVCL_6100

SY   SK-Mel-191; SKMEL-191

DR   Cosmic; 1669188

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-192

AC   CVCL_6101

SY   SK-Mel-192; SKMEL-192; SKMEL192

DR   Cosmic; 685211

DR   Cosmic; 1122262

DR   Cosmic; 1669189

DR   GEO; GSM555184

DR   Lonza; 1341

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-196

AC   CVCL_6102

SY   SK-Mel-196; SKMEL-196

DR   Cosmic; 933134

DR   Cosmic; 1669190

DR   GEO; GSM784528

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-197

AC   CVCL_8082

SY   SK-Mel-197; SK-MEL 197; SK-Mel 197; SKMEL-197; SKMEL197

DR   Cosmic; 685212

DR   Cosmic; 1122263

DR   GEO; GSM555185

DR   Lonza; 1342

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-198

AC   CVCL_6103

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-199

AC   CVCL_6104

SY   SK-Mel-199; SKMEL-199; SK-MEL-199A; SK-MEL-199 (adhesion); SK-MEL-199S; SK-MEL-199 (suspension)

DR   Cosmic; 1669192

DR   Cosmic; 1669193

DR   GEO; GSM784529

DR   GEO; GSM784530

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-2

AC   CVCL_0069

SY   SK-Mel-2; SK-mel-2; SK.MEL.2; SK Mel 2; SK MEL 2; SKMEL-2; SKMEL2; SKmel2; SK-ML2; SKml2

DR   BTO; BTO:0003476

DR   CLO; CLO_0009041

DR   EFO; EFO_0002079

DR   ATCC; HTB-68

DR   BioSample; SAMN03471882

DR   BioSample; SAMN03472752

DR   CCLE; SKMEL2_SKIN

DR   CGH-DB; 9322-4

DR   ChEMBL-Cells; CHEMBL3307743

DR   ChEMBL-Cells; CHEMBL3308684

DR   ChEMBL-Targets; CHEMBL614858

DR   ChEMBL-Targets; CHEMBL614917

DR   CLS; 300423/NA

DR   Cosmic; 724824

DR   Cosmic; 875885

DR   Cosmic; 897468

DR   Cosmic; 905235

DR   Cosmic; 905955

DR   Cosmic; 974073

DR   Cosmic; 974257

DR   Cosmic; 1006555

DR   Cosmic; 1022288

DR   Cosmic; 1044266

DR   Cosmic; 1045411

DR   Cosmic; 1067222

DR   Cosmic; 1092632

DR   Cosmic; 1132585

DR   Cosmic; 1155283

DR   Cosmic; 1175871

DR   Cosmic; 1303053

DR   Cosmic; 1305367

DR   Cosmic; 1458964

DR   Cosmic; 1459662

DR   Cosmic; 1477419

DR   Cosmic; 1669129

DR   Cosmic; 1995633

DR   Cosmic; 1998475

DR   Cosmic; 2159450

DR   Cosmic; 2479250

DR   Cosmic-CLP; 905955

DR   GDSC; 905955

DR   GEO; GSM50204

DR   GEO; GSM50266

DR   GEO; GSM188225

DR   GEO; GSM188255

DR   GEO; GSM188314

DR   GEO; GSM750824

DR   GEO; GSM799356

DR   GEO; GSM799419

DR   GEO; GSM847115

DR   GEO; GSM844688

DR   GEO; GSM844689

DR   GEO; GSM887585

DR   GEO; GSM888668

DR   GEO; GSM1153426

DR   GEO; GSM1181281

DR   GEO; GSM1181359

DR   GEO; GSM1670437

DR   KCLB; 30068

DR   SKY/M-FISH/CGH; 2820

RX   DOI=10.1007/978-1-4757-1647-4_5;

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=2041050;

RX   PubMed=7999427;

RX   PubMed=8755562;

RX   PubMed=15467732;

RX   PubMed=17088437;

RX   PubMed=19372543;

RX   PubMed=19727395;

RX   PubMed=21725359;

RX   PubMed=22460905;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=24576830;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=45

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-melanoma-cell-line-sk-mel-2

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 779.

CC   Doubling time: 45.5 hours (DTP).

CC   Microsatellite instability: Instable (MSI-high) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'SKm12' in ChEMBL CHEMBL614858 and CHEMBL3308684.

CC   Discontinued: CLS; 300423; true.

CC   Derived from metastatic site: Thigh skin.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=19372543; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 10,11 (ATCC)

ST   D13S317: 11 (Cosmic-CLP; PubMed=19372543; PubMed=25877200)

ST   D16S539: 8,9

ST   D18S51: 15,16

ST   D19S433: 12,15

ST   D21S11: 29,30

ST   D3S1358: 14,16

ST   D5S818: 11,12,13 (ATCC)

ST   D5S818: 12,13 (Cosmic-CLP; PubMed=19372543; PubMed=25877200)

ST   D7S820: 11,12

ST   D8S1179: 12,13

ST   FGA: 19,25

ST   Penta D: 10,15

ST   Penta E: 7,16

ST   TH01: 9

ST   TPOX: 8,9

ST   vWA: 16,17 (ATCC)

ST   vWA: 17 (Cosmic-CLP; PubMed=19372543; PubMed=25877200)

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-MEL-2-Luc

AC   CVCL_J266

DR   JCRB; JCRB1393

DR   JCRB; NIHS0640

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Discontinued: JCRB; NIHS0640; true.

CC   Derived from metastatic site: Thigh skin.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11

ST   D16S539: 8,9

ST   D5S818: 12,13

ST   D7S820: 11,12

ST   TH01: 9

ST   TPOX: 8,9

ST   vWA: 17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0069 ! SK-MEL-2

SX   Male

CA   Cancer cell line

//

ID   SK-MEL-20

AC   CVCL_U925

SY   AM-Mel

RX   PubMed=833871;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-200

AC   CVCL_6105

SY   SK-Mel-200; SKMEL-200

DR   Cosmic; 1669194

DR   GEO; GSM784531

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-202

AC   CVCL_6106

SY   SK-Mel-202; SKMEL-202

DR   Cosmic; 1669195

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-203

AC   CVCL_U908

RX   PubMed=1716514;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-204

AC   CVCL_U909

RX   PubMed=1716514;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-205

AC   CVCL_6107

SY   SK-Mel-205; SKMEL-205

DR   Cosmic; 1669196

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-207

AC   CVCL_6108

SY   SK-Mel-207; SKMEL-207

DR   Cosmic; 1669197

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-208

AC   CVCL_6109

SY   SK-Mel-208; SKMEL-208

DR   Cosmic; 1669198

DR   GEO; GSM784532

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-209

AC   CVCL_6110

SY   SK-Mel-209; SKMEL-209

DR   Cosmic; 1669199

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-21

AC   CVCL_3877

SY   SK-Mel-21; SK MEL 21; SK-MEL21; AN-Mel

DR   BTO; BTO:0002966

DR   Cosmic; 897471

DR   Cosmic; 923386

DR   Cosmic; 933127

DR   Cosmic; 1669137

RX   PubMed=327080;

RX   PubMed=6864164;

RX   PubMed=6933476;

RX   PubMed=7747814;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-210-3

AC   CVCL_D772

SY   SKMEL-210-3; SK-Mel-210

DR   Cosmic; 1669200

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-215-1

AC   CVCL_U911

SY   SKMEL-215-1; SK-Mel-215

DR   Cosmic; 1669201

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-217

AC   CVCL_6111

SY   SK-Mel-217; SKMEL-217

DR   Cosmic; 1669202

DR   GEO; GSM784533

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-22

AC   CVCL_6026

SY   SK-Mel-22; SKMEL-22; SK-MEL-022; AO-Mel

DR   Cosmic; 1669138

DR   GEO; GSM784520

RX   PubMed=833871;

RX   PubMed=978138;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-222

AC   CVCL_6112

SY   SK-Mel-222; SKMEL-222

DR   Cosmic; 1669203

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-227

AC   CVCL_6113

SY   SK-Mel-227; SKMEL-227

DR   Cosmic; 1669204

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-228

AC   CVCL_6114

SY   SK-Mel-228; SKMEL-228

DR   Cosmic; 1669205

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-229

AC   CVCL_6115

SY   SK-Mel-229; SKMEL-229

DR   Cosmic; 1669206

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-23

AC   CVCL_6027

SY   SK-Mel-23; SK-Mel 23; SK-mel-23; SK MEL 23; SK Mel 23; Sk Mel23; SKMEL-23; SKMEL23; SK23-MEL; SK23-mel; SK23; AP-Mel

DR   BTO; BTO:0005333

DR   EFO; EFO_0006490

DR   BioSample; SAMN03470872

DR   BioSample; SAMN03473194

DR   CGH-DB; 9318-4

DR   Cosmic; 706107

DR   Cosmic; 721823

DR   Cosmic; 851051

DR   Cosmic; 876705

DR   Cosmic; 888852

DR   Cosmic; 897493

DR   Cosmic; 905231

DR   Cosmic; 1060423

DR   Cosmic; 1303054

DR   Cosmic; 1507594

DR   Cosmic; 1669139

DR   GEO; GSM206542

DR   GEO; GSM784516

DR   Lonza; 1343

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=978138;

RX   PubMed=6582512;

RX   PubMed=6864164;

RX   PubMed=6933476;

RX   PubMed=9692547;

RX   PubMed=10766161;

RX   PubMed=15009714;

RX   PubMed=15467732;

RX   PubMed=17308088;

RX   PubMed=21725359;

RX   PubMed=24576830;

RX   PubMed=25485619;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8,12

ST   D16S539: 11,13

ST   D18S51: 14,21

ST   D21S11: 26,29

ST   D2S1338: 20,25

ST   D3S1358: 16,17

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   D8S1179: 10,11

ST   FGA: 18,22,23

ST   Penta D: 9.1,11,12

ST   Penta E: 12

ST   TH01: 7,9.3

ST   TPOX: 8,9

ST   vWA: 15,16

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-230

AC   CVCL_6116

SY   SK-Mel-230; SKMEL-230

DR   Cosmic; 1669207

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-232

AC   CVCL_6117

SY   SK-Mel-232; SKMEL-232

DR   Cosmic; 1669208

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-233

AC   CVCL_6118

SY   SK-Mel-233; SKMEL-233

DR   Cosmic; 1669209

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-234

AC   CVCL_6119

SY   SK-Mel-234; SKMEL-234

DR   Cosmic; 933139

DR   Cosmic; 1669210

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-235

AC   CVCL_4Z29

SY   SKMEL-235

DR   Cosmic; 2233680

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-237

AC   CVCL_6120

SY   SK-Mel-237; SKMEL-237

DR   Cosmic; 1669211

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-238

AC   CVCL_6121

SY   SK-Mel-238; SKMEL-238

DR   Cosmic; 1669212

DR   GEO; GSM784534

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-239

AC   CVCL_6122

SY   SK-Mel-239; SKMEL-239

DR   Cosmic; 1507603

DR   Cosmic; 1669213

DR   GEO; GSM784535

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-24

AC   CVCL_0599

SY   Sk-Mel-24; SK Mel 24; SKMEL-24; SK-Mel24; SKMEL24; SKMel24; AQ-Mel

DR   BTO; BTO:0005861

DR   CLO; CLO_0009042

DR   EFO; EFO_0006487

DR   CLDB; cl7124

DR   ATCC; HTB-71

DR   BioSample; SAMN03473230

DR   CCLE; SKMEL24_SKIN

DR   ChEMBL-Cells; CHEMBL3308324

DR   ChEMBL-Targets; CHEMBL2366314

DR   Cosmic; 687441

DR   Cosmic; 851405

DR   Cosmic; 909725

DR   Cosmic; 932997

DR   Cosmic; 1022274

DR   Cosmic; 1054858

DR   Cosmic; 1102581

DR   Cosmic; 1155265

DR   Cosmic; 1458965

DR   Cosmic; 1459651

DR   Cosmic; 1507625

DR   Cosmic; 1669140

DR   Cosmic; 1995634

DR   Cosmic-CLP; 909725

DR   GDSC; 909725

DR   GEO; GSM784509

DR   GEO; GSM887583

DR   GEO; GSM888666

DR   GEO; GSM1670438

DR   ICLC; HTL02001

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=978138;

RX   PubMed=7459858;

RX   PubMed=10709110;

RX   PubMed=17308088;

RX   PubMed=21654344;

RX   PubMed=21725359;

RX   PubMed=22460905;

RX   PubMed=24576830;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-melanoma-cell-line-sk-mel-24

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK2003-078.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 12,13

ST   D16S539: 9,12

ST   D18S51: 16

ST   D21S11: 29,31.2

ST   D3S1358: 15

ST   D5S818: 9,13

ST   D7S820: 9,12

ST   D8S1179: 14,15

ST   FGA: 22,23

ST   Penta D: 9

ST   Penta E: 11,12

ST   TH01: 6,9

ST   TPOX: 11

ST   vWA: 15

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-MEL-241

AC   CVCL_8083

DR   Cosmic; 933140

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-243

AC   CVCL_6123

SY   SK-Mel-243; SKMEL-243

DR   Cosmic; 1669214

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-244

AC   CVCL_6124

SY   SK-Mel-244; SKMEL-244

DR   Cosmic; 1669215

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-245

AC   CVCL_6125

SY   SK-Mel-245

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-246

AC   CVCL_6126

SY   SK-Mel-246; SKMEL-246

DR   Cosmic; 1669216

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-249

AC   CVCL_6961

SY   JU-MEL

RX   PubMed=7814883;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-25

AC   CVCL_6028

SY   SK-Mel-25; SK Mel 25; SK 25; AR-Mel

DR   ChEMBL-Cells; CHEMBL3308005

DR   ChEMBL-Targets; CHEMBL612706

DR   CLS; 300336/NA

RX   PubMed=978138;

RX   PubMed=6895502;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-250

AC   CVCL_6962

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-252

AC   CVCL_6127

SY   SK-Mel-252; SKMEL-252

DR   Cosmic; 1669217

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-256

AC   CVCL_6128

SY   SK-Mel-256; SKMEL-256; JX-MEL

DR   Cosmic; 1669218

RX   PubMed=7814883;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-258

AC   CVCL_6129

DR   Cosmic; 933112

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-26

AC   CVCL_6029

SY   SK-Mel-26; SKMEL-26; AS-Mel

DR   Cosmic; 1669141

RX   PubMed=327080;

RX   PubMed=978138;

RX   PubMed=6582512;

RX   PubMed=6864164;

RX   PubMed=6933476;

RX   PubMed=6935474;

RX   PubMed=7459858;

RX   PubMed=21725359;

RX   PubMed=24576830;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-mel-26-human-melanoma-cell-line

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-546.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-MEL-263

AC   CVCL_6130

SY   SKMEL-263

DR   Cosmic; 1669219

RX   PubMed=17308088;

RX   PubMed=21725359;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-264

AC   CVCL_6131

SY   SK-Mel-264; SKMEL-264

DR   Cosmic; 1669220

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-265

AC   CVCL_6132

SY   SK-Mel-265; SKMEL-265

DR   Cosmic; 1669221

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-266

AC   CVCL_6133

SY   SK-Mel-266; SKMEL-266

DR   Cosmic; 1669222

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-267

AC   CVCL_6134

SY   SK-Mel-267; SKMEL-267; SK-Mel 267

DR   Cosmic; 1669223

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-268

AC   CVCL_6135

SY   SK-Mel-268; SKMEL-268

DR   Cosmic; 1669224

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-269

AC   CVCL_6136

SY   SK-Mel-269; SKMEL-269

DR   Cosmic; 1669225

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-27

AC   CVCL_6030

SY   SK-Mel-27; SK-Mel/27; AT-Mel

DR   Cosmic; 1507592

DR   GEO; GSM784517

RX   PubMed=327080;

RX   PubMed=978138;

RX   PubMed=6933476;

RX   PubMed=6935474;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-27-1

AC   CVCL_U913

SY   SKMEL-27-1

DR   Cosmic; 1669142

RX   PubMed=21725359;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6030 ! SK-MEL-27

CA   Cancer cell line

//

ID   SK-MEL-27-2

AC   CVCL_U914

SY   SKMEL-27-2

DR   Cosmic; 1669143

RX   PubMed=21725359;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6030 ! SK-MEL-27

CA   Cancer cell line

//

ID   SK-MEL-271

AC   CVCL_6137

SY   SK-Mel-271; SKMEL-271

DR   Cosmic; 1669226

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-272

AC   CVCL_6138

SY   SK-Mel-272; SKMEL-272

DR   Cosmic; 1669227

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-275

AC   CVCL_6139

SY   SK-Mel-275; SKMEL-275

DR   Cosmic; 1669228

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-276

AC   CVCL_6140

SY   SK-Mel-276; SKMEL-276

DR   Cosmic; 1669229

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-279

AC   CVCL_6141

SY   SK-Mel-279; SKMEL-279

DR   Cosmic; 1669230

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-28

AC   CVCL_0526

SY   SK-Mel-28; SK Mel 28; SK-MEL 28; SK.MEL.28; SK MEL 28; SKMel-28; SKMEL-28; SK-MEL28; SK-Mel28; SKMEL28; SKMel28; SKmel28; AU-Mel; P-36; P36

DR   BTO; BTO:0002131

DR   CLO; CLO_0009043

DR   EFO; EFO_0003081

DR   MCCL; MCC:0000426

DR   CLDB; cl4321

DR   CLDB; cl4954

DR   ATCC; HTB-72

DR   BCRJ; 0289

DR   BioSample; SAMN03470899

DR   BioSample; SAMN03472092

DR   BioSample; SAMN03472754

DR   CCLE; SKMEL28_SKIN

DR   CGH-DB; 9317-4

DR   ChEMBL-Cells; CHEMBL3307334

DR   ChEMBL-Cells; CHEMBL3308494

DR   ChEMBL-Targets; CHEMBL614216

DR   ChEMBL-Targets; CHEMBL614919

DR   CLS; 300337/p495_SK-MEL-28

DR   Cosmic; 686472

DR   Cosmic; 686476

DR   Cosmic; 687442

DR   Cosmic; 706106

DR   Cosmic; 721824

DR   Cosmic; 851050

DR   Cosmic; 874384

DR   Cosmic; 874446

DR   Cosmic; 875887

DR   Cosmic; 886831

DR   Cosmic; 888846

DR   Cosmic; 897491

DR   Cosmic; 898252

DR   Cosmic; 905230

DR   Cosmic; 905954

DR   Cosmic; 928748

DR   Cosmic; 932712

DR   Cosmic; 933135

DR   Cosmic; 974072

DR   Cosmic; 974262

DR   Cosmic; 1006554

DR   Cosmic; 1007156

DR   Cosmic; 1022271

DR   Cosmic; 1045407

DR   Cosmic; 1047687

DR   Cosmic; 1054859

DR   Cosmic; 1067227

DR   Cosmic; 1092633

DR   Cosmic; 1102386

DR   Cosmic; 1109809

DR   Cosmic; 1132589

DR   Cosmic; 1155280

DR   Cosmic; 1155570

DR   Cosmic; 1175872

DR   Cosmic; 1183772

DR   Cosmic; 1187579

DR   Cosmic; 1221590

DR   Cosmic; 1238109

DR   Cosmic; 1295337

DR   Cosmic; 1303055

DR   Cosmic; 1305368

DR   Cosmic; 1312350

DR   Cosmic; 1425350

DR   Cosmic; 1458966

DR   Cosmic; 1459645

DR   Cosmic; 1477319

DR   Cosmic; 1477408

DR   Cosmic; 1507598

DR   Cosmic; 1598350

DR   Cosmic; 1665022

DR   Cosmic; 1669144

DR   Cosmic; 1995635

DR   Cosmic; 1998476

DR   Cosmic; 2159448

DR   Cosmic; 2479251

DR   Cosmic-CLP; 905954

DR   GDSC; 905954

DR   GEO; GSM50205

DR   GEO; GSM50267

DR   GEO; GSM156050

DR   GEO; GSM171012

DR   GEO; GSM188226

DR   GEO; GSM188256

DR   GEO; GSM188315

DR   GEO; GSM206543

DR   GEO; GSM228378

DR   GEO; GSM276739

DR   GEO; GSM750825

DR   GEO; GSM784506

DR   GEO; GSM799357

DR   GEO; GSM799420

DR   GEO; GSM844690

DR   GEO; GSM847116

DR   GEO; GSM887584

DR   GEO; GSM888667

DR   GEO; GSM952581

DR   GEO; GSM1138790

DR   GEO; GSM1153427

DR   GEO; GSM1153428

DR   GEO; GSM1181282

DR   GEO; GSM1181283

DR   GEO; GSM1588919

DR   GEO; GSM1670439

DR   ICLC; HTL99010

DR   LINCS; 51101

DR   Lonza; 79

DR   RCB; RCB1930

DR   SKY/M-FISH/CGH; 2745

RX   PubMed=327080;

RX   PubMed=978138;

RX   PubMed=1716514;

RX   PubMed=2041050;

RX   PubMed=2068080;

RX   PubMed=2983346;

RX   PubMed=6203018;

RX   PubMed=6349783;

RX   PubMed=6582512;

RX   PubMed=6864164;

RX   PubMed=6933476;

RX   PubMed=7999427;

RX   PubMed=10766161;

RX   PubMed=11016658;

RX   PubMed=14692828;

RX   PubMed=15009714;

RX   PubMed=15299072;

RX   PubMed=15467732;

RX   PubMed=17088437;

RX   PubMed=17260012;

RX   PubMed=17308088;

RX   PubMed=17363583;

RX   PubMed=17516929;

RX   PubMed=19147755;

RX   PubMed=19372543;

RX   PubMed=20041153;

RX   PubMed=21725359;

RX   PubMed=22460905;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=24576830;

RX   PubMed=25485619;

RX   PubMed=27087056;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=47

WW   http://www.addexbio.com/productdetail?pid=66

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-melanoma-cell-line-sk-mel-28

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-524.

CC   Doubling time: 35.1 hours (DTP).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: RCB; RCB1930; true.

ST   Source(s): ATCC; CLS; Cosmic-CLP; PubMed=19372543; PubMed=25877200; PubMed=27087056; RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12 (ATCC; CLS; Cosmic-CLP; PubMed=27087056; RCB)

ST   CSF1PO: 10 (PubMed=19372543; PubMed=25877200)

ST   D13S317: 11,12

ST   D16S539: 9,12

ST   D18S51: 12,16

ST   D19S433: 14

ST   D21S11: 28,29

ST   D2S1338: 18

ST   D3S1358: 16,18

ST   D5S818: 11,13 (ATCC; Cosmic-CLP; PubMed=27087056; RCB)

ST   D5S818: 13 (CLS; PubMed=19372543; PubMed=25877200)

ST   D7S820: 9.3,10 (ATCC)

ST   D7S820: 10 (CLS; Cosmic-CLP; PubMed=19372543; PubMed=25877200; PubMed=27087056; RCB)

ST   D8S1179: 13

ST   FGA: 19

ST   Penta D: 9,10

ST   Penta E: 8,12

ST   TH01: 7

ST   TPOX: 8,12 (ATCC; CLS; Cosmic-CLP; PubMed=27087056; RCB)

ST   TPOX: 12 (PubMed=19372543; PubMed=25877200)

ST   vWA: 16,19 (ATCC; CLS; Cosmic-CLP; PubMed=25877200; PubMed=27087056; RCB)

ST   vWA: 19 (PubMed=19372543)

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-MEL-28-Luc

AC   CVCL_J267

DR   JCRB; JCRB1376

DR   JCRB; NIHS0641

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Discontinued: JCRB; NIHS0641; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 11,12

ST   D16S539: 9,12

ST   D5S818: 13

ST   D7S820: 9.3,10

ST   TH01: 7

ST   TPOX: 8,12

ST   vWA: 19

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0526 ! SK-MEL-28

SX   Male

CA   Cancer cell line

//

ID   SK-MEL-28-VR

AC   CVCL_AP99

RX   PubMed=26497853;

CC   Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0526 ! SK-MEL-28

SX   Male

CA   Cancer cell line

//

ID   SK-MEL-281

AC   CVCL_6142

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-282

AC   CVCL_6143

SY   SK-Mel-282; SKMEL-282

DR   Cosmic; 1669231

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-283

AC   CVCL_6144

SY   SK-Mel-283; SKMEL-283

DR   Cosmic; 1669232

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-284

AC   CVCL_6145

SY   SK-Mel-284; SKMEL-284

DR   Cosmic; 1669233

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-285

AC   CVCL_6146

SY   SK-Mel-285; SKMEL-285

DR   Cosmic; 1669234

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-28DDR1-PLXAZD

AC   CVCL_IM75

SY   SkMel28DDR1-PLXAZD

DR   GEO; GSM1588921

RX   PubMed=26359985;

CC   Selected for resistance to: ChEBI; CHEBI:90227; Selumetinib (AZD6244).

CC   Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0526 ! SK-MEL-28

SX   Male

CA   Cancer cell line

//

ID   SK-MEL-28R1-PLX

AC   CVCL_IM76

SY   SkMel28R1-PLX

DR   GEO; GSM1588920

RX   PubMed=26359985;

CC   Selected for resistance to: ChEBI; CHEBI:63637; Vemurafenib (Zelboraf; PLX4032).

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0526 ! SK-MEL-28

SX   Male

CA   Cancer cell line

//

ID   SK-MEL-29

AC   CVCL_6031

SY   SK-Mel-29; SKMEL-29; SKMEL29; AV-Mel

DR   Cosmic; 685203

DR   Cosmic; 933136

DR   Cosmic; 1669145

DR   GEO; GSM555176

DR   GEO; GSM784513

DR   Lonza; 1333

RX   PubMed=978138;

RX   PubMed=2983346;

RX   PubMed=6582512;

RX   PubMed=6864164;

RX   PubMed=6933476;

RX   PubMed=6935474;

RX   PubMed=21725359;

RX   PubMed=24576830;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-mel-29-human-melanoma-cell-line

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-525.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-MEL-3

AC   CVCL_0550

SY   SK-Mel-3; Sk-mel-3; SK-Mel3; SKMEL3

DR   BTO; BTO:0002132

DR   CLO; CLO_0009044

DR   EFO; EFO_0002333

DR   ATCC; HTB-69

DR   BioSample; SAMN03472882

DR   CCLE; SKMEL3_SKIN

DR   ChEMBL-Cells; CHEMBL3307449

DR   ChEMBL-Targets; CHEMBL614920

DR   Cosmic; 687443

DR   Cosmic; 874445

DR   Cosmic; 888063

DR   Cosmic; 909724

DR   Cosmic; 1022286

DR   Cosmic; 1047688

DR   Cosmic; 1459671

DR   Cosmic; 1995636

DR   Cosmic; 2159449

DR   Cosmic-CLP; 909724

DR   DSMZ; ACC-321

DR   GDSC; 909724

DR   GEO; GSM156045

DR   GEO; GSM827519

DR   GEO; GSM887588

DR   GEO; GSM888671

DR   GEO; GSM1670440

DR   IGRhCellID; SKMEL3

DR   KCLB; 30069

DR   NCBI_Iran; C458

RX   DOI=10.1007/978-1-4757-1647-4_5;

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=8755562;

RX   PubMed=17260012;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-melanoma-cell-line-sk-mel-3

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-523.

CC   Doubling time: ~40-50 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC; Cosmic-CLP; DSMZ; KCLB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 9,10

ST   D13S317: 12,13

ST   D16S539: 11

ST   D18S51: 10,18

ST   D21S11: 29,30

ST   D3S1358: 17,18

ST   D5S818: 11

ST   D7S820: 8,10

ST   D8S1179: 14

ST   FGA: 24

ST   Penta D: 9,13

ST   Penta E: 11,15

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 14,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-MEL-30

AC   CVCL_0039

SY   SK-Mel-30; SK Mel 30; SKMEL-30; Sk Mel30; AW-Mel

DR   BTO; BTO:0002133

DR   CLO; CLO_0009045

DR   EFO; EFO_0006488

DR   CLDB; cl4323

DR   BioSample; SAMN03473251

DR   CCLE; SKMEL30_SKIN

DR   ChEMBL-Cells; CHEMBL3308128

DR   ChEMBL-Targets; CHEMBL1075577

DR   Cosmic; 706090

DR   Cosmic; 721825

DR   Cosmic; 851035

DR   Cosmic; 888061

DR   Cosmic; 888834

DR   Cosmic; 909726

DR   Cosmic; 933128

DR   Cosmic; 1022283

DR   Cosmic; 1060425

DR   Cosmic; 1669146

DR   Cosmic-CLP; 909726

DR   DSMZ; ACC-151

DR   GDSC; 909726

DR   GEO; GSM784510

DR   GEO; GSM887586

DR   GEO; GSM888669

DR   GEO; GSM1670441

RX   PubMed=978138;

RX   PubMed=1067619;

RX   PubMed=1716514;

RX   PubMed=3081645;

RX   PubMed=6864164;

RX   PubMed=6933476;

RX   PubMed=10766161;

RX   PubMed=15009714;

RX   PubMed=21725359;

RX   PubMed=22460905;

RX   PubMed=24576830;

RX   PubMed=25485619;

RX   PubMed=27397505;

WW   http://www.proteinatlas.org/learn/cellines

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-mel-30-human-melanoma-cell-line

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-526.

CC   Doubling time: ~30 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep antibody staining analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 8,11

ST   D16S539: 8,11

ST   D18S51: 13,15

ST   D21S11: 29,31.2

ST   D3S1358: 15,16

ST   D5S818: 9,12

ST   D7S820: 8,9

ST   D8S1179: 8,14

ST   FGA: 20,21

ST   Penta D: 12

ST   Penta E: 5,14

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 15,17

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-MEL-301

AC   CVCL_6147

SY   SK-Mel-301; SKMEL-301

DR   Cosmic; 1669235

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-304

AC   CVCL_6148

SY   SK-Mel-304; SKMEL-304

DR   Cosmic; 1669236

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-306

AC   CVCL_6149

SY   SK-Mel-306; SKMEL-306

DR   Cosmic; 1669237

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-307

AC   CVCL_6150

SY   SK-Mel-307; SKMEL-307

DR   Cosmic; 1669238

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-309B

AC   CVCL_U912

SY   SKMEL-309B; SK-Mel-309

DR   Cosmic; 1669239

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-31

AC   CVCL_0600

SY   Sk-Mel-31; SKMEL-31; SKMel-31; SkMel31; SKMEL31; AX-Mel

DR   CLO; CLO_0009046

DR   EFO; EFO_0006489

DR   ATCC; HTB-73

DR   BioSample; SAMN03472881

DR   CCLE; SKMEL31_SKIN

DR   Cosmic; 688054

DR   Cosmic; 851406

DR   Cosmic; 932998

DR   Cosmic; 933113

DR   Cosmic; 1022273

DR   Cosmic; 1047689

DR   Cosmic; 1102384

DR   Cosmic; 1459643

DR   Cosmic; 1669147

DR   Cosmic; 2159444

DR   Cosmic; 2479254

DR   Cosmic-CLP; 909727

DR   GDSC; 909727

DR   GEO; GSM156033

DR   GEO; GSM276762

DR   GEO; GSM887587

DR   GEO; GSM888670

DR   GEO; GSM1670442

DR   KCLB; 30073

DR   Lonza; 1344

RX   PubMed=978138;

RX   PubMed=6582512;

RX   PubMed=6864164;

RX   PubMed=6933476;

RX   PubMed=17260012;

RX   PubMed=21725359;

RX   PubMed=22460905;

RX   PubMed=24576830;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-melanoma-cell-line-sk-mel-31

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-527.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: KCLB; 30073; probable.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 12

ST   D16S539: 13

ST   D18S51: 15

ST   D21S11: 30,32.2

ST   D3S1358: 17,18

ST   D5S818: 11,13

ST   D7S820: 10

ST   D8S1179: 12,14

ST   FGA: 24

ST   Penta D: 9

ST   Penta E: 12,18

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-MEL-313

AC   CVCL_1T59

SY   SK-Mel-313

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-315-02

AC   CVCL_E090

SY   SK-Mel-315-02; SKMEL-315-02

DR   Cosmic; 1669240

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_E091 ! SK-MEL-315-03

OI   CVCL_E092 ! SK-MEL-315-05

CA   Cancer cell line

//

ID   SK-MEL-315-03

AC   CVCL_E091

SY   SKMEL-315-03

DR   Cosmic; 1669241

RX   PubMed=21725359;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_E090 ! SK-MEL-315-02

OI   CVCL_E092 ! SK-MEL-315-05

CA   Cancer cell line

//

ID   SK-MEL-315-05

AC   CVCL_E092

SY   SK-Mel-315-05; SKMEL-315-05

DR   Cosmic; 1669242

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_E090 ! SK-MEL-315-02

OI   CVCL_E091 ! SK-MEL-315-03

CA   Cancer cell line

//

ID   SK-MEL-316

AC   CVCL_6151

SY   SK-Mel-316

DR   Cosmic; 1669243

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-318

AC   CVCL_1T60

SY   SK-Mel-318

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-32

AC   CVCL_6032

SY   SK-Mel-32; SKMEL-32; SK-Mel 32; AY-Mel

DR   Cosmic; 1669148

RX   PubMed=6935474;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-MEL-321A

AC   CVCL_D771

SY   SK-Mel-321A; SKMEL-321A

DR   Cosmic; 1669244

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_E089 ! SK-MEL-321B

CA   Cancer cell line

//

ID   SK-MEL-321B

AC   CVCL_E089

SY   SK-Mel-321B; SKMEL-321B

DR   Cosmic; 1669245

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_D771 ! SK-MEL-321A

CA   Cancer cell line

//

ID   SK-MEL-323

AC   CVCL_6152

SY   SK-Mel-323; SKMEL-323

DR   Cosmic; 1669246

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-325

AC   CVCL_6153

SY   SK-Mel-325; SKMEL-325

DR   Cosmic; 1669247

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-326

AC   CVCL_6154

SY   SK-Mel-326; SKMEL-326

DR   Cosmic; 1669248

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-33

AC   CVCL_6033

SY   SK-Mel-33; AZ-Mel

DR   Cosmic; 923387

RX   PubMed=2983346;

RX   PubMed=6864164;

RX   PubMed=6933476;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-330

AC   CVCL_6155

SY   SK-Mel-330; SKMEL-330

DR   Cosmic; 1669249

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-332

AC   CVCL_1T61

SY   SK-Mel-332

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-334

AC   CVCL_6156

SY   SK-Mel-334; SKMEL-334

DR   Cosmic; 1669250

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-339

AC   CVCL_6157

SY   SK-Mel-339; SKMEL-339

DR   Cosmic; 1669251

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-34

AC   CVCL_8084

SY   BA-Mel

DR   Cosmic; 721842

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-341

AC   CVCL_6158

SY   SKMEL-341

DR   Cosmic; 1669252

RX   PubMed=21725359;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-346

AC   CVCL_6159

SY   SK-Mel-346; SKMEL-346

DR   Cosmic; 1669253

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-35

AC   CVCL_6034

SY   SK-Mel-35; SKMEL-35; BB-Mel

DR   Cosmic; 1669149

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-351

AC   CVCL_6160

SY   SK-Mel-351; SKMEL-351

DR   Cosmic; 1669254

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-359

AC   CVCL_6161

SY   SK-Mel-359; SKMEL-359

DR   Cosmic; 1669255

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-36

AC   CVCL_6035

SY   SK-Mel-36; SKMEL-36; BC-Mel

DR   Cosmic; 1669150

RX   PubMed=978138;

RX   PubMed=1778766;

RX   PubMed=6933476;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-364

AC   CVCL_6162

SY   SK-Mel-364; SKMEL-364

DR   Cosmic; 1669256

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-366

AC   CVCL_6163

SY   SK-Mel-366; SKMEL-366

DR   Cosmic; 1669257

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-367

AC   CVCL_6164

SY   SK-Mel-367; SKMEL-367

DR   Cosmic; 1669258

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-369

AC   CVCL_6165

SY   SK-Mel-369; SKMEL-369

DR   Cosmic; 1669259

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-37

AC   CVCL_3878

SY   SK-Mel-37; SK-MEL37; SK-Mel 37; SK MEL 37; Sk Mel37; SKMEL-37; SK-37; BD-Mel

DR   BTO; BTO:0002967

DR   Cosmic; 706102

DR   Cosmic; 721826

DR   Cosmic; 851046

DR   Cosmic; 888842

DR   Cosmic; 933137

DR   Cosmic; 1303056

DR   Cosmic; 1669151

RX   PubMed=978138;

RX   PubMed=1778766;

RX   PubMed=2983346;

RX   PubMed=3081645;

RX   PubMed=6582512;

RX   PubMed=6864164;

RX   PubMed=6933476;

RX   PubMed=9692547;

RX   PubMed=10766161;

RX   PubMed=15009714;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-38

AC   CVCL_U926

SY   BE-Mel

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-380

AC   CVCL_6166

SY   SK-Mel-380; SKMEL-380

DR   Cosmic; 1669260

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-381

AC   CVCL_6167

SY   SK-Mel-381; SKMEL-381

DR   Cosmic; 1669261

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-39

AC   CVCL_6036

SY   SK-Mel-39; SK-Mel 39; SK Mel 39; Sk Mel39; SKMEL-39; BF-Mel

DR   Cosmic; 706098

DR   Cosmic; 851042

DR   Cosmic; 888840

DR   Cosmic; 897487

DR   Cosmic; 933138

DR   Cosmic; 1669152

RX   PubMed=9692547;

RX   PubMed=10766161;

RX   PubMed=15009714;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-390

AC   CVCL_6168

SY   SK-Mel-390; SKMEL-390

DR   Cosmic; 1669262

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-391

AC   CVCL_1T62

SY   SK-Mel-391

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-393

AC   CVCL_1T63

SY   SK-Mel-393

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-394

AC   CVCL_1T64

SY   SK-Mel-394

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-398

AC   CVCL_1T65

SY   SK-Mel-398

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-40

AC   CVCL_6037

SY   SK-Mel-40; SKMEL-40; BG-Mel

DR   Cosmic; 721844

DR   Cosmic; 1669153

RX   PubMed=1778766;

RX   PubMed=6933476;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-400

AC   CVCL_1T66

SY   SK-Mel-400

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-406

AC   CVCL_1T67

SY   SK-Mel-406

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-408

AC   CVCL_1T68

SY   SK-Mel-408

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-41

AC   CVCL_6038

SY   SK-Mel-41; SKMEL-41; BH-Mel

DR   Cosmic; 1669154

RX   PubMed=6864164;

RX   PubMed=6933476;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-MEL-410

AC   CVCL_1T69

SY   SK-Mel-410

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-411

AC   CVCL_1T70

SY   SK-Mel-411

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-412Parotid

AC   CVCL_1T71

SY   SK-Mel-412Parotid

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-413-2

AC   CVCL_1T72

SY   SK-Mel-413-2

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-42

AC   CVCL_6039

SY   SK-Mel-42; BR-Mel

RX   PubMed=6933476;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-MEL-423A

AC   CVCL_1T73

SY   SK-Mel-423A

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1T74 ! SK-MEL-423B

CA   Cancer cell line

//

ID   SK-MEL-423B

AC   CVCL_1T74

SY   SK-Mel-423B

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1T73 ! SK-MEL-423A

CA   Cancer cell line

//

ID   SK-MEL-426

AC   CVCL_1T75

SY   SK-Mel-426

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-427

AC   CVCL_1T76

SY   SK-Mel-427

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-428

AC   CVCL_1T77

SY   SK-Mel-428

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-43

AC   CVCL_U927

SY   BS-Mel

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-MEL-430

AC   CVCL_1T78

SY   SK-Mel-430

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-431

AC   CVCL_1T79

SY   SK-Mel-431

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-432

AC   CVCL_1T80

SY   SK-Mel-432

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-435

AC   CVCL_1T81

SY   SK-Mel-435

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-439

AC   CVCL_1T82

SY   SK-Mel-439

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-44

AC   CVCL_6040

SY   SK-Mel 44; BT-Mel

DR   Cosmic; 721827

RX   PubMed=2983346;

RX   PubMed=6933476;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-MEL-441

AC   CVCL_1T83

SY   SK-Mel-441

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-444

AC   CVCL_1T84

SY   SK-Mel-444

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-445

AC   CVCL_1T85

SY   SK-Mel-445

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-446

AC   CVCL_1T86

SY   SK-Mel-446

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-447

AC   CVCL_1T87

SY   SK-Mel-447

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-45

AC   CVCL_U928

SY   BU-Mel

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-MEL-451

AC   CVCL_1T88

SY   SK-Mel-451

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-452

AC   CVCL_1T89

SY   SK-Mel-452

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-455

AC   CVCL_1T90

SY   SK-Mel-455

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-457

AC   CVCL_1T91

SY   SK-Mel-457

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-459

AC   CVCL_1T92

SY   SK-Mel-459

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-46

AC   CVCL_U929

SY   BV-Mel

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-MEL-462

AC   CVCL_1T93

SY   SK-Mel-462

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-464A

AC   CVCL_1T94

SY   SK-Mel-464a

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1T95 ! SK-MEL-464B

CA   Cancer cell line

//

ID   SK-MEL-464B

AC   CVCL_1T95

SY   SK-Mel-464b

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1T94 ! SK-MEL-464A

CA   Cancer cell line

//

ID   SK-MEL-47

AC   CVCL_U930

SY   BW-Mel

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-MEL-479

AC   CVCL_1T96

SY   SK-Mel-479

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-48

AC   CVCL_U931

SY   BX-Mel

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-MEL-481

AC   CVCL_1T97

SY   SK-Mel-481

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-483

AC   CVCL_1T98

SY   SK-Mel-483

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-49

AC   CVCL_6229

SY   BZ-Mel

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-MEL-495

AC   CVCL_1T99

SY   SK-Mel-495

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-498

AC   CVCL_1U00

SY   SK-Mel-498

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-5

AC   CVCL_0527

SY   SK-Mel-5; SK MEL 5; SK.MEL.5; SK-MEL5; SKMel-5; SKMEL-5; SKMEL5; SKMel5; SKmel5; AA-Mel

DR   BTO; BTO:0002134

DR   CLO; CLO_0009047

DR   EFO; EFO_0005720

DR   MCCL; MCC:0000427

DR   CLDB; cl7123

DR   ATCC; HTB-70

DR   BioSample; SAMN03472753

DR   CCLE; SKMEL5_SKIN

DR   CGH-DB; 9316-4

DR   ChEMBL-Cells; CHEMBL3307744

DR   ChEMBL-Targets; CHEMBL614922

DR   CLS; 300157/p634_SK-MEL-5

DR   Cosmic; 686475

DR   Cosmic; 688055

DR   Cosmic; 875886

DR   Cosmic; 905229

DR   Cosmic; 905956

DR   Cosmic; 932996

DR   Cosmic; 974074

DR   Cosmic; 974258

DR   Cosmic; 1022282

DR   Cosmic; 1092634

DR   Cosmic; 1132588

DR   Cosmic; 1175873

DR   Cosmic; 1247851

DR   Cosmic; 1303057

DR   Cosmic; 1305369

DR   Cosmic; 1312351

DR   Cosmic; 1458967

DR   Cosmic; 1459648

DR   Cosmic; 1477410

DR   Cosmic; 1481415

DR   Cosmic; 1507626

DR   Cosmic; 1669130

DR   Cosmic; 1998477

DR   Cosmic; 2159434

DR   Cosmic; 2479253

DR   Cosmic-CLP; 905956

DR   ENCODE; ENCBS029HXQ

DR   ENCODE; ENCBS324XRL

DR   ENCODE; ENCBS398HNX

DR   ENCODE; ENCBS465YNJ

DR   ENCODE; ENCBS518AAA

DR   ENCODE; ENCBS519AAA

DR   ENCODE; ENCBS524EJL

DR   ENCODE; ENCBS697RNA

DR   ENCODE; ENCBS981ZNI

DR   GDSC; 905956

DR   GEO; GSM50206

DR   GEO; GSM50268

DR   GEO; GSM171011

DR   GEO; GSM188227

DR   GEO; GSM188257

DR   GEO; GSM188316

DR   GEO; GSM226866

DR   GEO; GSM750826

DR   GEO; GSM799358

DR   GEO; GSM799421

DR   GEO; GSM847117

DR   GEO; GSM844691

DR   GEO; GSM887589

DR   GEO; GSM888672

DR   GEO; GSM1138791

DR   GEO; GSM1153429

DR   GEO; GSM1181267

DR   GEO; GSM1181310

DR   GEO; GSM1670443

DR   ICLC; HTL01023

DR   KCLB; 30070

DR   Lonza; 1202

DR   SKY/M-FISH/CGH; 2821

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=2041050;

RX   PubMed=7747814;

RX   PubMed=7999427;

RX   PubMed=11016658;

RX   PubMed=15299072;

RX   PubMed=15467732;

RX   PubMed=17088437;

RX   PubMed=17363583;

RX   PubMed=17516929;

RX   PubMed=19372543;

RX   PubMed=21725359;

RX   PubMed=22460905;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=24576830;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=46

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-melanoma-cell-line-sk-mel-5

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-522.

CC   Doubling time: 70 hours (PubMed=25984343); 25.2 hours (DTP).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Axillary lymph node.

ST   Source(s): ATCC; CLS; Cosmic-CLP; KCLB; PubMed=19372543

ST   Amelogenin: X

ST   CSF1PO: 10,13

ST   D13S317: 10,12

ST   D16S539: 10,12

ST   D18S51: 15,16

ST   D19S433: 14,15

ST   D21S11: 29

ST   D2S1338: 17,25

ST   D3S1358: 16,17

ST   D5S818: 11,13

ST   D7S820: 9,12

ST   D8S1179: 12,15

ST   FGA: 20.2,22.2

ST   Penta D: 9,11

ST   Penta E: 5,12

ST   TH01: 6,9

ST   TPOX: 11

ST   vWA: 14,18 (ATCC; CLS; Cosmic-CLP; KCLB)

ST   vWA: 14 (PubMed=19372543)

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-MEL-50

AC   CVCL_U935

SY   CA-Mel

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-506

AC   CVCL_1U01

SY   SK-Mel-506

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-507

AC   CVCL_1U02

SY   SK-Mel-507

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-509

AC   CVCL_1U03

SY   SK-Mel-509

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-51

AC   CVCL_6041

SY   CB-Mel

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-513

AC   CVCL_1U04

SY   SK-Mel-513

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-52

AC   CVCL_8085

SY   Sk-Mel-52; CC-Mel

DR   Cosmic; 721828

RX   PubMed=6933476;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-524

AC   CVCL_1U05

SY   SK-Mel-524

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-529

AC   CVCL_1U06

SY   SK-Mel-529

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-534

AC   CVCL_1U07

SY   SK-Mel-534

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-538

AC   CVCL_1U08

SY   SK-Mel-538

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-55

AC   CVCL_6042

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-56

AC   CVCL_6046

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-57

AC   CVCL_6043

SY   CH-Mel

RX   PubMed=6933476;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-6

AC   CVCL_U932

SY   AB-Mel

RX   PubMed=833871;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-MEL-60

AC   CVCL_6047

SY   CK-Mel

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-61

AC   CVCL_6044

SY   SK-Mel-61; CL-Mel

DR   Cosmic; 721836

DR   Cosmic; 923388

DR   Cosmic; 933129

RX   PubMed=2983346;

RX   PubMed=6933476;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-62

AC   CVCL_8086

SY   CM-Mel

DR   Cosmic; 721837

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-63

AC   CVCL_6045

SY   SK-Mel-63; Sk Mel 63; SKMEL63; Sk Mel63; SkMel63; CN-Mel

DR   Cosmic; 706095

DR   Cosmic; 721811

DR   Cosmic; 851040

DR   Cosmic; 888838

DR   Cosmic; 897477

DR   Cosmic; 933130

DR   Cosmic; 1054852

RX   PubMed=1716514;

RX   PubMed=6933476;

RX   PubMed=10766161;

RX   PubMed=15009714;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-64

AC   CVCL_6048

SY   SK-Mel-64; SKMEL-64; CO-Mel

DR   Cosmic; 721838

DR   Cosmic; 1669155

RX   PubMed=2983346;

RX   PubMed=6864164;

RX   PubMed=6933476;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-65

AC   CVCL_6050

SY   SK-Mel-65

DR   Cosmic; 721815

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-68

AC   CVCL_6051

SY   CR-Mel

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-69

AC   CVCL_6058

SY   CS-Mel

RX   PubMed=6933476;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-7

AC   CVCL_D854

SY   SK-Mel-7; SKMEL-7; AC-Mel

DR   Cosmic; 1669131

RX   PubMed=327080;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-72

AC   CVCL_6052

SY   SK-Mel-72

DR   Cosmic; 721839

DR   Cosmic; 923389

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-73

AC   CVCL_6053

SY   SK-Mel-73; SKMEL-73

DR   Cosmic; 721840

DR   Cosmic; 1669156

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-75

AC   CVCL_6054

SY   SK-Mel-75; SKMEL-75

DR   Cosmic; 721829

DR   Cosmic; 933114

DR   Cosmic; 1060424

DR   Cosmic; 1669157

RX   PubMed=6582512;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-76

AC   CVCL_6221

RX   PubMed=7747814;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-78

AC   CVCL_6056

SY   SK-Mel-78; SKMEL78; DC-Mel

DR   Cosmic; 721845

DR   Cosmic; 1507606

DR   Cosmic; 2233681

RX   PubMed=2983346;

RX   PubMed=6933476;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-79

AC   CVCL_6222

SY   DD-Mel

RX   PubMed=6933476;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-8

AC   CVCL_6960

SY   AD-Mel

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=978138;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-80

AC   CVCL_6057

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-81

AC   CVCL_6223

DR   Cosmic; 721846

RX   PubMed=1716514;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-83

AC   CVCL_6059

SY   DH-Mel

RX   PubMed=6933476;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-85

AC   CVCL_6224

SY   SK-Mel-85; SK-MEL 85; SKMEL-85; SKMEL85; SK-MEL-085; DJ-Mel

DR   Cosmic; 685204

DR   Cosmic; 1669158

DR   GEO; GSM555177

DR   GEO; GSM784521

DR   Lonza; 1334

RX   PubMed=7747814;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-86

AC   CVCL_6225

SY   SK-Mel-86; DK-Mel

DR   Cosmic; 923390

RX   PubMed=6933476;

RX   PubMed=7747814;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-87

AC   CVCL_6060

SY   DL-Mel

RX   PubMed=6933476;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-88

AC   CVCL_6049

SY   SK-Mel-88; SKMEL88; DM-Mel

DR   Cosmic; 721847

RX   PubMed=2983346;

RX   PubMed=6933476;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-89

AC   CVCL_6226

SY   DN-Mel

RX   PubMed=6933476;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-9

AC   CVCL_U934

SY   AE-Mel

RX   PubMed=327080;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-90

AC   CVCL_6227

SY   SK-Mel-90; SKMEL-90; DO-Mel

DR   Cosmic; 1669159

RX   PubMed=6864164;

RX   PubMed=6933476;

RX   PubMed=21725359;

RX   PubMed=24576830;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-91

AC   CVCL_6228

SY   DP-Mel

RX   PubMed=6933476;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-93 DX-1

AC   CVCL_5651

AS   CVCL_3879; CVCL_U902

SY   SK-MEL-93-DX-1; SK-MEL-93 DX1; SK-MEL-93 (DX1); DX-1; DX1; SK-MEL-93(1); SK-MEL-93-1; SK-MEL-93; SK-Mel-93; SK-MEL93; SKMel-93; SKMEL93; SKMel93

DR   BTO; BTO:0002968

DR   Cosmic; 721816

DR   Cosmic; 926000

DR   Cosmic; 933119

DR   Cosmic; 1060426

RX   PubMed=2886213;

RX   PubMed=6864164;

RX   PubMed=6976407;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Derived from metastatic site: Subcutaneous; left thigh.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5652 ! SK-MEL-93 DX-2

OI   CVCL_5650 ! SK-MEL-93 DX-3

OI   CVCL_A432 ! SK-MEL-93 DX-4

OI   CVCL_A433 ! SK-MEL-93 DX-5

OI   CVCL_A434 ! SK-MEL-93 DX-6

OI   CVCL_A435 ! SK-MEL-93 DX-B

SX   Female

CA   Cancer cell line

//

ID   SK-MEL-93 DX-2

AC   CVCL_5652

AS   CVCL_6062

SY   SK-MEL-93-DX-2; SK-MEL-93 DX2; SK-MEL-93 (DX2); DX-2; DX2; SK-MEL-93(2); SK-MEL-93-2; DX-Mel-2

DR   Cosmic; 721817

DR   Cosmic; 926001

DR   Cosmic; 933120

RX   PubMed=1716514;

RX   PubMed=2886213;

RX   PubMed=2983346;

RX   PubMed=3081645;

RX   PubMed=6582512;

RX   PubMed=6864164;

RX   PubMed=6976407;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Derived from metastatic site: Hypodermis.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5651 ! SK-MEL-93 DX-1

OI   CVCL_5650 ! SK-MEL-93 DX-3

OI   CVCL_A432 ! SK-MEL-93 DX-4

OI   CVCL_A433 ! SK-MEL-93 DX-5

OI   CVCL_A434 ! SK-MEL-93 DX-6

OI   CVCL_A435 ! SK-MEL-93 DX-B

SX   Female

CA   Cancer cell line

//

ID   SK-MEL-93 DX-3

AC   CVCL_5650

AS   CVCL_U903

SY   SK-MEL-93-DX-3; SK-MEL-93 DX3; SK-MEL-93 (DX3); DX-3; DX3; SK-MEL-93(3); SK-MEL-93-3; DX-Mel-3

DR   BTO; BTO:0003988

DR   Cosmic; 721806

DR   Cosmic; 926002

DR   Cosmic; 932703

DR   Cosmic; 933121

DR   KCLB; 80012

RX   PubMed=1716514;

RX   PubMed=2886213;

RX   PubMed=2983346;

RX   PubMed=6582512;

RX   PubMed=6976407;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Derived from metastatic site: Hypodermis.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5651 ! SK-MEL-93 DX-1

OI   CVCL_5652 ! SK-MEL-93 DX-2

OI   CVCL_A432 ! SK-MEL-93 DX-4

OI   CVCL_A433 ! SK-MEL-93 DX-5

OI   CVCL_A434 ! SK-MEL-93 DX-6

OI   CVCL_A435 ! SK-MEL-93 DX-B

SX   Female

CA   Cancer cell line

//

ID   SK-MEL-93 DX-4

AC   CVCL_A432

AS   CVCL_U904

SY   SK-MEL-93-DX-4; SK-MEL-93 DX4; SK-MEL-93 (DX4); DX-4; DX4; SK-MEL-93(4); DX-Mel-4

DR   Cosmic; 721818

DR   Cosmic; 926003

DR   Cosmic; 933122

RX   PubMed=1716514;

RX   PubMed=2886213;

RX   PubMed=2983346;

RX   PubMed=6976407;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Derived from metastatic site: Hypodermis.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5651 ! SK-MEL-93 DX-1

OI   CVCL_5652 ! SK-MEL-93 DX-2

OI   CVCL_5650 ! SK-MEL-93 DX-3

OI   CVCL_A433 ! SK-MEL-93 DX-5

OI   CVCL_A434 ! SK-MEL-93 DX-6

OI   CVCL_A435 ! SK-MEL-93 DX-B

SX   Female

CA   Cancer cell line

//

ID   SK-MEL-93 DX-5

AC   CVCL_A433

AS   CVCL_U905

SY   SK-MEL-93-DX-5; SK-MEL-93 DX5; SK-MEL-93 (DX5); DX-5; DX5; SK-MEL-93(5)

DR   Cosmic; 721819

DR   Cosmic; 926004

DR   Cosmic; 933123

RX   PubMed=2886213;

RX   PubMed=6976407;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Derived from metastatic site: Hypodermis.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5651 ! SK-MEL-93 DX-1

OI   CVCL_5652 ! SK-MEL-93 DX-2

OI   CVCL_5650 ! SK-MEL-93 DX-3

OI   CVCL_A432 ! SK-MEL-93 DX-4

OI   CVCL_A434 ! SK-MEL-93 DX-6

OI   CVCL_A435 ! SK-MEL-93 DX-B

SX   Female

CA   Cancer cell line

//

ID   SK-MEL-93 DX-6

AC   CVCL_A434

AS   CVCL_U906

SY   SK-MEL-93-DX-6; SK-MEL-93 DX 6; SK-MEL-93 DX6; SK-MEL-93 (DX6); DX-6; DX6; SK-MEL-93(6); DX-Mel-6

DR   Cosmic; 721820

DR   Cosmic; 926005

DR   Cosmic; 933124

RX   PubMed=1716514;

RX   PubMed=2886213;

RX   PubMed=2983346;

RX   PubMed=6976407;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Derived from metastatic site: Hypodermis.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5651 ! SK-MEL-93 DX-1

OI   CVCL_5652 ! SK-MEL-93 DX-2

OI   CVCL_5650 ! SK-MEL-93 DX-3

OI   CVCL_A432 ! SK-MEL-93 DX-4

OI   CVCL_A433 ! SK-MEL-93 DX-5

OI   CVCL_A435 ! SK-MEL-93 DX-B

SX   Female

CA   Cancer cell line

//

ID   SK-MEL-93 DX-B

AC   CVCL_A435

SY   DX-B; DX B

RX   PubMed=2886213;

RX   PubMed=6976407;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5651 ! SK-MEL-93 DX-1

OI   CVCL_5652 ! SK-MEL-93 DX-2

OI   CVCL_5650 ! SK-MEL-93 DX-3

OI   CVCL_A432 ! SK-MEL-93 DX-4

OI   CVCL_A433 ! SK-MEL-93 DX-5

OI   CVCL_A434 ! SK-MEL-93 DX-6

SX   Female

CA   Transformed cell line

//

ID   SK-MEL-94

AC   CVCL_3880

SY   SK-Mel-94; SKMEL94

DR   Cosmic; 685205

DR   Cosmic; 1122256

DR   GEO; GSM555178

DR   Lonza; 1335

RX   PubMed=7747814;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-95

AC   CVCL_6064

SY   DT-Mel

RX   PubMed=6933476;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-96

AC   CVCL_U939

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-97

AC   CVCL_6065

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MEL-98

AC   CVCL_6066

SY   DW-Mel

RX   PubMed=6933476;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MES-1

AC   CVCL_0630

AS   CVCL_8913

SY   SK MES 1; SKMES-1; SK-Mes-1; SKMES1; SK-MES; SKMES

DR   BTO; BTO:0002203

DR   CLO; CLO_0009033

DR   CLO; CLO_0009048

DR   CLO; CLO_0009049

DR   EFO; EFO_0002334

DR   CLDB; cl4325

DR   CLDB; cl4326

DR   CLDB; cl4329

DR   ATCC; HTB-58

DR   BioSample; SAMN03473164

DR   CCLE; SKMES1_LUNG

DR   CCRID; 3111C0001CCC000262

DR   CCRID; 3131C0001000700110

DR   CGH-DB; 191-1

DR   CGH-DB; 9180-4

DR   ChEMBL-Cells; CHEMBL3307450

DR   ChEMBL-Cells; CHEMBL3308366

DR   ChEMBL-Targets; CHEMBL613528

DR   ChEMBL-Targets; CHEMBL614923

DR   CLS; 300339/p1465_SK-MES-1

DR   Cosmic; 687832

DR   Cosmic; 909728

DR   Cosmic; 933577

DR   Cosmic; 934464

DR   Cosmic; 1006538

DR   Cosmic; 1071896

DR   Cosmic; 1089225

DR   Cosmic; 1176620

DR   Cosmic; 1219089

DR   Cosmic; 1239912

DR   Cosmic; 1434962

DR   Cosmic; 1995637

DR   Cosmic; 2060529

DR   Cosmic; 2125289

DR   Cosmic-CLP; 909728

DR   DSMZ; ACC-353

DR   ECACC; 91091804

DR   ECACC; 93120837

DR   GDSC; 909728

DR   GEO; GSM62971

DR   GEO; GSM206544

DR   GEO; GSM513971

DR   GEO; GSM514561

DR   GEO; GSM784266

DR   GEO; GSM827318

DR   GEO; GSM887590

DR   GEO; GSM888673

DR   GEO; GSM1374881

DR   GEO; GSM1670444

DR   ICLC; HTL95004

DR   IGRhCellID; SKMES1

DR   IZSLER; BS TCL 72

DR   LINCS; 50043

DR   KCB; KCB 200821YJ

DR   KCLB; 30058

DR   NCBI_Iran; C562

DR   TOKU-E; 3142

RX   DOI=10.1007/978-1-4757-1647-4_5;

RX   PubMed=833871;

RX   PubMed=2990217;

RX   PubMed=6935474;

RX   PubMed=7736387;

RX   PubMed=14581340;

RX   PubMed=15746151;

RX   PubMed=19472407;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-mes-1-lung-cell-line

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK2009-091.

CC   Doubling time: ~50 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ECACC; 91091804; probable.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; KCLB; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 13

ST   D18S51: 17

ST   D21S11: 29,30

ST   D3S1358: 16

ST   D5S818: 11

ST   D7S820: 8

ST   D8S1179: 13,14

ST   FGA: 20,24

ST   Penta D: 12,13

ST   Penta E: 5,11

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 14

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-MG-1

AC   CVCL_1698

SY   SKMG1; AJ

DR   BioSample; SAMN03151837

DR   BioSample; SAMN03472786

DR   ChEMBL-Cells; CHEMBL3308547

DR   ChEMBL-Targets; CHEMBL2366151

DR   Cosmic; 909729

DR   Cosmic; 2367547

DR   Cosmic-CLP; 909729

DR   GDSC; 909729

DR   GEO; GSM1670445

DR   IFO; IFO50344

RX   PubMed=6182568;

RX   PubMed=6582512;

RX   PubMed=6864164;

RX   PubMed=20143388;

RX   PubMed=27397505;

WW   http://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a Marcus derivative (PubMed=20143388).

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Discontinued: IFO; IFO50344; probable.

ST   Source(s): Cosmic-CLP; JCRB

ST   Amelogenin: X

ST   CSF1PO: 12,15

ST   D13S317: 11

ST   D16S539: 12,13

ST   D5S818: 11,12

ST   D7S820: 9,11 (Cosmic-CLP)

ST   D7S820: 9 (JCRB)

ST   TH01: 9,9.3

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3019 ! Marcus

SX   Female

CA   Cancer cell line

//

ID   SK-MG-10

AC   CVCL_8568

RX   PubMed=6182568;

RX   PubMed=6864164;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MG-11

AC   CVCL_8569

RX   PubMed=6182568;

RX   PubMed=6582512;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MG-12

AC   CVCL_8570

RX   PubMed=6182568;

RX   PubMed=6864164;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MG-13

AC   CVCL_8571

RX   PubMed=6182568;

RX   PubMed=6864164;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MG-14

AC   CVCL_GS21

RX   PubMed=6582512;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MG-15

AC   CVCL_8572

RX   PubMed=6582512;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MG-16

AC   CVCL_8573

RX   PubMed=6864164;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MG-17

AC   CVCL_8574

SY   SK-MG 17

DR   Cosmic; 1038408

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MG-2

AC   CVCL_8575

RX   PubMed=6182568;

RX   PubMed=6582512;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MG-21

AC   CVCL_Y195

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MG-26

AC   CVCL_D701

SY   SK-MG 26; SKMG26

DR   Cosmic; 1038414

DR   Cosmic; 1672407

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MG-3

AC   CVCL_8576

SY   SKMG-3; SKMG3

DR   Cosmic; 847808

DR   Cosmic; 1175819

DR   Cosmic; 1217676

DR   Cosmic; 2550360

RX   PubMed=2994648;

RX   PubMed=6182568;

RX   PubMed=6582512;

RX   PubMed=6864164;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MG-4

AC   CVCL_8577

SY   SKMG4; SK-MG4

RX   PubMed=6182568;

RX   PubMed=6864164;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MG-5

AC   CVCL_GS19

RX   PubMed=6582512;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MG-6

AC   CVCL_GS20

RX   PubMed=6582512;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MG-7

AC   CVCL_8578

RX   PubMed=6182568;

RX   PubMed=6864164;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MG-8

AC   CVCL_Y196

RX   PubMed=6582512;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MG-9

AC   CVCL_8579

SY   SK-MG 9

DR   Cosmic; 1038409

RX   PubMed=6182568;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-MM-1

AC   CVCL_A478

SY   SK-MM1; SKMM-1; SKMM1; SK-MY-1; SK-My-1

DR   EFO; EFO_0005457

DR   BioSample; SAMN03470877

DR   Cosmic; 720782

DR   Cosmic; 760399

DR   Cosmic; 2081407

DR   Cosmic; 2302414

DR   Cosmic; 2367273

DR   Cosmic; 2391803

DR   DSMZ; ACC-758

DR   GEO; GSM143343

DR   SKY/M-FISH/CGH; 2544

RX   PubMed=2506399;

RX   PubMed=6582512;

RX   PubMed=8943038;

RX   PubMed=10557056;

RX   PubMed=10936422;

RX   PubMed=11429052;

RX   PubMed=12886255;

RX   PubMed=17171682;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-multiple-myeloma-cell-line-sk-mm-1

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 440.

CC   Doubling time: ~48 hours (DSMZ).

CC   Omics: Transcriptome analysis.

ST   Source(s): DSMZ; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 12

ST   D16S539: 13,14

ST   D18S51: 16,17

ST   D19S433: 13

ST   D21S11: 28,32

ST   D2S1338: 22,26

ST   D3S1358: 14,17

ST   D5S818: 8,11

ST   D7S820: 8,12

ST   D8S1179: 14

ST   FGA: 24

ST   Penta D: 2.2,13

ST   Penta E: 10,12

ST   TH01: 7

ST   TPOX: 8,10

ST   vWA: 18

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-MM-2

AC   CVCL_1699

SY   SK-MM2; SKMM-2; SKMM2

DR   CLO; CLO_0009050

DR   EFO; EFO_0005458

DR   BioSample; SAMN03472942

DR   CCLE; SKMM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   ChEMBL-Cells; CHEMBL3308277

DR   ChEMBL-Targets; CHEMBL2366232

DR   Cosmic; 720793

DR   Cosmic; 753612

DR   Cosmic; 2081408

DR   Cosmic; 2302409

DR   Cosmic; 2367263

DR   Cosmic-CLP; 753612

DR   DSMZ; ACC-430

DR   GDSC; 753612

DR   GEO; GSM887591

DR   GEO; GSM888674

DR   GEO; GSM1374882

DR   GEO; GSM1670446

RX   PubMed=2506399;

RX   PubMed=8943038;

RX   PubMed=10936422;

RX   PubMed=21173094;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-multiple-myeloma-cell-line-sk-mm-2

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1989-002.

CC   Doubling time: 85 hours (PubMed=25984343); ~100 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 10

ST   D16S539: 11

ST   D18S51: 11

ST   D21S11: 30,31.2

ST   D3S1358: 16

ST   D5S818: 9,11

ST   D7S820: 8,11

ST   D8S1179: 12,13

ST   FGA: 21

ST   Penta D: 11,15

ST   Penta E: 10,20

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 14,20

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-N-AS

AC   CVCL_1700

SY   SKN-AS; SKNAS

DR   BTO; BTO:0002827

DR   CLO; CLO_0009051

DR   EFO; EFO_0002859

DR   CLDB; cl4330

DR   CLDB; cl4331

DR   ATCC; CRL-2137

DR   BioSample; SAMN03473210

DR   CCLE; SKNAS_AUTONOMIC_GANGLIA

DR   CGH-DB; 61-1

DR   CGH-DB; 9098-4

DR   ChEMBL-Cells; CHEMBL3308785

DR   ChEMBL-Targets; CHEMBL1075578

DR   Cosmic; 724828

DR   Cosmic; 848935

DR   Cosmic; 930074

DR   Cosmic; 1019941

DR   Cosmic; 1109104

DR   Cosmic; 1162002

DR   Cosmic; 1167418

DR   Cosmic; 1518070

DR   Cosmic; 1526646

DR   Cosmic; 1543772

DR   Cosmic; 2058112

DR   Cosmic; 2239472

DR   Cosmic; 2393642

DR   Cosmic; 2485950

DR   Cosmic-CLP; 724828

DR   ECACC; 94092302

DR   GDSC; 724828

DR   GEO; GSM563352

DR   GEO; GSM692855

DR   GEO; GSM887592

DR   GEO; GSM888675

DR   GEO; GSM1670449

DR   ICLC; HTL95026

DR   IGRhCellID; SKNAS

RX   DOI=10.1007/0-306-46872-7_2;

RX   DOI=10.1016/B978-0-12-333530-2.50006-X;

RX   DOI=10.1159/00040702;

RX   PubMed=2987426;

RX   PubMed=7838528;

RX   PubMed=11550280;

RX   PubMed=12702577;

RX   PubMed=22213050;

RX   PubMed=22460905;

RX   PubMed=23202128;

RX   PubMed=25485619;

RX   PubMed=27397505;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=SK-N-AS

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-509.html

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): ATCC; Cosmic-CLP; ECACC; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 9

ST   D16S539: 14

ST   D18S51: 14,15

ST   D21S11: 32.2,33.2

ST   D3S1358: 14

ST   D5S818: 11,12

ST   D7S820: 11,13

ST   D8S1179: 13,14

ST   FGA: 20,22

ST   Penta D: 9

ST   Penta E: 7,14

ST   TH01: 9.3

ST   TPOX: 11,12

ST   vWA: 16,17

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-N-BE(1)

AC   CVCL_9898

SY   SKNBE(1); SKNBE-1

RX   DOI=10.1007/0-306-46872-7_2;

RX   PubMed=29704;

RX   PubMed=2535691;

RX   PubMed=24792489;

WW   http://www.cogcell.org/dl/NB_Data_Sheets/SK-N-BE1_Cell_Line_Data_Sheet_COGcell_org.pdf

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): COG

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 9,11

ST   D18S51: 14,16

ST   D19S433: 12,13

ST   D21S11: 30,32.2

ST   D2S1338: 17,23

ST   D3S1358: 19

ST   D5S818: 12

ST   D7S820: 9,10

ST   D8S1179: 13,14

ST   FGA: 22,25

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0528 ! SK-N-BE(2)

SX   Male

CA   Cancer cell line

//

ID   SK-N-BE(2)

AC   CVCL_0528

SY   SK-N-BE2; SKNBE(2); SKNBE-2; SKNBE2; SK-N-BE; SKNBE

DR   BTO; BTO:0002696

DR   CLO; CLO_0009052

DR   MCCL; MCC:0000505

DR   CLDB; cl4332

DR   CLDB; cl4333

DR   ATCC; CRL-2271

DR   BCRJ; 0381

DR   BioSample; SAMN03472880

DR   BioSample; SAMN03473451

DR   CCLE; SKNBE2_AUTONOMIC_GANGLIA

DR   Cosmic; 1019928

DR   Cosmic; 2485941

DR   DSMZ; ACC-632

DR   ECACC; 95011815

DR   GEO; GSM554389

DR   GEO; GSM563358

DR   GEO; GSM692869

DR   GEO; GSM827352

DR   GEO; GSM887593

DR   GEO; GSM888676

DR   GEO; GSM1366411

DR   GEO; GSM1670450

DR   ICLC; HTL96015

DR   KCB; KCB 201199YJ

RX   DOI=10.1007/0-306-46872-7_2;

RX   DOI=10.1007/978-1-4757-1647-4_13;

RX   DOI=10.1016/B978-0-12-333530-2.50006-X;

RX   PubMed=29704;

RX   PubMed=62055;

RX   PubMed=2535691;

RX   PubMed=6582512;

RX   PubMed=7838528;

RX   PubMed=11550280;

RX   PubMed=20631050;

RX   PubMed=22213050;

RX   PubMed=22460905;

RX   PubMed=24792489;

WW   http://www.cogcell.org/dl/NB_Data_Sheets/SK-N-BE2_Cell_Line_Data_Sheet_COGcell_org.pdf

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-565.html

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-n-be-2-human-neuroblastoma-cell-line

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-530.

CC   Doubling time: ~36 hours (DSMZ).

CC   Omics: Array-based CGH.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): ATCC; COG; DSMZ; PubMed=25877200

ST   Amelogenin: X,Y (ATCC; COG; PubMed=25877200)

ST   Amelogenin: X (DSMZ)

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 9,11

ST   D18S51: 16 (COG)

ST   D18S51: 14,16 (PubMed=25877200)

ST   D19S433: 12,13

ST   D21S11: 30,32.2 (COG)

ST   D21S11: 30,31,32.2 (PubMed=25877200)

ST   D2S1338: 17,23

ST   D3S1358: 19

ST   D5S818: 12

ST   D7S820: 9,10

ST   D8S1179: 13,14

ST   FGA: 22,25

ST   Penta D: 13,14

ST   Penta E: 14,18

ST   TH01: 6,7 (ATCC; COG; PubMed=25877200)

ST   TH01: 6 (DSMZ)

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_9898 ! SK-N-BE(1)

SX   Male

CA   Cancer cell line

//

ID   SK-N-BE(2)-C

AC   CVCL_0529

SY   SK-N-BE(2)C; SK-N-BE-2c; SK-N-BE(2C); SK-N-BE2C; SK_N_BE2C; BE(2)-C; BE(2)C; BE2-C; BE2_C; Be2-C; BE2C; Be2C

DR   BTO; BTO:0004782

DR   CLO; CLO_0001915

DR   CLO; CLO_0009053

DR   EFO; EFO_0005725

DR   MCCL; MCC:0000428

DR   CLDB; cl413

DR   CLDB; cl4334

DR   ATCC; CRL-2268

DR   BioSample; SAMN03471855

DR   Cosmic; 688061

DR   Cosmic; 922659

DR   Cosmic; 1162003

DR   Cosmic; 1167421

DR   Cosmic; 1526648

DR   ECACC; 95011817

DR   ENCODE; ENCBS271SFD

DR   ENCODE; ENCBS403ENC

DR   ENCODE; ENCBS427ENC

DR   ENCODE; ENCBS982TUR

DR   GEO; GSM651567

DR   GEO; GSM651568

DR   GEO; GSM945241

DR   GEO; GSM945283

DR   GEO; GSM923434

DR   ICLC; HTL96018

DR   IGRhCellID; BE2C

DR   NCBI_Iran; C577

DR   PRIDE; PXD003596

RX   PubMed=1985865;

RX   PubMed=2535691;

RX   PubMed=6582512;

RX   PubMed=23202128;

RX   PubMed=23325432;

WW   http://genome.ucsc.edu/ENCODE/protocols/cell/human/BE2-C_Myers_protocol.pdf

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-162.html

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-n-be-2-c-human-neuroblastoma-cell-line

CC   Part of: ENCODE project common cell types; tier 3.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-532.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: H3K4me3 ChIP-seq epigenome analysis.

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): ATCC; ECACC

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 9,11

ST   D5S818: 12

ST   D7S820: 9,10

ST   TH01: 6

ST   TPOX: 11

ST   vWA: 18

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0528 ! SK-N-BE(2)

SX   Male

CA   Cancer cell line

//

ID   SK-N-BE(2)-M17

AC   CVCL_0167

SY   BE(2)-M17; BE(2)M17; BE(2)M-17; BE2-M17

DR   BTO; BTO:0002104

DR   CLO; CLO_0001916

DR   MCCL; MCC:0000059

DR   CLDB; cl407

DR   ATCC; CRL-2267

DR   BioSample; SAMN03471024

DR   BioSample; SAMN03472366

DR   CCRID; 3111C0001CCC000076

DR   Cosmic; 753616

DR   Cosmic; 1167416

DR   Cosmic-CLP; 753616

DR   ECACC; 95011816

DR   GDSC; 753616

DR   GEO; GSM1669614

DR   JCRB; JCRB9131

DR   JCRB; NIHS0221

DR   Lonza; 1236

DR   NCBI_Iran; C614

RX   PubMed=2535691;

RX   PubMed=27397505;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-n-be-2-m17-human-neuroblastoma-cell-line

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-531.

CC   Doubling time: 20-24 hours (ECACC).

CC   Microsatellite instability: Instable (MSI-low) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Discontinued: JCRB; JCRB9131; true.

CC   Discontinued: JCRB; NIHS0221; true.

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): ATCC; Cosmic-CLP; ECACC; JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 11

ST   D18S51: 14

ST   D19S433: 12,13

ST   D21S11: 30,32.2

ST   D2S1338: 17,23

ST   D3S1358: 19

ST   D5S818: 12

ST   D7S820: 9,10

ST   D8S1179: 13,14

ST   FGA: 22,25

ST   Penta D: 13,14

ST   Penta E: 14,18

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 18 (ATCC; ECACC; PubMed=25877200)

ST   vWA: 17,18 (Cosmic-CLP; JCRB)

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0528 ! SK-N-BE(2)

SX   Male

CA   Cancer cell line

//

ID   SK-N-DZ

AC   CVCL_1701

SY   SKNDZ

DR   BTO; BTO:0004217

DR   CLO; CLO_0009054

DR   EFO; EFO_0005721

DR   CLDB; cl4335

DR   ATCC; CRL-2149

DR   BioSample; SAMN03473093

DR   CCLE; SKNDZ_AUTONOMIC_GANGLIA

DR   CGH-DB; 77-1

DR   CGH-DB; 9094-4

DR   ChEMBL-Cells; CHEMBL3308474

DR   ChEMBL-Targets; CHEMBL1075579

DR   Cosmic; 688086

DR   Cosmic; 897447

DR   Cosmic; 930076

DR   Cosmic; 1019931

DR   Cosmic; 1109370

DR   Cosmic; 1162004

DR   Cosmic; 1167415

DR   Cosmic; 2058115

DR   Cosmic; 2485951

DR   Cosmic-CLP; 688086

DR   ECACC; 94092305

DR   ENCODE; ENCBS373BOT

DR   ENCODE; ENCBS439FDS

DR   ENCODE; ENCBS478IFE

DR   ENCODE; ENCBS514GVM

DR   ENCODE; ENCBS520AAA

DR   ENCODE; ENCBS521AAA

DR   ENCODE; ENCBS580YYW

DR   ENCODE; ENCBS707BMT

DR   ENCODE; ENCBS715HTH

DR   ENCODE; ENCBS773LCT

DR   ENCODE; ENCBS893THB

DR   GDSC; 688086

DR   GEO; GSM887594

DR   GEO; GSM888677

DR   GEO; GSM1366412

DR   GEO; GSM1670451

DR   IGRhCellID; SKNDZ

DR   Lonza; 1190

RX   DOI=10.1016/B978-0-12-333530-2.50006-X;

RX   DOI=10.1159/00040702;

RX   PubMed=2987426;

RX   PubMed=12702577;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): ATCC; Cosmic-CLP; ECACC; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 9,11

ST   D18S51: 15,17

ST   D21S11: 29,31

ST   D3S1358: 17

ST   D5S818: 12

ST   D7S820: 12,13

ST   D8S1179: 12,13

ST   FGA: 18,22

ST   Penta D: 9,14

ST   Penta E: 7,10

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 16,18

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-N-FI

AC   CVCL_1702

SY   SK_N_FI; SKNFI; SK-N-F1; SKNF1

DR   BTO; BTO:0004218

DR   CLO; CLO_0009056

DR   CLO; CLO_0009057

DR   EFO; EFO_0002338

DR   CLDB; cl4336

DR   CLDB; cl4337

DR   ATCC; CRL-2142

DR   BioSample; SAMN03473095

DR   CCLE; SKNFI_AUTONOMIC_GANGLIA

DR   ChEMBL-Cells; CHEMBL3308278

DR   ChEMBL-Targets; CHEMBL2366120

DR   Cosmic; 688087

DR   Cosmic; 930077

DR   Cosmic; 965555

DR   Cosmic; 1019946

DR   Cosmic; 1109102

DR   Cosmic; 1162005

DR   Cosmic; 1212540

DR   Cosmic; 1518064

DR   Cosmic; 1526649

DR   Cosmic; 1543769

DR   Cosmic; 2058111

DR   Cosmic; 2393644

DR   Cosmic-CLP; 688087

DR   ECACC; 94092304

DR   GDSC; 688087

DR   GEO; GSM393037

DR   GEO; GSM692854

DR   GEO; GSM827414

DR   GEO; GSM887595

DR   GEO; GSM888678

DR   GEO; GSM1670453

DR   ICLC; HTL97020

DR   IGRhCellID; SKNFI

DR   IGRhCellID; SKNFI%20GEO

DR   Lonza; 1196

RX   DOI=10.1016/B978-0-12-333530-2.50006-X;

RX   DOI=10.1159/00040702;

RX   PubMed=2987426;

RX   PubMed=7838528;

RX   PubMed=11550280;

RX   PubMed=15150091;

RX   PubMed=22213050;

RX   PubMed=22460905;

RX   PubMed=23202128;

RX   PubMed=24792489;

RX   PubMed=25485619;

RX   PubMed=27397505;

WW   http://www.cogcell.org/dl/NB_Data_Sheets/SK-N-FI_Cell_Line_Data_Sheet_COGcell_org.pdf

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'SN-N-FI' in Cosmic 2393644.

ST   Source(s): ATCC; COG; Cosmic-CLP; ECACC; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11,14

ST   D16S539: 11,12

ST   D18S51: 12,14

ST   D19S433: 12

ST   D21S11: 28,30

ST   D2S1338: 17,18

ST   D3S1358: 16,18

ST   D5S818: 12,13

ST   D7S820: 8,9

ST   D8S1179: 11,12

ST   FGA: 22

ST   Penta D: 2.2,13

ST   Penta E: 11,20

ST   TH01: 6,9.3

ST   TPOX: 8,9

ST   vWA: 16,17

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-N-LE

AC   CVCL_5G80

RX   DOI=10.1016/B978-0-12-333530-2.50006-X;

RX   PubMed=2987426;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-N-LO

AC   CVCL_4569

SY   SK-N-L0; SKN-LO; SKNLO

DR   BTO; BTO:0004787

DR   CLS; 300400/p758_SK-N-LO

DR   Cosmic; 1078368

DR   Cosmic; 1212539

DR   GEO; GSM393039

DR   IGRhCellID; SKNLO%20GEO

RX   DOI=10.1159/00040702;

RX   PubMed=2987426;

RX   PubMed=7591257;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Caution: It is not certain if this is a neuroblastoma cell line as indicated by CLS or an Ewing sarcoma cell line as indicated in PubMed=7591257.

ST   Source(s): CLS; COG

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8,11

ST   D16S539: 12

ST   D18S51: 12

ST   D19S433: 13,14

ST   D21S11: 27,28

ST   D2S1338: 16,20

ST   D3S1358: 14,17

ST   D5S818: 11,12

ST   D7S820: 11

ST   D8S1179: 12,15

ST   FGA: 25 (CLS)

ST   FGA: 20,25 (COG)

ST   Penta D: 9,13

ST   Penta E: 7

ST   TH01: 10

ST   TPOX: 8,11

ST   vWA: 14,17

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-N-MC

AC   CVCL_0530

SY   SKNMC; SK-NM-C; SK-NMC

DR   BTO; BTO:0002914

DR   CLO; CLO_0009058

DR   EFO; EFO_0002860

DR   MCCL; MCC:0000429

DR   CLDB; cl4338

DR   CLDB; cl4339

DR   CLDB; cl4340

DR   CLDB; cl4341

DR   CLDB; cl4342

DR   CLDB; cl4343

DR   ATCC; HTB-10

DR   BioSample; SAMN01821666

DR   BioSample; SAMN03151999

DR   CCLE; SKNMC_BONE

DR   CCRID; 3111C0001CCC000263

DR   CCRID; 3131C0001000700050

DR   ChEMBL-Cells; CHEMBL3307551

DR   ChEMBL-Targets; CHEMBL614163

DR   CLS; 300340/p797_SK-N-MC

DR   Cosmic; 753613

DR   Cosmic; 897448

DR   Cosmic; 922655

DR   Cosmic; 1078367

DR   Cosmic; 1078391

DR   Cosmic; 1082511

DR   Cosmic; 1084314

DR   Cosmic; 2228233

DR   Cosmic; 2250468

DR   Cosmic; 2301579

DR   DSMZ; ACC-203

DR   ECACC; 90022302

DR   ENCODE; ENCBS203EZT

DR   ENCODE; ENCBS366AET

DR   ENCODE; ENCBS400ENC

DR   ENCODE; ENCBS426ENC

DR   ENCODE; ENCBS556HGY

DR   GEO; GSM393038

DR   GEO; GSM510009

DR   GEO; GSM824868

DR   GEO; GSM824869

DR   GEO; GSM887596

DR   GEO; GSM888679

DR   GEO; GSM945247

DR   GEO; GSM945264

DR   GEO; GSM1676318

DR   GEO; GSM1701651

DR   IGRhCellID; SKNMC%20GEO

DR   IZSLER; BS TCL 93

DR   KCB; KCB 2012033YJ

DR   KCLB; 30010

DR   Lonza; 82

DR   NCBI_Iran; C535

DR   TOKU-E; 3148

RX   DOI=10.1007/978-1-4757-1647-4_13;

RX   DOI=10.1016/B978-0-12-333530-2.50006-X;

RX   PubMed=29704;

RX   PubMed=62055;

RX   PubMed=327080;

RX   PubMed=2987426;

RX   PubMed=4748425;

RX   PubMed=6582512;

RX   PubMed=7037175;

RX   PubMed=7459858;

RX   PubMed=7591257;

RX   PubMed=8617485;

RX   PubMed=19787792;

RX   PubMed=20143388;

RX   PubMed=22460905;

RX   PubMed=23325432;

RX   PubMed=24312454;

RX   PubMed=25010205;

RX   PubMed=25223734;

RX   PubMed=26351324;

WW   http://genome.ucsc.edu/encode/protocols/cell/human/SK-N-MC_protocol.pdf

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-97.html

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-n-mc-human-neuroblastoma-cell-line

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Misidentified. Originally thought to be a neuroblastoma cell line but shown to be from an Askin tumor (PubMed=20143388).

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: ENCODE project common cell types; tier 3.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK 776.

CC   Doubling time: ~48 hours (DSMZ).

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: H3K4me3 ChIP-seq epigenome analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Supra-orbital region.

ST   Source(s): ATCC; CLS; COG; DSMZ; KCLB; PubMed=24312454

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 12

ST   D18S51: 13,14

ST   D19S433: 13,15.2

ST   D21S11: 30,31.2

ST   D2S1338: 17,21

ST   D3S1358: 15 (CLS; KCLB)

ST   D3S1358: 15,16 (PubMed=24312454)

ST   D5S818: 11

ST   D7S820: 8

ST   D8S1179: 10

ST   FGA: 21,25

ST   Penta D: 9,13

ST   Penta E: 16,18

ST   TH01: 9.3

ST   TPOX: 9,11

ST   vWA: 17,18

DI   NCIt; C7542; Askin tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-N-MC-IXC

AC   CVCL_1398

SY   MC-IXC; MCIXC

DR   BTO; BTO:0005372

DR   CLO; CLO_0007615

DR   EFO; EFO_0002230

DR   ATCC; CRL-2270

DR   BioSample; SAMN03472918

DR   ChEMBL-Cells; CHEMBL3308758

DR   ChEMBL-Targets; CHEMBL1075495

DR   Cosmic; 688068

DR   Cosmic; 908118

DR   Cosmic-CLP; 908118

DR   GDSC; 908118

DR   GEO; GSM1670077

DR   IGRhCellID; MCIXC

DR   TOKU-E; 4055

RX   PubMed=4748425;

RX   PubMed=27397505;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-n-mc-ixc-human-neuroblastoma-cell-line

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK2010-067.

CC   Microsatellite instability: Instable (MSI-low) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Derived from metastatic site: Supra-orbital region.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 12

ST   D18S51: 13,14,15

ST   D19S433: 13,15.2

ST   D21S11: 30,31.2

ST   D2S1338: 17,21

ST   D3S1358: 15

ST   D5S818: 11

ST   D7S820: 8

ST   D8S1179: 10

ST   FGA: 21,25

ST   Penta D: 9,13

ST   Penta E: 16,18

ST   TH01: 9.3

ST   TPOX: 9,11

ST   vWA: 17,18

DI   NCIt; C7542; Askin tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0530 ! SK-N-MC

SX   Female

CA   Cancer cell line

//

ID   SK-N-PI

AC   CVCL_S664

SY   SK-N-P1

DR   Cosmic; 1078366

DR   GEO; GSM393036

DR   IGRhCellID; SKNPI%20GEO

RX   PubMed=7591257;

CC   Miscellaneous: Only mentioned as a Ewing sarcoma cell line in PubMed=7591257.

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-N-RA

AC   CVCL_AQ53

RX   DOI=10.1159/00040702;

RX   PubMed=24792489;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

ST   Source(s): COG

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 9

ST   D16S539: 14

ST   D18S51: 14,15

ST   D19S433: 12,14

ST   D21S11: 32.2,33.2

ST   D2S1338: 17,24

ST   D3S1358: 14

ST   D5S818: 11,12

ST   D7S820: 11,13

ST   D8S1179: 13,14

ST   FGA: 20,22

ST   TH01: 9.3

ST   TPOX: 11,12

ST   vWA: 16,17

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-N-SH

AC   CVCL_0531

SY   SK N SH; SKN-SH; SK-NSH; SKNSH; NSH

DR   BTO; BTO:0001620

DR   CLO; CLO_0009059

DR   CLO; CLO_0050268

DR   EFO; EFO_0003072

DR   MCCL; MCC:0000430

DR   CLDB; cl4345

DR   CLDB; cl4347

DR   CLDB; cl4348

DR   CLDB; cl4349

DR   CLDB; cl4351

DR   CLDB; cl4352

DR   ATCC; HTB-11

DR   BioSample; SAMN01821600

DR   BioSample; SAMN03472879

DR   CCLE; SKNSH_AUTONOMIC_GANGLIA

DR   CCRID; 3111C0001CCC000086

DR   CCRID; 3131C0001000700051

DR   CCRID; 3142C0001000000047

DR   CGH-DB; 62-1

DR   CGH-DB; 9093-4

DR   ChEMBL-Cells; CHEMBL3307745

DR   ChEMBL-Targets; CHEMBL614924

DR   Cosmic; 697284

DR   Cosmic; 717431

DR   Cosmic; 801743

DR   Cosmic; 848936

DR   Cosmic; 922656

DR   Cosmic; 923830

DR   Cosmic; 930078

DR   Cosmic; 947706

DR   Cosmic; 1019929

DR   Cosmic; 1037355

DR   Cosmic; 1078393

DR   Cosmic; 1082519

DR   Cosmic; 1099151

DR   Cosmic; 1109108

DR   Cosmic; 1109371

DR   Cosmic; 1153800

DR   Cosmic; 1153806

DR   Cosmic; 1162006

DR   Cosmic; 1167420

DR   Cosmic; 1167993

DR   Cosmic; 1518079

DR   Cosmic; 1526640

DR   Cosmic; 2058116

DR   Cosmic; 2131595

DR   Cosmic; 2239469

DR   Cosmic; 2393645

DR   Cosmic; 2485952

DR   Cosmic-CLP; 717431

DR   ECACC; 86012802

DR   ENCODE; ENCBS018DDZ

DR   ENCODE; ENCBS324TZB

DR   ENCODE; ENCBS360ENC

DR   ENCODE; ENCBS361ENC

DR   ENCODE; ENCBS362ENC

DR   ENCODE; ENCBS363ENC

DR   ENCODE; ENCBS364ENC

DR   ENCODE; ENCBS365ENC

DR   ENCODE; ENCBS376ENC

DR   ENCODE; ENCBS428ENC

DR   ENCODE; ENCBS433ENC

DR   ENCODE; ENCBS434ENC

DR   ENCODE; ENCBS435ENC

DR   ENCODE; ENCBS436ENC

DR   ENCODE; ENCBS437ENC

DR   ENCODE; ENCBS438ENC

DR   ENCODE; ENCBS489AAA

DR   ENCODE; ENCBS490AAA

DR   ENCODE; ENCBS491AAA

DR   ENCODE; ENCBS492AAA

DR   ENCODE; ENCBS495AAA

DR   ENCODE; ENCBS500EWH

DR   ENCODE; ENCBS592MTQ

DR   GDSC; 717431

DR   GEO; GSM314027

DR   GEO; GSM333814

DR   GEO; GSM563357

DR   GEO; GSM692864

DR   GEO; GSM887597

DR   GEO; GSM888680

DR   GEO; GSM923419

DR   GEO; GSM1008585

DR   GEO; GSM1622296

DR   GEO; GSM1670454

DR   ICLC; HTL96019

DR   IZSLER; BS TCL 143

DR   KCB; KCB 200426YJ

DR   KCLB; 30011

DR   Lonza; 80

DR   RCB; RCB0426

DR   TOKU-E; 3149

DR   Wikidata; Q28308636

RX   DOI=10.1007/0-306-46872-7_2;

RX   DOI=10.1007/978-1-4757-1647-4_13;

RX   DOI=10.1016/B978-0-12-333530-2.50006-X;

RX   DOI=10.1159/00040702;

RX   PubMed=29704;

RX   PubMed=62055;

RX   PubMed=833871;

RX   PubMed=922665;

RX   PubMed=2535691;

RX   PubMed=2846152;

RX   PubMed=2987426;

RX   PubMed=4748425;

RX   PubMed=6582512;

RX   PubMed=6888561;

RX   PubMed=6935474;

RX   PubMed=7037175;

RX   PubMed=7838528;

RX   PubMed=8617485;

RX   PubMed=10074188;

RX   PubMed=11550280;

RX   PubMed=12702577;

RX   PubMed=18923524;

RX   PubMed=22213050;

RX   PubMed=22460905;

RX   PubMed=23325432;

RX   PubMed=25485619;

RX   PubMed=27397505;

WW   http://genome.ucsc.edu/ENCODE/protocols/cell/human/SK-N-SH_Myers_protocol.pdf

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-398.html

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-neuroblastoma-cell-line-sk-n-sh

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: ENCODE project common cell types; tier 3.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-529.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: Occasionally 'SK-N-CH'.

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): ATCC; Cosmic-CLP; ECACC; KCLB; PubMed=25877200; RCB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 8,13

ST   D18S51: 13,16

ST   D21S11: 31,31.2

ST   D3S1358: 15,16

ST   D5S818: 12

ST   D7S820: 7,10

ST   D8S1179: 15

ST   FGA: 23.2,24

ST   Penta D: 10,12

ST   Penta E: 7,11

ST   TH01: 7,10

ST   TPOX: 8,11

ST   vWA: 14,18

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-N-SH_RA

AC   CVCL_D044

SY   SK-N-SH Retinoic acid

DR   EFO; EFO_0002802

DR   ENCODE; ENCBS172JMM

DR   ENCODE; ENCBS366ENC

DR   ENCODE; ENCBS367ENC

DR   ENCODE; ENCBS404ENC

DR   ENCODE; ENCBS606NNZ

DR   ENCODE; ENCBS718MJZ

DR   ENCODE; ENCBS767VYD

DR   ENCODE; ENCBS799ICU

DR   GEO; GSM472912

DR   GEO; GSM472913

DR   GEO; GSM472917

DR   GEO; GSM945202

DR   GEO; GSM945209

DR   GEO; GSM945210

DR   GEO; GSM945317

RX   PubMed=23325432;

CC   Part of: ENCODE project common cell types; tier 3.

CC   Omics: DNA methylation analysis.

CC   Omics: H3K27me3 ChIP-seq epigenome analysis.

CC   Omics: H3K36me3 ChIP-seq epigenome analysis.

CC   Omics: H3K4me3 ChIP-seq epigenome analysis.

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0531 ! SK-N-SH

SX   Female

CA   Cancer cell line

//

ID   SK-Neo

AC   CVCL_8597

SY   SKNeo

RX   PubMed=9717829;

RX   PubMed=17513613;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

DI   NCIt; C40318; Vulvar leiomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0628 ! SK-LMS-1

SX   Female

CA   Cancer cell line

//

ID   SK-NEP-1

AC   CVCL_0631

SY   SKNEP-1; SKNEP1; SKNEP

DR   CLO; CLO_0009055

DR   EFO; EFO_0002337

DR   CLDB; cl4353

DR   ATCC; HTB-48

DR   BioSample; SAMN03472745

DR   ChEMBL-Cells; CHEMBL3308141

DR   ChEMBL-Targets; CHEMBL1075580

DR   CLS; 300341/p618_SK-NEP-1

DR   Cosmic; 688125

DR   Cosmic; 909730

DR   Cosmic; 1112129

DR   Cosmic; 1196558

DR   Cosmic; 2060801

DR   Cosmic; 2228232

DR   Cosmic; 2294587

DR   Cosmic-CLP; 909730

DR   GDSC; 909730

DR   GEO; GSM827180

DR   GEO; GSM845556

DR   GEO; GSM844692

DR   GEO; GSM1670452

DR   IGRhCellID; SKNEP1

DR   IZSLER; BS TCL 61

RX   DOI=10.1007/978-1-4757-1647-4_5;

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=6244232;

RX   PubMed=7459858;

RX   PubMed=17154184;

RX   PubMed=25010205;

RX   PubMed=28196595;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-nep-1-human-ewing-sarcoma-cell-line

WW   http://tcpaportal.org/mclp/

CC   Problematic cell line: Misidentified. Originally thought to be a Wilm's tumor cell line but shown to be from an Ewing sarcoma (PubMed=17154184).

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK2008-052.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; CLS; Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 11

ST   D18S51: 15,17

ST   D21S11: 29,31

ST   D3S1358: 14,15

ST   D5S818: 13

ST   D7S820: 8,10

ST   D8S1179: 12

ST   FGA: 24

ST   Penta D: 11,12

ST   Penta E: 7,18

ST   TH01: 8,9.3

ST   TPOX: 8,11

ST   vWA: 15,19

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-OS-10

AC   CVCL_1E47

RX   DOI=10.1007/978-1-4757-1647-4_5;

RX   PubMed=833871;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Derived from metastatic site: Lung.

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-OS-3B

AC   CVCL_1E41

SY   OS3B

RX   PubMed=833871;

RX   PubMed=4329447;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-OV-1

AC   CVCL_X208

RX   DOI=10.1007/978-1-4757-1647-4_5;

RX   PubMed=833871;

RX   PubMed=1013510;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-OV-3

AC   CVCL_0532

SY   SKOV-3; SK.OV.3; SKOV3; Skov3; SKO3

DR   BTO; BTO:0000948

DR   CLO; CLO_0009063

DR   EFO; EFO_0002340

DR   MCCL; MCC:0000431

DR   CLDB; cl4354

DR   CLDB; cl4355

DR   CLDB; cl4356

DR   ATCC; HTB-77

DR   BioSample; SAMN03471310

DR   CCLE; SKOV3_OVARY

DR   CCRID; 3111C0001CCC000027

DR   CCRID; 3131C0001000700107

DR   CCRID; 3142C0001000000090

DR   ChEMBL-Cells; CHEMBL3307443

DR   ChEMBL-Cells; CHEMBL3307746

DR   ChEMBL-Targets; CHEMBL614904

DR   ChEMBL-Targets; CHEMBL614925

DR   CLS; 300342/p657_SK-OV-3

DR   Cosmic; 687925

DR   Cosmic; 688110

DR   Cosmic; 755846

DR   Cosmic; 809115

DR   Cosmic; 844348

DR   Cosmic; 849611

DR   Cosmic; 875858

DR   Cosmic; 897436

DR   Cosmic; 897739

DR   Cosmic; 905959

DR   Cosmic; 906578

DR   Cosmic; 920359

DR   Cosmic; 923106

DR   Cosmic; 924150

DR   Cosmic; 927563

DR   Cosmic; 932983

DR   Cosmic; 947358

DR   Cosmic; 948289

DR   Cosmic; 949228

DR   Cosmic; 991320

DR   Cosmic; 1044243

DR   Cosmic; 1057759

DR   Cosmic; 1066218

DR   Cosmic; 1070900

DR   Cosmic; 1071897

DR   Cosmic; 1092635

DR   Cosmic; 1102817

DR   Cosmic; 1113276

DR   Cosmic; 1129658

DR   Cosmic; 1139226

DR   Cosmic; 1175886

DR   Cosmic; 1176622

DR   Cosmic; 1305333

DR   Cosmic; 1312193

DR   Cosmic; 1312359

DR   Cosmic; 1436037

DR   Cosmic; 1482526

DR   Cosmic; 1523762

DR   Cosmic; 1524361

DR   Cosmic; 1707561

DR   Cosmic; 1708388

DR   Cosmic; 1709249

DR   Cosmic; 1998478

DR   Cosmic; 2301586

DR   Cosmic; 2464670

DR   Cosmic; 2582807

DR   Cosmic-CLP; 905959

DR   ECACC; 91091004

DR   GDSC; 905959

DR   GEO; GSM50223

DR   GEO; GSM50287

DR   GEO; GSM183338

DR   GEO; GSM183341

DR   GEO; GSM313702

DR   GEO; GSM459638

DR   GEO; GSM459643

DR   GEO; GSM459644

DR   GEO; GSM459645

DR   GEO; GSM659405

DR   GEO; GSM750833

DR   GEO; GSM784565

DR   GEO; GSM799368

DR   GEO; GSM799431

DR   GEO; GSM827322

DR   GEO; GSM847159

DR   GEO; GSM851940

DR   GEO; GSM887598

DR   GEO; GSM888681

DR   GEO; GSM1001423

DR   GEO; GSM1001424

DR   GEO; GSM1001486

DR   GEO; GSM1153439

DR   GEO; GSM1181272

DR   GEO; GSM1181301

DR   GEO; GSM1374883

DR   GEO; GSM1670455

DR   ICLC; HTL01014

DR   IGRhCellID; SKOV3

DR   IZSLER; BS TCL 84

DR   KCB; KCB 200810YJ

DR   KCLB; 30077

DR   LINCS; 50044

DR   NCBI_Iran; C209

DR   PRIDE; PXD001402

DR   SKY/M-FISH/CGH; 1438

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=1423261;

RX   PubMed=1892748;

RX   PubMed=2041050;

RX   PubMed=2653399;

RX   PubMed=4016745;

RX   PubMed=6582512;

RX   PubMed=7459858;

RX   PubMed=9041185;

RX   PubMed=10972993;

RX   PubMed=11793438;

RX   PubMed=12080474;

RX   PubMed=12417041;

RX   PubMed=12960427;

RX   PubMed=17088437;

RX   PubMed=17726699;

RX   PubMed=19372543;

RX   PubMed=22328975;

RX   PubMed=22336246;

RX   PubMed=22460905;

RX   PubMed=22710073;

RX   PubMed=23415752;

RX   PubMed=23839242;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=24023729;

RX   PubMed=24434149;

RX   PubMed=25230021;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27235858;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=27

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=SK-OV-3

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-19.html

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-ovarian-cell-line-sk-ov-3

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: JFCR39 cancer cell line panel.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Part of: OCCP ovarian cancer cell line panel.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-528.

CC   Doubling time: 75 hours (PubMed=25984343); 48.7 hours (DTP).

CC   Microsatellite instability: Instable (MSI-high) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Exosome proteome analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'SCOV-3' in ChEMBL CHEMBL614904 and CHEMBL3307443.

CC   Misspelling: Occasionally 'SCOV3'.

CC   Discontinued: ICLC; HTL01014; true.

CC   Derived from metastatic site: Ascites.

ST   Source(s): ATCC; CLS; Cosmic-CLP; ECACC; KCLB; PubMed=11416159; PubMed=19372543; PubMed=25230021; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 8,11

ST   D16S539: 12

ST   D18S51: 16,17,18 (CLS; PubMed=11416159)

ST   D18S51: 16,17 (PubMed=19372543; PubMed=25230021_ECACC_version; PubMed=25877200)

ST   D18S51: 16,18 (PubMed=25230021_academic_version)

ST   D19S433: 14,14.2

ST   D21S11: 30,31,31.2 (CLS; PubMed=11416159)

ST   D21S11: 30,31.2 (PubMed=19372543; PubMed=25230021; PubMed=25877200)

ST   D2S1338: 18,23

ST   D3S1358: 14 (CLS; PubMed=25230021; PubMed=25877200)

ST   D3S1358: 13,14 (PubMed=19372543)

ST   D5S818: 11

ST   D7S820: 13,14

ST   D8S1179: 14,15

ST   FGA: 24,25,26 (CLS; PubMed=11416159)

ST   FGA: 24,25 (KCLB; PubMed=25230021_academic_version; PubMed=25877200)

ST   FGA: 23,24,25 (PubMed=25230021_ECACC_version)

ST   Penta D: 12,13

ST   Penta E: 5,13

ST   TH01: 9,9.3

ST   TPOX: 8,11

ST   vWA: 17,18 (ATCC; CLS; Cosmic-CLP; ECACC; KCLB; PubMed=11416159; PubMed=25230021_ECACC_version; PubMed=25877200)

ST   vWA: 18 (PubMed=19372543)

ST   vWA: 17 (PubMed=25230021_acedemic_version)

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-OV-3-Luc

AC   CVCL_4Y20

DR   JCRB; NIHS0737

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0532 ! SK-OV-3

SX   Female

CA   Cancer cell line

//

ID   SK-OV-3/CBP

AC   CVCL_D621

SY   SKOV3/CBP; S-car

RX   PubMed=15254775;

RX   PubMed=17269733;

CC   Selected for resistance to: ChEBI; CHEBI:31355; Carboplatin (CBP; Paraplatin).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0532 ! SK-OV-3

SX   Female

CA   Cancer cell line

//

ID   SK-OV-3/CDDP

AC   CVCL_D622

SY   SKOV3/CDDP

RX   PubMed=17269733;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0532 ! SK-OV-3

SX   Female

CA   Cancer cell line

//

ID   SK-OV-3/CMV-Luc

AC   CVCL_4Y19

DR   JCRB; NIHS0736

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0532 ! SK-OV-3

SX   Female

CA   Cancer cell line

//

ID   SK-OV-4

AC   CVCL_X008

SY   SKOV-4; SKOV4

DR   BioSample; SAMN03151613

DR   GEO; GSM851941

RX   PubMed=6582512;

RX   PubMed=22710073;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a C-33 A derivative (PubMed=22710073).

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4028; Cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1094 ! C-33 A

SX   Female

CA   Cancer cell line

//

ID   SK-OV-6

AC   CVCL_A457

SY   SKOV-6; SKOV6

DR   BioSample; SAMN03151614

DR   Cosmic; 923107

DR   Cosmic; 1709253

DR   GEO; GSM851942

RX   PubMed=6582512;

RX   PubMed=22328975;

RX   PubMed=22710073;

RX   PubMed=25230021;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a C-33 A derivative (PubMed=22710073).

CC   Part of: OCCP ovarian cancer cell line panel.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4028; Cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1094 ! C-33 A

SX   Female

CA   Cancer cell line

//

ID   SK-OV-8

AC   CVCL_A458

SY   SKOV-8; SKOV8

DR   Cosmic; 1709254

RX   PubMed=8349167;

RX   PubMed=22328975;

RX   PubMed=22710073;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-p53-1

AC   CVCL_8598

SY   SKp53-1

RX   PubMed=9717829;

DI   NCIt; C40318; Vulvar leiomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0628 ! SK-LMS-1

SX   Female

CA   Cancer cell line

//

ID   SK-p53-2

AC   CVCL_8599

SY   SKp53-2

RX   PubMed=9717829;

DI   NCIt; C40318; Vulvar leiomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0628 ! SK-LMS-1

SX   Female

CA   Cancer cell line

//

ID   SK-p53-3

AC   CVCL_8600

SY   SKp53-3

RX   PubMed=9717829;

DI   NCIt; C40318; Vulvar leiomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0628 ! SK-LMS-1

SX   Female

CA   Cancer cell line

//

ID   SK-PC-1

AC   CVCL_4054

SY   SK-PC1

DR   BTO; BTO:0002823

DR   Cosmic; 710871

DR   Cosmic; 948737

RX   PubMed=7723277;

RX   PubMed=9665481;

RX   PubMed=11169957;

RX   PubMed=11787853;

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=SK-PC-1

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-PC-3

AC   CVCL_4055

DR   Cosmic; 948729

RX   PubMed=7723277;

RX   PubMed=9665481;

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=SK-PC-3

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Derived from metastatic site: Omentum.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-PN-AG

AC   CVCL_M167

RX   PubMed=3024811;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3716; Primitive neuroectodermal tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-PN-DW

AC   CVCL_1703

DR   CLO; CLO_0009064

DR   CLDB; cl4358

DR   ATCC; CRL-2139

DR   BioSample; SAMN03472556

DR   ChEMBL-Cells; CHEMBL3308886

DR   ChEMBL-Targets; CHEMBL2366108

DR   Cosmic; 684073

DR   Cosmic; 909731

DR   Cosmic; 1078390

DR   Cosmic; 1718431

DR   Cosmic-CLP; 909731

DR   ECACC; 94092301

DR   GDSC; 909731

DR   GEO; GSM1670456

RX   DOI=10.1016/B978-0-12-333530-2.50006-X;

RX   PubMed=2987426;

RX   PubMed=3024811;

RX   PubMed=27397505;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): ATCC; Cosmic-CLP; ECACC

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 9

ST   D16S539: 12

ST   D5S818: 13,14

ST   D7S820: 8,14

ST   TH01: 6

ST   TPOX: 8,9

ST   vWA: 16

DI   NCIt; C3716; Primitive neuroectodermal tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-PN-LI

AC   CVCL_A748

SY   SK-PNET-Li; SKPNETLI

DR   Cosmic; 1078389

DR   Cosmic; 2228234

RX   DOI=10.1016/B978-0-12-333530-2.50006-X;

RX   PubMed=2987426;

RX   PubMed=3024811;

RX   PubMed=25010205;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C3716; Primitive neuroectodermal tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-PN-WA

AC   CVCL_M168

RX   PubMed=3024811;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C3716; Primitive neuroectodermal tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-RC-1

AC   CVCL_4017

SY   SK-RC 1; SKRC-1

DR   BTO; BTO:0003193

RX   PubMed=479762;

RX   PubMed=2386958;

RX   PubMed=6582512;

RX   PubMed=6864164;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Doubling time: 42 hours (PubMed=2386958).

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-RC-10

AC   CVCL_6175

SY   SKRC-10

RX   PubMed=479762;

RX   PubMed=6582512;

RX   PubMed=6864164;

RX   PubMed=27993170;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-RC-11

AC   CVCL_6176

RX   PubMed=479762;

RX   PubMed=6864164;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-RC-12

AC   CVCL_6177

SY   SKRC-12

DR   Cosmic; 945057

RX   PubMed=479762;

RX   PubMed=2386958;

RX   PubMed=6582512;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-RC-13

AC   CVCL_6178

DR   Cosmic; 737185

RX   PubMed=479762;

RX   PubMed=2386958;

RX   PubMed=27993170;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Doubling time: 42 hours (PubMed=2386958).

CC   Derived from metastatic site: Brain.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-RC-14

AC   CVCL_6179

SY   SKRC-14

DR   Cosmic; 945058

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-15

AC   CVCL_6180

RX   PubMed=2386958;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-16

AC   CVCL_GS24

RX   PubMed=6582512;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-17

AC   CVCL_4018

SY   SK-RC 17; SKRC-17

DR   BTO; BTO:0003196

DR   Cosmic; 737186

DR   Cosmic; 945059

RX   PubMed=2386958;

RX   PubMed=6582512;

RX   PubMed=27993170;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Derived from metastatic site: Soft tissue.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-18

AC   CVCL_6181

SY   SKRC18; SKRC-18; SKRC 18

RX   PubMed=2386958;

RX   PubMed=27993170;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Doubling time: 42 hours (PubMed=2386958).

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-2

AC   CVCL_6169

SY   SKRC-02

DR   Cosmic; 737183

RX   PubMed=479762;

RX   PubMed=2386958;

RX   PubMed=6582512;

RX   PubMed=6864164;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Doubling time: 60 hours (PubMed=2386958).

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-RC-20

AC   CVCL_V605

SY   SKRC-20; SKRC20

DR   CCLE; SKRC20_KIDNEY

RX   PubMed=25984343;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Doubling time: 55 hours (PubMed=25984343).

CC   Omics: shRNA library screening.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-21

AC   CVCL_6182

SY   SKRC-21

RX   PubMed=2386958;

RX   PubMed=27993170;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Doubling time: 38 hours (PubMed=2386958).

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-26A

AC   CVCL_6183

SY   SK-RC-26a

RX   PubMed=2386958;

RX   PubMed=27993170;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-m-metastatic-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Derived from metastatic site: Lung.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_3120 ! SK-RC-26B

CA   Cancer cell line

//

ID   SK-RC-26B

AC   CVCL_3120

SY   SK-RC-26b; SK-RC 26B; SKRC-26B; SK-RC26b

DR   BTO; BTO:0004781

RX   PubMed=2386958;

RX   PubMed=27993170;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-m-metastatic-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_6183 ! SK-RC-26A

CA   Cancer cell line

//

ID   SK-RC-28

AC   CVCL_6184

SY   SKRC28

DR   Cosmic; 972918

RX   PubMed=2386958;

RX   PubMed=6582512;

RX   PubMed=6864164;

RX   PubMed=7915601;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-29

AC   CVCL_4019

SY   SK-RC 29; SKRC-29

DR   BTO; BTO:0003197

DR   Cosmic; 737187

DR   Cosmic; 945060

DR   GEO; GSM374462

RX   PubMed=2386958;

RX   PubMed=6864164;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Doubling time: 36 hours (PubMed=2386958).

CC   Derived from metastatic site: Ovary.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-RC-3

AC   CVCL_6170

SY   SK-RC 3

RX   PubMed=479762;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-RC-30

AC   CVCL_6185

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-31

AC   CVCL_6186

SY   SKRC-31; SKRC31

DR   CCLE; SKRC31_KIDNEY

DR   GEO; GSM374463

RX   PubMed=2386958;

RX   PubMed=25984343;

RX   PubMed=27993170;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Doubling time: 120 hours (PubMed=25984343).

CC   Derived from metastatic site: Lung.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-33

AC   CVCL_6187

SY   SKRC-33; SKRC33

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-35

AC   CVCL_4020

SY   SK-RC 35; SKRC-35

DR   BTO; BTO:0003198

DR   Cosmic; 737180

RX   PubMed=2386958;

RX   PubMed=6582512;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Doubling time: 30 hours (PubMed=2386958).

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-37

AC   CVCL_6188

SY   SKRC37

DR   Cosmic; 737181

DR   Cosmic; 972885

RX   PubMed=2386958;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-38

AC   CVCL_6189

SY   SK-RC 38; SKRC-38; SKRC38

DR   GEO; GSM374464

RX   PubMed=2386958;

RX   PubMed=6864164;

RX   PubMed=27993170;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Derived from metastatic site: Lung.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-39

AC   CVCL_4021

SY   SK-RC 39; SKRC-39; SKRC 39

DR   BTO; BTO:0003199

RX   PubMed=2386958;

RX   PubMed=27993170;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Doubling time: 42 hours (PubMed=2386958).

CC   Derived from metastatic site: Soft tissue.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-4

AC   CVCL_6171

RX   PubMed=479762;

RX   PubMed=2386958;

RX   PubMed=6582512;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-RC-40

AC   CVCL_6190

RX   PubMed=2386958;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-41

AC   CVCL_6191

RX   PubMed=2386958;

RX   PubMed=6864164;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-42

AC   CVCL_6192

SY   SK-RC 42; SKRC-42

DR   Cosmic; 737188

DR   GEO; GSM374465

RX   PubMed=2386958;

RX   PubMed=27993170;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Doubling time: 48 hours (PubMed=2386958).

CC   Derived from metastatic site: Bone.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-44

AC   CVCL_4022

SY   SK-RC 44; SKRC-44

DR   BTO; BTO:0003200

RX   PubMed=2386958;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-45

AC   CVCL_4016

SY   SK-RC 45; SKRC-45; SKRC45

DR   BTO; BTO:0003201

DR   Cosmic; 737189

RX   PubMed=2386958;

RX   PubMed=27993170;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Doubling time: 48 hours (PubMed=2386958).

CC   Derived from metastatic site: Adrenal gland.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-46

AC   CVCL_6193

DR   Cosmic; 737190

RX   PubMed=2386958;

RX   PubMed=27993170;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Derived from metastatic site: Bone.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-47

AC   CVCL_6194

SY   SKRC 47

RX   PubMed=2386958;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-48

AC   CVCL_6195

SY   SKRC48

DR   Cosmic; 972919

RX   PubMed=2386958;

RX   PubMed=7915601;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-49

AC   CVCL_6196

RX   PubMed=2386958;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Doubling time: 42 hours (PubMed=2386958).

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-5

AC   CVCL_6172

RX   PubMed=479762;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-RC-51

AC   CVCL_6197

RX   PubMed=2386958;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-52

AC   CVCL_6198

SY   SK-RC 52; SKRC-52

DR   Cosmic; 945061

DR   GEO; GSM374466

RX   PubMed=2386958;

RX   PubMed=27993170;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Doubling time: 36 hours (PubMed=2386958).

CC   Derived from metastatic site: Mediastinum.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-53

AC   CVCL_6199

RX   PubMed=2386958;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-54

AC   CVCL_6200

SY   SKRC-54

RX   PubMed=2386958;

RX   PubMed=27993170;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Derived from metastatic site: Lung.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-54V

AC   CVCL_6201

RX   PubMed=16818659;

CC   Derived from metastatic site: Lung.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6200 ! SK-RC-54

CA   Cancer cell line

//

ID   SK-RC-55

AC   CVCL_6202

RX   PubMed=2386958;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-56

AC   CVCL_6203

SY   SKRC56

DR   Cosmic; 972886

RX   PubMed=2386958;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Doubling time: 48 hours (PubMed=2386958).

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-57

AC   CVCL_6204

RX   PubMed=2386958;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Doubling time: 48 hours (PubMed=2386958).

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-58

AC   CVCL_6205

SY   SKRC58

DR   Cosmic; 972887

RX   PubMed=2386958;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Doubling time: 36 hours (PubMed=2386958).

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-59

AC   CVCL_6206

SY   SKRC-59; SKRC59

DR   Cosmic; 945062

DR   Cosmic; 972888

RX   PubMed=2386958;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Doubling time: 36 hours (PubMed=2386958).

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-6

AC   CVCL_4023

SY   SK-RC 6; SKRC-6; SKRC6

DR   BTO; BTO:0003194

RX   PubMed=479762;

RX   PubMed=2386958;

RX   PubMed=6582512;

RX   PubMed=6864164;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Doubling time: 60 hours (PubMed=2386958).

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-RC-60

AC   CVCL_6207

RX   PubMed=2386958;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-61

AC   CVCL_6208

SY   SKRC61

DR   Cosmic; 972920

RX   PubMed=2386958;

RX   PubMed=7915601;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Doubling time: 48 hours (PubMed=2386958).

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-62

AC   CVCL_6209

SY   SKRC62

DR   Cosmic; 972921

RX   PubMed=2386958;

RX   PubMed=7915601;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Doubling time: 96 hours (PubMed=2386958).

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RC-7

AC   CVCL_4024

SY   SK-RC 7; SKRC-7

DR   BTO; BTO:0003195

RX   PubMed=479762;

RX   PubMed=2386958;

RX   PubMed=6582512;

RX   PubMed=27993170;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-RC-8

AC   CVCL_6173

SY   SKRC8; SKRC-8; SKRC-08

DR   Cosmic; 972916

RX   PubMed=479762;

RX   PubMed=2386958;

RX   PubMed=6582512;

RX   PubMed=6864164;

RX   PubMed=7915601;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-RC-9

AC   CVCL_6174

SY   SKRC-9; SK-RC9; SK-RC-09; SKRC9M

DR   Cosmic; 737184

DR   Cosmic; 972917

RX   PubMed=479762;

RX   PubMed=2386958;

RX   PubMed=6582512;

RX   PubMed=6864164;

RX   PubMed=7915601;

RX   PubMed=27993170;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-m-metastatic-human-renal-cell-carcinoma-rcc-cell-line-collection

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Derived from metastatic site: Brain.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-RC-99

AC   CVCL_4025

SY   SK-RC 99; SKRC-99

DR   BTO; BTO:0003202

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SK-RST

AC   CVCL_K279

SY   Swine Kidney-RST

DR   ATCC; CRL-2842

RX   PubMed=19508353;

OX   NCBI_TaxID=9823; ! Sus scrofa

SX   Male

CA   Spontaneously immortalized cell line

//

ID   SK-SC-1

AC   CVCL_1E48

RX   DOI=10.1007/978-1-4757-1647-4_5;

RX   PubMed=327080;

RX   PubMed=833871;

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SK-UT-1

AC   CVCL_0533

SY   SK UT 1; SKUT-1; SKUT1; Skut1

DR   BTO; BTO:0002034

DR   CLO; CLO_0009065

DR   EFO; EFO_0002341

DR   MCCL; MCC:0000432

DR   ATCC; HTB-114

DR   BioSample; SAMN03471095

DR   CCLE; SKUT1_SOFT_TISSUE

DR   ChEMBL-Cells; CHEMBL3308848

DR   ChEMBL-Targets; CHEMBL2366316

DR   CLS; 300455/p492_SK-UT-1

DR   Cosmic; 687595

DR   Cosmic; 848888

DR   Cosmic; 909732

DR   Cosmic; 923382

DR   Cosmic; 1071895

DR   Cosmic; 1091504

DR   Cosmic; 1176619

DR   Cosmic; 1622903

DR   Cosmic-CLP; 909732

DR   GDSC; 909732

DR   GEO; GSM887599

DR   GEO; GSM888682

DR   GEO; GSM1670457

DR   GEO; GSM1676327

DR   GEO; GSM1701660

DR   IGRhCellID; SKUT1

RX   DOI=10.1007/978-1-4757-1647-4_5;

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=6582512;

RX   PubMed=6935474;

RX   PubMed=7459858;

RX   PubMed=22460905;

RX   PubMed=26351324;

RX   PubMed=27397505;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-329.html

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-ut-1-human-uterine-leiomyosarcoma-cell-line

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK1980-537.

CC   Microsatellite instability: Instable (MSI-high) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; CLS; Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 13

ST   D16S539: 13,14

ST   D18S51: 11,16

ST   D21S11: 29,32.2

ST   D3S1358: 15,16

ST   D5S818: 10,11

ST   D7S820: 9,10

ST   D8S1179: 13,15

ST   FGA: 22,24

ST   Penta D: 11,15

ST   Penta E: 17

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 15,16

DI   NCIt; C6340; Uterine corpus leiomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK-UT-1B

AC   CVCL_2250

SY   SKUT1B; SK-UT 1B; SKUT-1B; Skut1B

DR   BTO; BTO:0003725

DR   CLO; CLO_0009066

DR   CLDB; cl4359

DR   ATCC; HTB-115

DR   BioSample; SAMN03471096

DR   BioSample; SAMN03472878

DR   ChEMBL-Cells; CHEMBL3307682

DR   ChEMBL-Targets; CHEMBL614678

DR   CLS; 300406/p535_SK-UT-1B

DR   Cosmic; 713478

DR   Cosmic; 871555

DR   Cosmic; 889118

DR   Cosmic; 1007164

DR   Cosmic; 1066227

DR   Cosmic; 1091505

DR   GEO; GSM185152

DR   GEO; GSM185153

DR   GEO; GSM844693

DR   GEO; GSM844694

DR   GEO; GSM1676334

DR   GEO; GSM1701666

DR   IGRhCellID; SKUT1B

DR   IZSLER; BS TCL 210

RX   PubMed=327080;

RX   PubMed=2372783;

RX   PubMed=2766249;

RX   PubMed=3383166;

RX   PubMed=6935474;

RX   PubMed=9541971;

RX   PubMed=26351324;

RX   PubMed=28196595;

WW   https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-ut-1b-human-uterine-leiomyosarcoma-cell-line

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Registration: Memorial Sloan-Kettering Cancer Center Office of Technology Development; SK2010-071.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; CLS; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 10,13

ST   D16S539: 12,14

ST   D18S51: 11,17

ST   D19S433: 12,13

ST   D21S11: 29,32.2

ST   D2S1338: 19,21

ST   D3S1358: 15,16

ST   D5S818: 10,11

ST   D7S820: 9,10

ST   D8S1179: 14,15

ST   FGA: 22,23

ST   Penta D: 11,14

ST   Penta E: 17

ST   TH01: 7

ST   TPOX: 8 (ATCC; CLS)

ST   TPOX: 5,8 (PubMed=25877200)

ST   vWA: 16

DI   NCIt; C6340; Uterine corpus leiomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0533 ! SK-UT-1

SX   Female

CA   Cancer cell line

//

ID   SK-UT-2

AC   CVCL_IW37

SY   SKUT2

DR   Cosmic; 1576465

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C7558; Endometrial carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SK24

AC   CVCL_4V70

RX   PubMed=10771091;

RX   PubMed=11330054;

CC   Transfected with: UniProtKB; P42212; GFP.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   SK3/VP16

AC   CVCL_Y203

DR   CGH-DB; 9124-4

RX   PubMed=14973057;

CC   Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).

CC   Derived from metastatic site: Pericardial effusion.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_7005 ! ACC-LC-172

SX   Male

CA   Cancer cell line

//

ID   SK32

AC   CVCL_4708

DR   BTO; BTO:0003220

RX   PubMed=10771091;

RX   PubMed=11330054;

CC   Transfected with: UniProtKB; P42212; GFP.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Ska-3-68

AC   CVCL_S488

DR   Cosmic; 688109

RX   PubMed=12068308;

DI   NCIt; C5228; Ovarian cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SKBR3-AZDRa

AC   CVCL_EI04

RX   PubMed=26883193;

CC   Selected for resistance to: ChEBI; CHEBI:132986; Sapitinib (AZD8931).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0033 ! SK-BR-3

SX   Female

CA   Cancer cell line

//

ID   SKBR3-AZDRb

AC   CVCL_EI05

RX   PubMed=26883193;

CC   Selected for resistance to: ChEBI; CHEBI:132986; Sapitinib (AZD8931).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0033 ! SK-BR-3

SX   Female

CA   Cancer cell line

//

ID   SKBR3-AZDRc

AC   CVCL_EI06

DR   PRIDE; PXD002057

RX   PubMed=26883193;

CC   Selected for resistance to: ChEBI; CHEBI:132986; Sapitinib (AZD8931).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0033 ! SK-BR-3

SX   Female

CA   Cancer cell line

//

ID   SKBR3-LAP[r]

AC   CVCL_4V68

WW   http://www.chemoscreen.com/product/skbr3-lapr-dna

CC   Selected for resistance to: ChEBI; CHEBI:49603; Lapatinib.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0033 ! SK-BR-3

SX   Female

CA   Cancer cell line

//

ID   SKBR3-LAPRa

AC   CVCL_EI07

RX   PubMed=26883193;

CC   Selected for resistance to: ChEBI; CHEBI:49603; Lapatinib.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0033 ! SK-BR-3

SX   Female

CA   Cancer cell line

//

ID   SKBR3-LAPRb

AC   CVCL_EI08

RX   PubMed=26883193;

CC   Selected for resistance to: ChEBI; CHEBI:49603; Lapatinib.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0033 ! SK-BR-3

SX   Female

CA   Cancer cell line

//

ID   SKBR3-PR

AC   CVCL_EQ69

SY   SKBR3 PR

DR   GEO; GSM183442

DR   GEO; GSM183443

RX   PubMed=17560336;

CC   Knockout cell: Method=shRNA knockdown; HGNC; 9588; PTEN.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0033 ! SK-BR-3

SX   Female

CA   Cancer cell line

//

ID   SkCa1

AC   CVCL_HC05

DR   GEO; GSM29836

DR   GEO; GSM29837

DR   GEO; GSM29838

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SkCa10

AC   CVCL_HC14

DR   GEO; GSM29863

DR   GEO; GSM29864

DR   GEO; GSM29865

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SkCa11

AC   CVCL_HC15

DR   GEO; GSM29866

DR   GEO; GSM29867

DR   GEO; GSM29868

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SkCa12

AC   CVCL_HC16

DR   GEO; GSM29869

DR   GEO; GSM29870

DR   GEO; GSM29871

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SkCa13

AC   CVCL_HC17

DR   GEO; GSM29872

DR   GEO; GSM29873

DR   GEO; GSM29874

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SkCa14

AC   CVCL_HC18

DR   GEO; GSM29875

DR   GEO; GSM29876

DR   GEO; GSM29877

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SkCa15

AC   CVCL_HC19

DR   GEO; GSM29878

DR   GEO; GSM29879

DR   GEO; GSM29880

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SkCa2

AC   CVCL_HC06

DR   GEO; GSM29839

DR   GEO; GSM29840

DR   GEO; GSM29841

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SkCa3

AC   CVCL_HC07

DR   GEO; GSM29842

DR   GEO; GSM29843

DR   GEO; GSM29844

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SkCa4

AC   CVCL_HC08

DR   GEO; GSM29845

DR   GEO; GSM29846

DR   GEO; GSM29847

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SkCa5

AC   CVCL_HC09

DR   GEO; GSM29848

DR   GEO; GSM29849

DR   GEO; GSM29850

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SkCa6

AC   CVCL_HC10

DR   GEO; GSM29851

DR   GEO; GSM29852

DR   GEO; GSM29853

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SkCa7

AC   CVCL_HC11

DR   GEO; GSM29854

DR   GEO; GSM29855

DR   GEO; GSM29856

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SkCa8

AC   CVCL_HC12

DR   GEO; GSM29857

DR   GEO; GSM29858

DR   GEO; GSM29859

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SkCa9

AC   CVCL_HC13

DR   GEO; GSM29860

DR   GEO; GSM29861

DR   GEO; GSM29862

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SKE-hTERT

AC   CVCL_Z586

RX   PubMed=16621759;

CC   Transfected with: HGNC; 11730; TERT.

CC   Breed/subspecies: Large white.

OX   NCBI_TaxID=9823; ! Sus scrofa

OI   CVCL_Z587 ! SKE-Spon

OI   CVCL_Z588 ! SKE-SV40LT

CA   Telomerase immortalized cell line

//

ID   SKE-Spon

AC   CVCL_Z587

RX   PubMed=16621759;

CC   Breed/subspecies: Large white.

OX   NCBI_TaxID=9823; ! Sus scrofa

OI   CVCL_Z586 ! SKE-hTERT

OI   CVCL_Z588 ! SKE-SV40LT

CA   Spontaneously immortalized cell line

//

ID   SKE-SV40LT

AC   CVCL_Z588

RX   PubMed=16621759;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: Large white.

OX   NCBI_TaxID=9823; ! Sus scrofa

OI   CVCL_Z586 ! SKE-hTERT

OI   CVCL_Z587 ! SKE-Spon

CA   Transformed cell line

//

ID   SKG-I

AC   CVCL_2793

SY   SKG-1; SKG1

DR   BioSample; SAMN03472778

DR   Cosmic; 877459

DR   Cosmic; 1152537

DR   IFO; IFO50308

RX   PubMed=3029293;

RX   PubMed=6163305;

RX   PubMed=6174649;

RX   PubMed=7196935;

CC   Doubling time: 35-42 hours (PubMed=7196935).

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10

ST   D16S539: 10

ST   D5S818: 12

ST   D7S820: 10

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 16,18

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SKG-I/TS

AC   CVCL_4J75

RX   PubMed=12845668;

CC   Transfected with: HGNC; 12441; TYMS.

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2793 ! SKG-I

SX   Female

CA   Cancer cell line

//

ID   SKG-II

AC   CVCL_2794

SY   SKG-2; SKG2

DR   BioSample; SAMN03470893

DR   BioSample; SAMN03472779

DR   Cosmic; 877460

DR   Cosmic; 1152538

DR   IFO; IFO50309

DR   JCRB; JCRB0171

RX   PubMed=3029293;

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

CC   Discontinued: JCRB; JCRB0171; true.

ST   Source(s): JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8

ST   D16S539: 11

ST   D18S51: 18

ST   D19S433: 14,16.2

ST   D21S11: 28

ST   D2S1338: 20

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 11

ST   D8S1179: 13

ST   FGA: 22

ST   Penta D: 10

ST   Penta E: 12

ST   TH01: 7,9 (JCRB)

ST   TH01: 9 (PubMed=25877200)

ST   TPOX: 8,9

ST   vWA: 16,18

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SKG-II-SF

AC   CVCL_8159

SY   SKG-II SF

DR   CLO; CLO_0050918

DR   RCB; RCB0685

RX   PubMed=9573483;

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8

ST   D16S539: 11

ST   D5S818: 12

ST   D7S820: 11

ST   TH01: 9

ST   TPOX: 8,9

ST   vWA: 16,18

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2794 ! SKG-II

SX   Female

CA   Cancer cell line

//

ID   SKG-II/LUC

AC   CVCL_4J76

SY   SKG-II/luciferase

RX   PubMed=12239455;

RX   PubMed=12845668;

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2794 ! SKG-II

SX   Female

CA   Cancer cell line

//

ID   SKG-II/TS

AC   CVCL_4J77

RX   PubMed=12239455;

RX   PubMed=12845668;

CC   Transfected with: HGNC; 12441; TYMS.

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2794 ! SKG-II

SX   Female

CA   Cancer cell line

//

ID   SKG-IIIa

AC   CVCL_1704

SY   SKG-IIIA; SKG IIIa; SKG-3a; SKG3A; SKG3a

DR   CLO; CLO_0050923

DR   BioSample; SAMN01821739

DR   BioSample; SAMN03470894

DR   BioSample; SAMN03471660

DR   ChEMBL-Cells; CHEMBL3308786

DR   ChEMBL-Targets; CHEMBL1075581

DR   Cosmic; 877461

DR   Cosmic; 930298

DR   Cosmic; 1152539

DR   Cosmic; 1995630

DR   Cosmic-CLP; 930298

DR   GDSC; 930298

DR   GEO; GSM1670429

DR   IFO; IFO50310

DR   JCRB; JCRB0232

DR   RCB; RCB1892

DR   TKG; TKG 0462

RX   PubMed=6699456;

RX   PubMed=9290701;

RX   PubMed=15099960;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; JCRB; PubMed=25877200; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 12

ST   D16S539: 9,11

ST   D18S51: 16

ST   D19S433: 13

ST   D21S11: 31.2,32.2

ST   D2S1338: 19,26

ST   D3S1358: 16

ST   D5S818: 10,11

ST   D7S820: 10 (JCRB)

ST   D7S820: 10,12 (Cosmic-CLP; PubMed=25877200; RCB; TKG)

ST   D8S1179: 11,15

ST   FGA: 21,22

ST   Penta D: 9

ST   Penta E: 10

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2795 ! SKG-IIIb

SX   Female

CA   Cancer cell line

//

ID   SKG-IIIb

AC   CVCL_2795

SY   SKG-3b; SKG3B; SKG3b

DR   BioSample; SAMN03470895

DR   BioSample; SAMN03472780

DR   Cosmic; 1152540

DR   GEO; GSM827212

DR   IFO; IFO50311

DR   JCRB; JCRB0232.1

RX   PubMed=3029293;

RX   PubMed=6699456;

RX   PubMed=15099960;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).

CC   Omics: Transcriptome analysis.

ST   Source(s): JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 12

ST   D16S539: 9,11

ST   D18S51: 16

ST   D19S433: 13

ST   D21S11: 31.2

ST   D2S1338: 26

ST   D3S1358: 16

ST   D5S818: 10,11

ST   D7S820: 10,12

ST   D8S1179: 11,15

ST   FGA: 22

ST   Penta D: 9

ST   Penta E: 10

ST   TH01: 9 (JCRB)

ST   TH01: 6,9 (PubMed=25877200)

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1704 ! SKG-IIIa

SX   Female

CA   Cancer cell line

//

ID   SKH-R

AC   CVCL_0I62

DR   CCLV; CCLV-RIE 0483

RX   PubMed=19941903;

CC   Group: Reptilian cell line.

OX   NCBI_TaxID=31138; ! Trachemys scripta elegans

CA   Spontaneously immortalized cell line

//

ID   SKH1

AC   CVCL_C124

SY   SKH-1

DR   Cosmic; 919117

DR   Cosmic; 1012118

RX   PubMed=8313895;

RX   PubMed=15156182;

RX   PubMed=16408098;

DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SKI-DLCL-1

AC   CVCL_E053

SY   SKI-DLBCL1; SKI; SKI-DCLC; GM20259

DR   CLO; CLO_0027837

DR   EFO; EFO_0005460

DR   Coriell; GM20259

DR   Cosmic; 1945191

RX   PubMed=11426565;

RX   PubMed=23292937;

CC   Omics: Deep exome analysis.

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SKiPSc1

AC   CVCL_GQ04

RX   PubMed=27558616;

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   SKK-1

AC   CVCL_S607

DR   Cosmic; 1465963

RX   PubMed=15996938;

DI   NCIt; C3171; Acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SKM-1

AC   CVCL_0098

SY   SKM1

DR   EFO; EFO_0006753

DR   BioSample; SAMN03470798

DR   BioSample; SAMN03473113

DR   CCLE; SKM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   ChEMBL-Cells; CHEMBL3308216

DR   ChEMBL-Targets; CHEMBL2366085

DR   Cosmic; 787477

DR   Cosmic; 909722

DR   Cosmic; 975300

DR   Cosmic; 1012119

DR   Cosmic; 1078731

DR   Cosmic; 1465964

DR   Cosmic; 1551462

DR   Cosmic; 2131566

DR   Cosmic-CLP; 909722

DR   DSMZ; ACC-547

DR   GDSC; 909722

DR   GEO; GSM482513

DR   GEO; GSM887581

DR   GEO; GSM888664

DR   GEO; GSM1374880

DR   GEO; GSM1670435

DR   JCRB; JCRB0118

DR   JCRB; NIHS0147

RX   PubMed=16408098;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~48 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: JCRB; NIHS0147; true.

ST   Source(s): Cosmic-CLP; DSMZ; JCRB; PubMed=25877200

ST   Amelogenin: X (Cosmic-CLP; JCRB)

ST   Amelogenin: X,Y (DSMZ; PubMed=25877200)

ST   CSF1PO: 10,12

ST   D13S317: 11,13

ST   D16S539: 9,11

ST   D18S51: 14,15

ST   D21S11: 31.2,32.2

ST   D3S1358: 18

ST   D5S818: 10,12

ST   D7S820: 10,11

ST   D8S1179: 11,13

ST   FGA: 22,23

ST   Penta D: 9,12

ST   Penta E: 15,20

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SKM-1/HHT

AC   CVCL_IM24

RX   PubMed=22967374;

CC   Selected for resistance to: ChEBI; CHEBI:71019; Omacetaxine mepesuccinate (Homoharringtonine; HHT).

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0098 ! SKM-1

SX   Male

CA   Cancer cell line

//

ID   SKMEL5/R

AC   CVCL_IW12

RX   PubMed=26365896;

CC   Selected for resistance to: ChEBI; CHEBI:90295; PLX-4720.

CC   Derived from metastatic site: Axillary lymph node.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0527 ! SK-MEL-5

SX   Female

CA   Cancer cell line

//

ID   SKMES-1-Taxol

AC   CVCL_X336

RX   PubMed=18503785;

CC   Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).

CC   Omics: Proteome analysis.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0630 ! SK-MES-1

SX   Male

CA   Cancer cell line

//

ID   SKMES-1-Taxotere

AC   CVCL_X337

RX   PubMed=18503785;

CC   Selected for resistance to: ChEBI; CHEBI:4672; Docetaxel anhydrous (Taxotere).

CC   Omics: Proteome analysis.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0630 ! SK-MES-1

SX   Male

CA   Cancer cell line

//

ID   SKN

AC   CVCL_3167

DR   CLO; CLO_0050881

DR   BioSample; SAMN03470820

DR   BioSample; SAMN03472277

DR   Cosmic; 1330908

DR   Cosmic-CLP; 1240215

DR   GDSC; 1240215

DR   GEO; GSM827211

DR   GEO; GSM1670447

DR   IFO; IFO50314

DR   JCRB; JCRB0173

DR   RCB; RCB0513

RX   PubMed=556976;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP; JCRB; RCB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11

ST   D16S539: 9

ST   D5S818: 12,13

ST   D7S820: 8,12

ST   TH01: 8

ST   TPOX: 8

ST   vWA: 18,19 (JCRB)

ST   vWA: 19 (Cosmic-CLP; RCB)

DI   NCIt; C6340; Uterine corpus leiomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SKN-3

AC   CVCL_3168

SY   SKN3

DR   BioSample; SAMN03472486

DR   CGH-DB; 370-2

DR   Cosmic; 1530758

DR   Cosmic; 1530759

DR   Cosmic-CLP; 1299059

DR   GDSC; 1299059

DR   GEO; GSM827179

DR   GEO; GSM1670448

DR   JCRB; JCRB1039

RX   PubMed=17599052;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP; JCRB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 10,12

ST   D5S818: 9

ST   D7S820: 10,11

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 18,20

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SKNO-1

AC   CVCL_2196

SY   Skno-1; SKNO1

DR   BioSample; SAMN03473440

DR   Cosmic; 787478

DR   Cosmic; 975301

DR   Cosmic; 1149337

DR   Cosmic; 1281353

DR   Cosmic; 1524841

DR   Cosmic; 2306239

DR   DSMZ; ACC-690

DR   GEO; GSM236805

DR   GEO; GSM236841

DR   JCRB; JCRB1170

RX   PubMed=7772516;

RX   PubMed=9738977;

RX   PubMed=15843827;

RX   PubMed=25984343;

CC   Doubling time: 24 hours (PubMed=25984343); ~35-50 hours (DSMZ).

CC   Omics: shRNA library screening.

ST   Source(s): DSMZ; JCRB

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 8,11

ST   D16S539: 10,11

ST   D5S818: 10,13

ST   D7S820: 10,12

ST   TH01: 7

ST   TPOX: 8,9

ST   vWA: 14,17

DI   NCIt; C7961; Adult acute myeloid leukemia with maturation

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SKO-007

AC   CVCL_4974

SY   SKO007; U-226AR1; U-266 AR1

DR   CLO; CLO_0009061

DR   EFO; EFO_0002339

DR   ATCC; CRL-8033-1

DR   IGRhCellID; SKO007

RX   PubMed=6159646;

RX   PubMed=6864164;

CC   Group: Hybridoma fusion partner cell line.

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 12

ST   D16S539: 10

ST   D5S818: 11,12

ST   D7S820: 11,12

ST   TH01: 5,7

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0566 ! U266B1

SX   Male

CA   Cancer cell line

//

ID   SKO-007 clone J3

AC   CVCL_4975

SY   Clone J3 of SKO-007

DR   CLO; CLO_0009062

DR   ATCC; CRL-8033-2

CC   Group: Hybridoma fusion partner cell line.

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 12

ST   D16S539: 10

ST   D5S818: 11,12

ST   D7S820: 11,12

ST   TH01: 5,7

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4974 ! SKO-007

SX   Male

CA   Cancer cell line

//

ID   SKOV-3/Luc

AC   CVCL_M089

WW   http://www.cellbiolabs.com/skov-3-reporter-cells

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0532 ! SK-OV-3

SX   Female

CA   Cancer cell line

//

ID   SKOV-3/RFP

AC   CVCL_M090

WW   http://www.cellbiolabs.com/skov-3-reporter-cells

CC   Transfected with: UniProtKB; Q9U6Y8; RFP.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0532 ! SK-OV-3

SX   Female

CA   Cancer cell line

//

ID   SKOV-3TR

AC   CVCL_4V89

RX   PubMed=10095106;

CC   Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0532 ! SK-OV-3

SX   Female

CA   Cancer cell line

//

ID   SKOV3-luc-D3

AC   CVCL_5J38

SY   SKOV-3-luc-D3

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Discontinued: PerkinElmer; Catalog number 119276.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0532 ! SK-OV-3

SX   Female

CA   Cancer cell line

//

ID   SKOV3-Red-FLuc

AC   CVCL_5J11

SY   SKOV3 Red-FLuc

WW   http://www.perkinelmer.com/Catalog/Product/ID/BW119276

CC   Transfected with: UniProtKB; Q1AG35; Italian firefly luciferase.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0532 ! SK-OV-3

SX   Female

CA   Cancer cell line

//

ID   SKOV3.ip1

AC   CVCL_0C84

SY   SKOV3ip1; SKOV3IP1; SKOV3IP

RX   PubMed=8094034;

RX   PubMed=27561551;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Deep proteome analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0532 ! SK-OV-3

SX   Female

CA   Cancer cell line

//

ID   SKOV3/TR

AC   CVCL_HF69

RX   PubMed=25815442;

CC   Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0532 ! SK-OV-3

SX   Female

CA   Cancer cell line

//

ID   SKOV3/VP

AC   CVCL_Y280

DR   CGH-DB; 9125-4

RX   PubMed=7911742;

RX   PubMed=14973057;

CC   Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0532 ! SK-OV-3

SX   Female

CA   Cancer cell line

//

ID   SKPT-0193 Cl.1

AC   CVCL_R942

RX   PubMed=8807581;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: Spontaneously hypertensive rat (SHR).

OX   NCBI_TaxID=10116; ! Rattus norvegicus

OI   CVCL_R943 ! SKPT-0193 Cl.2

OI   CVCL_R944 ! SKPT-0193 Cl.5

SX   Male

CA   Transformed cell line

//

ID   SKPT-0193 Cl.2

AC   CVCL_R943

RX   PubMed=8807581;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: Spontaneously hypertensive rat (SHR).

OX   NCBI_TaxID=10116; ! Rattus norvegicus

OI   CVCL_R942 ! SKPT-0193 Cl.1

OI   CVCL_R944 ! SKPT-0193 Cl.5

SX   Male

CA   Transformed cell line

//

ID   SKPT-0193 Cl.5

AC   CVCL_R944

RX   PubMed=8807581;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: Spontaneously hypertensive rat (SHR).

OX   NCBI_TaxID=10116; ! Rattus norvegicus

OI   CVCL_R942 ! SKPT-0193 Cl.1

OI   CVCL_R943 ! SKPT-0193 Cl.2

SX   Male

CA   Transformed cell line

//

ID   SKPT-1092 Cl.1

AC   CVCL_R945

RX   PubMed=8807581;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: Spontaneously hypertensive rat (SHR).

OX   NCBI_TaxID=10116; ! Rattus norvegicus

OI   CVCL_R946 ! SKPT-1092 Cl.2

SX   Male

CA   Transformed cell line

//

ID   SKPT-1092 Cl.2

AC   CVCL_R946

RX   PubMed=8807581;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: Spontaneously hypertensive rat (SHR).

OX   NCBI_TaxID=10116; ! Rattus norvegicus

OI   CVCL_R945 ! SKPT-1092 Cl.1

SX   Male

CA   Transformed cell line

//

ID   SKR1

AC   CVCL_G366

DR   TKG; TKG 0700

RX   PubMed=9183637;

ST   Source(s): TKG

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 12

ST   D16S539: 9

ST   D5S818: 10,12

ST   D7S820: 10,11

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SKS

AC   CVCL_S989

RX   PubMed=11408806;

DI   NCIt; C7982; Cervical small cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SKT-1A

AC   CVCL_Y112

RX   PubMed=2972890;

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y113 ! SKT-1B

SX   Male

CA   Cancer cell line

//

ID   SKT-1B

AC   CVCL_Y113

SY   SKT1B

DR   Cosmic; 919150

RX   PubMed=2972890;

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y112 ! SKT-1A

SX   Male

CA   Cancer cell line

//

ID   SKVLB0.03

AC   CVCL_IN03

SY   SK VLB 0.03; SKVLB (0.03)

RX   PubMed=2565764;

CC   Selected for resistance to: ChEBI; CHEBI:27375; Vincaleukoblastine (Vinblastine).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0532 ! SK-OV-3

SX   Female

CA   Cancer cell line

//

ID   SKVLB0.06

AC   CVCL_IN04

SY   SK VLB 0.06; SKVLB (0.06)

RX   PubMed=2565764;

CC   Selected for resistance to: ChEBI; CHEBI:27375; Vincaleukoblastine (Vinblastine).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0532 ! SK-OV-3

SX   Female

CA   Cancer cell line

//

ID   SKVLB1

AC   CVCL_IN05

SY   SKVLB 1; SKVLB-1; SK VLB 1; SKVLB (1.0); SKVLB

RX   PubMed=2565764;

CC   Selected for resistance to: ChEBI; CHEBI:27375; Vincaleukoblastine (Vinblastine).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0532 ! SK-OV-3

SX   Female

CA   Cancer cell line

//

ID   SKVCR0.015

AC   CVCL_IN06

SY   SK VCR 0.015; SKVCR (0.015)

RX   PubMed=2565764;

CC   Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0532 ! SK-OV-3

SX   Female

CA   Cancer cell line

//

ID   SKVCR0.1

AC   CVCL_IN07

SY   SK VCR 0.1

RX   PubMed=2565764;

CC   Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0532 ! SK-OV-3

SX   Female

CA   Cancer cell line

//

ID   SKVCR0.25

AC   CVCL_IN08

SY   SK VCR 0.25

RX   PubMed=2565764;

CC   Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0532 ! SK-OV-3

SX   Female

CA   Cancer cell line

//

ID   SKVCR2.0

AC   CVCL_IN09

SY   SKVCR 2.0; SK VCR 2

DR   GEO; GSM183342

DR   GEO; GSM183344

RX   PubMed=2565764;

RX   PubMed=17726699;

CC   Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0532 ! SK-OV-3

SX   Female

CA   Cancer cell line

//

ID   SKW 6.4

AC   CVCL_3796

SY   SKW6.4; Skw6.4; SKW6-Cl4; SKW6-CL4; SWK6 clone 4; SKW6-4

DR   BTO; BTO:0001936

DR   CLO; CLO_0009067

DR   ATCC; TIB-215

DR   ChEMBL-Cells; CHEMBL3307453

DR   ChEMBL-Targets; CHEMBL614928

RX   PubMed=6339249;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=SKW6-Cl4

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 11,12

ST   D5S818: 12,13

ST   D7S820: 9,11

ST   TH01: 8,9.3

ST   TPOX: 8,11

ST   vWA: 17,20

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SKW-3

AC   CVCL_2197

SY   SKW3

DR   CLO; CLO_0009068

DR   CLO; CLO_0051007

DR   CLDB; cl4362

DR   BioSample; SAMN03151818

DR   BioSample; SAMN03473523

DR   CLS; 300343/p2953_SKW-3

DR   Cosmic; 913412

DR   Cosmic; 919156

DR   Cosmic; 933546

DR   Cosmic; 1524820

DR   Cosmic; 1641385

DR   DSMZ; ACC-53

DR   NCBI_Iran; C182

DR   RCB; RCB1168

DR   TKG; TKG 0247

RX   PubMed=7849311;

RX   PubMed=9933131;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a KE-37 derivative (PubMed=20143388).

CC   Doubling time: ~30-40 hours (DSMZ).

ST   Source(s): DSMZ; RCB; TKG

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 8,12

ST   D16S539: 11,12

ST   D5S818: 12,13

ST   D7S820: 8,12

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1327 ! KE-37

SX   Male

CA   Cancer cell line

//

ID   SKW-4

AC   CVCL_A477

SY   SKW4; SKW 4

DR   Cosmic; 999779

RX   PubMed=6329938;

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SKW3/Clo

AC   CVCL_4V58

RX   PubMed=25461250;

CC   Problematic cell line: Contaminated. Parent cell line (SKW-3) has been shown to be a KE-37 derivative.

CC   Selected for resistance to: ChEBI; CHEBI:681569; Clofarabine (CAFdA).

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2197 ! SKW-3

SX   Male

CA   Cancer cell line

//

ID   SL-1-TC

AC   CVCL_AS19

SY   SL-1

DR   TKG; TKG 0136

DR   TKG; TKG 0639

CC   Derived from metastatic site: Lymph node.

CC   Breed/subspecies: ACI/N.

DI   NCIt; C60505; Rat sarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Cancer cell line

//

ID   SL-15

AC   CVCL_Y285

DR   GEO; GSM866165

RX   PubMed=16049984;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C35425; Splenic lymphoma with circulating villous lymphocytes

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SL-29

AC   CVCL_5587

DR   CLO; CLO_0009072

DR   ATCC; CRL-1590

DR   BCRJ; 0367

CC   Group: Bird cell line.

CC   Breed/subspecies: White Leghorn SPAFAS.

OX   NCBI_TaxID=9031; ! Gallus gallus

CA   Finite cell line

//

ID   SL-ZSU-1

AC   CVCL_Z321

SY   SL-zsu-1; ZSU-SL-1

RX   CelloPub=CLPUB00174;

RX   DOI=10.3923/jas.2007.4040.4043;

RX   PubMed=21335011;

CC   Group: Insect cell line.

CC   Doubling time: 100-144 hours (CelloPub=CLPUB00174).

OX   NCBI_TaxID=69820; ! Spodoptera litura

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Sl/Sl4

AC   CVCL_6525

DR   CLO; CLO_0009069

DR   ATCC; CRL-2452

RX   PubMed=1380155;

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   Sl/Sl4 hSCF220

AC   CVCL_6526

DR   CLO; CLO_0009070

DR   ATCC; CRL-2453

RX   PubMed=1380155;

CC   Transfected with: HGNC; 6343; KITLG.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6525 ! Sl/Sl4

CA   Transformed cell line

//

ID   Sl/Sl4 hSCF248

AC   CVCL_6527

DR   CLO; CLO_0009071

DR   ATCC; CRL-2454

RX   PubMed=1380155;

CC   Transfected with: HGNC; 6343; KITLG.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6525 ! Sl/Sl4

CA   Transformed cell line

//

ID   SL1

AC   CVCL_X934

SY   SL-1

DR   CGH-DB; 9206-4

RX   PubMed=4321974;

RX   PubMed=6018567;

RX   PubMed=14293797;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SL12

AC   CVCL_F832

RX   PubMed=6201262;

CC   Breed/subspecies: AKR.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   SL12.1

AC   CVCL_F833

RX   PubMed=6201262;

CC   Breed/subspecies: AKR.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_F832 ! SL12

CA   Cancer cell line

//

ID   SL12.4

AC   CVCL_F834

RX   PubMed=6201262;

CC   Breed/subspecies: AKR.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_F832 ! SL12

CA   Cancer cell line

//

ID   SL4c

AC   CVCL_U294

RX   PubMed=2414213;

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Spontaneously immortalized cell line

//

ID   SLC

AC   CVCL_5365

SY   Sato Lung Cancer; Sato Lung Carcinoma

DR   CLO; CLO_0050828

DR   RCB; RCB2862

DR   TKG; TKG 0135

CC   Breed/subspecies: Donryu.

DI   NCIt; C64112; Carcinoma of the rat lung

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Cancer cell line

//

ID   Sld1

AC   CVCL_E235

RX   PubMed=3595763;

CC   Breed/subspecies: (WC x C57BL/6)-Sl/Sld.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Stromal cell line

//

ID   Sld2

AC   CVCL_E236

RX   PubMed=3595763;

CC   Breed/subspecies: (WC x C57BL/6)-Sl/Sld.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Stromal cell line

//

ID   Sld3

AC   CVCL_E237

RX   PubMed=3595763;

CC   Breed/subspecies: (WC x C57BL/6)-Sl/Sld.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Stromal cell line

//

ID   SLE005

AC   CVCL_E829

SY   SLE

DR   dbMHC; 49020

DR   ECACC; 88052059

DR   IHW; IHW9059

DR   IMGT/HLA; 11391

WW   http://bioinformatics.hsanmartino.it/ecbr/cl59.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SLET-1

AC   CVCL_F756

SY   Sheep Lymphatic Endothelial Transformed-1

RX   PubMed=10100190;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [776].

OX   NCBI_TaxID=9940; ! Ovis aries

CA   Transformed cell line

//

ID   SLF [Leiostomus]

AC   CVCL_S947

SY   Spot Liver Fibroblastic

RX   DOI=10.1016/0044-8486(94)00382-X;

CC   Group: Fish cell line.

OX   NCBI_TaxID=59837; ! Leiostomus xanthurus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SLF [Rat]

AC   CVCL_IQ78

SY   Spiral Ligament Fibrocyte

RX   PubMed=17214269;

CC   Doubling time: 28.0 +- 8.2 hours (PubMed=17214269).

CC   Transformant: Ad12-SV40.

CC   Breed/subspecies: Wistar Kyoto.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Transformed cell line

//

ID   SLK

AC   CVCL_9569

SY   KS-SLK

DR   BioSample; SAMN03151616

DR   NIH-ARP; 9402-141

DR   SKY/M-FISH/CGH; 3862

RX   PubMed=7520247;

RX   PubMed=22987579;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a Caki-1 derivative (PubMed=22987579).

CC   Derived from metastatic site: Skin.

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0234 ! Caki-1

SX   Male

CA   Cancer cell line

//

ID   SLMT-1

AC   CVCL_E305

SY   SLMT1

DR   TOKU-E; 3591

RX   PubMed=11165320;

RX   PubMed=15885884;

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SLN

AC   CVCL_S948

CC   Group: Fish cell line.

OX   NCBI_TaxID=59837; ! Leiostomus xanthurus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SLR 20

AC   CVCL_V606

SY   SLR20

DR   CCLE; SLR20_KIDNEY

DR   GEO; GSM374467

RX   PubMed=19470766;

RX   PubMed=25984343;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 24 hours (PubMed=25984343).

CC   Omics: shRNA library screening.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SLR 21

AC   CVCL_V607

SY   SLR21

DR   CCLE; SLR21_KIDNEY

DR   Cosmic; 2520630

DR   GEO; GSM374468

RX   PubMed=19470766;

RX   PubMed=25984343;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 60 hours (PubMed=25984343).

CC   Omics: shRNA library screening.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SLR 22

AC   CVCL_V608

SY   SLR22

DR   Cosmic; 2520634

DR   GEO; GSM374469

RX   PubMed=19470766;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SLR 23

AC   CVCL_V609

SY   SLR23

DR   CCLE; SLR23_KIDNEY

DR   Cosmic; 2520635

DR   GEO; GSM374470

RX   PubMed=19470766;

RX   PubMed=25984343;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 40 hours (PubMed=25984343).

CC   Omics: shRNA library screening.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SLR 24

AC   CVCL_V610

SY   SLR24

DR   CCLE; SLR24_KIDNEY

DR   Cosmic; 2520643

DR   GEO; GSM374471

RX   PubMed=19470766;

RX   PubMed=25984343;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 30 hours (PubMed=25984343).

CC   Omics: shRNA library screening.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SLR 25

AC   CVCL_V611

SY   SLR25

DR   CCLE; SLR25_KIDNEY

DR   Cosmic; 2520639

DR   GEO; GSM374472

RX   PubMed=19470766;

RX   PubMed=25984343;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 80 hours (PubMed=25984343).

CC   Omics: shRNA library screening.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SLR 26

AC   CVCL_V612

SY   SLR26

DR   CCLE; SLR26_KIDNEY

DR   Cosmic; 2520644

DR   GEO; GSM374473

DR   GEO; GSM482712

RX   PubMed=19470766;

RX   PubMed=25984343;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 55 hours (PubMed=25984343).

CC   Omics: shRNA library screening.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SLT4

AC   CVCL_3922

DR   BTO; BTO:0004892

CC   Part of: BLA-40 bladder carcinoma cell line panel.

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0554 ! T24

SX   Female

CA   Cancer cell line

//

ID   SLUGEO

AC   CVCL_F723

DR   IMGT/HLA; 11392

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SLW

AC   CVCL_S949

CC   Group: Fish cell line.

OX   NCBI_TaxID=59837; ! Leiostomus xanthurus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SM [Human B-cell]

AC   CVCL_E830

SY   S.M.

DR   dbMHC; 49021

DR   ECACC; 94061621

DR   IHW; IHW9353

DR   IMGT/HLA; 11350

WW   http://bioinformatics.hsanmartino.it/ecbr/cl353.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SM [Human chondrosarcoma]

AC   CVCL_M607

RX   PubMed=16039953;

CC   Doubling time: 36 hours (PubMed=16039953).

DI   NCIt; C2946; Chondrosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SM-1

AC   CVCL_IU19

SY   SM1

DR   EFO; EFO_0002706

DR   BioSamples; SAMEA365986

DR   BioSamples; SAMEA366011

DR   GEO; GSM38808

DR   GEO; GSM38809

RX   PubMed=10554028;

RX   PubMed=15613351;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

DI   NCIt; C8285; AIDS related immunoblastic lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SM-AP1

AC   CVCL_D117

RX   PubMed=19622142;

DI   NCIt; C40409; Salivary gland pleomorphic adenoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_D118 ! SM-AP2

OI   CVCL_D119 ! SM-AP3

OI   CVCL_D120 ! SM-AP4

OI   CVCL_D121 ! SM-AP5

SX   Female

CA   Cancer cell line

//

ID   SM-AP2

AC   CVCL_D118

RX   PubMed=19622142;

DI   NCIt; C40409; Salivary gland pleomorphic adenoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_D117 ! SM-AP1

OI   CVCL_D119 ! SM-AP3

OI   CVCL_D120 ! SM-AP4

OI   CVCL_D121 ! SM-AP5

SX   Female

CA   Cancer cell line

//

ID   SM-AP3

AC   CVCL_D119

RX   PubMed=19622142;

DI   NCIt; C40409; Salivary gland pleomorphic adenoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_D117 ! SM-AP1

OI   CVCL_D118 ! SM-AP2

OI   CVCL_D120 ! SM-AP4

OI   CVCL_D121 ! SM-AP5

SX   Female

CA   Cancer cell line

//

ID   SM-AP4

AC   CVCL_D120

RX   PubMed=19622142;

DI   NCIt; C40409; Salivary gland pleomorphic adenoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_D117 ! SM-AP1

OI   CVCL_D118 ! SM-AP2

OI   CVCL_D119 ! SM-AP3

OI   CVCL_D121 ! SM-AP5

SX   Female

CA   Cancer cell line

//

ID   SM-AP5

AC   CVCL_D121

RX   PubMed=19622142;

DI   NCIt; C40409; Salivary gland pleomorphic adenoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_D117 ! SM-AP1

OI   CVCL_D118 ! SM-AP2

OI   CVCL_D119 ! SM-AP3

OI   CVCL_D120 ! SM-AP4

SX   Female

CA   Cancer cell line

//

ID   SM-E

AC   CVCL_0C26

RX   PubMed=7736387;

RX   PubMed=9815546;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SM-MI-1

AC   CVCL_W283

DR   CGH-DB; 9285-4

DR   Cosmic; 905199

RX   PubMed=15467732;

CC   Misspelling: 'SM-M1-1' in CGH-DB 9285-4.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Sm-MT

AC   CVCL_5588

SY   SmMT

RX   PubMed=4060590;

OX   NCBI_TaxID=9378; ! Suncus murinus

CA   Cancer cell line

//

ID   SM1

AC   CVCL_D051

SY   HVTs-SM1

RX   PubMed=10764661;

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Conditionally immortalized cell line

//

ID   SM1/9

AC   CVCL_0A33

RX   PubMed=7570575;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   SM2-1

AC   CVCL_H200

DR   Cosmic; 2144976

RX   PubMed=19035443;

RX   PubMed=22578220;

CC   From: Department of Dermatology; Shinshu University; Japan.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Subcutaneous.

DI   NCIt; C4022; Acral lentiginous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SM25/3

AC   CVCL_0A34

RX   PubMed=7570575;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   SM27-1045

AC   CVCL_F765

DR   CLO; CLO_0009078

DR   ATCC; HB-11917

RX   Patent=US6127135;

CC   Monoclonal antibody target: Human stem and progenitor cells marker EM10.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   SM3

AC   CVCL_H202

RX   PubMed=19035443;

RX   PubMed=22578220;

CC   From: Department of Dermatology; Shinshu University; Japan.

DI   NCIt; C4022; Acral lentiginous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SM5

AC   CVCL_D158

SY   SM-5

DR   BTO; BTO:0004275

RX   PubMed=15051493;

RX   PubMed=18544163;

CC   Omics: Proteome analysis by 2D-DE/MS.

CC   Breed/subspecies: C57BL/6J-Trp53tm1Tyj.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   SM7

AC   CVCL_D159

SY   SM-7

DR   BTO; BTO:0004276

RX   PubMed=15051493;

RX   PubMed=18544163;

CC   Omics: Proteome analysis by 2D-DE/MS.

CC   Breed/subspecies: C57BL/6J-Trp53tm1Tyj.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   SMA-497

AC   CVCL_6E76

SY   P497

RX   PubMed=3806112;

RX   PubMed=7435141;

RX   PubMed=10493969;

CC   Breed/subspecies: VM/Dk.

DI   NCIt; C21932; Mouse astrocytic tumours

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_6E75 ! SMA-540

OI   CVCL_8580 ! SMA-560

CA   Cancer cell line

//

ID   SMA-540

AC   CVCL_6E75

SY   P540

RX   PubMed=3806112;

RX   PubMed=7435141;

CC   Breed/subspecies: VM/Dk.

DI   NCIt; C21932; Mouse astrocytic tumours

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_6E76 ! SMA-497

OI   CVCL_8580 ! SMA-560

CA   Cancer cell line

//

ID   SMA-560

AC   CVCL_8580

SY   SMA 560; SMA560; P560

DR   PRIDE; PXD000589

RX   PubMed=3806112;

RX   PubMed=7435141;

RX   PubMed=9402588;

RX   PubMed=25894527;

CC   Omics: Cell surface proteome.

CC   Breed/subspecies: VM/Dk.

DI   NCIt; C21932; Mouse astrocytic tumours

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_6E76 ! SMA-497

OI   CVCL_6E75 ! SMA-540

CA   Cancer cell line

//

ID   SMA-iPS1

AC   CVCL_L670

DR   ISCR; 1994

RX   PubMed=22673189;

CC   From: Guangzhou Medical College; China.

DI   NCIt; C85075; Spinal muscular atrophy

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L671 ! SMA-iPS2

SX   Female

CA   Induced pluripotent stem cell

//

ID   SMA-iPS2

AC   CVCL_L671

DR   ISCR; 1995

RX   PubMed=22673189;

CC   From: Guangzhou Medical College; China.

DI   NCIt; C85075; Spinal muscular atrophy

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L670 ! SMA-iPS1

SX   Female

CA   Induced pluripotent stem cell

//

ID   Smac.4M

AC   CVCL_1E65

WW   http://axiogenesis.com/products/murine-smooth-muscle-cells/smac-4m.html

CC   From: Axiogenesis AG; Germany.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Breed/subspecies: 129S2/SvPas.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Finite cell line

//

ID   SMAP1dm

AC   CVCL_F960

SY   SMAP1-deficient macrophage

DR   TKG; TKG 0661

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   SMAT1

AC   CVCL_U449

RX   PubMed=9510068;

RX   PubMed=15541572;

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   SMB

AC   CVCL_S863

SY   SIM-1

DR   Cosmic; 1388896

RX   PubMed=2844401;

CC   Derived from metastatic site: Skin.

DI   NCIt; C8776; Peripheral primitive neuroectodermal tumor of bone

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SMC-1

AC   CVCL_J121

DR   CCRID; 3131C0001000700085

RX   PubMed=3159086;

DI   NCIt; C9351; Pleural mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SMC-L001

AC   CVCL_X018

DR   Cosmic; 2563250

RX   PubMed=24569940;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SmcMF

AC   CVCL_T067

RX   PubMed=23674870;

CC   Doubling time: 17.2 hours (PubMed=23674870).

CC   Breed/subspecies: C57BL/6J.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   SME-1

AC   CVCL_T726

SY   Silurus Meridionalis Embryo-1

RX   CelloPub=CLPUB00253;

CC   Group: Fish cell line.

OX   NCBI_TaxID=175797; ! Silurus meridionalis

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SMF No.12

AC   CVCL_0H75

DR   SKIP; SKIP000569

RX   PubMed=24859480;

DI   NCIt; C27701; Secondary myelofibrosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0H70 ! SMF No.5

OI   CVCL_0H71 ! SMF No.6

OI   CVCL_0H72 ! SMF No.7

OI   CVCL_0H73 ! SMF No.8

OI   CVCL_0H74 ! SMF No.9

OI   CVCL_0H76 ! SMF No.15

OI   CVCL_0H77 ! SMF No.16

OI   CVCL_0H78 ! SMF No.17

OI   CVCL_0H79 ! SMF No.20

OI   CVCL_0H80 ! SMF No.21

SX   Female

CA   Induced pluripotent stem cell

//

ID   SMF No.15

AC   CVCL_0H76

DR   SKIP; SKIP000570

RX   PubMed=24859480;

DI   NCIt; C27701; Secondary myelofibrosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0H70 ! SMF No.5

OI   CVCL_0H71 ! SMF No.6

OI   CVCL_0H72 ! SMF No.7

OI   CVCL_0H73 ! SMF No.8

OI   CVCL_0H74 ! SMF No.9

OI   CVCL_0H75 ! SMF No.12

OI   CVCL_0H77 ! SMF No.16

OI   CVCL_0H78 ! SMF No.17

OI   CVCL_0H79 ! SMF No.20

OI   CVCL_0H80 ! SMF No.21

SX   Female

CA   Induced pluripotent stem cell

//

ID   SMF No.16

AC   CVCL_0H77

DR   SKIP; SKIP000571

RX   PubMed=24859480;

DI   NCIt; C27701; Secondary myelofibrosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0H70 ! SMF No.5

OI   CVCL_0H71 ! SMF No.6

OI   CVCL_0H72 ! SMF No.7

OI   CVCL_0H73 ! SMF No.8

OI   CVCL_0H74 ! SMF No.9

OI   CVCL_0H75 ! SMF No.12

OI   CVCL_0H76 ! SMF No.15

OI   CVCL_0H78 ! SMF No.17

OI   CVCL_0H79 ! SMF No.20

OI   CVCL_0H80 ! SMF No.21

SX   Female

CA   Induced pluripotent stem cell

//

ID   SMF No.17

AC   CVCL_0H78

DR   SKIP; SKIP000572

RX   PubMed=24859480;

DI   NCIt; C27701; Secondary myelofibrosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0H70 ! SMF No.5

OI   CVCL_0H71 ! SMF No.6

OI   CVCL_0H72 ! SMF No.7

OI   CVCL_0H73 ! SMF No.8

OI   CVCL_0H74 ! SMF No.9

OI   CVCL_0H75 ! SMF No.12

OI   CVCL_0H76 ! SMF No.15

OI   CVCL_0H77 ! SMF No.16

OI   CVCL_0H79 ! SMF No.20

OI   CVCL_0H80 ! SMF No.21

SX   Female

CA   Induced pluripotent stem cell

//

ID   SMF No.20

AC   CVCL_0H79

DR   SKIP; SKIP000573

RX   PubMed=24859480;

DI   NCIt; C27701; Secondary myelofibrosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0H70 ! SMF No.5

OI   CVCL_0H71 ! SMF No.6

OI   CVCL_0H72 ! SMF No.7

OI   CVCL_0H73 ! SMF No.8

OI   CVCL_0H74 ! SMF No.9

OI   CVCL_0H75 ! SMF No.12

OI   CVCL_0H76 ! SMF No.15

OI   CVCL_0H77 ! SMF No.16

OI   CVCL_0H78 ! SMF No.17

OI   CVCL_0H80 ! SMF No.21

SX   Female

CA   Induced pluripotent stem cell

//

ID   SMF No.21

AC   CVCL_0H80

DR   SKIP; SKIP000574

RX   PubMed=24859480;

DI   NCIt; C27701; Secondary myelofibrosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0H70 ! SMF No.5

OI   CVCL_0H71 ! SMF No.6

OI   CVCL_0H72 ! SMF No.7

OI   CVCL_0H73 ! SMF No.8

OI   CVCL_0H74 ! SMF No.9

OI   CVCL_0H75 ! SMF No.12

OI   CVCL_0H76 ! SMF No.15

OI   CVCL_0H77 ! SMF No.16

OI   CVCL_0H78 ! SMF No.17

OI   CVCL_0H79 ! SMF No.20

SX   Female

CA   Induced pluripotent stem cell

//

ID   SMF No.5

AC   CVCL_0H70

DR   SKIP; SKIP000565

RX   PubMed=24859480;

DI   NCIt; C27701; Secondary myelofibrosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0H71 ! SMF No.6

OI   CVCL_0H72 ! SMF No.7

OI   CVCL_0H73 ! SMF No.8

OI   CVCL_0H74 ! SMF No.9

OI   CVCL_0H75 ! SMF No.12

OI   CVCL_0H76 ! SMF No.15

OI   CVCL_0H77 ! SMF No.16

OI   CVCL_0H78 ! SMF No.17

OI   CVCL_0H79 ! SMF No.20

OI   CVCL_0H80 ! SMF No.21

SX   Female

CA   Induced pluripotent stem cell

//

ID   SMF No.6

AC   CVCL_0H71

DR   SKIP; SKIP000566

RX   PubMed=24859480;

DI   NCIt; C27701; Secondary myelofibrosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0H70 ! SMF No.5

OI   CVCL_0H72 ! SMF No.7

OI   CVCL_0H73 ! SMF No.8

OI   CVCL_0H74 ! SMF No.9

OI   CVCL_0H75 ! SMF No.12

OI   CVCL_0H76 ! SMF No.15

OI   CVCL_0H77 ! SMF No.16

OI   CVCL_0H78 ! SMF No.17

OI   CVCL_0H79 ! SMF No.20

OI   CVCL_0H80 ! SMF No.21

SX   Female

CA   Induced pluripotent stem cell

//

ID   SMF No.7

AC   CVCL_0H72

DR   SKIP; SKIP000567

RX   PubMed=24859480;

DI   NCIt; C27701; Secondary myelofibrosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0H70 ! SMF No.5

OI   CVCL_0H71 ! SMF No.6

OI   CVCL_0H73 ! SMF No.8

OI   CVCL_0H74 ! SMF No.9

OI   CVCL_0H75 ! SMF No.12

OI   CVCL_0H76 ! SMF No.15

OI   CVCL_0H77 ! SMF No.16

OI   CVCL_0H78 ! SMF No.17

OI   CVCL_0H79 ! SMF No.20

OI   CVCL_0H80 ! SMF No.21

SX   Female

CA   Induced pluripotent stem cell

//

ID   SMF No.8

AC   CVCL_0H73

DR   SKIP; SKIP000568

RX   PubMed=24859480;

DI   NCIt; C27701; Secondary myelofibrosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0H70 ! SMF No.5

OI   CVCL_0H71 ! SMF No.6

OI   CVCL_0H72 ! SMF No.7

OI   CVCL_0H74 ! SMF No.9

OI   CVCL_0H75 ! SMF No.12

OI   CVCL_0H76 ! SMF No.15

OI   CVCL_0H77 ! SMF No.16

OI   CVCL_0H78 ! SMF No.17

OI   CVCL_0H79 ! SMF No.20

OI   CVCL_0H80 ! SMF No.21

SX   Female

CA   Induced pluripotent stem cell

//

ID   SMF No.9

AC   CVCL_0H74

RX   PubMed=24859480;

DI   NCIt; C27701; Secondary myelofibrosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0H70 ! SMF No.5

OI   CVCL_0H71 ! SMF No.6

OI   CVCL_0H72 ! SMF No.7

OI   CVCL_0H73 ! SMF No.8

OI   CVCL_0H75 ! SMF No.12

OI   CVCL_0H76 ! SMF No.15

OI   CVCL_0H77 ! SMF No.16

OI   CVCL_0H78 ! SMF No.17

OI   CVCL_0H79 ! SMF No.20

OI   CVCL_0H80 ! SMF No.21

SX   Female

CA   Induced pluripotent stem cell

//

ID   SMG-C10

AC   CVCL_6953

SY   SMG C10; SMGC10

RX   PubMed=9112124;

RX   PubMed=9825893;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: Sprague-Dawley.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Transformed cell line

//

ID   SMG-C6

AC   CVCL_6954

SY   SMG C6; SMGC6

DR   BTO; BTO:0004220

RX   PubMed=9112124;

RX   PubMed=9825893;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: Sprague-Dawley.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Transformed cell line

//

ID   SMIE

AC   CVCL_9Y73

SY   RSMG 2C-2

RX   PubMed=2164809;

RX   PubMed=9426293;

CC   Transformant: NCBI_TaxID; 28282; Adenovirus 12 [E1A].

CC   Miscellaneous: Assignment of SMIE to RSMG 2C-2 by personal communication of Tabak L.A.

CC   Breed/subspecies: Long-Evans.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Transformed cell line

//

ID   sMISK

AC   CVCL_W333

RX   PubMed=7531680;

CC   Derived from metastatic site: Neck lymph node.

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_W332 ! MISK81-5

SX   Female

CA   Cancer cell line

//

ID   SMITH

AC   CVCL_W397

RX   CelloPub=CLPUB00019;

RX   PubMed=10936422;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SMKT-R1

AC   CVCL_A749

SY   SMKT-R-1; SMKTR1

RX   PubMed=1433606;

RX   PubMed=2051699;

RX   PubMed=2815432;

RX   PubMed=27993170;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SMKT-R2

AC   CVCL_A750

SY   SMKT-R-2; SMKTR2

DR   Cosmic; 849380

RX   PubMed=1433606;

RX   PubMed=2051699;

RX   PubMed=2815432;

RX   PubMed=11146448;

RX   PubMed=27993170;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SMKT-R3

AC   CVCL_A751

SY   SMKT-R-3; SMKTR3

DR   Cosmic; 849381

RX   PubMed=1433606;

RX   PubMed=2051699;

RX   PubMed=2815432;

RX   PubMed=11146448;

RX   PubMed=27993170;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SMKT-R4

AC   CVCL_A752

SY   SMKT-R-4; SMKTR4

RX   PubMed=1433606;

RX   PubMed=2051699;

RX   PubMed=27993170;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SML, clone 4D8

AC   CVCL_6446

SY   SML; Squirrel Monkey Lymphoblastic cell line

DR   CLO; CLO_0009090

DR   ATCC; CRL-2311

RX   PubMed=10090044;

WW   http://www.mdanderson.org/education-and-research/departments-programs-and-labs/programs-centers-institutes/michale-e-keeling-center-for-comparative-medicine-and-research/animal-resources/squirel-monkey-cell-lines.html

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=39432; ! Saimiri boliviensis boliviensis

SX   Male

CA   Transformed cell line

//

ID   SMMC-7721

AC   CVCL_0534

AS   CVCL_B400

SY   SMMC 7721; SMMC7721; H7721; H-7721

DR   BTO; BTO:0003227

DR   MCCL; MCC:0000433

DR   CCRID; 3111C0001CCC000087

DR   CCRID; 3131C0001000700052

DR   CCRID; 3142C0001000000063

DR   CCRID; 3153C0001000000015

DR   ChEMBL-Cells; CHEMBL3308059

DR   ChEMBL-Targets; CHEMBL613831

DR   Cosmic; 852773

DR   Cosmic; 1060081

DR   Cosmic; 1499248

DR   GEO; GSM936777

DR   GEO; GSM1374884

RX   PubMed=17552011;

RX   PubMed=23505090;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-587.html

CC   Omics: Proteome analysis by 2D-DE/MS.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: Occasionally 'SMMU-7721'.

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SMMU-1

AC   CVCL_DG22

RX   PubMed=7511044;

RX   PubMed=8755562;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_DG23 ! SMMU-2

CA   Cancer cell line

//

ID   SMMU-2

AC   CVCL_DG23

SY   SMMU2

RX   PubMed=7511044;

RX   PubMed=8755562;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_DG22 ! SMMU-1

CA   Cancer cell line

//

ID   SMOV-1

AC   CVCL_S916

SY   SMOV1

RX   DOI=10.1007/BF02492857;

CC   Doubling time: 61.4 hours (DOI=10.1007/BF02492857).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C4182; Serous surface papillary carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SMOV-2

AC   CVCL_S920

SY   SMOV2

RX   PubMed=10695021;

CC   Doubling time: 48.2 hours (PubMed=10695021).

DI   NCIt; C40078; Ovarian clear cell adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SMRC-1

AC   CVCL_5898

RX   PubMed=11737483;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SMRC-3

AC   CVCL_5899

RX   PubMed=11737483;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SMS-CTR

AC   CVCL_A770

SY   SMS_CTR; SMSCTR

DR   Cosmic; 802048

DR   Cosmic; 1097752

DR   Cosmic; 1718105

DR   Cosmic; 2355930

RX   PubMed=2302710;

RX   PubMed=8275086;

RX   PubMed=21948088;

RX   PubMed=23882450;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Reynolds C.P.; Children's Hospital of Los Angeles; Los Angeles; USA.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): COG; PubMed=21948088

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 10,11

ST   D18S51: 13

ST   D19S433: 14

ST   D21S11: 29,31.2

ST   D2S1338: 24

ST   D3S1358: 17

ST   D5S818: 12

ST   D7S820: 8,11

ST   D8S1179: 10,12

ST   FGA: 21,22

ST   TH01: 6

ST   TPOX: 8,12

ST   vWA: 18,19

DI   NCIt; C8971; Embryonal rhabdomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SMS-KAN

AC   CVCL_7131

DR   CGH-DB; 9096-4

DR   Cosmic; 717425

DR   Cosmic; 848932

DR   Cosmic; 922671

DR   Cosmic; 923826

DR   Cosmic; 930079

DR   Cosmic; 1019938

DR   Cosmic; 1526650

RX   DOI=10.1007/0-306-46872-7_2;

RX   DOI=10.1016/B978-0-12-333530-2.50006-X;

RX   PubMed=3456456;

RX   PubMed=7037175;

RX   PubMed=12702577;

RX   PubMed=24792489;

WW   http://www.cogcell.org/dl/NB_Data_Sheets/SMS-KAN_Cell_Line_Data_Sheet_COGcell_org.pdf

CC   Doubling time: ~95 hours (PubMed=3456456).

ST   Source(s): COG

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 9,11

ST   D16S539: 11,13

ST   D18S51: 17,21

ST   D19S433: 12

ST   D21S11: 28,30

ST   D2S1338: 18,19

ST   D3S1358: 15,17

ST   D5S818: 9,13

ST   D7S820: 8,9

ST   D8S1179: 14,16

ST   FGA: 19,21

ST   TH01: 7,8

ST   TPOX: 8,11

ST   vWA: 15,16

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7132 ! SMS-KANR

SX   Female

CA   Cancer cell line

//

ID   SMS-KANR

AC   CVCL_7132

DR   Cosmic; 922672

DR   Cosmic; 1890105

RX   DOI=10.1007/0-306-46872-7_2;

RX   DOI=10.1016/B978-0-12-333530-2.50006-X;

RX   PubMed=3456456;

RX   PubMed=7037175;

RX   PubMed=23202128;

WW   http://www.cogcell.org/dl/NB_Data_Sheets/SMS-KANR_Cell_Line_Data_Sheet_COGcell_org.pdf

CC   Doubling time: ~69 hours (PubMed=3456456).

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): COG

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 9,11

ST   D16S539: 11,13

ST   D18S51: 17,21

ST   D19S433: 12

ST   D21S11: 28,30

ST   D2S1338: 18,19

ST   D3S1358: 15,17

ST   D5S818: 9,13

ST   D7S820: 8,9

ST   D8S1179: 14,16

ST   FGA: 19,21

ST   TH01: 7,8

ST   TPOX: 8,11

ST   vWA: 15,16

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7131 ! SMS-KAN

SX   Female

CA   Cancer cell line

//

ID   SMS-KCL

AC   CVCL_AQ28

RX   PubMed=7037175;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

ST   Source(s): COG

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 12,13

ST   D16S539: 10,11

ST   D18S51: 15,19

ST   D19S433: 14,15

ST   D21S11: 30,31.2

ST   D2S1338: 17,22

ST   D3S1358: 14,15

ST   D5S818: 11

ST   D7S820: 9,11

ST   D8S1179: 13,14

ST   FGA: 19,22

ST   TH01: 9.3

ST   TPOX: 11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7133 ! SMS-KCN

OI   CVCL_7134 ! SMS-KCNR

SX   Male

CA   Transformed cell line

//

ID   SMS-KCN

AC   CVCL_7133

SY   KCN; NB07C

DR   BTO; BTO:0003548

DR   CGH-DB; 71-1

DR   CGH-DB; 9091-4

DR   Cosmic; 717426

DR   Cosmic; 848940

DR   Cosmic; 923827

DR   Cosmic; 1019932

DR   Cosmic; 1162007

DR   Cosmic; 1890077

DR   Cosmic; 2393632

RX   DOI=10.1007/0-306-46872-7_2;

RX   DOI=10.1016/B978-0-12-333530-2.50006-X;

RX   PubMed=2535691;

RX   PubMed=3456456;

RX   PubMed=7037175;

RX   PubMed=12702577;

RX   PubMed=15150091;

RX   PubMed=23202128;

RX   PubMed=24792489;

WW   http://www.cogcell.org/dl/NB_Data_Sheets/SMS-KCN_Cell_Line_Data_Sheet_COGcell_org.pdf

CC   Doubling time: ~109 hours (PubMed=3456456).

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Genome sequenced.

ST   Source(s): COG

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 12,13

ST   D16S539: 10,11

ST   D18S51: 15,19

ST   D19S433: 14,15

ST   D21S11: 30,31.2

ST   D2S1338: 17,22

ST   D3S1358: 14,15

ST   D5S818: 11

ST   D7S820: 9,11

ST   D8S1179: 13,14

ST   FGA: 19,22

ST   TH01: 9.3

ST   TPOX: 11

ST   vWA: 17,18

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AQ28 ! SMS-KCL

OI   CVCL_7134 ! SMS-KCNR

SX   Male

CA   Cancer cell line

//

ID   SMS-KCNR

AC   CVCL_7134

SY   SMSKCNR; KCNR; KCN-R

DR   CGH-DB; 9100-4

DR   Cosmic; 848941

DR   Cosmic; 922673

DR   Cosmic; 1019950

DR   Cosmic; 1109112

DR   Cosmic; 1153804

DR   Cosmic; 1167413

DR   Cosmic; 1518067

DR   Cosmic; 1526651

DR   Cosmic; 2239460

DR   Cosmic; 2393633

DR   GEO; GSM692866

RX   DOI=10.1007/0-306-46872-7_2;

RX   DOI=10.1016/B978-0-12-333530-2.50006-X;

RX   PubMed=3456456;

RX   PubMed=7037175;

RX   PubMed=7838528;

RX   PubMed=12702577;

RX   PubMed=22213050;

RX   PubMed=24792489;

WW   http://www.cogcell.org/dl/NB_Data_Sheets/SMS-KCNR_Cell_Line_Data_Sheet_COGcell_org.pdf

CC   Doubling time: ~72 hours (PubMed=3456456).

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): COG

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 12,13

ST   D16S539: 10,11

ST   D18S51: 15,19

ST   D19S433: 14,15

ST   D21S11: 30,31.2

ST   D2S1338: 17,22

ST   D3S1358: 14,15

ST   D5S818: 11

ST   D7S820: 9,11

ST   D8S1179: 13,14

ST   FGA: 19,22

ST   TH01: 9.3

ST   TPOX: 11

ST   vWA: 17,18

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AQ28 ! SMS-KCL

OI   CVCL_7133 ! SMS-KCN

SX   Male

CA   Cancer cell line

//

ID   SMS-LHN

AC   CVCL_9539

DR   Cosmic; 717429

DR   Cosmic; 848931

RX   DOI=10.1007/0-306-46872-7_2;

RX   PubMed=7037175;

RX   PubMed=8242562;

RX   PubMed=24792489;

WW   http://www.cogcell.org/dl/NB_Data_Sheets/SMS-LHN_Cell_Line_Data_Sheet_COGcell_org.pdf

ST   Source(s): COG

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 9,13

ST   D16S539: 8,9

ST   D18S51: 16,19

ST   D19S433: 15

ST   D21S11: 27,28

ST   D2S1338: 17,19

ST   D3S1358: 16,18

ST   D5S818: 10,11

ST   D7S820: 8,11

ST   D8S1179: 13,14

ST   FGA: 19,23

ST   TH01: 9.3,10

ST   TPOX: 8,9

ST   vWA: 15,18

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SMS-MSN

AC   CVCL_7135

DR   Cosmic; 930080

RX   DOI=10.1007/0-306-46872-7_2;

RX   PubMed=3456456;

RX   PubMed=7037175;

CC   Doubling time: ~85 hours (PubMed=3456456).

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SMS-SAL

AC   CVCL_AQ29

RX   PubMed=7037175;

RX   PubMed=11986953;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

ST   Source(s): COG

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11,12

ST   D16S539: 12

ST   D18S51: 16,19

ST   D19S433: 13,14

ST   D21S11: 29,31.2

ST   D2S1338: 19

ST   D3S1358: 15,17

ST   D5S818: 11

ST   D7S820: 8,11

ST   D8S1179: 10,11

ST   FGA: 19

ST   TH01: 6,9.3

ST   TPOX: 8,12

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7136 ! SMS-SAN

SX   Female

CA   Transformed cell line

//

ID   SMS-SAN

AC   CVCL_7136

SY   SMS SAN

DR   Cosmic; 717428

DR   Cosmic; 848933

DR   Cosmic; 1019951

DR   Cosmic; 1162008

DR   Cosmic; 1890107

RX   DOI=10.1007/0-306-46872-7_2;

RX   PubMed=3456456;

RX   PubMed=7037175;

RX   PubMed=23202128;

RX   PubMed=24792489;

WW   http://www.cogcell.org/dl/NB_Data_Sheets/SMS-SAN_Cell_Line_Data_Sheet_COGcell_org.pdf

CC   Doubling time: ~71 hours (PubMed=3456456).

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): COG

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11,12

ST   D16S539: 12

ST   D18S51: 16,19

ST   D19S433: 13,14

ST   D21S11: 29,31.2

ST   D2S1338: 19

ST   D3S1358: 15,17

ST   D5S818: 11

ST   D7S820: 8,11

ST   D8S1179: 10,11

ST   FGA: 19

ST   TH01: 6,9.3

ST   TPOX: 8,12

ST   vWA: 17,18

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AQ29 ! SMS-SAL

SX   Female

CA   Cancer cell line

//

ID   SMS-SB

AC   CVCL_AQ30

SY   SMS/SB; SB

DR   Cosmic; 1226861

DR   Cosmic; 922680

DR   Cosmic; 2361361

DR   Cosmic; 2491100

RX   PubMed=6778921;

RX   PubMed=8547074;

RX   PubMed=9067587;

RX   PubMed=9207458;

RX   PubMed=11986953;

ST   Source(s): COG

ST   Amelogenin: X

ST   CSF1PO: 7,10

ST   D13S317: 11,12

ST   D16S539: 11,14

ST   D18S51: 16,17

ST   D19S433: 12,15

ST   D21S11: 28,30

ST   D2S1338: 19,22

ST   D3S1358: 16,17

ST   D5S818: 12,14

ST   D7S820: 8,10

ST   D8S1179: 14

ST   FGA: 18.2,21

ST   TH01: 8,9.3

ST   TPOX: 8,11

ST   vWA: 18,21

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SMT/2A LNM

AC   CVCL_3601

DR   CLO; CLO_0009091

DR   ATCC; CRL-6602

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Derived from metastatic site: Lymph node.

CC   Breed/subspecies: Wistar Furth.

DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland

OX   NCBI_TaxID=10116; ! Rattus norvegicus

OI   CVCL_Y904 ! Rama 900

SX   Female

CA   Cancer cell line

//

ID   SMTK-1

AC   CVCL_GS48

RX   PubMed=15160996;

CC   From: Matsumoto; Shinsyu University School of Medicine; Matsumoto; Japan.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SMU1-10

AC   CVCL_IN93

RX   PubMed=9170108;

WW   https://www.abmgood.com/Immortalized-Mouse-Smooth-Muscle/Myometrial-Like-Cells-(SMU1-10)-T0651.html

CC   Characteristics: At the permissive temperature (33 Celsius) grow continuously. At the restrictive temperature (39 Celsius) stop dividing and ultimately die within 3 weeks.

CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Conditionally immortalized cell line

//

ID   SMYM-PRGP

AC   CVCL_H199

DR   Cosmic; 2144973

RX   PubMed=17488338;

RX   PubMed=19035443;

RX   PubMed=22578220;

CC   Omics: Deep exome analysis.

DI   NCIt; C4022; Acral lentiginous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SN-1

AC   CVCL_B075

DR   Cosmic; 996312

DR   Cosmic; 998747

DR   Cosmic; 1037663

DR   Cosmic; 2393017

RX   PubMed=10706136;

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SN-512

AC   CVCL_8759

DR   CLO; CLO_0051544

DR   BioSample; SAMN03472137

DR   RCB; RCB1429

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 13

ST   D13S317: 8

ST   D16S539: 13

ST   D5S818: 10

ST   D7S820: 11

ST   TH01: 9

ST   TPOX: 8,9

ST   vWA: 14

DI   NCIt; C3171; Acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SN-56/OBR

AC   CVCL_4457

DR   BTO; BTO:0003557

RX   PubMed=10806392;

CC   Transfected with: HGNC; 6554; LEPR.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4456 ! SN56

CA   Hybrid cell line

//

ID   SN-Mel

AC   CVCL_7137

DR   Cosmic; 1109810

DR   Cosmic; 1295342

RX   PubMed=11121133;

RX   PubMed=18384130;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SN-SY-1

AC   CVCL_N584

DR   Cosmic; 1206121

RX   PubMed=9378564;

DI   NCIt; C3400; Synovial sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SN-T4

AC   CVCL_M849

RX   PubMed=3167823;

DI   NCIt; C3513; Esophageal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_M848 ! SNO

SX   Male

CA   Cancer cell line

//

ID   SN12A1

AC   CVCL_D105

RX   PubMed=3731078;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1705 ! SN12C

OI   CVCL_D106 ! SN12K1

OI   CVCL_D107 ! SN12L1

OI   CVCL_D108 ! SN12S1

SX   Male

CA   Cancer cell line

//

ID   SN12C

AC   CVCL_1705

SY   SN-12C

DR   BTO; BTO:0004221

DR   ChEMBL-Cells; CHEMBL3307518

DR   ChEMBL-Targets; CHEMBL614054

DR   Cosmic; 687942

DR   Cosmic; 849372

DR   Cosmic; 897464

DR   Cosmic; 905979

DR   Cosmic; 974307

DR   Cosmic; 1044262

DR   Cosmic; 1092636

DR   Cosmic; 1175852

DR   Cosmic; 1305377

DR   Cosmic; 1312365

DR   Cosmic; 1998479

DR   Cosmic-CLP; 905979

DR   GDSC; 905979

DR   GEO; GSM50230

DR   GEO; GSM50294

DR   GEO; GSM579204

DR   GEO; GSM579205

DR   GEO; GSM579404

DR   GEO; GSM750840

DR   GEO; GSM799376

DR   GEO; GSM799439

DR   GEO; GSM847160

DR   GEO; GSM844695

DR   GEO; GSM844696

DR   GEO; GSM1153449

DR   GEO; GSM1181307

DR   GEO; GSM1181325

DR   GEO; GSM1670459

DR   KCLB; 80025

DR   SKY/M-FISH/CGH; 2804

RX   PubMed=2041050;

RX   PubMed=2706827;

RX   PubMed=3731078;

RX   PubMed=8053494;

RX   PubMed=11146448;

RX   PubMed=17088437;

RX   PubMed=19372543;

RX   PubMed=20952505;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=36

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Doubling time: 29.5 hours (DTP).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; PubMed=19372543

ST   Amelogenin: X

ST   CSF1PO: 9,10

ST   D13S317: 9

ST   D16S539: 11

ST   D18S51: 12

ST   D19S433: 14

ST   D21S11: 29,30

ST   D2S1338: 17,25

ST   D3S1358: 15

ST   D5S818: 11

ST   D7S820: 9

ST   D8S1179: 12

ST   FGA: 21,22

ST   TH01: 6,8

ST   TPOX: 8,11

ST   vWA: 15

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_D105 ! SN12A1

OI   CVCL_D106 ! SN12K1

OI   CVCL_D107 ! SN12L1

OI   CVCL_D108 ! SN12S1

SX   Male

CA   Cancer cell line

//

ID   SN12C-PM6

AC   CVCL_9549

SY   SN12CPM6; SN12-PM6; SN12PM6; PM6; LM1

DR   GEO; GSM374474

DR   GEO; GSM579206

DR   GEO; GSM579401

DR   KCLB; 80026

RX   PubMed=2706827;

RX   PubMed=8053494;

RX   PubMed=10987313;

RX   PubMed=20952505;

CC   Omics: CNV analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1705 ! SN12C

SX   Male

CA   Cancer cell line

//

ID   SN12C-PM6-2

AC   CVCL_DG80

SY   LM2

DR   GEO; GSM579207

DR   GEO; GSM579208

DR   GEO; GSM579402

DR   GEO; GSM579403

RX   PubMed=20952505;

CC   Omics: CNV analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9549 ! SN12C-PM6

SX   Male

CA   Cancer cell line

//

ID   SN12K1

AC   CVCL_D106

DR   ChEMBL-Cells; CHEMBL3307784

DR   ChEMBL-Targets; CHEMBL1909241

RX   PubMed=3731078;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_D105 ! SN12A1

OI   CVCL_1705 ! SN12C

OI   CVCL_D107 ! SN12L1

OI   CVCL_D108 ! SN12S1

SX   Male

CA   Cancer cell line

//

ID   SN12L1

AC   CVCL_D107

RX   PubMed=3731078;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_D105 ! SN12A1

OI   CVCL_1705 ! SN12C

OI   CVCL_D106 ! SN12K1

OI   CVCL_D108 ! SN12S1

SX   Male

CA   Cancer cell line

//

ID   SN12S1

AC   CVCL_D108

RX   PubMed=3731078;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_D105 ! SN12A1

OI   CVCL_1705 ! SN12C

OI   CVCL_D106 ! SN12K1

OI   CVCL_D107 ! SN12L1

SX   Male

CA   Cancer cell line

//

ID   SN161

AC   CVCL_5U32

RX   PubMed=1855225;

RX   PubMed=2185890;

CC   Transformant: ChEBI; CHEBI:59032; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).

CC   Derived from metastatic site: Lymph node.

CC   Breed/subspecies: 129 x NIH Swiss.

DI   NCIt; C21609; Mouse squamous cell carcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   SN36

AC   CVCL_F954

SY   SN-36

DR   TKG; TKG 0171

DI   NCIt; C21604; Mouse leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   SN4741

AC   CVCL_S466

RX   PubMed=9870933;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: (CBA/J x C57BL/6) F2 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   SN56

AC   CVCL_4456

SY   SN-56; SN56.B5.G4; SN56 B5 G4

DR   BTO; BTO:0003556

DR   EFO; EFO_0002081

RX   PubMed=2331789;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2132 ! N18TG2

CA   Hybrid cell line

//

ID   SNA-BLL

AC   CVCL_E831

SY   SNANI-BLL; SNA

DR   dbMHC; 49022

DR   ECACC; 94050325

DR   IHW; IHW9245

DR   IMGT/HLA; 11394

WW   http://bioinformatics.hsanmartino.it/ecbr/cl245.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SNB-19

AC   CVCL_0535

SY   SNB.19; SNB19

DR   BTO; BTO:0003761

DR   CLO; CLO_0009093

DR   EFO; EFO_0002342

DR   MCCL; MCC:0000434

DR   ATCC; CRL-2219

DR   BioSample; SAMN03151977

DR   BioSample; SAMN03471000

DR   BioSample; SAMN03472567

DR   CCLE; SNB19_CENTRAL_NERVOUS_SYSTEM

DR   ChEMBL-Cells; CHEMBL3307552

DR   ChEMBL-Targets; CHEMBL614164

DR   Cosmic; 875894

DR   Cosmic; 897439

DR   Cosmic; 905966

DR   Cosmic; 974241

DR   Cosmic; 1044249

DR   Cosmic; 1092637

DR   Cosmic; 1305361

DR   Cosmic; 1312343

DR   Cosmic; 1746950

DR   Cosmic; 1998480

DR   Cosmic; 2302333

DR   Cosmic; 2367548

DR   Cosmic; 2550361

DR   DSMZ; ACC-325

DR   GEO; GSM50178

DR   GEO; GSM50242

DR   GEO; GSM326246

DR   GEO; GSM750785

DR   GEO; GSM799326

DR   GEO; GSM799389

DR   GEO; GSM847161

DR   GEO; GSM844697

DR   GEO; GSM887600

DR   GEO; GSM888683

DR   GEO; GSM1153396

DR   GEO; GSM1181304

DR   GEO; GSM1181321

DR   IGRhCellID; SNB19

DR   JCRB; NIHS0294

DR   SKY/M-FISH/CGH; 2822

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=2041050;

RX   PubMed=3121170;

RX   PubMed=17088437;

RX   PubMed=19372543;

RX   PubMed=20143388;

RX   PubMed=22460905;

RX   PubMed=22570425;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=24335698;

RX   PubMed=27807467;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://dtp.cancer.gov/discovery_development/nci-60/u251_snb-19.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=55

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-111.html

WW   http://www.atcc.org/Products/Cells_and_Microorganisms/Cell_Lines/Misidentified_Cell_Lines.aspx

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a U-251MG derivative (PubMed=20143388, PubMed=22570425).

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: NCI60 cancer cell line panel.

CC   Doubling time: 34.6 hours (DTP); ~24 hours (DSMZ).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CRL-2219; true.

CC   Discontinued: JCRB; NIHS0294; true.

ST   Source(s): ATCC; DSMZ; PubMed=19372543; PubMed=25877200

ST   Amelogenin: X,Y (ATCC; DSMZ; PubMed=19372543)

ST   Amelogenin: X (PubMed=25877200)

ST   CSF1PO: 11,12 (ATCC; DSMZ; PubMed=25877200)

ST   CSF1PO: 12 (PubMed=19372543)

ST   D13S317: 10,11

ST   D16S539: 12

ST   D18S51: 13

ST   D19S433: 13,15

ST   D21S11: 29

ST   D2S1338: 22,24

ST   D3S1358: 16,17

ST   D5S818: 11,12

ST   D7S820: 10,12 (ATCC; DSMZ; PubMed=25877200)

ST   D7S820: 10 (PubMed=19372543)

ST   D8S1179: 13,15

ST   FGA: 21 (PubMed=19372543)

ST   FGA: 21,25 (PubMed=25877200)

ST   Penta D: 12

ST   Penta E: 7,10

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 16,18

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0021 ! U-251MG

SX   Male

CA   Cancer cell line

//

ID   SNB-56

AC   CVCL_B320

SY   SNB56

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=3121170;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNB-75

AC   CVCL_1706

SY   SNB.75; SNB75

DR   BTO; BTO:0004222

DR   ChEMBL-Cells; CHEMBL3307616

DR   ChEMBL-Targets; CHEMBL614451

DR   Cosmic; 687583

DR   Cosmic; 875895

DR   Cosmic; 905982

DR   Cosmic; 974242

DR   Cosmic; 1092638

DR   Cosmic; 1175820

DR   Cosmic; 1305362

DR   Cosmic; 1312344

DR   Cosmic; 1436042

DR   Cosmic; 1998481

DR   Cosmic; 2367549

DR   Cosmic-CLP; 905982

DR   GDSC; 905982

DR   GEO; GSM50179

DR   GEO; GSM50243

DR   GEO; GSM750786

DR   GEO; GSM799327

DR   GEO; GSM799390

DR   GEO; GSM847162

DR   GEO; GSM844698

DR   GEO; GSM844699

DR   GEO; GSM844700

DR   GEO; GSM1153397

DR   GEO; GSM1181270

DR   GEO; GSM1181313

DR   GEO; GSM1670460

DR   LINCS; 50045

DR   SKY/M-FISH/CGH; 2823

RX   PubMed=2041050;

RX   PubMed=3121170;

RX   PubMed=17088437;

RX   PubMed=19372543;

RX   PubMed=22336246;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=56

WW   http://tcpaportal.org/mclp/

CC   Part of: JFCR39 cancer cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Doubling time: 62.8 hours (DTP).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; PubMed=19372543

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8,12

ST   D16S539: 11,13

ST   D18S51: 18

ST   D19S433: 13,14

ST   D21S11: 30

ST   D2S1338: 17,23

ST   D3S1358: 17

ST   D5S818: 12

ST   D7S820: 9,11 (Cosmic-CLP)

ST   D7S820: 9 (PubMed=19372543)

ST   D8S1179: 12

ST   FGA: 19,23

ST   TH01: 6,9 (Cosmic-CLP)

ST   TH01: 9 (PubMed=19372543)

ST   TPOX: 8,10

ST   vWA: 16,18

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNB-78

AC   CVCL_B321

SY   SNB78

DR   ChEMBL-Cells; CHEMBL3307969

DR   ChEMBL-Targets; CHEMBL612543

DR   Cosmic; 1436043

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=3121170;

RX   PubMed=22336246;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

CC   Part of: JFCR39 cancer cell line panel.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNEC-MI

AC   CVCL_9481

RX   PubMed=15218315;

DI   NCIt; C116318; Nasal cavity and paranasal sinus small cell neuroendocrine carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   sNF02.2

AC   CVCL_K280

SY   sNF02-2

DR   ATCC; CRL-2885

DR   BioSample; SAMN03471811

DR   Cosmic; 1644554

RX   PubMed=14762442;

RX   PubMed=22346343;

CC   Derived from metastatic site: Lung.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11,14

ST   D16S539: 11,12

ST   D5S818: 12

ST   D7S820: 10,11

ST   TH01: 7,9

ST   TPOX: 8,12

ST   vWA: 16

DI   NCIt; C3273; Neurofibromatosis type 1

DI   NCIt; C3798; Malignant peripheral nerve sheath tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   sNF94.3

AC   CVCL_K164

DR   ATCC; CRL-2886

DR   BioSample; SAMN03471812

RX   PubMed=14762442;

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 9,12

ST   D5S818: 10,12

ST   D7S820: 9,14

ST   TH01: 7,9.3

ST   TPOX: 11,12

ST   vWA: 17,18

DI   NCIt; C3798; Malignant peripheral nerve sheath tumor

DI   NCIt; C3273; Neurofibromatosis type 1

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   sNF96.2

AC   CVCL_K281

SY   SNF96.2; sNF96-2

DR   ATCC; CRL-2884

DR   BioSample; SAMN03471810

DR   Cosmic; 1644553

RX   PubMed=14762442;

RX   PubMed=22346343;

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10

ST   D16S539: 11

ST   D5S818: 11

ST   D7S820: 10,11

ST   TH01: 6

ST   TPOX: 11

ST   vWA: 17,19

DI   NCIt; C3798; Malignant peripheral nerve sheath tumor

DI   NCIt; C3273; Neurofibromatosis type 1

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNG-II

AC   CVCL_3170

SY   SNGII

DR   BioSample; SAMN03472781

DR   Cosmic; 1241343

DR   Cosmic; 2030482

DR   IFO; IFO50312

DR   JCRB; JCRB0175

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Discontinued: JCRB; JCRB0175; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 11,14

ST   D13S317: 9,12

ST   D16S539: 12,13

ST   D5S818: 6,12

ST   D7S820: 9,13

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 15,16,17

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNG-M

AC   CVCL_1707

SY   SNGM

DR   BioSample; SAMN03470892

DR   BioSample; SAMN03472782

DR   CCLE; SNGM_ENDOMETRIUM

DR   ChEMBL-Cells; CHEMBL3308466

DR   ChEMBL-Targets; CHEMBL1075582

DR   Cosmic; 909735

DR   Cosmic; 1152552

DR   Cosmic; 1241347

DR   Cosmic; 2030483

DR   Cosmic-CLP; 909735

DR   GDSC; 909735

DR   GEO; GSM827242

DR   GEO; GSM887601

DR   GEO; GSM888684

DR   GEO; GSM1670461

DR   IFO; IFO50313

DR   JCRB; JCRB0179

RX   PubMed=858140;

RX   PubMed=22460905;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Instable (MSI-high) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Obturator lymph node.

ST   Source(s): Cosmic-CLP; JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,11 (Cosmic-CLP; PubMed=25877200)

ST   D13S317: 8,10,11 (JCRB)

ST   D16S539: 10,12 (Cosmic-CLP)

ST   D16S539: 10,11,12 (JCRB; PubMed=25877200)

ST   D18S51: 12,18,19

ST   D19S433: 13.2,14,15

ST   D21S11: 29,30

ST   D2S1338: 19,24,25

ST   D3S1358: 13,14,15

ST   D5S818: 9,13

ST   D7S820: 10,12,13 (Cosmic-CLP)

ST   D7S820: 10,11 (JCRB)

ST   D7S820: 10,11,12 (PubMed=25877200)

ST   D8S1179: 11,13

ST   FGA: 22

ST   Penta D: 8,11

ST   Penta E: 11,14

ST   TH01: 6,7

ST   TPOX: 8,9

ST   vWA: 17,20 (Cosmic-CLP; PubMed=25877200)

ST   vWA: 17,18,20 (JCRB)

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_S914 ! SNG-P

SX   Female

CA   Cancer cell line

//

ID   SNG-P

AC   CVCL_S914

RX   PubMed=858140;

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1707 ! SNG-M

SX   Female

CA   Cancer cell line

//

ID   SNK-1

AC   CVCL_A671

SY   SNK1

DR   Cosmic; 1542073

DR   GEO; GSM472003

RX   PubMed=11881730;

RX   PubMed=12780797;

RX   PubMed=19194464;

RX   PubMed=21052088;

CC   Characteristics: IL2 dependent.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

DI   NCIt; C4684; Nasal type extranodal NK/T-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNK-10

AC   CVCL_A672

SY   SNK10

DR   Cosmic; 1534878

DR   Cosmic; 2025328

DR   GEO; GSM472004

DR   GEO; GSM472005

RX   PubMed=12780797;

RX   PubMed=21052088;

RX   PubMed=22102884;

CC   Characteristics: IL2 dependent.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

DI   NCIt; C126348; Chronic active Epstein-Barr virus

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SNK-57

AC   CVCL_3923

SY   SNK57

DR   BTO; BTO:0003480

DR   TKG; TKG 0701

RX   PubMed=9183630;

CC   Problematic cell line: Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).

ST   Source(s): TKG

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 11,12

ST   D16S539: 9,12

ST   D5S818: 12

ST   D7S820: 10,11

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNK-6

AC   CVCL_A673

SY   SNK6

DR   Cosmic; 1534873

DR   Cosmic; 1542074

DR   Cosmic; 2025327

DR   Cosmic; 2390118

DR   GEO; GSM472006

RX   PubMed=11157488;

RX   PubMed=12780797;

RX   PubMed=19194464;

RX   PubMed=21052088;

RX   PubMed=22102884;

RX   PubMed=25586472;

CC   Characteristics: IL2 dependent.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

DI   NCIt; C4684; Nasal type extranodal NK/T-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNL 76/7

AC   CVCL_K227

SY   SNL76/7

DR   ATCC; SCRC-1049

DR   ECACC; 07032801

CC   Selected for resistance to: ChEBI; CHEBI:472805; Ouabain.

CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

CC   Breed/subspecies: SIM.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3420 ! STO

SX   Female

CA   Transformed cell line

//

ID   SNLP 76/7-4

AC   CVCL_K228

DR   ATCC; SCRC-1050

CC   Selected for resistance to: ChEBI; CHEBI:472805; Ouabain.

CC   Selected for resistance to: ChEBI; CHEBI:17939; Puromycin.

CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

CC   Breed/subspecies: SIM.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_K227 ! SNL 76/7

SX   Female

CA   Transformed cell line

//

ID   SNO

AC   CVCL_M848

SY   SN

RX   PubMed=174997;

RX   PubMed=3167823;

DI   NCIt; C3513; Esophageal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNP

AC   CVCL_IP76

RX   PubMed=26726024;

CC   Doubling time: 26.2 hours (PubMed=26726024).

DI   NCIt; C124249; Canine mammary carcinoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   SNT-13

AC   CVCL_A674

SY   SNT13

DR   Cosmic; 2390217

DR   GEO; GSM349852

DR   GEO; GSM349853

DR   GEO; GSM472007

RX   PubMed=12780797;

RX   PubMed=20132662;

RX   PubMed=21052088;

RX   PubMed=25586472;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

DI   NCIt; C126348; Chronic active Epstein-Barr virus

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SNT-15

AC   CVCL_A675

SY   SNT15

DR   Cosmic; 2390122

DR   GEO; GSM349854

DR   GEO; GSM349855

DR   GEO; GSM472008

RX   PubMed=12780797;

RX   PubMed=20132662;

RX   PubMed=21052088;

RX   PubMed=22102884;

RX   PubMed=25586472;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

DI   NCIt; C126348; Chronic active Epstein-Barr virus

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SNT-16

AC   CVCL_A676

SY   SNT16

RX   PubMed=12780797;

RX   PubMed=22102884;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C126348; Chronic active Epstein-Barr virus

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SNT-8

AC   CVCL_A677

SY   SNT8

DR   Cosmic; 2390121

DR   GEO; GSM349850

DR   GEO; GSM349851

DR   GEO; GSM472009

RX   PubMed=11157488;

RX   PubMed=12780797;

RX   PubMed=20132662;

RX   PubMed=21052088;

RX   PubMed=22102884;

RX   PubMed=25586472;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

DI   NCIt; C4684; Nasal type extranodal NK/T-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-1

AC   CVCL_0099

SY   SNU1; NCI-SNU-1

DR   BTO; BTO:0005786

DR   CLO; CLO_0009094

DR   EFO; EFO_0002343

DR   ATCC; CRL-5971

DR   BCRC; 60210

DR   BioSample; SAMN03472628

DR   CCLE; SNU1_STOMACH

DR   ChEMBL-Cells; CHEMBL3307455

DR   ChEMBL-Targets; CHEMBL614931

DR   Cosmic; 685584

DR   Cosmic; 724854

DR   Cosmic; 737362

DR   Cosmic; 848136

DR   Cosmic; 887260

DR   Cosmic; 908444

DR   Cosmic; 921595

DR   Cosmic; 1090450

DR   Cosmic; 1154647

DR   Cosmic; 1187294

DR   Cosmic; 1294954

DR   Cosmic; 1528871

DR   Cosmic; 1995595

DR   Cosmic; 2069772

DR   Cosmic; 2484960

DR   Cosmic-CLP; 908444

DR   GDSC; 908444

DR   GEO; GSM267421

DR   GEO; GSM267428

DR   GEO; GSM267435

DR   GEO; GSM267442

DR   GEO; GSM562406

DR   GEO; GSM827406

DR   GEO; GSM844701

DR   GEO; GSM887614

DR   GEO; GSM888698

DR   GEO; GSM1237679

DR   GEO; GSM1237704

DR   GEO; GSM1374885

DR   GEO; GSM1670273

DR   GEO; GSM1670462

DR   IGRhCellID; SNU1

DR   KCLB; 00001

RX   PubMed=2158397;

RX   PubMed=8806092;

RX   PubMed=8806095;

RX   PubMed=10674020;

RX   PubMed=18804159;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=24807215;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Microsatellite instability: Instable (MSI-high) (PubMed=10674020; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13 (ATCC; Cosmic-CLP)

ST   CSF1PO: 12,14 (KCLB)

ST   D13S317: 11,14 (ATCC; Cosmic-CLP)

ST   D13S317: 12,14 (KCLB)

ST   D16S539: 9,12

ST   D3S1358: 16,17

ST   D5S818: 12,13 (ATCC; Cosmic-CLP)

ST   D5S818: 13 (KCLB)

ST   D7S820: 9,12

ST   FGA: 22

ST   TH01: 8,9.3

ST   TPOX: 8,10

ST   vWA: 14

DI   NCIt; C4911; Gastric carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-1-DOX

AC   CVCL_L042

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

DI   NCIt; C4911; Gastric carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0099 ! SNU-1

SX   Male

CA   Cancer cell line

//

ID   SNU-1000

AC   CVCL_5000

SY   SNU1000

DR   KCLB; 01000

RX   PubMed=9219839;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 96 hours (PubMed=9219839).

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 9,12

ST   D13S317: 8

ST   D3S1358: 15

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   FGA: 22.2

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 18

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-1005

AC   CVCL_5001

SY   SNU1005

DR   KCLB; 01005

RX   PubMed=9219839;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 48 hours (PubMed=9219839).

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 9

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 8

ST   FGA: 24

ST   TH01: 9,10

ST   TPOX: 11

ST   vWA: 17

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-1033

AC   CVCL_5002

SY   SNU1033

DR   CCLE; SNU1033_LARGE_INTESTINE

DR   Cosmic; 738855

DR   GEO; GSM1448078

DR   KCLB; 01033

RX   PubMed=10362137;

RX   PubMed=10674020;

RX   PubMed=19956504;

RX   PubMed=25926053;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 42 hours (PubMed=10362137).

CC   Microsatellite instability: Stable (MSS) (PubMed=10674020; PubMed=25926053).

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 10

ST   D3S1358: 14,17

ST   D5S818: 13

ST   D7S820: 12

ST   FGA: 23

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 17,19

DI   NCIt; C9383; Rectal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-1040

AC   CVCL_5003

SY   SNU1040; NCI-SNU-1040

DR   CCLE; SNU1040_LARGE_INTESTINE

DR   Cosmic; 738857

DR   Cosmic; 848830

DR   Cosmic-CLP; 1659823

DR   GDSC; 1659823

DR   GEO; GSM887602

DR   GEO; GSM888685

DR   GEO; GSM1448189

DR   GEO; GSM1670463

DR   KCLB; 01040

RX   PubMed=10362137;

RX   PubMed=10674020;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=25926053;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 63 hours (PubMed=10362137).

CC   Microsatellite instability: Instable (MSI) (PubMed=10674020; PubMed=25926053)) / Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12 (Cosmic-CLP)

ST   CSF1PO: 12 (KCLB)

ST   D13S317: 12

ST   D16S539: 9,10

ST   D3S1358: 16,18

ST   D5S818: 10,13

ST   D7S820: 11,13

ST   FGA: 23

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 17,18,19 (Cosmic-CLP)

ST   vWA: 17,19 (KCLB)

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-1041

AC   CVCL_L085

SY   SNU 1041; SNU1041

DR   CCLE; SNU1041_UPPER_AERODIGESTIVE_TRACT

DR   KCLB; 01041

RX   CelloPub=CLPUB00001;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 8,11

ST   D3S1358: 15

ST   D5S818: 9

ST   D7S820: 8,12

ST   FGA: 24,25

ST   TH01: 7,9

ST   TPOX: 9,11

ST   vWA: 14,18

DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-1047

AC   CVCL_5004

SY   SNU1047

DR   Cosmic; 738858

DR   Cosmic; 848831

DR   Cosmic; 875423

DR   GEO; GSM1448085

DR   KCLB; 01047

RX   PubMed=10362137;

RX   PubMed=10674020;

RX   PubMed=19956504;

RX   PubMed=25926053;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 36 hours (PubMed=10362137).

CC   Microsatellite instability: Instable (MSI) (PubMed=10674020; PubMed=25926053).

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   CSF1PO: 9,11

ST   D13S317: 10,11

ST   D3S1358: 15,16

ST   D5S818: 8,12

ST   D7S820: 8,10

ST   FGA: 18,21

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 14,21

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-1066

AC   CVCL_5005

SY   SNU1066

DR   BTO; BTO:0005924

DR   CCLE; SNU1066_UPPER_AERODIGESTIVE_TRACT

DR   Cosmic; 934176

DR   KCLB; 01066

RX   PubMed=10369293;

RX   PubMed=19956504;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 48 hours (PubMed=10369293).

ST   Source(s): KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 8,12

ST   D3S1358: 17

ST   D5S818: 9,11

ST   D7S820: 12

ST   FGA: 23

ST   TH01: 7,9

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-1076

AC   CVCL_5006

SY   SNU1076; NCI-SNU-1076

DR   BTO; BTO:0005922

DR   CCLE; SNU1076_UPPER_AERODIGESTIVE_TRACT

DR   Cosmic; 934177

DR   GEO; GSM887603

DR   GEO; GSM888686

DR   KCLB; 01076

RX   PubMed=10369293;

RX   PubMed=19956504;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 36 hours (PubMed=10369293).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8,10

ST   D3S1358: 15

ST   D5S818: 9,12

ST   D7S820: 11,12

ST   FGA: 24,25

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 15,16

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-1077

AC   CVCL_5007

SY   SNU1077

DR   CCLE; SNU1077_ENDOMETRIUM

DR   GEO; GSM887604

DR   GEO; GSM888687

DR   KCLB; 01077

RX   PubMed=9299262;

RX   PubMed=19956504;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 43 hours (PubMed=9299262).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   D13S317: 12

ST   D3S1358: 15,16

ST   D5S818: 11,13

ST   D7S820: 8

ST   FGA: 24,25

ST   TH01: 7,9

ST   TPOX: 8

ST   vWA: 14,18

DI   NCIt; C42700; Uterine carcinosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-1079

AC   CVCL_5008

SY   SNU1079; SNU 1079; NCI-SNU-1079

DR   CCLE; SNU1079_BILIARY_TRACT

DR   Cosmic; 738874

DR   GEO; GSM887605

DR   GEO; GSM888688

DR   KCLB; 01079

RX   CelloPub=CLPUB00275;

RX   PubMed=12107841;

RX   PubMed=19956504;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 72 hours (PubMed=12107841).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 8

ST   D3S1358: 15

ST   D5S818: 10,13

ST   D7S820: 8,12

ST   FGA: 22

ST   TH01: 8

ST   TPOX: 8

ST   vWA: 16,18

DI   NCIt; C35417; Intrahepatic cholangiocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-1103

AC   CVCL_5009

SY   SNU1103

RX   PubMed=9542645;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SNU-1105

AC   CVCL_5010

SY   SNU1105; NCI-SNU-1105

DR   CCLE; SNU1105_CENTRAL_NERVOUS_SYSTEM

DR   Cosmic; 2516037

DR   GEO; GSM887606

DR   GEO; GSM888689

DR   KCLB; 01105

RX   PubMed=11776963;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=25984343;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 84 hours (PubMed=11776963); 73 hours (PubMed=25984343).

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 8,11

ST   D3S1358: 15,16

ST   D5S818: 11

ST   D7S820: 8,11

ST   FGA: 24,25

ST   TH01: 7,8

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-1118

AC   CVCL_5011

SY   SNU1118

DR   KCLB; 01118

RX   PubMed=11776963;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 78 hours (PubMed=11776963).

ST   Source(s): KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8

ST   D3S1358: 14,15

ST   D5S818: 9,12

ST   D7S820: 8

ST   FGA: 23,25

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 14,18

DI   NCIt; C3716; Primitive neuroectodermal tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-1160

AC   CVCL_5012

SY   SNU1160

DR   KCLB; 01160

RX   PubMed=9219839;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 54 hours (PubMed=9219839).

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-1181

AC   CVCL_5013

SY   SNU1181

DR   Cosmic; 1322287

DR   GEO; GSM1448219

DR   KCLB; 01181

RX   PubMed=20176655;

RX   PubMed=25926053;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 52 hours (PubMed=20176655).

CC   Microsatellite instability: Stable (MSS) (PubMed=20176655; PubMed=25926053).

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Liver.

ST   Source(s): KCLB; PubMed=20176655

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10,11

ST   D16S539: 10,12

ST   D18S51: 17

ST   D19S433: 14,15

ST   D21S11: 29,32.2

ST   D2S1338: 25

ST   D3S1358: 16

ST   D5S818: 10

ST   D7S820: 10,11

ST   D8S1179: 10,12

ST   FGA: 18,23

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 14,18

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-119

AC   CVCL_5014

SY   SNU119; NCI-SNU-119

DR   CCLE; SNU119_OVARY

DR   GEO; GSM887608

DR   GEO; GSM888691

DR   KCLB; 00119

RX   PubMed=9299249;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=23839242;

RX   PubMed=27561551;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 53 hours (PubMed=9299249).

CC   Omics: Deep proteome analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 10,11

ST   FGA: 25

ST   TH01: 7

ST   TPOX: 9,11

ST   vWA: 16,17

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-1196

AC   CVCL_5015

SY   SNU1196

DR   CCLE; SNU1196_BILIARY_TRACT

DR   Cosmic; 738876

DR   GEO; GSM887607

DR   GEO; GSM888690

DR   KCLB; 01196

RX   CelloPub=CLPUB00275;

RX   PubMed=12107841;

RX   PubMed=19956504;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 48 hours (PubMed=12107841).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 9

ST   D3S1358: 14,15

ST   D5S818: 11

ST   D7S820: 8,11

ST   FGA: 24,25

ST   TH01: 5,7

ST   TPOX: 10,11

ST   vWA: 14,16

DI   NCIt; C36077; Hilar cholangiocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SNU-1197

AC   CVCL_5016

SY   SNU1197

DR   CCLE; SNU1197_LARGE_INTESTINE

DR   Cosmic; 738859

DR   KCLB; 01197

RX   PubMed=10362137;

RX   PubMed=10674020;

RX   PubMed=19956504;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 60 hours (PubMed=10362137).

CC   Microsatellite instability: Stable (MSS) (PubMed=10674020).

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 9,11

ST   D3S1358: 18

ST   D5S818: 10,12

ST   D7S820: 11,12

ST   FGA: 23

ST   TH01: 8,9

ST   TPOX: 7,8

ST   vWA: 17

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-1214

AC   CVCL_5017

SY   SNU1214; NCI-SNU-1214

DR   BTO; BTO:0005923

DR   CCLE; SNU1214_UPPER_AERODIGESTIVE_TRACT

DR   Cosmic; 934178

DR   GEO; GSM887609

DR   GEO; GSM888692

DR   KCLB; 01214

RX   PubMed=10369293;

RX   PubMed=19956504;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 96 hours (PubMed=10369293).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 9

ST   D3S1358: 16

ST   D5S818: 9,10

ST   D7S820: 8,9

ST   FGA: 19

ST   TH01: 7,9

ST   TPOX: 11

ST   vWA: 16,19

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-1235

AC   CVCL_5018

SY   SNU1235

DR   Cosmic; 1322288

DR   GEO; GSM1448190

DR   KCLB; 01235

RX   PubMed=20176655;

RX   PubMed=25926053;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 45 hours (PubMed=20176655).

CC   Microsatellite instability: Stable (MSS) (PubMed=20176655; PubMed=25926053).

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB; PubMed=20176655

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 13

ST   D16S539: 9,12

ST   D18S51: 13

ST   D19S433: 14.2,15.2

ST   D21S11: 30

ST   D2S1338: 19

ST   D3S1358: 15,16

ST   D5S818: 12

ST   D7S820: 8,12

ST   D8S1179: 12,16

ST   FGA: 23

ST   TH01: 9

ST   TPOX: 8,9

ST   vWA: 17

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-1245

AC   CVCL_5019

SY   SNU1245

DR   KCLB; 01245

RX   PubMed=9219839;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 54 hours (PubMed=9219839).

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8,11

ST   D3S1358: 15

ST   D5S818: 11,12

ST   D7S820: 9,11

ST   FGA: 22

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 14,18

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-1272

AC   CVCL_8788

AS   CVCL_5020

SY   SNU1272; NCI-SNU-1272

DR   CCLE; SNU1272_KIDNEY

DR   GEO; GSM887610

DR   GEO; GSM888693

DR   KCLB; 01272

RX   PubMed=10619961;

RX   PubMed=14634222;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=27993170;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 153 hours (PubMed=10619961).

CC   Microsatellite instability: Stable (MSS) (PubMed=10619961).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'SNU-1271' in PubMed=19956504.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,10

ST   D3S1358: 16

ST   D5S818: 10,12

ST   D7S820: 11,12

ST   FGA: 21

ST   TH01: 6,7

ST   TPOX: 9,11

ST   vWA: 15,18

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-1299

AC   CVCL_5021

SY   SNU1299

DR   KCLB; 01299

RX   PubMed=9219839;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 48 hours (PubMed=9219839).

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11

ST   D3S1358: 15,16

ST   D5S818: 7,11

ST   D7S820: 11

ST   FGA: 22

ST   TH01: 7,9.3

ST   TPOX: 8,9

ST   vWA: 14,18

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-1327

AC   CVCL_5022

SY   SNU1327

DR   Cosmic; 1484499

DR   KCLB; 01327

RX   PubMed=21290211;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 42 hours (PubMed=21290211).

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 9

ST   D3S1358: 16

ST   D5S818: 11

ST   D7S820: 8,13

ST   FGA: 18

ST   TH01: 9

ST   TPOX: 10,11

ST   vWA: 18,19

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-1330

AC   CVCL_5023

SY   SNU1330

DR   Cosmic; 1484500

DR   KCLB; 01330

RX   PubMed=21290211;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 39 hours (PubMed=21290211).

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 8

ST   FGA: 22

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 14

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-1406

AC   CVCL_5024

SY   SNU1406

DR   Cosmic; 1322289

DR   GEO; GSM1448191

DR   KCLB; 01406

RX   PubMed=20176655;

RX   PubMed=25926053;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 25 hours (PubMed=20176655).

CC   Microsatellite instability: Stable (MSS) (PubMed=20176655; PubMed=25926053).

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB; PubMed=20176655

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,9

ST   D16S539: 11,12

ST   D18S51: 13,20

ST   D19S433: 14.2,16.2

ST   D21S11: 30,33.2

ST   D2S1338: 17,23

ST   D3S1358: 15

ST   D5S818: 11,12

ST   D7S820: 8,11

ST   D8S1179: 14,16

ST   FGA: 21,22

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 15,18

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-1411

AC   CVCL_5025

SY   SNU1411

DR   Cosmic; 1322290

DR   GEO; GSM1448157

DR   KCLB; 01411

RX   PubMed=20176655;

RX   PubMed=25926053;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 38 hours (PubMed=20176655).

CC   Microsatellite instability: Stable (MSS) (PubMed=20176655; PubMed=25926053).

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB; PubMed=20176655

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 10,11

ST   D16S539: 12,13

ST   D18S51: 14

ST   D19S433: 14

ST   D21S11: 30

ST   D2S1338: 19,24

ST   D3S1358: 15

ST   D5S818: 11,13

ST   D7S820: 11

ST   D8S1179: 15

ST   FGA: 23,24

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 20

DI   NCIt; C9383; Rectal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-1460

AC   CVCL_5026

SY   SNU1460

DR   Cosmic; 1322291

DR   GEO; GSM1448158

DR   KCLB; 01460

RX   PubMed=20176655;

RX   PubMed=25926053;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 67 hours (PubMed=20176655).

CC   Microsatellite instability: Stable (MSS) (PubMed=20176655; PubMed=25926053).

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB; PubMed=20176655

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 9,12

ST   D16S539: 10

ST   D18S51: 13

ST   D19S433: 13,14.2

ST   D21S11: 30.2,31

ST   D2S1338: 23,24

ST   D3S1358: 15,17

ST   D5S818: 11

ST   D7S820: 8,11

ST   D8S1179: 13

ST   FGA: 21,23

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 14,18

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-1528

AC   CVCL_T037

DR   Cosmic; 2068084

DR   KCLB; 01528

RX   PubMed=24141649;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 110 hours (PubMed=24141649).

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 9,10

ST   D13S317: 9

ST   D3S1358: 16

ST   D5S818: 11,12

ST   D7S820: 11

ST   FGA: 24

ST   TH01: 9.3

ST   TPOX: 11

ST   vWA: 17

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-1544

AC   CVCL_5027

SY   SNU1544

DR   Cosmic; 1322292

DR   GEO; GSM1448192

DR   KCLB; 01544

RX   PubMed=20176655;

RX   PubMed=25926053;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 42 hours (PubMed=20176655).

CC   Microsatellite instability: Instable (MSI-high) (PubMed=20176655; PubMed=25926053).

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB; PubMed=20176655

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 9,11

ST   D16S539: 8,14

ST   D18S51: 12,17

ST   D19S433: 14.2,16.2

ST   D21S11: 29,30

ST   D2S1338: 19

ST   D3S1358: 15,16

ST   D5S818: 12

ST   D7S820: 11,12

ST   D8S1179: 10

ST   FGA: 20,24

ST   TH01: 7,9

ST   TPOX: 8

ST   vWA: 14,20

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-1553

AC   CVCL_T038

DR   Cosmic; 2068085

DR   KCLB; 01553

RX   PubMed=24141649;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 89 hours (PubMed=24141649).

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11

ST   D3S1358: 17

ST   D5S818: 10

ST   D7S820: 12

ST   FGA: 22,23

ST   TH01: 7,9

ST   TPOX: 11,12

ST   vWA: 16,17

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-1581

AC   CVCL_T039

DR   Cosmic; 2068086

DR   KCLB; 01581

RX   PubMed=24141649;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 47 hours (PubMed=24141649).

CC   Derived from metastatic site: Pericardial effusion.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8

ST   D3S1358: 16

ST   D5S818: 12,13

ST   D7S820: 8,10

ST   FGA: 19,24

ST   TH01: 6,8

ST   TPOX: 8,9

ST   vWA: 17

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-16

AC   CVCL_0076

SY   SNU16; NCI-SNU-16

DR   BTO; BTO:0004987

DR   CLO; CLO_0009095

DR   EFO; EFO_0002344

DR   ATCC; CRL-5974

DR   BCRC; 60212

DR   BioSample; SAMN03473127

DR   CCLE; SNU16_STOMACH

DR   ChEMBL-Cells; CHEMBL3307273

DR   ChEMBL-Targets; CHEMBL613529

DR   Cosmic; 685588

DR   Cosmic; 687558

DR   Cosmic; 737365

DR   Cosmic; 848138

DR   Cosmic; 887247

DR   Cosmic; 908446

DR   Cosmic; 921597

DR   Cosmic; 1067204

DR   Cosmic; 1090452

DR   Cosmic; 1154649

DR   Cosmic; 1187295

DR   Cosmic; 1294962

DR   Cosmic; 1528873

DR   Cosmic; 1995596

DR   Cosmic; 2069774

DR   Cosmic; 2443799

DR   Cosmic; 2484966

DR   Cosmic-CLP; 908446

DR   GDSC; 908446

DR   GEO; GSM267423

DR   GEO; GSM267430

DR   GEO; GSM267437

DR   GEO; GSM267444

DR   GEO; GSM562407

DR   GEO; GSM827556

DR   GEO; GSM828829

DR   GEO; GSM844702

DR   GEO; GSM887611

DR   GEO; GSM888695

DR   GEO; GSM1237680

DR   GEO; GSM1237705

DR   GEO; GSM1374886

DR   GEO; GSM1670274

DR   IGRhCellID; SNU16

DR   KCLB; 00016

RX   PubMed=2158397;

RX   PubMed=8806092;

RX   PubMed=8806095;

RX   PubMed=10674020;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=24807215;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: FGFR genetic alteration cell panel (ATCC TCP-1034).

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: MYC genetic alteration cell panel (ATCC TCP-1035).

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Microsatellite instability: Stable (MSS) (PubMed=10674020; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

ST   Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,12

ST   D16S539: 11,13

ST   D18S51: 14,16

ST   D21S11: 29,33.2

ST   D3S1358: 15,16

ST   D5S818: 10,13

ST   D7S820: 12

ST   D8S1179: 14

ST   FGA: 23

ST   Penta D: 9,12

ST   Penta E: 11,17

ST   TH01: 6,9

ST   TPOX: 11

ST   vWA: 16

DI   NCIt; C4911; Gastric carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-16-DOX

AC   CVCL_L043

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

DI   NCIt; C4911; Gastric carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0076 ! SNU-16

SX   Female

CA   Cancer cell line

//

ID   SNU-1684

AC   CVCL_5028

SY   SNU1684

DR   Cosmic; 1322293

DR   GEO; GSM1448205

DR   KCLB; 01684

RX   PubMed=20176655;

RX   PubMed=25926053;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 53 hours (PubMed=20176655).

CC   Microsatellite instability: Instable (MSI-high) (PubMed=20176655; PubMed=25926053).

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB; PubMed=20176655

ST   Amelogenin: X

ST   CSF1PO: 9,10

ST   D13S317: 8

ST   D16S539: 9,10

ST   D18S51: 12

ST   D19S433: 14,15.2

ST   D21S11: 28

ST   D2S1338: 18,23

ST   D3S1358: 17

ST   D5S818: 10,11

ST   D7S820: 9,13

ST   D8S1179: 11,15

ST   FGA: 20,21

ST   TH01: 9

ST   TPOX: 8,10

ST   vWA: 14,17

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-17

AC   CVCL_5029

SY   SNU17

DR   KCLB; 00017

RX   PubMed=9219839;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 48 hours (PubMed=9219839).

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11

ST   D3S1358: 15

ST   D5S818: 10,12

ST   D7S820: 9

ST   FGA: 23

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 14,18

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-1746

AC   CVCL_5030

SY   SNU1746

DR   Cosmic; 1322294

DR   GEO; GSM1448206

DR   KCLB; 01746

RX   PubMed=20176655;

RX   PubMed=25926053;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 42 hours (PubMed=20176655).

CC   Microsatellite instability: Instable (MSI-high) (PubMed=20176655; PubMed=25926053).

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): KCLB; PubMed=20176655

ST   Amelogenin: X,Y

ST   CSF1PO: 7,9

ST   D13S317: 9

ST   D16S539: 9,14

ST   D18S51: 13,18

ST   D19S433: 13,17.2

ST   D21S11: 28,33

ST   D2S1338: 18,24

ST   D3S1358: 14,17

ST   D5S818: 11,12,13 (KCLB)

ST   D5S818: 12,13 (PubMed=20176655)

ST   D7S820: 8,11

ST   D8S1179: 11

ST   FGA: 17,22

ST   TH01: 6

ST   TPOX: 8,9

ST   vWA: 15,18

DI   NCIt; C7967; Colon signet ring cell adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-175

AC   CVCL_5031

SY   SNU175; NCI-SNU-175

DR   CCLE; SNU175_LARGE_INTESTINE

DR   Cosmic; 738861

DR   Cosmic; 848826

DR   Cosmic; 2302007

DR   Cosmic-CLP; 1659928

DR   GDSC; 1659928

DR   GEO; GSM887612

DR   GEO; GSM888696

DR   GEO; GSM1346853

DR   GEO; GSM1448216

DR   GEO; GSM1670464

DR   KCLB; 00175

RX   PubMed=10362137;

RX   PubMed=10674020;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=24755471;

RX   PubMed=25926053;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 33 hours (PubMed=10362137).

CC   Microsatellite instability: Instable (MSI-high) (PubMed=10674020; PubMed=25926053; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Peritoneum.

ST   Source(s): Cosmic-CLP; KCLB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 9,12

ST   D16S539: 9,12

ST   D3S1358: 16,18

ST   D5S818: 11

ST   D7S820: 11

ST   FGA: 19,21

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 14,17

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-1750

AC   CVCL_8914

DR   Cosmic; 1661032

DR   KCLB; 01750

RX   PubMed=22361929;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 74 hours (PubMed=22361929).

ST   Source(s): KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 11

ST   D3S1358: 15,17

ST   D5S818: 12

ST   D7S820: 11

ST   FGA: 24

ST   TH01: 6

ST   TPOX: 9

ST   vWA: 14,18

DI   NCIt; C5473; Gastric tubular adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-182

AC   CVCL_0090

SY   SNU182; NCI-SNU-182

DR   BTO; BTO:0003760

DR   CLO; CLO_0009096

DR   EFO; EFO_0002345

DR   ATCC; CRL-2235

DR   BioSample; SAMN03473221

DR   CCLE; SNU182_LIVER

DR   Cosmic; 684198

DR   Cosmic; 873399

DR   Cosmic; 928141

DR   Cosmic; 1995638

DR   Cosmic; 2162540

DR   Cosmic; 2321040

DR   Cosmic-CLP; 1240216

DR   GDSC; 1240216

DR   GEO; GSM481446

DR   GEO; GSM565919

DR   GEO; GSM887613

DR   GEO; GSM888697

DR   GEO; GSM936778

DR   GEO; GSM1670465

DR   IGRhCellID; SNU182

DR   KCLB; 00182

RX   PubMed=7543080;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=23505090;

RX   PubMed=23887712;

RX   PubMed=25485619;

RX   PubMed=25574106;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11,14 (ATCC; Cosmic-CLP; PubMed=25877200)

ST   D13S317: 14 (KCLB)

ST   D16S539: 11,13

ST   D18S51: 16

ST   D21S11: 29,34.2

ST   D3S1358: 17 (KCLB)

ST   D3S1358: 16,18 (PubMed=25877200)

ST   D5S818: 11,12

ST   D7S820: 11

ST   D8S1179: 10

ST   FGA: 22,24

ST   Penta D: 9

ST   Penta E: 20

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 17 (ATCC; Cosmic-CLP; PubMed=25877200)

ST   vWA: 17,18 (KCLB)

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-1958

AC   CVCL_T040

DR   Cosmic; 2068087

DR   KCLB; 01958

RX   PubMed=24141649;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 53 hours (PubMed=24141649).

CC   Misspelling: 'SNU-1598' in Cosmic 2068087.

CC   Derived from metastatic site: Ascites.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 10,13

ST   D13S317: 9,10

ST   D3S1358: 15

ST   D5S818: 9,11

ST   D7S820: 8,11

ST   FGA: 19,21

ST   TPOX: 8

ST   vWA: 16,17

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-1967

AC   CVCL_8915

DR   KCLB; 01967

DR   Cosmic; 1661033

RX   PubMed=22361929;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 49 hours (PubMed=22361929).

CC   Derived from metastatic site: Ascites.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D3S1358: 17

ST   D5S818: 13

ST   D7S820: 12,13

ST   FGA: 22

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 14,16

DI   NCIt; C5473; Gastric tubular adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-20

AC   CVCL_5032

SY   SNU20

RX   PubMed=9542645;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SNU-201

AC   CVCL_5033

SY   SNU201; NCI-SNU-201

DR   CCLE; SNU201_CENTRAL_NERVOUS_SYSTEM

DR   Cosmic; 2516038

DR   GEO; GSM887615

DR   GEO; GSM888699

DR   KCLB; 00201

RX   PubMed=11776963;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=25984343;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 61 hours (PubMed=11776963); 58 hours (PubMed=25984343).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 11

ST   D3S1358: 15,16

ST   D5S818: 9,10

ST   D7S820: 8,11

ST   FGA: 18,25

ST   TH01: 6,8

ST   TPOX: 9

ST   vWA: 16,18

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-213

AC   CVCL_5034

SY   SNU213; NCI-SNU-213

DR   CCLE; SNU213_PANCREAS

DR   Cosmic; 707181

DR   GEO; GSM887616

DR   GEO; GSM888700

DR   KCLB; 00213

RX   PubMed=12037578;

RX   PubMed=19956504;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 9,11

ST   D13S317: 11

ST   D3S1358: 15,16

ST   D5S818: 11,12

ST   D7S820: 9

ST   FGA: 23

ST   TH01: 6,9

ST   TPOX: 8,9

ST   vWA: 14,17

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-216

AC   CVCL_3946

SY   SNU216; NCI-SNU-216

DR   BTO; BTO:0004988

DR   EFO; EFO_0006754

DR   BioSample; SAMN03473182

DR   CCLE; SNU216_STOMACH

DR   CGH-DB; 124-1

DR   CGH-DB; 9012-4

DR   Cosmic; 685589

DR   Cosmic; 848139

DR   Cosmic; 1067205

DR   Cosmic; 1090453

DR   Cosmic; 1151969

DR   Cosmic; 1528874

DR   Cosmic; 2484970

DR   GEO; GSM887617

DR   GEO; GSM888701

DR   GEO; GSM1374887

DR   KCLB; 00216

RX   PubMed=9033653;

RX   PubMed=15723654;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=24807215;

RX   PubMed=25485619;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Characteristics: Homozygous for the TP53 p.Val216Met mutation.

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): KCLB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 9

ST   D16S539: 10,13

ST   D18S51: 16

ST   D21S11: 30,33.2

ST   D3S1358: 17

ST   D5S818: 11

ST   D7S820: 8,10

ST   D8S1179: 13,16

ST   FGA: 21

ST   Penta D: 9,13

ST   Penta E: 5

ST   TH01: 7

ST   TPOX: 9

ST   vWA: 14,20

DI   NCIt; C5473; Gastric tubular adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-228

AC   CVCL_5035

SY   SNU228

DR   KCLB; 00228

RX   PubMed=10619961;

RX   PubMed=19956504;

RX   PubMed=27993170;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 24 hours (PubMed=10619961).

CC   Microsatellite instability: Stable (MSS) (PubMed=10619961).

ST   Source(s): KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11,13

ST   D3S1358: 16

ST   D5S818: 10,12

ST   D7S820: 10,12

ST   FGA: 23

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 14

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-2292

AC   CVCL_5036

SY   SNU2292

DR   Cosmic; 1484501

DR   KCLB; 02292

RX   PubMed=21290211;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 72 hours (PubMed=21290211).

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 11

ST   D3S1358: 16

ST   D5S818: 11

ST   D7S820: 11

ST   FGA: 23,24

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-2315

AC   CVCL_5037

SY   SNU2315

DR   Cosmic; 1484502

DR   KCLB; 02315

RX   PubMed=21290211;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 141 hours (PubMed=21290211).

CC   Derived from metastatic site: Lymph node.

ST   Source(s): KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 9

ST   D3S1358: 17

ST   D5S818: 10,13

ST   D7S820: 10,11

ST   FGA: 23,25

ST   TPOX: 11

ST   vWA: 17

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-2372

AC   CVCL_T041

DR   Cosmic; 2068088

DR   KCLB; 02372

RX   PubMed=24141649;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 78 hours (PubMed=24141649).

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 9,11

ST   D3S1358: 15.2,18.2

ST   D5S818: 12

ST   D7S820: 11

ST   FGA: 25

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-245

AC   CVCL_5038

SY   SNU245; NCI-SNU-245

DR   CCLE; SNU245_BILIARY_TRACT

DR   Cosmic; 738866

DR   GEO; GSM887618

DR   GEO; GSM888702

DR   KCLB; 00245

RX   CelloPub=CLPUB00275;

RX   PubMed=12107841;

RX   PubMed=19956504;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 54 hours (PubMed=12107841).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 9,13

ST   D3S1358: 17,19

ST   D5S818: 7

ST   D7S820: 8,10

ST   FGA: 21.2,24

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 14,18

DI   NCIt; C4436; Cholangiocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SNU-247

AC   CVCL_5039

SY   SNU247

RX   PubMed=9542645;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SNU-251

AC   CVCL_5040

SY   SNU251

DR   KCLB; 00251

RX   PubMed=9299249;

RX   PubMed=19956504;

RX   PubMed=22710073;

RX   PubMed=23415752;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 46 hours (PubMed=9299249).

CC   Derived from metastatic site: Ascites.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 9

ST   D3S1358: 15,16

ST   D5S818: 11

ST   D7S820: 10,12

ST   FGA: 20

ST   TH01: 8

ST   TPOX: 12

ST   vWA: 15,18

DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-2535

AC   CVCL_R756

DR   Cosmic; 1859888

DR   KCLB; 02535

RX   PubMed=23344087;

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 9,11

ST   D3S1358: 15

ST   D5S818: 10,12

ST   D7S820: 11

ST   FGA: 24,27

ST   TH01: 7,9.3

ST   TPOX: 11

ST   vWA: 16,17

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-254

AC   CVCL_5041

SY   SNU254

DR   Cosmic; 1322283

DR   GEO; GSM1448207

DR   KCLB; 00254

RX   PubMed=20176655;

RX   PubMed=25926053;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 50 hours (PubMed=20176655).

CC   Microsatellite instability: Stable (MSS) (PubMed=20176655; PubMed=25926053).

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB; PubMed=20176655

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11

ST   D16S539: 9

ST   D18S51: 12

ST   D19S433: 12,15.2

ST   D21S11: 31

ST   D2S1338: 23

ST   D3S1358: 16,17

ST   D5S818: 10,11

ST   D7S820: 11,13

ST   D8S1179: 13,15

ST   FGA: 24,25

ST   TH01: 7

ST   TPOX: 8,12

ST   vWA: 14,17

DI   NCIt; C9383; Rectal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-265

AC   CVCL_5042

SY   SNU265

RX   PubMed=9542645;

RX   PubMed=11507201;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SNU-267

AC   CVCL_5043

SY   SNU267

DR   KCLB; 00267

RX   PubMed=10619961;

RX   PubMed=19956504;

RX   PubMed=27993170;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 24 hours (PubMed=10619961).

CC   Microsatellite instability: Stable (MSS) (PubMed=10619961).

ST   Source(s): KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 9,12

ST   D13S317: 10,12

ST   D3S1358: 15

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   FGA: 24,25

ST   TH01: 7,10

ST   TPOX: 8,11

ST   vWA: 14

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-283

AC   CVCL_5044

SY   SNU283; NCI-SNU-283

DR   CCLE; SNU283_LARGE_INTESTINE

DR   Cosmic; 738862

DR   Cosmic; 2302008

DR   Cosmic-CLP; 1659929

DR   GEO; GSM887619

DR   GEO; GSM888703

DR   GEO; GSM1346854

DR   GEO; GSM1448123

DR   GEO; GSM1670466

DR   KCLB; 00283

RX   PubMed=10362137;

RX   PubMed=10674020;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=24755471;

RX   PubMed=25926053;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 42 hours (PubMed=10362137).

CC   Microsatellite instability: Stable (MSS) (PubMed=10674020; PubMed=25926053; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Omentum.

ST   Source(s): Cosmic-CLP; KCLB

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 8,11

ST   D16S539: 9,12

ST   D3S1358: 15,18

ST   D5S818: 9

ST   D7S820: 11

ST   FGA: 23,25

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 14,19

DI   NCIt; C9383; Rectal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-285

AC   CVCL_5045

SY   SNU285

RX   PubMed=9542645;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SNU-291

AC   CVCL_5046

SY   SNU291; SNU-291BL; SNU-291EBV

DR   KCLB; 00291EBV

RX   PubMed=9542645;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SNU-299

AC   CVCL_5047

SY   SNU299

RX   PubMed=9542645;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SNU-306

AC   CVCL_T042

DR   Cosmic; 2068082

RX   PubMed=24141649;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 152 hours (PubMed=24141649).

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-308

AC   CVCL_5048

SY   SNU308; NCI-SNU-308

DR   CCLE; SNU308_BILIARY_TRACT

DR   ChEMBL-Cells; CHEMBL3307456

DR   ChEMBL-Targets; CHEMBL614932

DR   Cosmic; 738869

DR   GEO; GSM887620

DR   GEO; GSM888704

DR   KCLB; 00308

RX   CelloPub=CLPUB00275;

RX   PubMed=12107841;

RX   PubMed=19956504;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 48 hours (PubMed=12107841).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8

ST   D3S1358: 16

ST   D5S818: 9

ST   D7S820: 7,12

ST   FGA: 25,26

ST   TH01: 8

ST   TPOX: 8

ST   vWA: 16

DI   NCIt; C3844; Gallbladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SNU-315

AC   CVCL_5049

SY   SNU315

RX   PubMed=9542645;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SNU-321

AC   CVCL_5050

SY   SNU321

RX   PubMed=9542645;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SNU-324

AC   CVCL_5051

SY   SNU324; NCI-SNU-324

DR   CCLE; SNU324_PANCREAS

DR   Cosmic; 707182

DR   GEO; GSM887621

DR   GEO; GSM888705

DR   KCLB; 00324

RX   PubMed=12037578;

RX   PubMed=19956504;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   CSF1PO: 10,11

ST   D13S317: 9,11

ST   D3S1358: 15,16

ST   D5S818: 10,11

ST   D7S820: 11

ST   FGA: 21,22

ST   TH01: 7,9

ST   TPOX: 10,11

ST   vWA: 18,19

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-328

AC   CVCL_5052

SY   SNU328

RX   PubMed=10619961;

RX   PubMed=19956504;

RX   PubMed=27993170;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 120 hours (PubMed=10619961).

CC   Microsatellite instability: Stable (MSS) (PubMed=10619961).

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-333

AC   CVCL_5053

SY   SNU333

DR   KCLB; 00333

RX   PubMed=10619961;

RX   PubMed=19956504;

RX   PubMed=27993170;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 76 hours (PubMed=10619961).

CC   Microsatellite instability: Stable (MSS) (PubMed=10619961).

ST   Source(s): KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11

ST   D3S1358: 17

ST   D5S818: 11,13

ST   D7S820: 9,13

ST   FGA: 22,23

ST   TH01: 7,9

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-334

AC   CVCL_T043

DR   Cosmic; 2068083

RX   PubMed=24141649;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 80 hours (PubMed=24141649).

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-349

AC   CVCL_5054

SY   SNU349; NCI-SNU-349

DR   CCLE; SNU349_KIDNEY

DR   GEO; GSM888706

DR   KCLB; 00349

RX   PubMed=10619961;

RX   PubMed=14634222;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=27993170;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 120 hours (PubMed=10619961).

CC   Microsatellite instability: Instable (MSI) (PubMed=10619961).

CC   Omics: SNP array analysis.

ST   Source(s): KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 9,10

ST   D3S1358: 14

ST   D5S818: 10,11,13

ST   D7S820: 10,11

ST   FGA: 23,24

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-354

AC   CVCL_3947

SY   SNU354

DR   BTO; BTO:0003190

DR   ChEMBL-Cells; CHEMBL3307310

DR   ChEMBL-Targets; CHEMBL614165

DR   Cosmic; 2023865

DR   GEO; GSM1374888

DR   KCLB; 00354

RX   PubMed=7543080;

RX   PubMed=16616112;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Characteristics: Has lost chromosome Y.

CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).

CC   Omics: Array-based CGH.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 8,11

ST   D13S317: 10,11

ST   D3S1358: 15,17

ST   D5S818: 11,12

ST   D7S820: 7,11

ST   FGA: 21,22

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 17

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-368

AC   CVCL_3948

SY   SNU368

DR   BTO; BTO:0003169

DR   Cosmic; 2023866

DR   GEO; GSM1374889

DR   KCLB; 00368

RX   PubMed=7543080;

RX   PubMed=16616112;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Characteristics: Has lost chromosome Y.

CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).

CC   Omics: Array-based CGH.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   CSF1PO: 10,13

ST   D13S317: 8,9

ST   D3S1358: 16

ST   D5S818: 10

ST   D7S820: 11,12

ST   FGA: 25

ST   TH01: 6,9

ST   TPOX: 9,11

ST   vWA: 14,17

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-371

AC   CVCL_5055

SY   SNU371

DR   Cosmic; 1484497

RX   PubMed=21290211;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 98 hours (PubMed=21290211).

DI   NCIt; C3732; Pulmonary blastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-373

AC   CVCL_5056

SY   SNU373

DR   Cosmic; 1024885

DR   Cosmic; 1065284

RX   PubMed=17134824;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 41 hours (PubMed=17134824).

DI   NCIt; C4035; Thyroid gland papillary carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-374

AC   CVCL_5057

SY   SNU374; SNU-374BL; SNU-374EBV

DR   KCLB; 00374EBV

RX   PubMed=9542645;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 9,11

ST   D3S1358: 15

ST   D5S818: 11,12

ST   D7S820: 10,11

ST   FGA: 22,26

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 16,20

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SNU-387

AC   CVCL_0250

SY   SNU387; NCI-SNU-387

DR   BTO; BTO:0003191

DR   CLO; CLO_0009097

DR   EFO; EFO_0002346

DR   ATCC; CRL-2237

DR   BioSample; SAMN03471848

DR   BioSample; SAMN03473190

DR   CCLE; SNU387_LIVER

DR   ChEMBL-Cells; CHEMBL3308817

DR   ChEMBL-Targets; CHEMBL1075583

DR   Cosmic; 684199

DR   Cosmic; 873397

DR   Cosmic; 909736

DR   Cosmic; 928142

DR   Cosmic; 1995639

DR   Cosmic; 2023867

DR   Cosmic; 2162530

DR   Cosmic; 2321035

DR   Cosmic-CLP; 909736

DR   GDSC; 909736

DR   GEO; GSM481453

DR   GEO; GSM565921

DR   GEO; GSM887622

DR   GEO; GSM888707

DR   GEO; GSM936779

DR   GEO; GSM1670467

DR   IGRhCellID; SNU387

DR   KCLB; 00387

DR   PRIDE; PXD002486

RX   PubMed=7543080;

RX   PubMed=16616112;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=23505090;

RX   PubMed=23887712;

RX   PubMed=25485619;

RX   PubMed=25574106;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).

CC   Omics: Array-based CGH.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 13,14

ST   D13S317: 12

ST   D16S539: 9

ST   D18S51: 14

ST   D21S11: 31

ST   D3S1358: 16

ST   D5S818: 10,12

ST   D7S820: 8,10

ST   D8S1179: 13,14

ST   FGA: 22

ST   Penta D: 8

ST   Penta E: 16

ST   TH01: 7

ST   TPOX: 8,9

ST   vWA: 14,16 (ATCC; Cosmic-CLP; KCLB)

ST   vWA: 14 (PubMed=25877200)

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-398

AC   CVCL_0077

SY   SNU398; NCI-SNU-398

DR   BTO; BTO:0003170

DR   CLO; CLO_0009098

DR   EFO; EFO_0002347

DR   MCCL; MCC:0000435

DR   ATCC; CRL-2233

DR   BioSample; SAMN03473191

DR   CCLE; SNU398_LIVER

DR   ChEMBL-Cells; CHEMBL3307619

DR   ChEMBL-Targets; CHEMBL614454

DR   Cosmic; 873393

DR   Cosmic; 928143

DR   Cosmic; 1187337

DR   Cosmic; 1995640

DR   Cosmic; 2009538

DR   Cosmic; 2023868

DR   Cosmic; 2162531

DR   Cosmic; 2321036

DR   Cosmic-CLP; 1240217

DR   GDSC; 1240217

DR   GEO; GSM481448

DR   GEO; GSM565922

DR   GEO; GSM827415

DR   GEO; GSM887623

DR   GEO; GSM888708

DR   GEO; GSM936780

DR   GEO; GSM1374890

DR   GEO; GSM1670468

DR   IGRhCellID; SNU398

DR   KCLB; 00398

RX   PubMed=7543080;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=23505090;

RX   PubMed=23887712;

RX   PubMed=25485619;

RX   PubMed=25574106;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Characteristics: Has lost chromosome Y.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 13

ST   D13S317: 11

ST   D16S539: 10,14

ST   D18S51: 15

ST   D21S11: 29

ST   D3S1358: 17

ST   D5S818: 12

ST   D7S820: 10,11

ST   D8S1179: 12

ST   FGA: 22,23 (KCLB)

ST   FGA: 23 (PubMed=25877200)

ST   Penta D: 14

ST   Penta E: 12

ST   TH01: 7,9 (ATCC; Cosmic-CLP; PubMed=25877200)

ST   TH01: 8,9 (KCLB)

ST   TPOX: 11

ST   vWA: 17,18

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-407

AC   CVCL_5058

SY   SNU407; NCI-SNU-407

DR   CCLE; SNU407_LARGE_INTESTINE

DR   Cosmic; 738863

DR   Cosmic; 848827

DR   Cosmic; 875422

DR   Cosmic-CLP; 1660034

DR   GDSC; 1660034

DR   GEO; GSM887624

DR   GEO; GSM888709

DR   GEO; GSM1448217

DR   GEO; GSM1670469

DR   KCLB; 00407

RX   PubMed=10362137;

RX   PubMed=10674020;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=25926053;

RX   PubMed=27397505;

WW   http://www.addexbio.com/productdetail?pid=377

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 42 hours (PubMed=10362137).

CC   Microsatellite instability: Instable (MSI-high) (PubMed=10674020; PubMed=25926053; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Buttock.

ST   Source(s): AddexBio; Cosmic-CLP; KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 8,10

ST   D16S539: 11,12

ST   D3S1358: 15,18

ST   D5S818: 10,11 (AddexBio; KCLB)

ST   D5S818: 10 (Cosmic-CLP)

ST   D7S820: 8,10

ST   FGA: 22

ST   TH01: 6

ST   TPOX: 7,8

ST   vWA: 14,16

ST   D3S1358: 15,18

ST   FGA: 22

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-410

AC   CVCL_5059

SY   SNU410; NCI-SNU-410

DR   CCLE; SNU410_PANCREAS

DR   Cosmic; 707183

DR   GEO; GSM887625

DR   GEO; GSM888710

DR   KCLB; 00410

RX   PubMed=12037578;

RX   PubMed=19956504;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10,12

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 12,14

ST   FGA: 23

ST   TH01: 9

ST   TPOX: 8,12

ST   vWA: 17

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-423

AC   CVCL_0366

SY   SNU423; NCI-SNU-423

DR   BTO; BTO:0003187

DR   CLO; CLO_0009099

DR   EFO; EFO_0002348

DR   ATCC; CRL-2238

DR   BioSample; SAMN03471849

DR   BioSample; SAMN03473132

DR   CCLE; SNU423_LIVER

DR   ChEMBL-Cells; CHEMBL3308367

DR   ChEMBL-Targets; CHEMBL1075584

DR   Cosmic; 871513

DR   Cosmic; 909737

DR   Cosmic; 1177681

DR   Cosmic; 1995641

DR   Cosmic; 2023869

DR   Cosmic; 2162532

DR   Cosmic; 2321037

DR   Cosmic-CLP; 909737

DR   GDSC; 909737

DR   GEO; GSM565923

DR   GEO; GSM887626

DR   GEO; GSM888711

DR   GEO; GSM936781

DR   GEO; GSM1670470

DR   IGRhCellID; SNU423

DR   KCLB; 00423

RX   PubMed=7543080;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=23505090;

RX   PubMed=23887712;

RX   PubMed=25485619;

RX   PubMed=25574106;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12 (ATCC; KCLB; PubMed=25877200)

ST   CSF1PO: 11,12,13 (Cosmic-CLP)

ST   D13S317: 10,13

ST   D16S539: 9

ST   D18S51: 12,13

ST   D21S11: 30

ST   D3S1358: 17,18 (KCLB)

ST   D3S1358: 17 (PubMed=25877200)

ST   D5S818: 10

ST   D7S820: 12

ST   D8S1179: 11,16

ST   FGA: 21,24

ST   Penta D: 9

ST   Penta E: 11,12

ST   TH01: 6,9 (ATCC; Cosmic-CLP)

ST   TH01: 9 (KCLB; PubMed=25877200)

ST   TPOX: 8

ST   vWA: 15

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-444

AC   CVCL_5060

SY   SNU444

RX   PubMed=11776963;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 48 hours (PubMed=11776963).

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-445

AC   CVCL_5061

SY   SNU445

RX   PubMed=9542645;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SNU-447

AC   CVCL_5062

SY   SNU447

RX   PubMed=9542645;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SNU-449

AC   CVCL_0454

SY   SNU449; NCI-SNU-449

DR   BTO; BTO:0003188

DR   CLO; CLO_0009100

DR   EFO; EFO_0002349

DR   ATCC; CRL-2234

DR   BioSample; SAMN03471847

DR   BioSample; SAMN03473133

DR   CCLE; SNU449_LIVER

DR   ChEMBL-Cells; CHEMBL3308480

DR   ChEMBL-Targets; CHEMBL1075585

DR   Cosmic; 684200

DR   Cosmic; 871511

DR   Cosmic; 873396

DR   Cosmic; 909738

DR   Cosmic; 928144

DR   Cosmic; 1187338

DR   Cosmic; 1995642

DR   Cosmic; 2009539

DR   Cosmic; 2023870

DR   Cosmic; 2162541

DR   Cosmic; 2321041

DR   Cosmic-CLP; 909738

DR   GDSC; 909738

DR   GEO; GSM481452

DR   GEO; GSM565924

DR   GEO; GSM887627

DR   GEO; GSM888712

DR   GEO; GSM936782

DR   GEO; GSM1374891

DR   GEO; GSM1670471

DR   IGRhCellID; SNU449

DR   KCLB; 00449

RX   PubMed=7543080;

RX   PubMed=16616112;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=23505090;

RX   PubMed=23887712;

RX   PubMed=25485619;

RX   PubMed=25574106;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Characteristics: Has lost chromosome Y.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).

CC   Omics: Array-based CGH.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200

ST   Amelogenin: X,Y (ATCC; KCLB)

ST   Amelogenin: X (Cosmic-CLP; PubMed=25877200)

ST   CSF1PO: 11

ST   D13S317: 9

ST   D16S539: 9

ST   D18S51: 14,16

ST   D21S11: 29,31

ST   D3S1358: 15,16

ST   D5S818: 10

ST   D7S820: 8,13

ST   D8S1179: 10,13

ST   FGA: 22,24

ST   Penta D: 10,11

ST   Penta E: 10,15

ST   TH01: 6,9

ST   TPOX: 11

ST   vWA: 14,16

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-46

AC   CVCL_5063

SY   SNU46

DR   BTO; BTO:0005927

DR   CCLE; SNU46_UPPER_AERODIGESTIVE_TRACT

DR   Cosmic; 934173

DR   GEO; GSM887629

DR   GEO; GSM888714

DR   KCLB; 00046

RX   CelloPub=CLPUB00001;

RX   PubMed=10369293;

RX   PubMed=19956504;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 36 hours (PubMed=10369293).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11

ST   D3S1358: 15

ST   D5S818: 11

ST   D7S820: 10,11

ST   FGA: 21,24

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 15,16

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-466

AC   CVCL_5064

SY   SNU466; NCI-SNU-466

DR   CCLE; SNU466_CENTRAL_NERVOUS_SYSTEM

DR   GEO; GSM887628

DR   GEO; GSM888713

DR   KCLB; 00466

RX   PubMed=11776963;

RX   PubMed=19956504;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 54 hours (PubMed=11776963).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 8,12

ST   D3S1358: 15,18

ST   D5S818: 7,12

ST   D7S820: 10,12

ST   FGA: 22,24

ST   TH01: 6,9

ST   TPOX: 9,11

ST   vWA: 17,18

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-475

AC   CVCL_0497

SY   SNU475; NCI-SNU-475

DR   BTO; BTO:0003189

DR   CLO; CLO_0009101

DR   EFO; EFO_0002350

DR   ATCC; CRL-2236

DR   BioSample; SAMN03471846

DR   BioSample; SAMN03473134

DR   CCLE; SNU475_LIVER

DR   ChEMBL-Cells; CHEMBL3308787

DR   ChEMBL-Targets; CHEMBL1075586

DR   Cosmic; 684201

DR   Cosmic; 871512

DR   Cosmic; 873403

DR   Cosmic; 909739

DR   Cosmic; 928145

DR   Cosmic; 2023871

DR   Cosmic; 2162533

DR   Cosmic; 2321038

DR   Cosmic-CLP; 909739

DR   GDSC; 909739

DR   GEO; GSM481449

DR   GEO; GSM565920

DR   GEO; GSM887630

DR   GEO; GSM888715

DR   GEO; GSM936783

DR   GEO; GSM1670472

DR   IGRhCellID; SNU475

DR   KCLB; 00475

RX   PubMed=7543080;

RX   PubMed=16616112;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=23505090;

RX   PubMed=23887712;

RX   PubMed=25485619;

RX   PubMed=25574106;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Characteristics: Has lost chromosome Y.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).

CC   Omics: Array-based CGH.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8,11

ST   D16S539: 12

ST   D18S51: 13

ST   D21S11: 28,30

ST   D3S1358: 14

ST   D5S818: 10,13

ST   D7S820: 7,12 (ATCC; Cosmic-CLP; KCLB)

ST   D7S820: 7 (PubMed=25877200)

ST   D8S1179: 13,14

ST   FGA: 23

ST   Penta D: 9,12

ST   Penta E: 5,16

ST   TH01: 7,9

ST   TPOX: 8,9

ST   vWA: 14

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-478

AC   CVCL_5065

SY   SNU478; NCI-SNU-478

DR   CCLE; SNU478_BILIARY_TRACT

DR   Cosmic; 738871

DR   GEO; GSM887631

DR   GEO; GSM888716

DR   KCLB; 00478

DR   PRIDE; PXD002657

RX   CelloPub=CLPUB00275;

RX   PubMed=12107841;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=26951071;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 52 hours (PubMed=12107841).

CC   Omics: Deep proteome analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 9,11

ST   D3S1358: 16,17

ST   D5S818: 9,12

ST   D7S820: 8,11

ST   FGA: 24

ST   TH01: 7

ST   TPOX: 10,11

ST   vWA: 15,16

DI   NCIt; C6650; Ampulla of Vater adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SNU-479

AC   CVCL_5066

SY   SNU479

DR   Cosmic; 1322284

DR   GEO; GSM1448208

DR   KCLB; 00479

RX   PubMed=20176655;

RX   PubMed=25926053;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 44 hours (PubMed=20176655).

CC   Microsatellite instability: Stable (MSS) (PubMed=20176655; PubMed=25926053).

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

ST   Source(s): KCLB; PubMed=20176655

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 9,11

ST   D16S539: 9,11

ST   D18S51: 17

ST   D19S433: 13,14

ST   D21S11: 32.2

ST   D2S1338: 19

ST   D3S1358: 15

ST   D5S818: 13

ST   D7S820: 9,12

ST   D8S1179: 10,12

ST   FGA: 22,24

ST   TH01: 6,7

ST   TPOX: 9,12

ST   vWA: 16,17

DI   NCIt; C43584; Rectosigmoid adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-482

AC   CVCL_5067

SY   SNU482

DR   KCLB; 00482

RX   PubMed=10619961;

RX   PubMed=14634222;

RX   PubMed=19956504;

RX   PubMed=27993170;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 60 hours (PubMed=10619961).

CC   Microsatellite instability: Stable (MSS) (PubMed=10619961).

ST   Source(s): KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 8

ST   D3S1358: 16

ST   D5S818: 10,11

ST   D7S820: 11

ST   FGA: 22,23

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 14,18

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-484

AC   CVCL_0100

SY   SNU484

DR   BTO; BTO:0003479

DR   EFO; EFO_0006755

DR   BioSample; SAMN03473176

DR   CGH-DB; 125-1

DR   CGH-DB; 9013-4

DR   Cosmic; 685590

DR   Cosmic; 848140

DR   Cosmic; 921598

DR   Cosmic; 1067206

DR   Cosmic; 1090454

DR   Cosmic; 1294958

DR   Cosmic; 1528875

DR   Cosmic; 2484965

DR   GEO; GSM1374892

DR   KCLB; 00484

RX   PubMed=9033653;

RX   PubMed=10812166;

RX   PubMed=15723654;

RX   PubMed=18804159;

RX   PubMed=19956504;

RX   PubMed=24807215;

RX   PubMed=25485619;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Characteristics: Homozygous for the TP53 p.Gly266Glu mutation.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 9

ST   D13S317: 11,12

ST   D16S539: 13

ST   D18S51: 13,15

ST   D21S11: 30

ST   D3S1358: 18

ST   D5S818: 10

ST   D7S820: 12

ST   D8S1179: 14

ST   FGA: 19,23

ST   Penta D: 12

ST   Penta E: 22

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 18

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-487

AC   CVCL_5068

SY   SNU487

DR   KCLB; 00487

RX   PubMed=9219839;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 52 hours (PubMed=9219839).

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 8,12

ST   D3S1358: 15,16

ST   D5S818: 10

ST   D7S820: 10,13

ST   FGA: 23

ST   TH01: 9,9.3

ST   TPOX: 11

ST   vWA: 14,16

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-489

AC   CVCL_5069

SY   SNU489; NCI-SNU-489

DR   CCLE; SNU489_CENTRAL_NERVOUS_SYSTEM

DR   GEO; GSM888717

DR   KCLB; 00489

RX   PubMed=11776963;

RX   PubMed=19956504;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 48 hours (PubMed=11776963).

CC   Omics: SNP array analysis.

ST   Source(s): KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 10,11

ST   D3S1358: 15,17

ST   D5S818: 10,13

ST   D7S820: 7,11

ST   FGA: 21,23

ST   TH01: 9

ST   TPOX: 10,11

ST   vWA: 17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-494

AC   CVCL_5070

SY   SNU494

DR   Cosmic; 707184

RX   PubMed=12037578;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-5

AC   CVCL_0078

SY   SNU5; NCI-SNU-5

DR   BTO; BTO:0004986

DR   CLO; CLO_0009102

DR   EFO; EFO_0002351

DR   MCCL; MCC:0000436

DR   ATCC; CRL-5973

DR   BCRC; 60213

DR   BioSample; SAMN03470906

DR   CCLE; SNU5_STOMACH

DR   CCRID; 3131C0001001200013

DR   ChEMBL-Cells; CHEMBL3307458

DR   ChEMBL-Targets; CHEMBL614934

DR   Cosmic; 685587

DR   Cosmic; 687559

DR   Cosmic; 737363

DR   Cosmic; 848137

DR   Cosmic; 868237

DR   Cosmic; 908445

DR   Cosmic; 921596

DR   Cosmic; 1066231

DR   Cosmic; 1067203

DR   Cosmic; 1090451

DR   Cosmic; 1154648

DR   Cosmic; 1187293

DR   Cosmic; 1294960

DR   Cosmic; 1329187

DR   Cosmic; 1482072

DR   Cosmic; 1528872

DR   Cosmic; 1995597

DR   Cosmic; 2069773

DR   Cosmic; 2484972

DR   Cosmic-CLP; 908445

DR   GDSC; 908445

DR   GEO; GSM267422

DR   GEO; GSM267429

DR   GEO; GSM267436

DR   GEO; GSM267443

DR   GEO; GSM562408

DR   GEO; GSM827398

DR   GEO; GSM828830

DR   GEO; GSM844703

DR   GEO; GSM887634

DR   GEO; GSM888720

DR   GEO; GSM1237681

DR   GEO; GSM1237706

DR   GEO; GSM1374893

DR   GEO; GSM1670275

DR   GEO; GSM1670473

DR   IGRhCellID; SNU5

DR   KCLB; 00005

RX   PubMed=2158397;

RX   PubMed=8806092;

RX   PubMed=8806095;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=24807215;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: MET genetic alteration cell panel (ATCC TCP-1036).

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

ST   Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,9 (ATCC; Cosmic-CLP; PubMed=25877200)

ST   D13S317: 8 (KCLB)

ST   D16S539: 13

ST   D18S51: 13

ST   D19S433: 13.2,15

ST   D21S11: 29

ST   D2S1338: 17

ST   D3S1358: 16

ST   D5S818: 10

ST   D7S820: 8,12

ST   D8S1179: 14,15

ST   FGA: 21

ST   Penta D: 9,13

ST   Penta E: 18,19

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 15,16

DI   NCIt; C4911; Gastric carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-503

AC   CVCL_5071

SY   SNU503; NCI-SNU-503

DR   CCLE; SNU503_LARGE_INTESTINE

DR   Cosmic; 738864

DR   GEO; GSM887632

DR   GEO; GSM888718

DR   GEO; GSM1448209

DR   KCLB; 00503

RX   PubMed=10362137;

RX   PubMed=10674020;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=25926053;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 64 hours (PubMed=10362137).

CC   Microsatellite instability: Stable (MSS) (PubMed=10674020; PubMed=25926053).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Abdominal wall.

ST   Source(s): KCLB

ST   CSF1PO: 11

ST   D13S317: 10

ST   D3S1358: 15

ST   D5S818: 10

ST   D7S820: 10

ST   FGA: 22

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 14,17

DI   NCIt; C9383; Rectal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-520

AC   CVCL_5072

SY   SNU520; NCI-SNU-520

DR   CCLE; SNU520_STOMACH

DR   Cosmic; 685591

DR   GEO; GSM887633

DR   GEO; GSM888719

DR   KCLB; 00520

RX   PubMed=9033653;

RX   PubMed=19956504;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8

ST   D3S1358: 14,15

ST   D5S818: 10,13

ST   D7S820: 9,11

ST   FGA: 21

ST   TH01: 8,9

ST   TPOX: 7,8

ST   vWA: 17,18

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-523

AC   CVCL_5073

SY   SNU523

DR   KCLB; 00523

RX   PubMed=9219839;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 72 hours (PubMed=9219839).

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).

CC   Discontinued: KCLB; 00523; probable.

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-538

AC   CVCL_5074

SY   SNU538; SNU-538BL; SNU-538EBV

DR   KCLB; 00538EBV

RX   PubMed=9542645;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

ST   Source(s): KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 8,9

ST   D3S1358: 15,16

ST   D5S818: 11,12

ST   D7S820: 10

ST   FGA: 21,24

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 14,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SNU-539

AC   CVCL_5075

SY   SNU539

DR   KCLB; 00539

RX   PubMed=9299262;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 46 hours (PubMed=9299262).

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 14

ST   D3S1358: 15,18

ST   D5S818: 11

ST   D7S820: 8

ST   FGA: 23,26

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 15,17

DI   NCIt; C42700; Uterine carcinosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-55

AC   CVCL_E107

SY   SNU55; NCI-SNU-55

RX   PubMed=8806092;

CC   Part of: Seoul National University (SNU) cell line collection.

DI   NCIt; C4911; Gastric carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SNU-563

AC   CVCL_5076

SY   SNU563

DR   KCLB; 00563

RX   PubMed=9299249;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 67 hours (PubMed=9299249).

CC   Discontinued: KCLB; 00563; probable.

DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-585

AC   CVCL_5077

SY   SNU585

DR   BTO; BTO:0005926

DR   Cosmic; 934174

DR   KCLB; 00585

RX   CelloPub=CLPUB00001;

RX   PubMed=10369293;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 54 hours (PubMed=10369293).

CC   Discontinued: KCLB; 00585; probable.

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-601

AC   CVCL_0101

SY   SNU601; NCI-SNU-601

DR   EFO; EFO_0006756

DR   BioSample; SAMN03473177

DR   CCLE; SNU601_STOMACH

DR   CGH-DB; 126-1

DR   CGH-DB; 9014-4

DR   Cosmic; 685585

DR   Cosmic; 848141

DR   Cosmic; 869513

DR   Cosmic; 921599

DR   Cosmic; 1090455

DR   Cosmic; 1294955

DR   Cosmic; 1528876

DR   Cosmic; 2484961

DR   GEO; GSM888721

DR   GEO; GSM1374894

DR   KCLB; 00601

RX   PubMed=9033653;

RX   PubMed=10812166;

RX   PubMed=15723654;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=24807215;

RX   PubMed=25485619;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Characteristics: Homozygous for the TP53 p.Arg273Leu mutation.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

ST   Source(s): KCLB; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 9,12

ST   D16S539: 12

ST   D18S51: 14

ST   D21S11: 29,30

ST   D3S1358: 16

ST   D5S818: 10

ST   D7S820: 9,11

ST   D8S1179: 13,14

ST   FGA: 23

ST   Penta D: 8,15

ST   Penta E: 11,18

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C5250; Signet ring cell gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-61

AC   CVCL_5078

SY   SNU61; NCI-SNU-61

DR   CCLE; SNU61_LARGE_INTESTINE

DR   Cosmic; 738860

DR   Cosmic-CLP; 1660035

DR   GDSC; 1660035

DR   GEO; GSM887635

DR   GEO; GSM888722

DR   GEO; GSM1448086

DR   GEO; GSM1670474

DR   KCLB; 00061

RX   PubMed=10362137;

RX   PubMed=10674020;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=25926053;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 39 hours (PubMed=10362137).

CC   Microsatellite instability: Stable (MSS) (PubMed=10674020; PubMed=25926053; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Liver.

ST   Source(s): Cosmic-CLP; KCLB

ST   Amelogenin: X (Cosmic-CLP)

ST   Amelogenin: X,Y (KCLB)

ST   CSF1PO: 12

ST   D13S317: 8

ST   D16S539: 12

ST   D3S1358: 15

ST   D5S818: 11 (Cosmic-CLP)

ST   D5S818: 9,11 (KCLB)

ST   D7S820: 8

ST   FGA: 22,26

ST   TH01: 9

ST   TPOX: 8,9

ST   vWA: 16

DI   NCIt; C9383; Rectal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-620

AC   CVCL_5079

SY   SNU620; NCI-SNU-620

DR   BTO; BTO:0005171

DR   EFO; EFO_0006757

DR   BioSample; SAMN03473178

DR   CCLE; SNU620_STOMACH

DR   Cosmic; 685592

DR   Cosmic; 848142

DR   Cosmic; 921600

DR   Cosmic; 1090456

DR   Cosmic; 1528877

DR   Cosmic; 2484958

DR   GEO; GSM887636

DR   GEO; GSM888723

DR   GEO; GSM1374895

DR   KCLB; 00620

RX   PubMed=9033653;

RX   PubMed=10812166;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=24807215;

RX   PubMed=25485619;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

ST   Source(s): KCLB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 12

ST   D16S539: 9,11

ST   D18S51: 14,15

ST   D21S11: 31,32,32.2

ST   D3S1358: 17,18

ST   D5S818: 11

ST   D7S820: 13

ST   D8S1179: 13

ST   FGA: 24 (KCLB)

ST   FGA: 19,24 (PubMed=25877200)

ST   Penta D: 11,13

ST   Penta E: 15,22

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 16,18 (KCLB)

ST   vWA: 16,17,18 (PubMed=25877200)

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-620-5FU

AC   CVCL_L044

SY   SNU-620R-5-FU/1000

DR   KCLB; 00620-5FU

RX   PubMed=14734480;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5079 ! SNU-620

SX   Female

CA   Cancer cell line

//

ID   SNU-620-ADR

AC   CVCL_L084

SY   SNU-620-ADR/300

DR   KCLB; 00620-ADR

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 12

ST   D3S1358: 17,18

ST   D5S818: 11

ST   D7S820: 13

ST   FGA: 19,24

ST   TH01: 6,7

ST   TPOX: 8

ST   vWA: 16,17,18

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5079 ! SNU-620

SX   Female

CA   Cancer cell line

//

ID   SNU-620-CIS

AC   CVCL_L045

SY   SNU-620R-CIS/2000

RX   PubMed=14734480;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5079 ! SNU-620

SX   Female

CA   Cancer cell line

//

ID   SNU-620-DOX

AC   CVCL_L046

SY   SNU-620R-DOX/300

RX   PubMed=14734480;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5079 ! SNU-620

SX   Female

CA   Cancer cell line

//

ID   SNU-626

AC   CVCL_5080

SY   SNU626; NCI-SNU-626

DR   CCLE; SNU626_CENTRAL_NERVOUS_SYSTEM

DR   GEO; GSM887637

DR   GEO; GSM888724

DR   KCLB; 00626

RX   PubMed=11776963;

RX   PubMed=19956504;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 92 hours (PubMed=11776963).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 10

ST   D3S1358: 17

ST   D5S818: 9,13

ST   D7S820: 10,11

ST   FGA: 19

ST   TH01: 6,9

ST   TPOX: 11

ST   vWA: 17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-638

AC   CVCL_0102

SY   SNU638

DR   EFO; EFO_0006758

DR   BioSample; SAMN03473180

DR   BTO; BTO:0003478

DR   CGH-DB; 127-1

DR   CGH-DB; 9015-4

DR   ChEMBL-Cells; CHEMBL3307747

DR   ChEMBL-Targets; CHEMBL614935

DR   Cosmic; 685583

DR   Cosmic; 848143

DR   Cosmic; 869511

DR   Cosmic; 921601

DR   Cosmic; 1067207

DR   Cosmic; 1090457

DR   Cosmic; 1294961

DR   Cosmic; 1528878

DR   Cosmic; 2036662

DR   Cosmic; 2484959

DR   GEO; GSM1374896

DR   KCLB; 00638

RX   PubMed=9033653;

RX   PubMed=10812166;

RX   PubMed=15723654;

RX   PubMed=19956504;

RX   PubMed=24807215;

RX   PubMed=25485619;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Characteristics: Heterozygous for the TP53 p.Arg282Trp mutation.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

ST   Source(s): KCLB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 10

ST   D16S539: 11,13

ST   D18S51: 14,16

ST   D21S11: 30.2,31

ST   D3S1358: 15

ST   D5S818: 10,14 (KCLB)

ST   D5S818: 10,13,14,15 (PubMed=25877200)

ST   D7S820: 9,10

ST   D8S1179: 11,13

ST   FGA: 17,27

ST   Penta D: 9

ST   Penta E: 14,18

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 14,19

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-638-5FU

AC   CVCL_L047

SY   SNU-638R-5-FU/50000

RX   PubMed=14734480;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0102 ! SNU-638

SX   Male

CA   Cancer cell line

//

ID   SNU-638-CIS

AC   CVCL_L048

SY   SNU-638R-CIS/400

RX   PubMed=14734480;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0102 ! SNU-638

SX   Male

CA   Cancer cell line

//

ID   SNU-668

AC   CVCL_5081

SY   SNU668; NCI-SNU-668

DR   EFO; EFO_0006759

DR   BioSample; SAMN03473141

DR   CCLE; SNU668_STOMACH

DR   CGH-DB; 128-1

DR   CGH-DB; 9016-4

DR   Cosmic; 685593

DR   Cosmic; 921602

DR   Cosmic; 1066232

DR   Cosmic; 1294956

DR   Cosmic; 1528879

DR   Cosmic; 2484962

DR   GEO; GSM888725

DR   GEO; GSM1374897

DR   KCLB; 00668

RX   PubMed=9033653;

RX   PubMed=10812166;

RX   PubMed=15723654;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=24807215;

RX   PubMed=25485619;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Characteristics: Homozygous for the TP53 p.Ser251Asn mutation.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

ST   Source(s): KCLB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8

ST   D16S539: 11,12

ST   D18S51: 13

ST   D21S11: 30

ST   D3S1358: 16

ST   D5S818: 13

ST   D7S820: 9,11

ST   D8S1179: 14,15

ST   FGA: 23

ST   Penta D: 9

ST   Penta E: 16,19

ST   TH01: 8

ST   TPOX: 9

ST   vWA: 17

DI   NCIt; C5250; Signet ring cell gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-668-5FU

AC   CVCL_L049

SY   SNU-668R-5-FU/4000

RX   PubMed=14734480;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).

DI   NCIt; C5250; Signet ring cell gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5081 ! SNU-668

SX   Male

CA   Cancer cell line

//

ID   SNU-668-CIS

AC   CVCL_L050

SY   SNU-668R-CIS/400

RX   PubMed=14734480;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

DI   NCIt; C5250; Signet ring cell gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5081 ! SNU-668

SX   Male

CA   Cancer cell line

//

ID   SNU-668-DOX

AC   CVCL_L051

SY   SNU-668R-DOX/50

RX   PubMed=14734480;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

DI   NCIt; C5250; Signet ring cell gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5081 ! SNU-668

SX   Male

CA   Cancer cell line

//

ID   SNU-682

AC   CVCL_5082

SY   SNU682

DR   KCLB; 00682

RX   PubMed=9219839;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 48 hours (PubMed=9219839).

CC   Transformant: NCBI_TaxID; 10586; Human papillomavirus type 33 (HPV33).

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 9,11

ST   D3S1358: 15,18

ST   D5S818: 9,12

ST   D7S820: 8,10

ST   FGA: 24

ST   TH01: 6,9

ST   TPOX: 11

ST   vWA: 16,17

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-685

AC   CVCL_5083

SY   SNU685; NCI-SNU-685

DR   CCLE; SNU685_ENDOMETRIUM

DR   GEO; GSM888726

DR   KCLB; 00685

RX   PubMed=9299262;

RX   PubMed=19956504;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 20 hours (PubMed=9299262).

CC   Omics: SNP array analysis.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 8

ST   D3S1358: 14

ST   D5S818: 12

ST   D7S820: 8,12

ST   FGA: 21

ST   TH01: 6,9.3

ST   TPOX: 9

ST   vWA: 17,19

DI   NCIt; C42700; Uterine carcinosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-70

AC   CVCL_5084

SY   SNU70

DR   Cosmic; 1322282

DR   GEO; GSM1448210

DR   KCLB; 00070

RX   PubMed=20176655;

RX   PubMed=25926053;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 118 hours (PubMed=20176655).

CC   Microsatellite instability: Stable (MSS) (PubMed=20176655).

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB; PubMed=20176655

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 8,12

ST   D16S539: 11

ST   D18S51: 13

ST   D19S433: 14

ST   D21S11: 31,32.2

ST   D2S1338: 18,19

ST   D3S1358: 15,16

ST   D5S818: 10,11

ST   D7S820: 8,11

ST   D8S1179: 12,14

ST   FGA: 21

ST   TH01: 7,9

ST   TPOX: 8,9

ST   vWA: 16,19

DI   NCIt; C9383; Rectal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-703

AC   CVCL_5085

SY   SNU703

DR   KCLB; 00703

RX   PubMed=9219839;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 48 hours (PubMed=9219839).

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 10,13

ST   D3S1358: 15,16

ST   D5S818: 11,12

ST   D7S820: 12,13

ST   FGA: 22,23

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 16

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-719

AC   CVCL_5086

SY   SNU719; NCI-SNU-719

DR   EFO; EFO_0006760

DR   BioSample; SAMN03473188

DR   CCLE; SNU719_STOMACH

DR   CGH-DB; 129-1

DR   CGH-DB; 9017-4

DR   Cosmic; 685594

DR   Cosmic; 848144

DR   Cosmic; 869512

DR   Cosmic; 921603

DR   Cosmic; 1090458

DR   Cosmic; 1294959

DR   Cosmic; 1528880

DR   GEO; GSM888727

DR   KCLB; 00719

RX   PubMed=9033653;

RX   PubMed=10812166;

RX   PubMed=15016554;

RX   PubMed=15723654;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=24807215;

RX   PubMed=25485619;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 10,11

ST   D16S539: 9,10

ST   D18S51: 13,15

ST   D21S11: 29,30

ST   D3S1358: 15

ST   D5S818: 11,12

ST   D7S820: 10,11

ST   D8S1179: 12

ST   FGA: 21,23

ST   Penta D: 10,11

ST   Penta E: 11,16

ST   TH01: 7,9

ST   TPOX: 8,9

ST   vWA: 16,18

DI   NCIt; C5473; Gastric tubular adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-719-5FU

AC   CVCL_L052

SY   SNU-719R-5-FU/600

RX   PubMed=14734480;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).

DI   NCIt; C5473; Gastric tubular adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5086 ! SNU-719

SX   Male

CA   Cancer cell line

//

ID   SNU-719-DOX

AC   CVCL_L053

SY   SNU-719R-DOX/100

RX   PubMed=14734480;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

DI   NCIt; C5473; Gastric tubular adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5086 ! SNU-719

SX   Male

CA   Cancer cell line

//

ID   SNU-738

AC   CVCL_5087

SY   SNU738; NCI-SNU-738

DR   CCLE; SNU738_CENTRAL_NERVOUS_SYSTEM

DR   GEO; GSM887638

DR   GEO; GSM888728

DR   KCLB; 00738

RX   PubMed=11776963;

RX   PubMed=19956504;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 56 hours (PubMed=11776963).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   Amelogenin: Y

ST   CSF1PO: 10

ST   D13S317: 8

ST   D3S1358: 16

ST   D5S818: 13

ST   FGA: 23

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C3288; Oligodendroglioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-739

AC   CVCL_5088

SY   SNU739

DR   GEO; GSM1374898

DR   KCLB; 00739

RX   PubMed=11819450;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 20 hours (PubMed=11819450).

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 8

ST   D3S1358: 15,17

ST   D5S818: 11,12

ST   D7S820: 9,11

ST   FGA: 24

ST   TH01: 7,9

ST   TPOX: 8,9

ST   vWA: 17

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-761

AC   CVCL_5089

SY   SNU761; NCI-SNU-761

DR   CCLE; SNU761_LIVER

DR   GEO; GSM887639

DR   GEO; GSM888729

DR   GEO; GSM1374899

DR   KCLB; 00761

RX   PubMed=11819450;

RX   PubMed=19956504;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 24 hours (PubMed=11819450).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 10

ST   D3S1358: 15,17

ST   D5S818: 9,12

ST   D7S820: 9

ST   FGA: 23,24

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 16

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-769A

AC   CVCL_5090

SY   SNU769A

DR   Cosmic; 738865

DR   Cosmic; 848828

RX   PubMed=10362137;

RX   PubMed=10674020;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 45 hours (PubMed=10362137).

CC   Microsatellite instability: Instable (MSI) (PubMed=10674020).

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5091 ! SNU-769B

SX   Male

CA   Cancer cell line

//

ID   SNU-769B

AC   CVCL_5091

SY   SNU769B

DR   Cosmic; 738854

DR   Cosmic; 848829

DR   GEO; GSM1448218

DR   KCLB; 00769B

RX   PubMed=10362137;

RX   PubMed=10674020;

RX   PubMed=19956504;

RX   PubMed=25926053;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 42 hours (PubMed=10362137).

CC   Microsatellite instability: Instable (MSI) (PubMed=10674020; PubMed=25926053).

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   CSF1PO: 11,14

ST   D13S317: 8,12

ST   D3S1358: 13,15

ST   TH01: 7,8

ST   TPOX: 8

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5090 ! SNU-769A

SX   Male

CA   Cancer cell line

//

ID   SNU-778

AC   CVCL_5092

SY   SNU778

DR   KCLB; 00778

RX   PubMed=9219839;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 48 hours (PubMed=9219839).

CC   Transformant: NCBI_TaxID; 10585; Human papillomavirus type 31 (HPV31).

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11

ST   D3S1358: 14,16

ST   D5S818: 10,12

ST   D7S820: 8,10

ST   FGA: 23.2

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 14,19

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-790

AC   CVCL_5093

SY   SNU790

DR   Cosmic; 1024886

DR   Cosmic; 1065285

DR   Cosmic; 1151968

DR   KCLB; 00790

RX   PubMed=17134824;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 33 hours (PubMed=17134824).

ST   Source(s): KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,13

ST   D13S317: 9,10

ST   D3S1358: 16,17

ST   D5S818: 10,12

ST   D7S820: 11,12

ST   FGA: 20,25

ST   TH01: 9

ST   TPOX: 8,9

ST   vWA: 17,18

DI   NCIt; C4035; Thyroid gland papillary carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-791

AC   CVCL_5094

SY   SNU791

RX   PubMed=11776963;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 60 hours (PubMed=11776963).

DI   NCIt; C3288; Oligodendroglioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-796

AC   CVCL_5095

SY   SNU796

DR   Cosmic; 1322285

DR   KCLB; 00796

RX   PubMed=20176655;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 121 hours (PubMed=20176655).

CC   Microsatellite instability: Stable (MSS) (PubMed=20176655).

ST   Source(s): KCLB; PubMed=20176655

ST   Amelogenin: X

ST   CSF1PO: 10,13

ST   D13S317: 8,11

ST   D16S539: 11,12

ST   D18S51: 13

ST   D19S433: 13,14

ST   D21S11: 29,30

ST   D2S1338: 18,23

ST   D3S1358: 15

ST   D5S818: 9,11

ST   D7S820: 10,13

ST   D8S1179: 10

ST   FGA: 22,23

ST   TH01: 7,9

ST   TPOX: 8

ST   vWA: 18

DI   NCIt; C9383; Rectal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-8

AC   CVCL_5096

SY   SNU8

DR   CCLE; SNU8_OVARY

DR   KCLB; 00008

RX   PubMed=9299249;

RX   PubMed=19956504;

RX   PubMed=23839242;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 44 hours (PubMed=9299249).

CC   Derived from metastatic site: Ascites.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 9,12

ST   D13S317: 8,9

ST   D3S1358: 14,16

ST   D5S818: 11,12

ST   D7S820: 8,12

ST   FGA: 20,26

ST   TH01: 7,9

ST   TPOX: 11

ST   vWA: 17

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-80

AC   CVCL_5097

SY   SNU80

DR   Cosmic; 1024884

DR   Cosmic; 1065283

DR   KCLB; 00080

RX   PubMed=17134824;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 37 hours (PubMed=17134824).

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8,10

ST   D3S1358: 15,16

ST   D5S818: 11,13

ST   D7S820: 12,13

ST   FGA: 20,23

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 16,19

DI   NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-81

AC   CVCL_5098

SY   SNU81; NCI-SNU-81

DR   CCLE; SNU81_LARGE_INTESTINE

DR   Cosmic; 738853

DR   Cosmic-CLP; 1660036

DR   GDSC; 1660036

DR   GEO; GSM888730

DR   GEO; GSM1448159

DR   GEO; GSM1670475

DR   KCLB; 00081

RX   PubMed=10362137;

RX   PubMed=10674020;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=25926053;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 30 hours (PubMed=10362137).

CC   Microsatellite instability: Stable (MSS) (PubMed=10674020; PubMed=25926053; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; KCLB

ST   Amelogenin: X (Cosmic-CLP)

ST   Amelogenin: X,Y (KCLB)

ST   CSF1PO: 11,13

ST   D13S317: 9,10

ST   D16S539: 9,12

ST   D3S1358: 15,16

ST   D5S818: 10,11

ST   D7S820: 12

ST   FGA: 19,25

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-817

AC   CVCL_5099

SY   SNU817; SNU-817BL; SNU-817EBV

DR   KCLB; 00817EBV

RX   PubMed=9542645;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

ST   Source(s): KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 13

ST   D13S317: 10

ST   D3S1358: 15,16

ST   D5S818: 10,12

ST   D7S820: 11,13

ST   FGA: 20,21

ST   TH01: 6,7

ST   TPOX: 9,11

ST   vWA: 12,17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SNU-840

AC   CVCL_5100

SY   SNU840; NCI-SNU-840

DR   CCLE; SNU840_OVARY

DR   GEO; GSM887640

DR   GEO; GSM888731

DR   KCLB; 00840

RX   PubMed=9299249;

RX   PubMed=10748297;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=23839242;

RX   PubMed=25984343;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 40 hours (PubMed=9299249); 36 hours (PubMed=25984343).

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 9,11

ST   D3S1358: 16

ST   D5S818: 11,12

ST   D7S820: 12

ST   FGA: 26,51.2

ST   TH01: 7,9

ST   TPOX: 9

ST   vWA: 14,17

DI   NCIt; C4270; Malignant ovarian Brenner tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-869

AC   CVCL_5101

SY   SNU869

DR   CCLE; SNU869_BILIARY_TRACT

DR   Cosmic; 738872

DR   KCLB; 00869

DR   PRIDE; PXD002657

RX   CelloPub=CLPUB00275;

RX   PubMed=12107841;

RX   PubMed=19956504;

RX   PubMed=26951071;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 48 hours (PubMed=12107841).

CC   Omics: Deep proteome analysis.

ST   Source(s): KCLB

ST   CSF1PO: 10

ST   D13S317: 12

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 8,11

ST   FGA: 23

ST   TH01: 7,9

ST   TPOX: 8,10

ST   vWA: 15

DI   NCIt; C6650; Ampulla of Vater adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SNU-878

AC   CVCL_5102

SY   SNU878; NCI-SNU-878

DR   CCLE; SNU878_LIVER

DR   GEO; GSM887641

DR   GEO; GSM888732

DR   GEO; GSM1374900

DR   KCLB; 00878

DR   PRIDE; PXD002486

RX   PubMed=11819450;

RX   PubMed=19956504;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 25 hours (PubMed=11819450).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 13

ST   D3S1358: 15

ST   D5S818: 9,12

ST   D7S820: 9,11

ST   FGA: 23,26

ST   TH01: 7

ST   TPOX: 11

ST   vWA: 16,17

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-886

AC   CVCL_5103

SY   SNU886; NCI-SNU-886

DR   CCLE; SNU886_LIVER

DR   GEO; GSM888733

DR   GEO; GSM1374901

DR   KCLB; 00886

RX   PubMed=11819450;

RX   PubMed=19956504;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 29 hours (PubMed=11819450).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 8,9

ST   D3S1358: 15,16

ST   D5S818: 11

ST   D7S820: 11,12

ST   FGA: 21,24

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 14,20

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-889

AC   CVCL_5104

SY   SNU889

RX   PubMed=9542645;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SNU-899

AC   CVCL_5105

SY   SNU899; NCI-SNU-899

DR   BTO; BTO:0005925

DR   CCLE; SNU899_UPPER_AERODIGESTIVE_TRACT

DR   Cosmic; 934175

DR   GEO; GSM887642

DR   GEO; GSM888734

DR   KCLB; 00899

RX   CelloPub=CLPUB00001;

RX   PubMed=10369293;

RX   PubMed=17923759;

RX   PubMed=19956504;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 48 hours (PubMed=10369293).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8

ST   D3S1358: 17

ST   D5S818: 11

ST   D7S820: 10,13

ST   FGA: 21

ST   TH01: 9,9.3

ST   TPOX: 8,11

ST   vWA: 14,18

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-9

AC   CVCL_5106

SY   SNU9

RX   PubMed=9542645;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SNU-902

AC   CVCL_5107

SY   SNU902

DR   KCLB; 00902

RX   PubMed=9219839;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 52 hours (PubMed=9219839).

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 10,12

ST   D3S1358: 16

ST   D5S818: 11

ST   D7S820: 10,11

ST   FGA: 22

ST   TH01: 9

ST   TPOX: 8,9

ST   vWA: 16,17

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-963

AC   CVCL_5108

SY   SNU963

DR   Cosmic; 1484498

RX   PubMed=21290211;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 149 hours (PubMed=21290211).

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-977

AC   CVCL_5109

SY   SNU977

DR   Cosmic; 1322286

DR   GEO; GSM1448211

DR   KCLB; 00977

RX   PubMed=20176655;

RX   PubMed=25926053;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 63 hours (PubMed=20176655).

CC   Microsatellite instability: Stable (MSS) (PubMed=20176655; PubMed=25926053).

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB; PubMed=20176655

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11,12

ST   D16S539: 10

ST   D18S51: 15

ST   D19S433: 13

ST   D3S1358: 16

ST   D21S11: 29

ST   D2S1338: 19,22

ST   D5S818: 11

ST   D7S820: 10,12

ST   D8S1179: 10

ST   FGA: 20

ST   TH01: 7

ST   TPOX: 11

ST   vWA: 16,18

DI   NCIt; C9383; Rectal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-99

AC   CVCL_5110

SY   SNU99

RX   PubMed=9542645;

RX   PubMed=19956504;

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SNU-C1

AC   CVCL_1708

SY   SNUC1; NCI-SNU-C1

DR   CLO; CLO_0009103

DR   EFO; EFO_0006761

DR   ATCC; CRL-5972

DR   BioSample; SAMN03472966

DR   CCLE; SNUC1_LARGE_INTESTINE

DR   ChEMBL-Cells; CHEMBL3308249

DR   ChEMBL-Targets; CHEMBL2366304

DR   Cosmic; 687539

DR   Cosmic; 910905

DR   Cosmic; 1187319

DR   Cosmic; 1995643

DR   Cosmic; 2302009

DR   Cosmic-CLP; 910905

DR   GDSC; 910905

DR   GEO; GSM844704

DR   GEO; GSM887643

DR   GEO; GSM888735

DR   GEO; GSM1346855

DR   GEO; GSM1448115

DR   GEO; GSM1670476

DR   KCLB; 0000C1

RX   PubMed=3479249;

RX   PubMed=8806092;

RX   PubMed=8806095;

RX   PubMed=19956504;

RX   PubMed=20606684;

RX   PubMed=22460905;

RX   PubMed=24755471;

RX   PubMed=25485619;

RX   PubMed=25926053;

RX   PubMed=25984343;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 31 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 9,11

ST   D16S539: 9,11

ST   D18S51: 16

ST   D21S11: 30

ST   D3S1358: 17

ST   D5S818: 10

ST   D7S820: 10,11

ST   D8S1179: 13,15

ST   FGA: 24

ST   Penta D: 9,10

ST   Penta E: 13,16

ST   TH01: 7,9

ST   TPOX: 11,12

ST   vWA: 16,18

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-C2A

AC   CVCL_1709

SY   SNUC2A; NCI-SNU-C2A; C2A

DR   CLO; CLO_0009104

DR   ATCC; CCL-250.1

DR   BioSample; SAMN03471382

DR   CCLE; SNUC2A_LARGE_INTESTINE

DR   Cosmic; 687540

DR   Cosmic; 848824

DR   GEO; GSM887644

DR   GEO; GSM888736

DR   GEO; GSM1448096

DR   KCLB; 0000C2A

RX   PubMed=3479249;

RX   PubMed=8806095;

RX   PubMed=10674020;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=25926053;

RX   PubMed=25984343;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Doubling time: 50 hours (PubMed=25984343).

CC   Microsatellite instability: Instable (MSI) (PubMed=10674020; PubMed=25926053).

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: Occasionally 'SUN-C2A'.

ST   Source(s): ATCC; KCLB

ST   Amelogenin: X

ST   CSF1PO: 11,14

ST   D13S317: 9,12

ST   D16S539: 8,9

ST   D3S1358: 13

ST   D5S818: 8,9

ST   D7S820: 13,16

ST   FGA: 20,22

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 15,19,20 (ATCC)

ST   vWA: 15,19 (KCLB)

DI   NCIt; C5543; Cecum adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1710 ! SNU-C2B

SX   Female

CA   Cancer cell line

//

ID   SNU-C2B

AC   CVCL_1710

SY   SNUC2B; NCI-SNU-C2B

DR   CLO; CLO_0009105

DR   ATCC; CCL-250

DR   BioSample; SAMN03471381

DR   ChEMBL-Cells; CHEMBL3308279

DR   ChEMBL-Targets; CHEMBL2366279

DR   Cosmic; 687541

DR   Cosmic; 909740

DR   Cosmic; 1218880

DR   Cosmic; 1312311

DR   Cosmic; 1479583

DR   Cosmic; 1995644

DR   Cosmic; 2302010

DR   Cosmic-CLP; 909740

DR   ECACC; 96020932

DR   GDSC; 909740

DR   GEO; GSM741262

DR   GEO; GSM1346856

DR   GEO; GSM1374902

DR   GEO; GSM1448087

DR   GEO; GSM1670477

DR   KCLB; 0000C2B

RX   PubMed=8806092;

RX   PubMed=19956504;

RX   PubMed=20606684;

RX   PubMed=24755471;

RX   PubMed=25926053;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Microsatellite instability: Instable (MSI-high) (PubMed=2592653; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; ECACC; KCLB

ST   Amelogenin: X

ST   CSF1PO: 11,13,14 (ATCC)

ST   CSF1PO: 11,14 (Cosmic-CLP; ECACC; KCLB)

ST   D13S317: 9,10,11 (ATCC; Cosmic-CLP)

ST   D13S317: 9,10 (ECACC; KCLB)

ST   D16S539: 8,9

ST   D3S1358: 13

ST   D5S818: 8,9

ST   D7S820: 13,16 (ATCC; Cosmic-CLP; KCLB)

ST   D7S820: 12,13 (ECACC)

ST   FGA: 20,23

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 15,18,19 (ATCC; Cosmic-CLP)

ST   vWA: 15,19 (ECACC)

ST   vWA: 15,18 (KCLB)

DI   NCIt; C5543; Cecum adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1709 ! SNU-C2A

SX   Female

CA   Cancer cell line

//

ID   SNU-C4

AC   CVCL_5111

SY   SNU C4; SNUC4; NCI-SNU-C4; C4

DR   CCLE; SNUC4_LARGE_INTESTINE

DR   ChEMBL-Cells; CHEMBL3307457

DR   ChEMBL-Targets; CHEMBL614933

DR   Cosmic; 848825

DR   Cosmic; 2302011

DR   GEO; GSM887645

DR   GEO; GSM888737

DR   GEO; GSM1448127

DR   KCLB; 0000C4

RX   PubMed=3479249;

RX   PubMed=8806092;

RX   PubMed=8806095;

RX   PubMed=10674020;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=24755471;

RX   PubMed=25926053;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Microsatellite instability: Instable (MSI) (PubMed=10674020; PubMed=25926053).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'SNU-4c' in ChEMBL CHEMBL614933 and CHEMBL3307457.

ST   Source(s): KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 8,9

ST   D3S1358: 16,20

ST   D5S818: 8,9

ST   D7S820: 8

ST   FGA: 20,21

ST   TH01: 7,9

ST   TPOX: 11

ST   vWA: 14,15

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SNU-C5

AC   CVCL_5112

SY   SNUC5; NCI-SNU-C5; SNU-C5/WT

DR   CCLE; SNUC5_LARGE_INTESTINE

DR   Cosmic-CLP; 1674021

DR   GDSC; 1674021

DR   GEO; GSM887646

DR   GEO; GSM888738

DR   GEO; GSM1448131

DR   GEO; GSM1670478

DR   KCLB; 0000C5

RX   PubMed=3479249;

RX   PubMed=8806092;

RX   PubMed=8806095;

RX   PubMed=19956504;

RX   PubMed=22460905;

RX   PubMed=25926053;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Seoul National University (SNU) cell line collection.

CC   Microsatellite instability: Instable (MSI-high) (PubMed=25926053; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; KCLB

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 8

ST   D16S539: 8,13

ST   D3S1358: 15

ST   D5S818: 11,12

ST   D7S820: 12 (Cosmic-CLP)

ST   D7S820: 12,13 (KCLB)

ST   FGA: 19,23

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 15

DI   NCIt; C5543; Cecum adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNU-C5/5FU-R

AC   CVCL_V482

RX   PubMed=17845510;

CC   Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).

DI   NCIt; C5543; Cecum adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5112 ! SNU-C5

SX   Female

CA   Cancer cell line

//

ID   SNU-C5/IRT-R

AC   CVCL_V483

RX   PubMed=17845510;

CC   Selected for resistance to: ChEBI; CHEBI:80630; Irinotecan (Camptothecin-11; CPT-11).

DI   NCIt; C5543; Cecum adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5112 ! SNU-C5

SX   Female

CA   Cancer cell line

//

ID   SNU-C5/OXT-R

AC   CVCL_V484

RX   PubMed=17845510;

CC   Selected for resistance to: ChEBI; CHEBI:31941; Oxaliplatin (Elotaxin; L-OHP).

DI   NCIt; C5543; Cecum adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5112 ! SNU-C5

SX   Female

CA   Cancer cell line

//

ID   SNU_MM1393_BM

AC   CVCL_IW63

RX   PubMed=25343143;

CC   Characteristics: IL6 dependent.

CC   Doubling time: ~48 hours (PubMed=25343143).

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IW64 ! SNU_MM1393_SC

SX   Male

CA   Cancer cell line

//

ID   SNU_MM1393_SC

AC   CVCL_IW64

RX   PubMed=25343143;

CC   Characteristics: IL6 independent.

CC   Doubling time: ~48 hours (PubMed=25343143).

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IW63 ! SNU_MM1393_BM

SX   Male

CA   Cancer cell line

//

ID   SNUCML-02

AC   CVCL_D773

DR   Cosmic; 1429043

RX   PubMed=20438801;

DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SNUhES1

AC   CVCL_9945

SY   SNUhES 1; Kor-hES16; SNUe001-A

DR   hPSCreg; SNUe001-A

DR   ISCR; 1402

RX   PubMed=15671144;

RX   PubMed=24159464;

CC   From: Seoul National University; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010003.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SNUhES10

AC   CVCL_B998

SY   SNUhES 10; Kor-hES21

RX   PubMed=24159464;

CC   From: Seoul National University; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010010.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SNUhES11

AC   CVCL_9946

SY   SNUhES 11; Kor-hES3; SNUe005-A

DR   hPSCreg; SNUe005-A

RX   PubMed=24159464;

CC   From: Seoul National University; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010011.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SNUhES12

AC   CVCL_B995

SY   SNUhES 12; Kor-hES22

RX   PubMed=24159464;

CC   From: Seoul National University; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010012.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SNUhES14

AC   CVCL_B996

SY   SNUhES 14; Kor-hES23

RX   PubMed=24159464;

CC   From: Seoul National University; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010013.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SNUhES16

AC   CVCL_9947

SY   SNUhES 16; Kor-hES4; SNUe006-A

DR   hPSCreg; SNUe006-A

RX   PubMed=24159464;

CC   From: Seoul National University; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010014.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SNUhES18

AC   CVCL_L116

SY   SNUhES 18; Kor-hES24

RX   PubMed=24159464;

CC   From: Seoul National University; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010025.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SNUhES19

AC   CVCL_B997

SY   SNUhES 19; Kor-hES25

RX   PubMed=24159464;

CC   From: Seoul National University; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010015.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SNUhES2

AC   CVCL_9948

SY   SNUhES 2; Kor-hES17; SNUe002-A

DR   hPSCreg; SNUe002-A

DR   ISCR; 1403

RX   PubMed=15671144;

RX   PubMed=24159464;

CC   From: Seoul National University; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010004.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SNUhES3

AC   CVCL_9949

SY   SNUhES 3; SNUhES#3; Kor-hES1; SNUe003-A

DR   hPSCreg; SNUe003-A

DR   ISCR; 1404

RX   PubMed=15671144;

RX   PubMed=24159464;

CC   From: Seoul National University; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010005.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SNUhES31

AC   CVCL_L117

SY   SNUhES 31; Kor-hES26

RX   PubMed=24159464;

CC   From: Seoul National University; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010037.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SNUhES32

AC   CVCL_L118

SY   SNUhES 32; Kor-hES27

RX   PubMed=24159464;

CC   From: Seoul National University; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010051.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SNUhES33

AC   CVCL_L119

SY   SNUhES 33; Kor-hES50

CC   From: Seoul National University; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12011001.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SNUhES34

AC   CVCL_L120

SY   SNUhES 34; Kor-hES51

CC   From: Seoul National University; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12011002.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SNUhES35

AC   CVCL_L121

SY   SNUhES 35; Kor-hES52

CC   From: Seoul National University; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12011003.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SNUhES36

AC   CVCL_Y990

CC   From: Seoul National University; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012009.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   SNUhES37

AC   CVCL_L122

SY   SNUhES 37; Kor-hES53

CC   From: Seoul National University; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12011004.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SNUhES38

AC   CVCL_L123

SY   SNUhES 38; Kor-hES54

CC   From: Seoul National University; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12011005.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SNUhES39

AC   CVCL_Y991

CC   From: Seoul National University; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12014001.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SNUhES4

AC   CVCL_9950

SY   SNUhES 4; SNUhES-4; Kor-hES2; SNUe004-A

DR   hPSCreg; SNUe004-A

DR   ISCR; 1921

RX   PubMed=24159464;

CC   From: Seoul National University; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010006.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SNUhES40

AC   CVCL_Y992

CC   From: Seoul National University; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12014002.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SNUhES41

AC   CVCL_IS20

CC   From: Seoul National University; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12014003.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SNUhES42

AC   CVCL_IS10

CC   From: Seoul National University; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12015001.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   SNUhES43

AC   CVCL_IS11

CC   From: Seoul National University; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12015002.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SNUhES44

AC   CVCL_IS12

CC   From: Seoul National University; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12016005.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SNUhES5

AC   CVCL_B999

SY   SNUhES 5; Kor-hES18

RX   PubMed=24159464;

CC   From: Seoul National University; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010007.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SNUhES6

AC   CVCL_C000

SY   SNUhES 6; Kor-hES19

RX   PubMed=24159464;

CC   From: Seoul National University; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010008.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SNUhES7

AC   CVCL_C001

SY   SNUhES 7; Kor-hES20

RX   PubMed=24159464;

CC   From: Seoul National University; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010009.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   SNUOT-Rb1

AC   CVCL_6210

SY   SNUOT-RB1

DR   BTO; BTO:0003759

RX   PubMed=17671685;

RX   PubMed=18799932;

CC   Doubling time: 24 hours (PubMed=17671685).

CC   Omics: Array-based CGH.

DI   NCIt; C7541; Retinoblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SNUOT-Rb4

AC   CVCL_IQ57

SY   SNUOT-RB4

RX   PubMed=18799932;

CC   Omics: Array-based CGH.

DI   NCIt; C7541; Retinoblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SO-MI

AC   CVCL_4764

RX   PubMed=12772193;

WW   http://capcelllines.ca/details.asp?id=161

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SO-Rb50

AC   CVCL_D543

SY   SO-RB50; So-Rb50; SO-Rb 50

RX   CelloPub=CLPUB00236;

RX   PubMed=2086157;

RX   PubMed=8253182;

RX   PubMed=9639853;

RX   PubMed=11877168;

CC   Doubling time: 44.32 hours (CelloPub=CLPUB00236).

DI   NCIt; C7541; Retinoblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SO-Rb50/CBP

AC   CVCL_0U08

RX   CelloPub=CLPUB00236;

CC   Doubling time: 50.9 hours (CelloPub=CLPUB00236).

CC   Selected for resistance to: ChEBI; CHEBI:31355; Carboplatin (CBP; Paraplatin).

DI   NCIt; C7541; Retinoblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D543 ! SO-Rb50

SX   Female

CA   Cancer cell line

//

ID   SO-Rb70

AC   CVCL_W459

RX   PubMed=9639853;

RX   PubMed=11877168;

RX   PubMed=12580037;

DI   NCIt; C7541; Retinoblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SOB-15

AC   CVCL_6447

DR   BTO; BTO:0005474

DR   CLO; CLO_0009106

DR   ATCC; CRL-2301

RX   PubMed=7543343;

CC   Group: Fish cell line.

CC   Breed/subspecies: Shasta.

OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SOCS3-/- ESC

AC   CVCL_AW04

SY   SOCS-3-Null ES Cells

RX   PubMed=16123385;

CC   Knockout cell: Method=KO mouse; MGI; MGI:1201791; Socs3.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Embryonic stem cell

//

ID   SODk1

AC   CVCL_6448

SY   SODK1; SODK1293

DR   CLO; CLO_0009107

DR   ATCC; CRL-12386

RX   PubMed=9847362;

CC   Group: Retrovirus packaging cell line.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

CC   Discontinued: ATCC; CRL-12386; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 12,14

ST   D16S539: 9

ST   D5S818: 8,9

ST   D7S820: 11,12

ST   TH01: 7,9.3

ST   TPOX: 11

ST   vWA: 16,19

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   SOE00363IN

AC   CVCL_E206

WW   http://www.biologia.uniba.it/primates/cell_lines.html

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9490; ! Saguinus oedipus

SX   Female

CA   Transformed cell line

//

ID   SOE00364IN

AC   CVCL_E207

WW   http://www.biologia.uniba.it/primates/cell_lines.html

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9490; ! Saguinus oedipus

SX   Male

CA   Transformed cell line

//

ID   SOE00365IN

AC   CVCL_E208

WW   http://www.biologia.uniba.it/primates/cell_lines.html

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9490; ! Saguinus oedipus

SX   Male

CA   Transformed cell line

//

ID   SOE00366IN

AC   CVCL_E209

WW   http://www.biologia.uniba.it/primates/cell_lines.html

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9490; ! Saguinus oedipus

SX   Male

CA   Transformed cell line

//

ID   SOE00367IN

AC   CVCL_E210

WW   http://www.biologia.uniba.it/primates/cell_lines.html

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9490; ! Saguinus oedipus

SX   Male

CA   Transformed cell line

//

ID   SOE00368IN

AC   CVCL_E211

WW   http://www.biologia.uniba.it/primates/cell_lines.html

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9490; ! Saguinus oedipus

SX   Female

CA   Transformed cell line

//

ID   Sog9

AC   CVCL_D242

SY   sog9

DR   CCLV; CCLV-RIE 0297

RX   PubMed=7745676;

CC   Breed/subspecies: C3H/An.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_D241 ! Gro2C

SX   Male

CA   Spontaneously immortalized cell line

//

ID   SOgE

AC   CVCL_Y592

RX   PubMed=12124462;

RX   PubMed=25903999;

CC   Group: Bird cell line.

CC   Group: Vaccine production cell line.

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

OX   NCBI_TaxID=93934; ! Coturnix coturnix japonica

HI   CVCL_3450 ! QM7

CA   Cancer cell line

//

ID   SOJ

AC   CVCL_B464

RX   PubMed=2083222;

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SOJ-6

AC   CVCL_B465

RX   PubMed=2083222;

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B464 ! SOJ

CA   Cancer cell line

//

ID   SOL,CA

AC   CVCL_E832

SY   SOL, CA

DR   dbMHC; 49023

DR   ECACC; 94082252

DR   IHW; IHW9152

DR   IMGT/HLA; 11695

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl152.html

CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   Sol8

AC   CVCL_6449

SY   Soleus clone 8

DR   CLO; CLO_0009108

DR   ATCC; CRL-2174

DR   BCRC; 60512

RX   PubMed=2456580;

RX   PubMed=2894633;

RX   PubMed=11162846;

CC   Breed/subspecies: C3H.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Finite cell line

//

ID   SOM-4D10

AC   CVCL_2198

DR   CLO; CLO_0009109

DR   DSMZ; ACC-480

CC   Doubling time: ~20-30 hours (DSMZ).

CC   Monoclonal antibody target: UniProtKB; P02786; Human TFRC/CD71.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   SOSP-9607

AC   CVCL_4V80

RX   PubMed=20016965;

RX   PubMed=25017716;

CC   Doubling time: 29.79 +- 0.57 hours (PubMed=25017716).

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SOSP-9607/CDDP

AC   CVCL_4V81

RX   PubMed=25017716;

CC   Doubling time: 45.11 +- 2.37 hours (PubMed=25017716).

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4V80 ! SOSP-9607

SX   Male

CA   Cancer cell line

//

ID   SOSP-9607/F4

AC   CVCL_4V82

SY   F4

RX   PubMed=20016965;

CC   Doubling time: 31 +- 3 hours (PubMed=20016965).

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4V80 ! SOSP-9607

SX   Male

CA   Cancer cell line

//

ID   SOSP-9607/F5M2

AC   CVCL_4V83

SY   F5M2

RX   PubMed=20016965;

CC   Doubling time: 20 +- 2 hours (PubMed=20016965).

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4V80 ! SOSP-9607

SX   Male

CA   Cancer cell line

//

ID   SP+

AC   CVCL_1Y11

SY   SP (HTLV)

DR   NIH-ARP; 3059-159

RX   PubMed=7564472;

CC   Characteristics: HTLV-1 producing cell line.

CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SP-1

AC   CVCL_R987

SY   Silver Perch-1

RX   PubMed=407147;

CC   Group: Fish cell line.

OX   NCBI_TaxID=331523; ! Bairdiella chrysoura

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SP-2

AC   CVCL_R988

SY   Silver Perch-2

RX   DOI=10.1007/BF02618106;

CC   Group: Fish cell line.

OX   NCBI_TaxID=331523; ! Bairdiella chrysoura

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SP-49

AC   CVCL_D022

SY   Sp-49; SP49

DR   Cosmic; 1070709

DR   Cosmic; 2296991

DR   GEO; GSM115806

RX   PubMed=3121553;

RX   PubMed=9738977;

RX   PubMed=16960149;

RX   PubMed=19358282;

DI   NCIt; C4337; Mantle cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C121 ! SP-50B

OI   CVCL_M655 ! SP-52EB

OI   CVCL_C122 ! SP-53

SX   Female

CA   Cancer cell line

//

ID   SP-50B

AC   CVCL_C121

RX   PubMed=2548699;

RX   PubMed=8971032;

DI   NCIt; C4337; Mantle cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_D022 ! SP-49

OI   CVCL_M655 ! SP-52EB

OI   CVCL_C122 ! SP-53

SX   Female

CA   Cancer cell line

//

ID   SP-52EB

AC   CVCL_M655

RX   PubMed=2548699;

RX   PubMed=8971032;

RX   PubMed=9738977;

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_D022 ! SP-49

OI   CVCL_C121 ! SP-50B

OI   CVCL_C122 ! SP-53

SX   Female

CA   Transformed cell line

//

ID   SP-53

AC   CVCL_C122

SY   SP53

DR   Cosmic; 1070710

DR   Cosmic; 2296998

DR   GEO; GSM119539

RX   PubMed=2548699;

RX   PubMed=8971032;

RX   PubMed=9738977;

RX   PubMed=12683869;

RX   PubMed=16960149;

DI   NCIt; C4337; Mantle cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_D022 ! SP-49

OI   CVCL_C121 ! SP-50B

OI   CVCL_M655 ! SP-52EB

SX   Female

CA   Cancer cell line

//

ID   SP-6.5

AC   CVCL_7997

SY   SP 6.5; SP6.5; SP6_5

DR   BTO; BTO:0002737

DR   Cosmic; 986620

DR   Cosmic; 1628411

RX   PubMed=9154388;

RX   PubMed=10892885;

RX   PubMed=15645125;

RX   PubMed=15714118;

RX   PubMed=17487557;

RX   PubMed=22236444;

CC   Omics: Transcriptome analysis.

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SP-8.0

AC   CVCL_W928

SY   SP8.0

RX   PubMed=10892885;

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Sp-E-HNU11

AC   CVCL_0A19

RX   DOI=10.16380/j.kcxb.2011.05.007;

CC   Group: Insect cell line.

CC   Doubling time: 42 hours (DOI=10.16380/j.kcxb.2011.05.007).

OX   NCBI_TaxID=7386; ! Sarcophaga peregrina

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SP-R

AC   CVCL_0I80

DR   CCLV; CCLV-RIE 0279

OX   NCBI_TaxID=9940; ! Ovis aries

CA   Spontaneously immortalized cell line

//

ID   SP02#1

AC   CVCL_V201

SY   ESi001-A

DR   BioSamples; SAMEA3302942

DR   hPSCreg; ESi001-A

DR   ISCR; 2237

WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/pdf_SP_2_1.pdf

CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   SP08#1

AC   CVCL_V202

SY   ESi002-A

DR   BioSamples; SAMEA3303008

DR   hPSCreg; ESi002-A

DR   ISCR; 2238

WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/pdf_SP_8_1.pdf

CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   SP1

AC   CVCL_AZ65

SY   SPI

RX   PubMed=1317363;

RX   PubMed=3191495;

CC   Breed/subspecies: CBA/J.

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Cancer cell line

//

ID   SP1-3M

AC   CVCL_AZ66

RX   PubMed=1317363;

CC   Caution: Could be identical to AC2M2 (CVCL_AZ67).

CC   Breed/subspecies: CBA/J.

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_AZ65 ! SP1

SX   Female

CA   Cancer cell line

//

ID   SP13#4

AC   CVCL_V203

SY   ESi006-A

DR   BioSamples; SAMEA3303225

DR   hPSCreg; ESi006-A

DR   ISCR; 2239

WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/pdf_SP_13_4.pdf

CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   Sp1K

AC   CVCL_4304

SY   Sp1K (NBL-10); Sp 1 K (NBL-10); Sp 1 K; Sp1.K; NBL-10

DR   CLO; CLO_0009110

DR   CLDB; cl4380

DR   ATCC; CCL-78

DR   ATCC; CRL-6262

DR   ECACC; 89120705

CC   Group: Cetacean cell line.

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CCL-78; true.

CC   Discontinued: ATCC; CRL-6262; true.

CC   Discontinued: ECACC; 89120705; probable.

OX   NCBI_TaxID=103590; ! Stenella frontalis

SX   Male

CA   Finite cell line

//

ID   Sp2ab

AC   CVCL_Z067

SY   SP2ab

RX   PubMed=19187782;

WW   http://www.enzolifesciences.com/ENZ-70008/sp2ab-myeloma-fusion-partner/

CC   Group: Hybridoma fusion partner cell line.

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C125417; Mouse plasma cell myeloma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

SX   Female

CA   Cancer cell line

//

ID   Sp2/0-Ag14

AC   CVCL_2199

SY   SP2/0-Ag14; SP2/0-AG14; SP2/0-ag14; Sp2/O-Ag14; SP2/O-Ag14; Sp2/0-Ag-14; SP2-0-Ag14; SP2/0 Ag-14; SP-2/0-AG14; Sp 2/0-Ag 14; Sp2/0; SP2/0; Sp2/O; SP2/O; SP-2; SP2; GM03569; GM03569B; GM3569

DR   BTO; BTO:0002291

DR   CLO; CLO_0009112

DR   CLO; CLO_0009113

DR   CLO; CLO_0009114

DR   CLO; CLO_0009115

DR   CLO; CLO_0017241

DR   CLO; CLO_0050178

DR   CLDB; cl4382

DR   CLDB; cl4383

DR   CLDB; cl4384

DR   CLDB; cl4385

DR   CLDB; cl4386

DR   ATCC; CRL-1581

DR   ATCC; CRL-8287

DR   BCRC; 60034

DR   BCRJ; 0227

DR   CCRID; 3111C0001CCC000054

DR   CCRID; 3111C0002000000011

DR   CCRID; 3131C0001000800018

DR   CCRID; 3142C0001000000019

DR   CCRID; 3153C0001000000025

DR   CLS; 400481/p756_Sp20-Ag14

DR   Coriell; GM03569

DR   DSMZ; ACC-146

DR   ECACC; 08060101

DR   ECACC; 85072401

DR   JCRB; JCRB9084

DR   KCB; KCB 92021YJ

DR   KCLB; 21581

DR   NCBI_Iran; C129

DR   RCB; RCB0209

DR   TKG; TKG 0248

RX   PubMed=714156;

CC   Group: Hybridoma fusion partner cell line.

CC   Doubling time: ~30-40 hours (DSMZ).

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C125417; Mouse plasma cell myeloma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3411 ! P3X63Ag8

SX   Female

CA   Cancer cell line

//

ID   Sp2/0-Ag14-Turbodoma

AC   CVCL_G697

DR   ECACC; 03092501

CC   Group: Hybridoma fusion partner cell line.

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C125417; Mouse plasma cell myeloma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

SX   Female

CA   Cancer cell line

//

ID   Sp2/01-Ag

AC   CVCL_6450

DR   CLO; CLO_0009111

DR   ATCC; CRL-8006

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Hybridoma

//

ID   Sp2/08A2

AC   CVCL_J171

SY   SP2/08A2; Sp2/08AZ; SP2/08AZ

CC   Group: Hybridoma fusion partner cell line.

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C125417; Mouse plasma cell myeloma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

SX   Female

CA   Cancer cell line

//

ID   Sp2/5

AC   CVCL_D037

CC   Group: Hybridoma fusion partner cell line.

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C125417; Mouse plasma cell myeloma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

SX   Female

CA   Cancer cell line

//

ID   Sp2/mIL-6

AC   CVCL_C561

DR   CLO; CLO_0009116

DR   ATCC; CRL-2016

CC   Group: Hybridoma fusion partner cell line.

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Transfected with: MGI; MGI:96559; Il6.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C125417; Mouse plasma cell myeloma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

SX   Female

CA   Cancer cell line


您正在向 biovector.net  发送关于产品 细胞株Cell Lines 87及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net 的询问

点击“立即发送”后,我们将在1个工作日内与您取得联系。